Genetically Engineered Food Edited by Knut J. Heller
Related Titles
Wink, Michael (Ed.)
Ahmet E. Yousef, Carolyn Ca...
57 downloads
1469 Views
5MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Genetically Engineered Food Edited by Knut J. Heller
Related Titles
Wink, Michael (Ed.)
Ahmet E. Yousef, Carolyn Carstrom
An Introduction to Molecular Biotechnology
A Laboratory Manual
Molecular Fundamentals, Methods and Applications in Modern Biotechnology
Food Microbiology 2003 ISBN 0-471-39105-0
2006 ISBN 3-527-31412-1
Nakai, S., Modler, H. W. (eds.) The World Life Sciences Forum (Eds.)
Health for All? – Agriculture and Nutrition – Bioindustry and Environment
Food Proteins Processing Applications 2000 ISBN 0-471-29785-2
Analyses and Recommendations 2005 ISBN 3-527-31489-X
Sharma, S. K., Mulvaney, S. J., Rizvi, S. S. H.
Food Process Engineering Theory and Laboratory Experiments
Fischer, R., Schillberg, S. (eds.)
Molecular Farming Plant-made Pharmaceuticals and Technical Proteins 2004 ISBN 3-527-30786-9
2000 ISBN 0-471-32241-5
Genetically Engineered Food Methods and Detection Second, Updated and Enlarged Edition
Edited by Knut J. Heller
Editor
Prof. Dr. Knut J. Heller Institut für Mikrobiologie Bundesanstalt Milchforschung Hermann-Weigmann-Str. 1 24103 Kiel Germany 1st Edition 2003 1st Reprint 2004 2nd Edition 2006
All books published by Wiley-VCH are carefully produced. Nevertheless, authors, editors, and publisher do not warrant the information contained in these books, including this book, to be free of errors. Readers are advised to keep in mind that statements, data, illustrations, procedural details or other items may inadvertently be inaccurate. Library of Congress Card No.: applied for British Library Cataloguing-in-Publication Data A catalogue record for this book is available from the British Library. Bibliographic information published by the Deutsche Nationalbibliothek The Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data are available in the Internet at http://dnb.d-nb.de. © 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim All rights reserved (including those of translation into other languages). No part of this book may be reproduced in any form – by photoprinting, microfilm, or any other means – nor transmitted or translated into a machine language without written permission from the publishers. Registered names, trademarks, etc. used in this book, even when not specifically marked as such, are not to be considered unprotected by law. Printed in the Federal Republic of Germany Printed on acid-free paper
Composition Hagedorn Kommunikation, Viernheim Printing Strauss GmbH, Mörlenbach Bookbinding Litges & Dopf Buchbinderei GmbH, Heppenheim ISBN-13: 978-3-527-31393-8 ISBN-10: 3-527-31393-1
Contents Preface
XIII
List of Contributors
XV
Part I
Application and Perspectives 1
1
Transgenic Modification of Production Traits in Farm Animals 3 Gottfried Brem and Mathias Müller Introduction 3 The Creation of Transgenic Animals 4 Pronuclear DNA Microinjection 4 Retroviral Vectors 5 Pluripotent Stem-cell Technology 6 Nuclear Transfer Using Transgenic Cells 6 Gene Transfer in Poultry 7 Gene Transfer in Fish 8 Transgenes – Gene Constructs 8 Transgenic Animals with Agricultural Traits 11 Improved Growth Rate, Carcass Composition, and Feed Efficiency 11 Transgenic Mammalian Farm Animals 11 Transgenic Fish 13 Alteration of the Composition of Milk 14 Improved Animal Health 16 Additive Gene Transfer of Resistance Genes 17 Gene Targeting of Susceptibility Genes 18 Improved Biochemical Pathways 19 Improved Wool Production 19 Transgenic Farm Animals, Biosafety Issues, Animal Welfare, and Ethics 20 Conclusion 21 References 22
1.1 1.2 1.2.1 1.2.2 1.2.3 1.2.4 1.3 1.4 1.5 1.6 1.7 1.7.1 1.7.2 1.8 1.9 1.9.1 1.9.2 1.10 1.11 1.12 1.13
VI
Contents
2 2.1 2.1.1 2.1.1.1 2.1.1.2 2.1.2 2.1.3 2.1.3.1 2.1.3.2 2.1.3.3 2.2 2.2.1 2.2.2 2.2.3 2.3 2.3.1 2.3.1.1 2.3.1.2 2.3.1.3 2.3.1.4 2.3.2 2.3.2.1 2.3.2.2 2.3.2.3 2.3.2.4 2.3.2.5 2.3.2.6 2.3.2.7 2.3.3 2.3.3.1 2.3.3.2 2.3.4 2.3.4.1 2.3.4.2 2.4
Genetically Modified Plants 27 Susanne Stirn and Horst Lörz Methods for Establishing Genetically Modified Plants 27 Transformation Methods 27 Agrobacterium Transformation 27 Direct Gene Transfer 28 Tissue Requirements 29 Molecular Requirements 29 Promoter 29 Codon Usage 30 Selectable Marker and Reporter Genes 30 GM Plants Already on the Market (EU, USA, Canada, Japan) 32 Herbicide Resistance in Soybean, Maize, Oil-seed rape, Sugar Beet, Wheat, Rice, and Cotton 34 Insect Resistance in Maize, Potatoes, Tomatoes, and Cotton 34 Virus-resistance, Male Sterility, Delayed Fruit Ripening, and Fatty Acid Content of GMPs 36 GM Plants “In the Pipeline” 41 Input Traits 41 Insect Resistance 41 Virus, Fungal, Bacterial, and Nematode Resistance 42 Tolerance Against Abiotic Stress 45 Improved Agronomic Properties 47 Traits Affecting Food Quality for Human Nutrition 48 Increased Vitamin Content 48 Production of Very-long-chain Polyunsaturated Fatty Acids 49 Increased Iron Level 49 Improved Amino Acid Composition 49 Reduction in the Amount of Antinutritive Factors 50 Production of “Low-calorie Sugar” 50 Seedless Fruits and Vegetables 50 Traits that Affect Processing 51 Altered Gluten Level in Wheat to Change Baking Quality 51 Altered Grain Composition in Barley to Improve Malting Quality 51 Traits of Pharmaceutical Interest 52 Production of Vaccines 52 Production of Pharmaceuticals 53 Outlook 54 References 55
Contents
3
3.1 3.1.1 3.1.2 3.2 3.2.1 3.2.2 3.2.2.1 3.2.2.2 3.2.2.3 3.2.2.4 3.2.3 3.3 3.3.1 3.3.1.1 3.3.1.2 3.3.1.3 3.3.2 3.3.3 3.3.3.1 3.3.3.2 3.3.3.3 3.3.3.4 3.4
4 4.1 4.2 4.3 4.4
Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi 64 Rena Leisegang, Elke Nevoigt, Anja Spielvogel, Georg Kristan, Anke Niederhaus and Ulf Stahl Introduction 64 Why do we Ferment Foodstuffs? 64 Fermented Foods of Plant and Animal Origin 65 Yeast 67 Methods of Recombinant DNA Technology in Yeast 67 Genetically Modified Saccharomyces Strains 72 Beer 73 Wine 75 Sake 76 Bread 76 Genetically Modified Non-Saccharomyces Strains 77 Filamentous Fungi 78 Recombinant DNA Technology in Filamentous Fungi 78 Strategies used to Transform Filamentous Fungi 78 Selection Systems 79 The Fate of the Transforming DNA 80 Application of RNA-based Methods for Strain Improvement 81 Industrial Filamentous Fungi 82 Fungi Used for Fermentation of Plant Material 82 Fungal Oils and Other Metabolites 83 Fungal Proteins and Enzymes 83 Fungi as Single-cell Protein (SCP) 84 Prospects 85 Acknowledgements 85 References 86 Production of Food Additives Using Filamentous Fungi 95 Carsten M. Hjort Filamentous Fungi in Food Production 95 Additives for the Food Industry 98 Design of Genetically Modified Microorganisms for Production of Food Additives and Processing Aids 98 Industrial Enzyme Production Processes 105 References 107
VII
VIII
Contents
5 5.1 5.2 5.2.1 5.2.2 5.2.3 5.2.4 5.2.5 5.2.6 5.3 5.3.1 5.3.2 5.3.3 5.3.4 5.3.5 5.3.6 5.4 5.4.1 5.4.2 5.5
Genetic Engineering of Bacteria Used in Food Fermentation 109 Arnold Geis Introduction 109 Lactic Acid Bacteria 110 Lactococcus lactis subsp. lactis and subsp. cremoris 110 Lactobacillus spp. 111 Streptococcus thermophilus 113 Leuconastoc spp. 113 Pediococcus spp. 114 Oenococcus spp. 114 Perspectives and Objectives 115 Bioconservation 115 Bacteriophage Resistance 116 Exopolysaccharides 118 Proteolysis 119 Metabolic Engineering of Lactic Acid Bacteria 120 Stress Responses in Lactic Acid Bacteria 121 Methods 122 Transformation 122 Gene Delivery and Expression Systems 122 Conclusions 124 References 124
Part II
Legislation in Europe 133
6
The Legal Situation for Genetically Engineered Food in Europe 135 Rudolf Steinz and Jan Kalbheim Introduction 135 The Need for Regulation 135 The History of the Regulation of Genetically Modified Food 135 The Law Applicable to Genetically Modified Food 137 The Genetically Modified Food and Feed Regulation 137 Introduction 137 Scope of Application 138 Requirements for Genetically Modified Food and Feed 138 Procedure 138 Labeling 141 Other Questions 144 Problems 145 Negative Labeling 145 Coexistence of Genetically Modified Food and Feed and Conventional or Organic Food and Feed 145 Compliance with World Trade Law 147 Competent Authorities in the Member States 147
6.1 6.1.1 6.1.2 6.2 6.2.1 6.2.1.1 6.2.1.2 6.2.1.3 6.2.1.4 6.2.1.5 6.2.1.6 6.2.2 6.2.2.1 6.2.2.2 6.2.2.3 6.2.3
Contents
6.2.4 6.2.5
6.2.5.1 6.2.5.2 6.2.5.3 6.2.5.4
Relation to Directive 2001/18/EC of the EP and the Council 148 Supplementary National Provisions in German Law: The ECBI Act, the Biotechnology Act, and the Novel Foods and Food Ingredients Instrument 148 General Rules for Genetically Modified Food and Feed 148 Availability of Negative Labeling of Foodstuffs Made Without Using Procedures of Genetic Engineering 149 The Element of the Label 150 Rules on Criminal Offences and Misdemeanors 151 References 151
Part III Methods of Detection 155 7 7.1 7.2 7.3 7.4 8 8.1 8.2 8.2.1 8.2.2 8.3 8.3.1 8.4 8.4.1 8.4.2 8.4.3 8.5 8.5.1 8.5.2 8.5.3 8.5.4 8.5.5 8.5.6 8.5.7 8.6
Detection of Genetic Modifications – Some Basic Considerations 157 Knut J. Heller The Conversion of Genetic Information from DNA to Phenotypes 157 DNA, Protein, and Phenotypes as Targets for Detection Assays 158 Food-grade Modifications 161 Detection of Unknown Modifications 162 DNA-based Methods for Detection of Genetic Modifications 163 Ralf Einspanier Introduction 163 Recent DNA Methodology 164 Sampling Procedure 165 Extraction and Purification of DNA 165 Specific Detection of Genetic Material 166 DNA Hybridization-based Detection Technique (Southern Blot) 166 Nucleic Acid Amplification Methods using PCR 167 Conventional PCR 167 Real-time PCR 169 Important Bioinformatic Considerations 172 Alternative and Promising DNA Detection Techniques 173 Thermal Cycling Procedures 173 Isothermic Amplification 173 DNA Microarrays 174 Microfluidic and Nanoparticle Techniques 174 Mass Spectrometry (MS) of DNA 176 Supplementary Photon-driven Monitoring Methods 176 Novel Biological Monitoring Approaches 177 Conclusions and Future Prospects for GMO Detection by DNA Analysis 178 References 180
IX
X
Contents
9 9.1 9.2 9.2.1 9.2.2 9.2.3 9.3 9.3.1 9.3.2 9.3.3 9.3.4 9.3.5 9.4 9.5 9.5.1 9.5.2
10 10.1 10.2 10.2.1 10.2.2 10.2.3 10.3 10.3.1 10.3.2 10.3.3 10.3.4 10.3.5 10.3.6 10.4
11
11.1 11.2 11.3 11.3.1 11.3.2
Genetic Engineering of Fish, and Methods of Detection 186 Hartmut Rehbein Introduction 186 Development and Production of Transgenic Fish 187 Structure of Gene Cassettes 189 Methods of Gene Transfer 189 Evidence of Gene Transfer and Expression 192 Examples of Successful Production of Transgenic Fish 193 Atlantic Salmon 193 Pacific Salmon 194 Tilapia (O. hornorum hybrid) 194 Tilapia (O. niloticum) 195 Carp (C. carpio) 195 Methods of Detecting Processed Transgenic Fish 196 Food Safety of Transgenic Fish 196 The Gene Product 197 Pleiotropic Effects 198 References 198 Detection Methods for Genetically Modified Crops Rolf Meyer Introduction 201 Isolation of plant DNA 202 Sampling 202 Sample Preparation 203 DNA Extraction and Analysis 204 Detection Strategies 205 Screening 206 Specific Detection 208 Example of Qualitative Detection 210 Quantification 210 Verification 211 Validation 212 Outlook, Conclusions 216 References 216
201
Methods for Detection of Genetically Modified Organisms in Composite and Processed Foods 219 Karl-Heinz Engel, Francisco Moreano, and Alexandra Ehlert Introduction 219 Challenges Specific to the Detection of GMO in Composite and Processed Foods 220 Degradation of Proteins and DNA 221 Proteins 221 DNA 222
Contents
11.4 11.4.1 11.4.2 11.4.2.1 11.4.2.2 11.4.2.3 11.4.2.4 11.5
Analytical Methods 224 Protein-based Methods 224 DNA-based Methods 224 Qualitative PCR 225 Quantitative PCR 230 Competitive PCR 231 Real-time PCR 233 Conclusions 239 References 240
12
Mutations in Lactococcus lactis and their Detection 248 Jan Kok and Bertus van den Burg Summary 248 Introduction 248 The Composition of the Genome of Lactococcus lactis 249 Flexibility in the Genome of Lactococcus lactis 250 Conjugation 250 Transduction 251 Transformation 252 IS Elements and Transposons 252 Lactococcal Phages as Sources of Genetic Plasticity 253 An Example of Natural Genetic Flexibility: The L. lactis NCDO712 Family 254 Mutations in Lactococcus lactis as a Consequence of Environmental Factors and DNA Metabolism 254 Methods of Mutating the Genome of L. lactis 255 Genetic Engineering of Lactococcus lactis 256 Strategies for Detection of Genetically Modified Lactococcus lactis 259 Sample Preparation 259 DNA-based Procedures 260 Southern Hybridization 260 PCR 260 Qualitative PCR 261 Quantitative PCR (End-point and Real-time) 261 Exhaustive Limiting Dilution PCR 262 Nucleotide Sequence-based Procedures 262 Microarrays 262 Protein-based Procedures 263 Western Hybridization 263 ELISA 263 Protein Chips 264 Two-dimensional Gel Electrophoresis and Mass Spectrometry 264 Conclusions 265 References 266
12.1 12.2 12.3 12.4 12.5 12.6 12.7 12.8 12.9 12.10 12.11 12.12 12.13 12.14 12.15 12.15.1 12.15.2 12.15.3 12.15.4 12.15.5 12.15.6 12.15.7 12.16 12.16.1 12.16.2 12.16.3 12.16.4 12.17
XI
XII
Contents
13
13.1 13.2 13.3 13.4 13.5 13.6
Methods for Detection of Genetically Modified Microorganisms used in Food Fermentation Processes 269 Walter P. Hammes, Christian Hertel, and Torsten Bauer Introduction 269 Current Methods for Detection of GMM 272 DNA Isolation 274 DNA Stability 275 Organism-specific Detection of the GMM 275 Conclusion 277 References 278 Index 281
Preface The first edition of this book was published in 2003. At that time one could not foresee its success, because admission of genetically engineered food into Europe had been suspended for several years. Since the lifting of the moratorium, however, applications, especially for admission of genetically engineered plants to be used as either food or feed, have again increased, showing that this is still a dynamic field of applied molecular biology. The era of molecular biology entered a new phase thirty years ago with the construction and successful transformation of the first recombinant DNA molecule (Cohen SN, Chang AC, Boyer HW, Helling RB. Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci USA 1973; 70:3240–3244). This event marked the birth of genetic engineering which enabled very thorough analysis of cellular functions and provided the tool for targeted manipulation of the genetic material of cells and organisms. Supported by the development of the efficient chain-termination method for DNA sequence analysis (Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463–5467) and the polymerase chain reaction method for targeted amplification of DNA segments of choice (Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 1986; 51:263–273), genetic engineering of prokaryotic organisms and, later, of eukaryotes became a task easily performed in many laboratories. The potential of genetic engineering for food production was very soon recognized and the first genetically engineered food organisms, the famous “Flavr Savr” tomato with delayed ripening, was constructed and approved in the United States of America in 1994. Many other plants followed, for example rape, maize, and soy beans. The development of this new breeding technique initiated in Europe the introduction of new legislation needed for harmonization of legislation concerning free trade, for protection of public health and consumer rights, and for consideration of environmental aspects. This legislation has been as dynamic as the science behind genetic engineering – for example, the famous “Regulation (258/97/EC) concerning novel foods and novel food ingredients“ established only in 1997 was replaced by “Regulation (EC) No 1829/2003 on genetically modified food and feed” to encompass food produced with the aid of genetic engineering. To enforce this legislation, detection methods had to be developed enabling unambiguous identification of foods produced with
XIV
Preface
the aid of genetic engineering. Today, these methods must be capable of quantitative determination of amounts of genetically engineered ingredients at levels of 0.9% of the entire amount of the ingredient. This is necessary to guarantee that the accepted level of contamination of food with technically unavoidable genetically engineered material is not exceeded. Because of the success of the first edition of this book, we have used the same structure in the second edition. Current applications and future potentials of this breeding technique are discussed in Part 1. Part 2 covers the current state of legislation in Europe; the framework it sets for application of this technique is presented. Methods developed for detection of foods produced with the aid of genetic engineering are highlighted in Part 3. The book is by no means comprehensive. The focus of detection methods is clearly on detection of DNA. Issues of food safety and consumer acceptance are deliberately not dealt with. Whereas food safety is not a specific issue for novel foods but an issue for food in general, consumer acceptance of genetically modified foods is a very controversial topic of debate, and often the arguments in that debate are all but scientific. It is my feeling as editor that covering the consumeracceptance issue would obstruct consideration of the scientific data presented in the book. Last but not least, I wish to acknowledge the excellent cooperation of all the authors in updating their contributions to this second edition and to thank Waltraud Wuest, Wiley-VCH, for her support during the entire production phase of this edition. Knut J. Heller Kiel, June 2006
List of Contributors Torsten Bauer Institute of Food Technology University of Hohenheim 70593 Stuttgart Germany Gottfried Brem Institut of Animal Breeding and Genetics Veterinary University of Vienna Veterinärsplatz 1 1210 Vienna Austria Bertus van den Burg IMEnz Bioengineering B.V. L.J. Zielstraweg 1 9713 GX Groningen The Netherlands Alexandra Ehlert Technical University of Munich Center of Food and Life Sciences Chair of General Food Technology Am Forum 2 85350 Freising-Weihenstephan Germany Ralf Einspanier Institut für Veterinär-Biochemie Freie Universität Berlin Oertzenweg 19b 14167 Berlin Germany
Karl-Heinz Engel Technical University of Munich Center of Food and Life Sciences Chair of General Food Technology Am Forum 2 85350 Freising-Weihenstephan Germany Arnold Geis Institut für Mikrobiologie Bundesanstalt für Milchforschung Hermann-Weigmann-Str. 1 24103 Kiel Germany Walter P. Hammes Institute of Food Technology University of Hohenheim 70593 Stuttgart Germany Knut J. Heller Institut für Mikrobiologie Bundesanstalt für Milchforschung Hermann-Weigmann-Str. 1 24103 Kiel Germany Christian Hertel Institute of Food Technology University of Hohenheim 70593 Stuttgart Germany
XVI
List of Contributors
Carsten M. Hjort Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark Jan Kalbheim Ludwig Maximilians Universität München Lehrstuhl für Öffentliches Recht und Europarecht Professor-Huber-Platz 2 80539 München Germany Jan Kok Department of Genetics Groningen Biomolecular Sciences and Biotechnology Institute University of Groningen Kerklaan 30 9751 NN Haren The Netherlands Georg Kristan Technische Universität FG Mikrobiologie und Genetik Gustav-Meier-Allee 25 13355 Berlin Germany Rena Leisegang Technische Universität FG Mikrobiologie und Genetik Gustav-Meier-Allee 25 13355 Berlin Germany Horst Lörz Biozentrum Klein-Flottbek Ohnhorststr. 18 22609 Hamburg Germany
Rolf Meyer Nestec Ltd Nestlé Product Technology Centre Orbe Quality Management Department 1350 Orbe Switzerland Francisco Moreano Bavarian Health and Food Safety Authority LGL Veterinärstr. 2 85764 Oberschleißheim Germany Elke Nevoigt Technische Universität FG Mikrobiologie und Genetik Gustav-Meier-Allee 25 13355 Berlin Germany Anke Niederhaus Technische Universität FG Mikrobiologie und Genetik Gustav-Meier-Allee 25 13355 Berlin Germany Hartmut Rehbein Institut für Fischereitechnik und Fischqualität Bundesforschungsanstalt für Fischerei Palmaille 9 22767 Hamburg Germany Anja Spielvogel Technische Universität FG Mikrobiologie und Genetik Gustav-Meier-Allee 25 13355 Berlin Germany
List of Contributors
Ulf Stahl Technische Universität FG Mikrobiologie und Genetik Gustav-Meier-Allee 25 13355 Berlin Germany Susanne Stirn Forschungsschwerpunkt Biotechnik Gesellschaft und Umwely (FSP BIOGUM) Universität Hamburg Ohnhorststr. 18 22609 Hamburg Germany
Rudolf Streinz Ludwig Maximilians Universität München Lehrstuhl für Öffentliches Recht und Europarecht Professor-Huber-Platz 2 80539 München Germany
XVII
Part I Application and Perspectives
1 Transgenic Modification of Production Traits in Farm Animals Gottfried Brem and Mathias Müller
1.1 Introduction
“Genetic engineering” is the umbrella term for procedures that result in a directed alteration in the genotype of an organism. The combined use of molecular genetics, DNA recombination and reproductive biology enables the generation of transgenic animals. For animals the term “transgenic” originally referred to the stable introduction of new genetic material into the germ line [1, 2]. This definition of transgenic animals has to be extended for two reasons. First, further developments in the genetic engineering of animals enable not only additive gene transfer (gain of function) but also deletive gene transfer (knock-out, loss of function), replacement gene transfer (knock-in, exchange of function), and spatial–temporal gene transfer (conditional knock-out) [3, 4]. Second, in addition to germ line integration of transgenes, somatic gene-transfer approaches result in (mostly transient) gene expression with the longest duration being a life span and no transmission of the transgenes to the progeny. Although somatic gene-transfer experiments in farm animals have been performed for production purposes [5, 6] this technology in animal production is more beneficial for the development of DNA-based vaccines [7]. Here we will mainly concentrate the discussion on germ line transgenic animals. The production of transgenic farm animals was first reported in the mid-1980s [8, 9]. The main progress in exploiting this technology has been made in the establishment of animal models for human diseases, production of heterologous proteins in animals (gene farming), and the production of organs for xenotransplantation [10–12]. In addition to these biomedical approaches research has focused on improvement of the efficiency and quality of animal production by transgenic means (this review and other work [13, 14]).
4
1.2 The Creation of Transgenic Animals
1.2 The Creation of Transgenic Animals
The main routes to transgenesis in mammals include: 1. microinjection of DNA into the pronucleus of a fertilized oocyte (zygote); 2. integration of a (retro)viral vector into an oocyte or an early embryo; 3. incorporation of genetically manipulated pluripotent stem cells into an early embryo; or 4. transfer of genetically altered nuclei into enucleated oocytes. For alternative gene transfer methods we refer to another review [15]. Spermmediated gene transfer, at least for pigs, has been proven to result in high-efficiency transgenesis ([16] and Refs. therein), although the method is not as broadly established as the methods described below. 1.2.1 Pronuclear DNA Microinjection
Microinjection of foreign DNA into pronuclei of zygotes is the classic method of gene transfer into farm animals. Since the first reports [8, 9] this technique, nearly unchanged, has accounted for most transgenic farm animals [15, 17]. DNA microinjection results in random integration of the foreign DNA into the host genome and is therefore not suitable for targeted modification of genomes. Although microinjections are performed at the one-cell-stage approximately 20–30% of the founder animals are mosaic and, therefore, may not transmit the integrated gene construct to their progeny [18]. Random integration of the gene constructs may cause alteration of one or more gene loci. Insertional mutagenesis is recessive and mostly characterized by a recombination event in the kilobase range at the transgene integration site. In mice approximately 5–15% are affected by this recessive mutation [19]. Except for studies in transgenic rabbits [20, 21], little has been published on analysis of homozygous transgenic farm animals. This is mainly because of the long generation intervals. There is, however, no reason to doubt the mutagenesis frequencies estimated for mice in other transgenic mammals generated by the same technology. Random integration of the gene constructs may also result in varying, aberrant, or abolished transgene expression, because of effects of the adjacent chromatin overcoming the transgene’s regulatory sequences. One possible means of avoiding these integration site-dependent effects is the transfer of large DNA constructs, which can form functionally independent chromatin domains [22]. The first successful example for this strategy in livestock was the generation of transgenic rabbits harboring yeast artificial chromosomes (YACs) [23]. An alternative means of protecting transgenes from chromosomal position effects is the use of boundary elements (e.g. insulators, locus control regions, matrix attachment regions) in the gene constructs to achieve copy number-dependent and promoter-dependent and position-independent expression of transgenes [24]. Although success with this strategy has been reported, the effects of the elements were not always as expected.
1 Transgenic Modification of Production Traits in Farm Animals
Gene transfer efficiency (transgenic newborns and/or microinjected zygotes) is usually rather low, especially for large animals. One transgenic animal can be expected after microinjection of 40, 100, 90–110, and 1600 zygotes in mice, pigs, small ruminants, and cattle, respectively [25]. Differences in efficiency emphasize fundamental differences in the reproductive biology of species. Hence a high level of technical skills and experience in embryo collection and embryo transfer are critical for efficient transgenic production. This applies for all gene-transfer programs, however. As mentioned above, the procedures for generating large mammals by DNA microinjection have remained basically unchanged and little improvement in DNA-transfer efficiency has been achieved. After DNA microinjection, embryos are transferred to synchronized foster mothers. Great progress has been made in the field of embryo transfer. For all farm animal species embryo transfer has been facilitated by the development of endoscopy-guided minimally invasive techniques, reducing stress to the foster mothers and maximizing embryo survival and pregnancy rates [26–29]. Methods are currently being developed with the objective of improving the in-vitro production (IVP) of embryos [30, 31]. Endoscopic embryo transfer and IVP is also advantageous in the gene transfer methods discussed next. 1.2.2 Retroviral Vectors
The first germ-line transgenic mice were produced by retroviral infection of early embryos [32]. Retroviruses can be considered natural vehicles for gene delivery to mammalian cells. Endogenous retroviruses (ERVs) are a subset of retro-elements which represent up to 10% of the mammalian genome [33]. The capability of ERVs to reintegrate into the genome through reverse transcription mechanisms results in continuous insertion of new ERVs into the host genome. Until recently, retroviral vectors were not considered for farm-animal transgenesis, because of biosafety concerns and the dependence of most retroviruses on dividing cells for integration into the host genome. Retroviral gene transfer therefore often results in genetic mosaics when developing embryos are infected. With the development of replication-defective retroviral vectors mainly for gene-therapy purposes, a powerful tool for gene transfer in mammalian cells has been established [34]. To avoid mosaicism Chan et al. [35] inoculated bovine oocytes in the final stage of maturation with retroviral vectors. They achieved a remarkably high rate of transgenesis and, as expected, no mosaic transgenic cattle. A similar approach resulted in the generation of transgenic piglets [36]. One major limitation of retroviral vectors is their limited cloning capacity (<10 kb). Gene constructs, however, grow larger and larger to omit variegated transgene expression (see above). A second problem with many retroviral vector-mediated transgenesis relates to transcriptional shutdown of the transgenes [37]. Lentiviral vectors are a new generation of retroviral vectors which, in contrast with standard oncoretrovirus-based vectors, are reported to escape transcriptional silencing. In addition, lentiviruses are able to infect both dividing and
5
6
1.2 The Creation of Transgenic Animals
nondividing cells (reviews are available elsewhere [38, 39]). Germ-line transmission and expression of transgenes delivered by lentiviral vectors to one-cell mouse embryos has been reported [40]. Subsequently lentiviral gene transfer has been successfully used in swine [38, 39] and cattle [41]. This technique of transgenesis is more efficient and cost-effective, and technically less demanding, than pronuclear injection. The obstacle of the limited size of the constructs to be transferred remains, however. In the same way as for gene transfer by pronuclear injection, retrovirus-mediated gene transfer can only be used for additive gene transfer and also bears the danger of insertional mutagenesis. Analysis of transgene expression in lentiviral transgenic pigs revealed that, in contrast with early reports, some transgenics showed epigenetic silencing [42]. 1.2.3 Pluripotent Stem-cell Technology
Pluripotent stem cells are capable of developing into many cell types, including germ cells, on fusion with pro-implantation embryos (morulae, blastococysts). Pluripotent stem cells can be maintained in tissue culture and genetically manipulated and selected in vitro before reconstitution of the embryo. With mice, handling of pluripotent cells has become a routine method for targeted modification of the genome by homologous recombination, i.e. deletive or replacement gene transfer [43]. Numerous efforts to establish pluripotent stem cells in species other than mice have so far failed. Possible reasons for this are discussed elsewhere (Refs [44, 45] and references cited therein). Since nuclear transfer using transgenic donor cells (see below) became an attractive alternative tool for targeted gene transfer, efforts to establish germ-line-competent stem cells from farm animals have been reduced. 1.2.4 Nuclear Transfer Using Transgenic Cells
Nuclear transfer technology – also known as cloning – comprises transfer of a donor nucleus (karyoplast) into the cytoplasm of an enucleated zygote or oocyte (cytoplast). Initial nuclear transfer experiments in farm animals used early embryonic stages as nuclear donors [46]. In breakthrough experiments with sheep it was demonstrated that in-vitro-cultured differentiated fetal cells and even cells derived from adult tissues could serve as nuclear donor for the reconstitution of enucleated oocytes [47, 48]. Cloning by nuclear transfer has subsequently been achieved in cattle [49–51], goats [52], pigs [53–55], rabbits [56], mules [57], horses [58], cats [59], dogs [60], and some wildlife species (a review is available elsewhere [61]). For farm animal transgenesis a novel tool has become available in that cultured cells can be genetically modified by conventional transfection methods before their use for nuclear transfer. The first reports on this novel gene transfer technique were the generation of transgenic sheep and cattle by nuclear transfer using transfected and selected fetal fibroblasts [62, 63]. Transgenesis by nuclear transfer of geneti-
1 Transgenic Modification of Production Traits in Farm Animals
cally modified cells has several advantages over the other additive gene transfer techniques: 1. mosaicism is avoided and germ-line transmission is guaranteed, because all cells of the cloned animal contain the transgene; 2. insertional mutagenesis and chromosomal positioning effects can be avoided, because integration and, eventually, transgene expression can be monitored in vitro; and 3. the use of male or female cell lines determines the gender of the transgenic animal. Most importantly, gene transfer by nuclear transfer provides a means of gene targeting in farm-animal species [64, 65]. Both the targeted disruption of genes by homologous recombination (deletive gene transfer, knock-out) in sheep and pigs [66–68] and the targeted integration of a gene of interest into a given locus (replacement gene transfer, knock-in) [69] have been reported. The sequential targeting of both alleles of two genes has been achieved in cattle [70]. Despite these impressive reports and the intriguing advantages of the nuclear transfer technique for generation of transgenic farm animals, widespread use is not an easy task because: 1. the primary fibroblasts currently used for gene transfer have limited capacity to divide; 2. homologous recombination is less frequent in somatic cells than in pluripotent stem cells; and 3. cloning by nuclear transfer has a low yield which is still diminished when nuclear donor cells are previously cultured [61]. There is also an ongoing debate about whether it is possible to overcome abnormalities observed in cloned animal [71, 72]. The abnormalities are not restricted to transgenic cloned animals, suggesting they originate from the nuclear transfer procedure or the in vitro culture conditions. Although healthy clones have been reported [73], improvement of the technology and further investigation of the effects of cloning are required [74].
1.3 Gene Transfer in Poultry
Depending on the developmental stage a variety of strategies are used for generation of transgenic birds, including DNA microinjection of fertilized ova, retroviral infection of blastodermal cells, and genetic manipulation of primordial germ cells (PGCs) or embryonic stem (ES) cells. In the same way as in mammals, the first method developed to transfer genes into birds was microinjection of DNA into the germinal disk of fertilized ova [75]. Although successful germ line transmission has been reported [76], the method is labor-intensive, ineffective, and frequently results in mosaicism. Retroviral vectors can introduce transgenes into the genome with low but acceptable efficiency. The first transgenic birds were produced using replication-competent vectors and thus could not be used for broad appli-
7
8
1.5 Transgenes – Gene Constructs
cation [77]. The development of replication-defective vectors led to wide use of this technique for production of transgenic birds and stable transgene expression [78, 79]. As an alternative, chimeras bearing transfected pluripotent cells originating from the blastoderm, from PGCs, or from ES cells have been reported (reviews are available elsewhere [80–82]).
1.4 Gene Transfer in Fish
The techniques for gene transfer into fish have focused on direct transfer of DNA into gametes or fertilized eggs and include DNA microinjection, electroporation, retroviral vector infection, and biolistic methods (Ref. [83] and references cited therein). Stem-cell-based technology is not available for farmed fish. The making of transgenic fish is different from gene transfer in mammals or birds because: 1. fish usually undergo external fertilization and no culture or transfer of eggs into recipient females is required; 2. the eggs of many fish have a tough chorion requiring special methods for delivering the gene constructs; and 3. DNA delivery, including by microinjection, is usually into the cytoplasm. Probably because of the cytoplasmic nature of DNA delivery, many founder transgenic fish are mosaic. Germ line mosaicism seems also to occur because frequencies of transgene transmission to F1 are clearly less than at Mendelian ratios. Transmission of the transgenes to later progeny occurs at Mendelian frequencies, indicating stable integration of the transgenes. A variety of inducible and targeted transgene strategies developed for mammals are now available to be tested and explored in fish (a review is available elsewhere [84]).
1.5 Transgenes – Gene Constructs
The exogenous DNA integrated into the host genome usually is referred to as the gene construct or transgene. The different transgenic sequences used for the different gene-delivery methods and gene-transfer programs are summarized in Table 1.1. For additive gene transfer experiments the gene construct encompasses the elements controlling gene expression (5 promoter region, 3 control regions) and the sequences (cDNA, genomic DNA) encoding the transgene product. For DNA microinjection or sperm-mediated gene transfer the prokaryotic cloning vector sequences are removed from the gene construct. Prokaryotic sequences – especially their CpG dinucleotide base pairs – may undergo methylation or heterochromatin formation in animal cells, which leads to transgene silencing. It is becoming increasingly clear that silenced transgenes have been recognized as foreign elements by host cellular mechanisms, as have retroviral and transposon sequences [85, 86].
*
RNAi expression construct
Unwanted sequences may be removed in vitro by site-specific recombinases
Pronuclear DNA microinjection; sperm-mediated; physical and/or chemical methods; retroviral vectors
Selectable marker genes*
Reduction of function by RNAi
• Introduction of novel allelic variants • exchange of coding sequences in a transcription unit
Selectable marker genes*
Cloning by transfer of genetically modified nuclei
Selectable marker genes*
Cloning by transfer of genetically modified nuclei
Exchange of function
Deleted or non-sense-mutated species-specific sequences
Viral sequences
Retroviral vector
Cloning by transfer of genetically modified nuclei
See above
Chromosomal elements
Artificial mammalian chromosomes
Loss of function
See above
PAC-, BAC-, YAC-vector elements
Artificial nonmammalian chromosomes
RNAi expression construct gene(s)
See above
See above
• Species-specific sequences • cross-species sequences • new combination of promoter and coding sequences (speciesspecific or cross-species)
–
Pronuclear DNA microinjection; sperm-mediated; physical and/or chemical methods
Composition and origin of the transgene
Gain of function
Sequences not related to the transgene per se
Methods of gene transfer
Functional consequence of gene transfer
Tab. 1.1 Characteristics of the transgenes used for different gene-delivery methods and gene-transfer programs in farm animals.
Specific “knock-down” of target
• Targeted alteration of milk protein genes • replacement of genes
Generation of PrPc gene-deficient ruminants
See above
See above
See above
See above
• Additional copies of casein alleles • humanized milk • mammary gland-specific expression of antibodies
Example (see below)
1 Transgenic Modification of Production Traits in Farm Animals 9
10
1.5 Transgenes – Gene Constructs
As mentioned above, one obvious way of avoiding transgene silencing or chromosomal positioning effects would be the use of large gene constructs and the abandoning of viral vectors. An increasing number of transgenic animals therefore carry gene constructs based on phage (PAC), bacterial (BAC), or yeast (YAC) artificial chromosomes [22]. For expression and replication, these large transgenes depend on integration into the host genome. In contrast, mammalian artificial chromosomes (MACs) provide independent transcription and replication units. Work originating mainly from human gene therapy programs has resulted in the development of human artificial chromosomes based on episomal viral vectors or engineered minimal chromosomal elements [87, 88]. MACs were recently used to generate “transchromosomic” cattle; this was achieved by introducing human artificial chromosomes in vitro into bovine cells which were subsequently used for cloning by nucleus transfer [89, 90]. Alternatively, gene transfer in vitro then reconstitution of embryos by nuclear transfer or stem-cell technology enables targeting of transcription units in the host genome or in-vitro analysis of the chromosomal integration site. These genetransfer techniques, however, require methods for the identification of the genetically modified cells. Identification of transgenic cells is mostly based on (drug) selectable markers, e.g. antibiotic-resistance genes, added to the gene constructs. In plants the presence of marker genes in the genetically modified organism is a topic of concern about biosafety [91]. Analogous a genetically modified farm animal going on the market should be free from such genes. This can be achieved by use of site-specific recombinases to remove undesirable sequences after successful identification of the transgenic cells [92, 93]. Additional methods for site-directed genome modification are reviewed elsewhere [94, 95]. It must, however, be mentioned that these additional genetic engineering steps have not yet been conducted in farm animals. RNA interference (RNAi) is the process in which dsRNA leads to gene silencing, by either inducing the sequence-specific degradation of complementary mRNA or inhibiting translation. RNAi has been very successfully applied as gene-silencing technology in both plants and invertebrates, but many practical obstacles need to be overcome before it becomes a versatile tool in mammalian cells. Greater specificity and efficiency of RNAi in mammals is being achieved by improving the design and selection of small interfering RNAs (siRNAs), by increasing the efficacy of their delivery to cells and organisms, and by engineering their conditional expression (reviews are available elsewhere [4, 96, 97]). The power of this technology in transgenic animals has been demonstrated by production of mice constitutively expressing RNAi directed against a given transcript which show a similar phenotype as mice with homologous targeted disruption of the locus [98]. Retroviral vector-mediated gene transfer methods have the advantage of the transgene being actively delivered to the cells and integrated into the host genome. The disadvantage of the system is the above mentioned transcriptional shutdown and heterochromatin formation of the transgenes, because of the presence of the viral sequences.
1 Transgenic Modification of Production Traits in Farm Animals
1.6 Transgenic Animals with Agricultural Traits
A key element of the enhanced production of domesticated species is the development of genetically superior breeding stocks tailored to their maintenance conditions and to the marketplace. Characteristics that are generally desirable in all species include improvement of growth rates, feed conversion efficiency, disease resistance, and a capacity to utilize low-cost or nonanimal protein diets. Attempts to improve productivity traits in farm animals by transgenesis can be divided into products designed for consumers’ consumption per se and traits not affecting the food chain in the first place. The first topic includes stimulation of growth rates, food conversion, and alteration of carcass and milk composition. The second aims at improvement of fiber products, enhanced disease resistance, and introduction of novel biochemical pathways. Although the transgene product in this field is not meant for food, the meat or milk of the genetically modified animal could be considered for consumption (reviews are available elsewhere [11, 14, 99]). At the outset it should be noted that progress on manipulation of agricultural animal traits is far slower than originally envisaged in the early days of transgene technology. First, this is because the most economically important traits are controlled by multiple genes, which are still largely unknown and hence not amendable to manipulation. Even after identification of all genes contributing to a complex trait, genetic engineering of this trait would require multiple gene transfers. Second, the low efficiency of gene transfer in farm animals (see above) makes research on transgenesis quite costly. Third, the ability to regulate expression of transgenes is still far from adequate (see above). Finally, public acceptance of genetically modified organisms in the food chain – at least in Europe – has not yet been achieved. Compared with mammals and fish gene-transfer experiments in chickens are still limited. The objectives of gene transfer in poultry are basically identically with those for other farm animals (reviews are available elsewhere [100, 101]).
1.7 Improved Growth Rate, Carcass Composition, and Feed Efficiency 1.7.1 Transgenic Mammalian Farm Animals
Among the genetically determined factors regulating growth rate and feed conversion the genes encoding polypeptides of the growth-hormone cascade are of particular interest. The positively acting growth hormone-releasing hormone (GHRH, somatoliberin) and its antagonist somatotropin release-inhibiting factor (SRIF, somatostatin) control the production of growth hormone (GH, somatotropic hormone (STH), somatotropin). The action of GH is very dependent on the metabolic state of the organism – low blood glucose levels result in catabolic effects (lipolysis)
11
12
1.7 Improved Growth Rate, Carcass Composition, and Feed Efficiency
and a positive energy balance causes anabolic effects which are mainly governed by insulin-like growth factor 1 (IGF-1, somatomedin C). The original workers on farmanimal transgenesis was impressed by the results of Palmiter et al. [102] which indicated that mice expressing excess GH grew much faster and bigger than nontransgenic control mice. Several GH transgenic pigs and sheep have been produced with human, bovine, ovine, porcine, or rat GH, under the control of several promoters (a review is available elsewhere [14]). GH-transgenic pigs expressing the gene constructs at high levels were found to have faster growth rates and increased feed efficiency. The most dramatic effect of elevated GH levels in pigs was reduction of carcass fat as transgenic pigs approached market weight [13, 103]. It was found, however, that constitutive and/or high level expression of GH in pigs had a variety of pathological side-effects [104, 105]. Transgenic ruminants (cattle, sheep, goats) carrying growth-promoting genes have been also generated but no positive effects on growth performance or carcass composition were reported (a review is available elsewhere [14]). Attempts to affect carcass composition in respect of beneficial dietary properties for human consumption are, nevertheless, of high priority for the meat-production industry (Section 1.10, below and Ref. [106]). It was recognized that tight regulation of transgene expression would be required to avoid deleterious effects from continuous exposure of mammals to elevated GH. So far, most attempts to use dietary inducible promoters have failed. Two studies reported the production of growth-promoting transgenic pig lines. A metal ion-inducible promoter linked to the porcine GH gene was introduced into pigs and many transgenic founder animals were produced. Transgenic pigs were tested for metal-induced transgene expression and animals with high basal levels of transgene expression or plasma GH levels outside the range of non-transgenics were excluded from the study. By following this strategy negative side-effects could be avoided [107]. Because of the random integration of the transgenes as a result of DNA microinjection and the lack of shielding sequences, however, the transgenic lines had a high level of variegated gene expression. In a second study the expression of IGF-1 was directed to muscle by using a skeletal muscle-specific expression cassette. By avoiding the systemic effects of GH increased carcass leanness was achieved with no detrimental side-effects [108]. Interestingly, in the context of the use of growth hormone cascade transgenes, somatic gene-transfer might satisfy demands for improved growth performance. A somatic gene-transfer procedure employing a singular intramuscular injection and electroporation of muscle-specific expression vectors encoding a protease-resistant GHRH resulted in elevated GH and IGF-1 levels which, in turn, augmented long-term growth without pathological side-effects [6]. An alternative means of altering the growth performance involves the differentiation process of muscle cells themselves. For example, the chicken c-ski proto-oncogene was found to induce myogenic differentiation. This muscle differentiation gene was introduced into cattle [109]. As observed with the growth hormone cascade genes, no effects or mainly deleterious effects of the transgene expression were reported, however. Myostatin, also known as growth and differentiation factor 8, negatively regulates skeletal muscle development. Deletion or
1 Transgenic Modification of Production Traits in Farm Animals
non-sense mutations in the myostatin gene are responsible for double muscling in cattle (a review is available elsewhere [110]). Myostatin-deficient mice, generated by gene targeting, produced twice the muscle mass with reduced carcass fatness as wild type mice, mirroring the phenotype of myostatin mutant cattle [111]. In an additive gene transfer experiment it was shown that expression of a dominantnegative myostatin transgene also led to increased muscle development, growth performance, and carcass weight [112]. By use of a two-step procedure involving insertional gene targeting and recombinase-mediated cassette exchange in ES cells, transgenic mice were generated which express a dominant-negative myostatin propeptide under control of a muscle and in a Y-chromosome-specific manner. Transgenic males were characterized by a 5–20% increase in skeletal muscle mass. This experiment demonstrates the feasibility of a more efficient cattle production system combining superior beef production for bulls and dairy output for cows [113]. The myostatin gene is therefore an attractive candidate for both gene targeting and gain of function experiments in farm animals [110]. 1.7.2 Transgenic Fish
Aquaculture is still in its infancy compared with the farming of mammals or poultry. Growth rates of the many fish species used are naturally slow but are currently being enhanced by traditional methods of domestication and selection. Programs for growth-promoting gene-transfer into fish usually use GH-based gene constructs [83]. Because of the lack of available piscine sequences, the first experiments were conducted with mammalian GH gene constructs. The effects on growth performance were, however, either not detectable or very small. Gene transfer using fish GH sequences driven by nonpiscine promoters has resulted in growth stimulatory effects in transgenic carp, catfish, and tilapia; weight increases were approximately twice those of controls. These experiments provided the first consistent data demonstrating that growth acceleration in fish can be achieved by transgenesis [83]. Subsequent use of all-piscine gene constructs produced fish with up to fortyfold elevated circulating GH levels and five- to elevenfold increased weight after one year of growth [114, 115]. Pleiotropic effects in the GH-transgenic fish included altered body composition (50% reduced fat levels), unpredictable variations in food consumption and conversion, and some pathological side-effects. Comparative gene-transfer programs demonstrated that GH-transgenes dramatically enhanced the growth of wild but not domesticated fish [116]. Thus in domesticated and selected farm animal species the capacity for further growth enhancement by GH may be restricted by limitations in other physiological pathways. In mammals this is reflected by dramatic growth stimulation in GH-transgenic mice but not in domestic livestock that have undergone many centuries of genetic selection (see above). Genetically engineered fish with enhanced phenotypic traits have yet to be implemented in commercial applications. In addition to the technical issues described, this is partly because of the difficulties in reliably predicting the ecological risk of transgenic fish should they escape into the wild. The ecological
13
14
1.8 Alteration of the Composition of Milk
consequences of the phenotypic differences between transgenic and wild-type fish, as determined in the laboratory, can be uncertain, because of genotype-by-environment effects. These biosafety issues are reviewed elsewhere [117]. Salmonids are fish of high economic value which are unable to survive in waters characterized by ice and subzero temperatures. Antifreeze proteins (AFP) are produced by several fish that inhabit extremely cold waters. One possible way of solving the problem of overwintering salmon in sea cages in the northern hemisphere is the transfer of antifreeze protein genes. The AFP-transgenic salmons produced so far express the transgene at levels insufficient to confer freeze resistance (a review is available elsewhere [83]).
1.8 Alteration of the Composition of Milk
Potential changes in milk composition or in the primary structures of milk proteins, and their presumed beneficial effects on the nutritional, physiochemical, and technological properties of milk and milk products have already been reviewed extensively [14, 118]. It should be noted that most transgenic strategies are at the stage of being tested by use of mouse models and gene-transfer technology for improvement of milk quality is far from commercial application. Attempts to improve the processing properties of milk include changing the casein content and the introduction of modified milk proteins. To enhance milk composition and milk processing efficiency by increasing the casein concentration in milk, cloning by transgenic female nucleus transfer was used to generate transgenic cows carrying additional copies of bovine beta-casein and kappa-casein genes. Analysis of the hormonally induced milk revealed substantial expression and secretion of the transgenederived caseins into milk. These results show it is feasible to substantially alter a major component of milk in high-producing dairy cows by a transgenic approach and thus to improve the functional properties of dairy milk [119]. Introduction of human milk protein genes or replacement of bovine genes by human genes may play an important role in the production of surrogates for human milk. Bovine and human milk differ substantially and, therefore, cows’ milk is not an ideal source of food for babies. Bovine milk can be humanized by increasing the whey protein content, e.g. by expressing the antimicrobial proteins lactoferrin and lysozyme [120, 121]. Large-scale production of human lactoferrin in the milk of transgenic cows has recently been reported [122]. The structure of the transgenic protein was reported to match that of human origin [123]. Beta-lactoglobulin is the major heat-labile whey protein of ruminant milk and does not occur in human milk. Although beta-lactoglobulin is not the only bovine milk protein with allergenic properties it is widely assumed that milk depleted of this protein would be a better source of humanized milk. In principle, the technology for gene knock-out in ruminants is now available. Depletion of particular proteins from the milk has been performed in mice for beta-casein [124] and alpha-lactalbumin
1 Transgenic Modification of Production Traits in Farm Animals
[125, 126]. Whereas beta-casein was found to be a non-essential component of the milk protein system, knock-out of alpha-lactalbumin resulted in disruption of lactation and lactose synthesis. Because the biological function of beta-lactoglobulin and its contribution to bovine milk physiology are not known, the side-effects of a knock-out approach cannot be predicted. RNAi technology – once established in farm animals – will be useful for determining the biology of these proteins and potentially down-regulating their expression. Tab. 1.2 Proposed modifications of milk composition.
Target gene
Gene transfer
Transgene effect
Overall effect
alpha- and beta-Caseins Gain of function
Improved cheese-making properties, increased Ca2+ content
Improved technical processing
kappa-Casein
Gain of function
Improved heat stability, reduced micelle size, reduced coagulation
Improved technical processing
Novel phosphorylation and proteolytic sites in caseins
Exchange of function
Increased Ca2+ content, improved cheese ripening
Improved technical processing
beta-Lactoblobulin
Loss of function
Increased temperature sta- Improved technical bility, improved digestibility, processing and/or humanized milk reduced allergenicity
Human lysozyme
Gain of function
Antimicrobial, increased cheese yield
Improved technical processing and/or humanized milk
Human lactoferrin
Gain of function
Antimicrobial
Humanized milk
alpha-Lactalbumin
Reduction of function
Reduced lactose
Improved nutritional value
Lactase
Gain of function
Reduced lactose
Improved nutritional value
Acetyl CoA carboxylase
Reduction of function
Reduced fat content
Improved nutritional value
Immunoglobulin genes Gain of function
Passive oral immunization
Nutraceutical
Antigen genes
Gain of function
Active oral immunization
Nutraceutical
Phe-free alpha-lacta bumin
Exchange of function
Source of amino acids for patients suffering from phenylketonuria
Nutraceutical
Stearoyl-CoA desaturase
Gain of function
Fatty acid pattern of benefit to cardiovascular health
Nutraceutical
15
16
1.9 Improved Animal Health
Lactose is the major sugar present in milk and is synthesized by the lactose synthase complex comprising a galactosyltransferase and alpha-lactalbumin. Most of the adult population suffers from intestinal disorders as a consequence of lactose maldigestion that results from physiological downregulation, at weaning, of the intestinal lactose-hydrolyzing enzyme. Low-lactose milk in vivo has been generated by partial inhibition of the alpha-lactalbumin gene by an RNA-antisense approach [127] and by the mammary gland-specific expression of an intestinal lactase [128]. Milk seems to be an ideal vehicle for development of nutraceuticals, i.e. dietary supplements and functional and medical food [129]. Examples of the use of milk as a nutraceutical are listed in Table 1.2. The enzyme stearoyl-CoA desaturase converts specific medium-chain and longchain saturated fatty acids into their monounsaturated forms. Transgenic goats expressing this enzyme in the mammary gland produce milk in which the fat has a less saturated and more monounsaturated fatty acid profile at some stages of lactation. Milk containing higher proportions of monounsaturated fatty acids and conjugated linoleic acid may benefit human cardiovascular health [130]. Bovine alpha-lactablumin gene transgenic pigs have been generated in an attempt to increase milk production and lactose content for the benefit of suckling offspring. Enhanced lactation performance and, consequently, enhanced litter growth performance were observed (a review is available elsewhere [131]).
1.9 Improved Animal Health
In contrast with selection for production performance, attempts to select for improved disease resistance by conventional breeding programs have not been successful. Reduction of the susceptibility of livestock to disease will be of benefit to animal welfare and will also be of economic importance. Improved health status in animal production results in improved production and reproduction performance. Both somatic and germ-line gene transfer can be used. To introduce new diseaseresistance traits to farm animals, germ-line transmission is required. Strategies for enhancing disease resistance by transgenesis have been extensively reviewed elsewhere [14, 132, 133]. Somatic gene transfer mainly focuses on DNA vaccines (genetic immunization, see above). Integration, stable germ-line transmission, and, occasionally, expression of gene constructs designed to confer disease resistance have been demonstrated. The final proof of successful generation of resistant farm animals, i.e. challenge with an infectious pathogen, has not, however, been reported until recently. In a breakthrough experiment, genetically engineered cows were shown to have enhanced resistance to mastitis [134]; reviews are available elsewhere [99, 135].
1 Transgenic Modification of Production Traits in Farm Animals
1.9.1 Additive Gene Transfer of Resistance Genes
The term “intracellular immunization” was originally used to denote the overexpression in the host of an aberrant form (dominant-negative mutant) of a viral protein that can interfere severely with replication of the wild type virus. This definition has since been extended to all approaches based on intracellular expression of transgene products which inhibit the replication of pathogens in host organisms (Ref. [133] and references cited therein). Initial studies with farm animals included the “classical” approach of overexpression of a viral protein in transgenic sheep [136], transgenic rabbits expressing antisense constructs complementary to adenovirus RNA [137], and the transfer of the specific disease resistance gene Mx1 of mice into swine [138]. The mouse Mx1 gene is one of the few examples of a single genetic locus encoding a disease resistance trait. Mice carrying the autosomal dominant Mx1 allele are resistant to influenza viruses and transfer of the Mx1 gene into susceptible mice that lacked the Mx1 allele was sufficient to restore virus resistance [139]. Swine are susceptible to influenza and provide a substantial reservoir for swine influenza viruses. Different gene constructs containing the mouse Mx1 cDNA controlled by two constitutive promoters and the inducible murine Mx1 promoter were transferred into swine. Constitutive Mx1 expression was found to be detrimental to the organism and the inducible Mx1 construct responded to stimuli by RNA synthesis, although at levels insufficient to produce detectable amounts of Mx1 protein. This again emphasizes the importance of tight transgene regulation to a positive outcome from gene-transfer experiments [138]. “Congenital immunization” is defined as transgenic expression and germ-line transmission of a gene encoding an immunoglobulin specific for a pathogen and therefore providing congenital immunity without prior exposure to that pathogen. The approach was tested in farm animals by expressing the gene constructs encoding mouse monoclonal antibodies in transgenic rabbits, pigs, and sheep [140, 141]. Both experiments resulted in transgene expression but revealed also some unexpected findings, e.g. aberrant sizes of the transgenic antibody or little antigen-binding capacity. Following this idea, preformed antibodies against a virus causing a neonatal disease were expressed in the mammary gland of mice. Transferred to farm animals this could improve the protection of suckling offspring by use of colostral-delivered antibodies [142]. It remains to be investigated, however, whether the efforts required to optimize the concept of “congenital immunization” are justified by its benefits in terms of increasing disease resistance in a particular species. When following this route one has must also remember that a given infectious pathogen will be readily able to escape the transgenic animal’s immunity by changing its antigenic determinants. Transfer of antibody-encoding genes into farm animals is, in general, of great importance for production of therapeutic antibodies for human medicine (Refs [90, 143] and references cited therein). “Extracellular immunization” refers to transgene products with extracellular antipathogenic function. This strategy includes the systemic or local expression of immunomodulatory cytokines and pathogen defense molecules of the innate
17
18
1.9 Improved Animal Health
immune system [132]. Peptide-based antimicrobial defense is an evolutionarily ancient mechanism of host response found in a wide range of animals from insects to mammals. The small lytic peptides interact with lipid bilayer membranes to cause osmotic disruption and cell death. Bacterial, protozoan, fungal, and damaged eukaryotic cells are most susceptible to disruption [144]. Experiments with transgenic mice and fish have revealed the power of overexpressing antimicrobial peptides in generating enhanced resistance of the animals against invading microbes [145–147]. Lysostaphin is a potent bacterial peptidoglycan hydrolase with specific bactericidal activity against Staphylococcus aureus, the major contagious mastitis pathogen. Mammary gland-specific expression of lyostaphin could therefore enable production of mastitis-resistant cows and reduce the major economic burden of the dairy industry. Proof of principle of mammary gland-expressed lysostaphin conferring protection against stapylococcal infection has been obtained for mice [148]. By use of gene transfer via cloning by nuclear transfer this concept was successfully extended to cows [134]. Transgenic mice expressing a soluble form of a protein known as herpesvirus entry mediator were generated. The transgenic mice had nearly complete resistance to challenge with the alpha-herpesvirus, suggesting the potential of the approach for generating pseudorabies-resistant livestock [149]. 1.9.2 Gene Targeting of Susceptibility Genes
Another potential means of improving disease resistance is the removal of disease susceptibility genes by homologous recombination to create null alleles or to replace a disease allele by a resistance allele [14]. This concept is discussed for generation of cattle and sheep resistant to spongiform encephalopathies caused by infectious prion particles. Mice devoid of the endogenous prion protein PrPc cannot be infected with the infectious particles and the loss of function mice now have gross abnormalities [150]. Targeted inactivation of the gene encoding PrPc in cattle and sheep might therefore create BSE or scrapie-resistant animals. Successful targeting of the PrP locus in sheep and bovine fetal fibroblasts for use of nuclear transfer has been reported, and living PrP-deficient sheep and cattle are to be obtained [67, 70]. The physiological role of the endogenous prion protein and the genetic components of susceptibility to the disease are still largely unknown. (More information is available elsewhere [151, 152]). Future experiments will show whether fundamental differences between mice and ruminants will prevent the generation of such loss of function animals. An attractive alternative to gene targeting by homologous recombination is provided by RNAi technology which, in future, should enable modulation or downregulation of the genes involved in disease processes (see the discussion above and Ref. [153]).
1 Transgenic Modification of Production Traits in Farm Animals
1.10 Improved Biochemical Pathways
Transgenesis enables the transfer of genetic information across species barriers. Combined with functional promoter elements, nonmammalian genes can be expressed in farm animals to modify intermediary metabolism. To address the problem of environmental pollution with manure in pig production, transgenic pigs were produced which express the Escherichia coli phytase gene in the salivary gland. Consequently, the transgenic pigs can digest the phosphorus in phytate, the most abundant source of phosphorus in the pig diet, and so fecal phosphorus excretion by transgenic pigs is substantially reduced [154]. “Phosphorus-friendly” pigs contributing to solution of a common form of environmental problem might also help overcome public skepticism toward transgenic livestock (see below and Ref. [155]). The introduction of new biochemical pathways to increase the availability of specific nutrients that are currently rate-limiting in animal production is a challenging task. Research programs on transferring prokaryotic genes to ruminants to introduce cysteine, threonine, and lysine biosynthesis or a functional glyoxylate cycle (for conversion of the major rumen metabolite acetate to glucose) have so far failed [156]. The first example of a plant gene expressed in a complex mammalian system was provided by Saeki et al. [157]. The work of the group is part of an international effort to improve pig meat quality (carcass composition, see also above). A fatty acids desaturase gene from spinach, functionally expressed in pigs, led to an significant increase of polyunsaturated fatty acids in pork. This success may pave the way toward production of healthier porcine meat and to diversification of the range of products available from livestock [106, 157].
1.11 Improved Wool Production
Improvement of wool production by transgenesis can be achieved by generating an abundant supply of the cysteine required for keratin synthesis. Keratins are the major structural proteins of wool fibers and cysteine is the rate-limiting amino acid in wool production. Dietary addition of cysteine does not increase wool production because of digestive degradation of the compound. When bacterial cysteine biosynthesis genes were transferred into sheep, however, improved wool growth was not observed, because transgene regulation was not adequate to integrate the novel pathway into the existing biochemical homeostasis [158]. The second attempt at improving wool quality was directed at modification of the protein composition of the wool fiber. The gene encoding the wool intermediate filament keratin was overexpressed in transgenic sheep and alteration of the fiber ultrastructure was observed. The changes did not have a positive effect on the processing quality of the wool [159]. Further investigations are in progress, using
19
20
1.12 Transgenic Farm Animals Biosafety Issues, Animal Welfare, and Ethics
transgenes encoding keratins rich in the amino acids which have a positive effect on wool quality [160]. The third approach used to improve wool production is the targeted overexpression of growth factors (EGF, IGF-1) in wool follicles or skin [161, 162]. So far, none of the approaches has resulted in a novel transgenic breed with improved wool production traits.
1.12 Transgenic Farm Animals, Biosafety Issues, Animal Welfare, and Ethics
The biosafety of transgenics concerns the consumer and affects the environment and the transgenic animals. Evaluation of the food safety of transgenic animal products (novel food, nutraceuticals) is handled by national and international authorities (a review is available elsewhere [129]). Theoretically, meat or milk from transgenic farm animals generated for nonfood purposes could also be consumed. For example, the transgene in the “phosphorus-friendly” pig is expressed exclusively in the salivary gland; the meat, therefore, contains only the transgene DNA not the transgene product. For consumers’ safety, the risk of toxicity and of transfer of the ingested transgenes must be assessed. DNA is an essential part of nutrition and is not usually toxic upon uptake through the digestive tract. Large alimentary DNA fragments seem to survive gastrointestinal passage, enter the blood stream, and can be found in the nuclei of a variety of types of cell [163]. It is obvious, however, that this does not lead to vertical gene transfer and there is no reason why a transgene should integrate into a consumer’s genome preferentially compared with nonrecombinant DNA. Nevertheless, especially with regard to the relevance and frequency of transfer of selectable DNA sequences from genetically modified plants in the gut of mammals to bacteria the debate is still ongoing (Ref. [164] and references cited therein). The biorisks resulting from transgenesis in farm animals depend on the animal species, the method of gene transfer, the nature of the transgene, and the fate of the transgenics. Genetically modified organisms are not allowed to multiply uncontrolled in the environment. Large farm animals have little opportunity to escape and no chance of crossing with wild animals. More concern is warranted over possible escape of transgenic growth-enhanced fish from cage culture with access to free waters [165] and subsequent spread of the transgene into the natural population [166]. The fish in such cages must therefore be rendered sterile or they must be kept in artificial containment facilities. Physiochemical gene-transfer methods and cloning by nuclear transfer do not have intrinsic biorisks, because the DNA is stably integrated into the host genome. Viral vectors are generally liable to the risk of recombination with wildtype viruses that in turn might create the means to spread the transgene.
1 Transgenic Modification of Production Traits in Farm Animals
The major biorisks arising from transgenes are to the animals themselves (see below). All transferred DNA fragments should be characterized by sequencing. This may be not always be possible, however, especially for large gene constructs, for example artificial chromosomes. Transgenic animals designed for human consumption will be devoid of marker genes and other sequences not required for transgene function. Methods for the removal of such sequences are available (see above). A transgenic founder animal has, a priori, unknown biological properties and must be tested for stable integration and transmission of the transgene. The F1 generation can be tested for stable and promoter-specific, i.e. nonectopic expression of the transgene. Homozygous animals are produced to prove the freedom of insertional mutagenesis. It is obvious that before use of the transgenic animal for production purposes wanted and possible unwanted transgene effects are thoroughly checked by laboratory and veterinarian methods. Programs for the systematic assessment of risks associated with transgenic farm animal welfare and breeding have been developed and must be applied rigorously [167]. Environmental issues and animal welfare are the most serious public concerns about animal biotechnology. Scientific uncertainty often hinders good risk assessment of animal biotechnology. Ethical assessments must openly address these uncertainties, with the precautionary principle providing a good criterion for responsible policies. A practical method for ethical assessment of animal biotechnology has been proposed [168].
1.13 Conclusion
Gene-transfer technology enables the direct introduction of novel traits into farm animals. The biological performance of the transgene in the animal can be measured in a few generations. Breeding success can be achieved in a shorter time compared with classical breeding programs. Gene transfer can, however, be only performed in a limited number of animals. When a positive biological outcome of the artificially added or altered allele in the founder animal’s offspring is established, the novel trait has to be spread in the production population by conventional strategies. So far no genetically engineered food from farm animals has been made available commercially. This is because of the above mentioned difficulties in the generation of transgenic farm animals, the frequent failure to transfer the proof of principle success in basic research models to farm animals, and the lack of public acceptance of novel food. The reasons for this lack of acceptance, and the ethics of transgenics are discussed elsewhere [168, 169]. Farm animal transgenics is undoubtedly important for biomedicine. Even if public perception moved in favor of transgenic food and if optimized gene-transfer technology increased efficiency in the generation and exploitation of transgenics, most livestock-derived products would still be for niche markets only, mainly because of limitations in the dissemination of the transgene (introgression).
21
22
References
Farm animal transgenics, farm animal reproductive biotechnology, and farm animal genomics have developed in parallel [170–173]. These three important aspects of the technology will develop further in the years to come and the tools, taken together, will eventually lead to genetically modified farm animals that meet the demands of productivity and biosafety.
References 1 Gordon, J.W., F.H. Ruddle, Science 1981, 214, 1244-1246. 2 Gordon, J.W., G.A. Scangos, D.J. Plotkin, J.A. Barbosa, F.H. Ruddle, Proc. Natl. Acad. Sci.U S A 1980, 77, 7380-7384. 3 Clark, J., B. Whitelaw, Nat. Rev. Genet. 2003, 4, 825-833. 4 Ristevski, S., Mol. Biotechnol. 2005, 29, 153-164. 5 Düchler, M., M. Pengg, S. Schüller, F. Pfneisl, C. Bugingo, G. Brem, E. Wagner, K. Schellande, M. Müller, J. Gene Med. 2002, 4, 282-291. 6 Draghia-Akli, R., M.L. Fiorotto, L.A. Hill, P.B. Malone, D.R. Deaver, R.J. Schwartz, Nat. Biotechnol. 1999, 17, 1179-1183. 7 Dunham, S.P., Res. Vet. Sci. 2002, 73, 9-16. 8 Hammer, R.E., V.G. Pursel, C.E. Rexroad Jr., R.J. Wall, R.D. Palmiter, R.L. Brinster, Nature 1985, 315, 680-683. 9 Brem, G., B. Brenig, H.M. Goodman, R.C. Selden, F. Graf, B. Kruff, K. Springman, J. Hondele, J. Meyer, E.-L. Winnacker, H. Kräußlich, Reprod. Dom. Anim. 1985, 20, 251-252. 10 Keefer, C.L., Anim. Reprod. Sci. 2004, 82-83, 5-12. 11 Kues, W.A., H. Niemann, Trends Biotechnol. 2004, 22, 286-294. 12 Houdebine, L.M., Reprod. Domest. Anim. 2005, 40, 269-281. 13 Pursel, V.G., C.A. Pinkert, K.F. Miller, D.J. Bolt, R.G. Campbell, R.D. Palmiter, R.L. Brinster, R.E. Hammer, Science 1989, 244, 1281-1288. 14 Wheeler, M.B., E.M. Walters, S.G. Clark, Anim. Reprod. Sci. 2003, 79, 265-289. 15 Wall, R.J., Theriogenology 2002, 57, 189-201. 16 Webster, N.L., M. Forni, M.L. Bacci, R. Giovannoni, R. Razzini, P. Fantinati, A. Zannoni, L. Fusetti, L. Dalpra, M.R. Bianco, M. Papa, E. Seren, M.S. Sandrin,
17 18
19 20
21
22 23
24 25 26 27 28
29 30
31
I.F. Mc Kenzie, M. Lavitrano, Mol. Reprod. Dev. 2005, 72, 68-76. Houdebine, L.M., Reprod. Nutr. Dev. 2005, 45, 363-376. Brem, G., M. Müller, Large transgenic animals, in Animals with novel genes, N. Maclean, Editor. 1994, Cambridge University Press: Cambridge, UK. p. 179-244. Rijkers, T., A. Peetz, U. Rüther, Transgenic Res. 1994, 3, 203-215. Zinovieva, N., C. Lassnig, D. Schams, U. Besenfelder, E. Wolf, S. Müller, L. Frenyo, J. Seregi, M. Müller, G. Brem, Transgenic Res. 1998, 7, 437-447. Aigner, B., U. Besenfelder, J. Seregi, L.V. Frenyo, T. Sahintoth, G. Brem, Transgenic Res. 1996, 5, 405-411. Giraldo, P., L. Montoliu, Transgenic Res. 2001, 10, 83-103. Brem, G., U. Besenfelder, B. Aigner, M. Müller, I. Liebl, G. Schütz, L. Montoliu, Mol. Reprod. Dev. 1996, 44, 56-62. West, A.G., M. Gaszner, G. Felsenfeld, Genes Dev. 2002, 16, 271-288. Wall, R.J., Theriogenology 1996, 45, 57-68. Besenfelder, U., G. Brem, Theriogenology 1998, 50, 739-745. Besenfelder, U., J. Mödl, M. Müller, G. Brem, Theriogenology 1997, 47, 1051-1060. Besenfelder, U., N. Zinovieva, E. Dietrich, B. Sohnrey, W. Holtz, G. Brem, Vet. Rec. 1994, 135. Besenfelder, U., G. Brem, J. Reprod. Fert. 1993, 99, 53-56. Wetscher, F., V. Havlicek, T. Huber, M. Gilles, D. Tesfaye, J. Griese, K. Wimmers, K. Schellander, M. Muller, G. Brem, U. Besenfelder, Theriogenology 2005, 64, 30-40. Havlicek, V., F. Wetscher, T. Huber, G. Brem, M. Mueller, U. Besenfelder, J. Vet. Med. A Physiol. Pathol. Clin. Med. 2005, 52, 94-98.
1 Transgenic Modification of Production Traits in Farm Animals 32 Jaenisch, R., Proc. Natl. Acad. Sci. USA 1976, 73, 1260-1264. 33 Temin, H.M., Genome 1989, 31, 17-22. 34 Pfeifer, A., I.M. Verma, Annu. Rev. Genomics Hum. Genet. 2001, 2, 177-211. 35 Chan, A.W., E.J. Homan, L.U. Ballou, J.C. Burns, R.D. Bremel, Proc. Natl. Acad. Sci. USA 1998, 95, 14028-14033. 36 Cabot, R.A., B. Kuhholzer, A.W. Chan, L. Lai, K.W. Park, K.Y. Chong, G. Schatten, C.N. Murphy, L.R. Abeydeera, B.N. Day, R.S. Prather, Anim. Biotechnol. 2001, 12, 205-214. 37 Pannell, D., J. Ellis, Rev. Med. Virol. 2001, 11, 205-217. 38 Whitelaw, C.B., Trends Biotechnol. 2004, 22, 157-159; discussion 159-160. 39 Pfeifer, A., Transgenic Res. 2004, 13, 513-522. 40 Lois, C., E.J. Hong, S. Pease, E.J. Brown, D. Baltimore, Science 2002, 295, 868-872. 41 Hofmann, A., V. Zakhartchenko, M. Weppert, H. Sebald, H. Wenigerkind, G. Brem, E. Wolf, A. Pfeifer, Biol. Reprod. 2004, 71, 405-409. 42 Hofmann, A., B. Kessler, S. Ewerling, A. Kabermann, G. Brem, E. Wolf, A. Pfeifer, Mol. Ther. 2006, 13, 59-66. 43 Capecchi, M.R., Nat. Genet. 2000, 26, 159-161. 44 Familari, M., L. Selwood, Mol. Reprod. Dev. 2006, 73, 123-131. 45 Gjorret, J.O., P. Maddox-Hyttel, Reprod. Fertil. Dev. 2005, 17, 113-124. 46 Willadsen, S.M., Nature 1986, 320, 63-65. 47 Wilmut, I., A.E. Schnieke, J. McWhir, A.J. Kind, K.H.S. Campbell, Nature 1997, 385, 810-813. 48 Campbell, K.H.S., J. McWhir, W.A. Ritchie, I. Wilmut, Nature 1996, 380, 64-66. 49 Wells, D.N., P.M. Misica, H.R. Tervit, Biol. Reprod. 1999, 60, 996-1005. 50 Zakhartchenko, V., V. Alberio, M. Stojkovic, K. Prelle, W. Schernthaner, P. Stojkovic, H. Wenigerkind, R. Wanke, M. Düchler, R. Steinborn, M. Müller, G. Brem, E. Wolf, Mol. Reprod. Dev. 1999, 54, 264-272. 51 Kato, Y., T. Tani, Y. Sotomaru, K. Kurokawa, J. Kato, H. Doguchi, H. Yasue, Y. Tsunoda, Science 1998, 282, 2095-2098. 52 Baguisi, A., E. Behboodi, D.T. Melican, J.S. Pollock, M.M. Destrempes, C. Cam-
53
54
55
56
57
58
59
60
61
62
63
64 65
muso, J.L. Williams, S.D. Nims, C.A. Porter, P. Midura, M.J. Palacios, S.L. Ayres, R.S. Denniston, M.L. Hayes, C.A. Ziomek, H.M. Meade, R.A. Godke, W.G. Gavin, E.W. Overstrom, Y. Echelard, Nat. Biotechnol. 1999, 17, 456-461. Betthauser, J., E. Forsberg, M. Augenstein, L. Childs, K. Eilertsen, J. Enos, T. Forsythe, P. Golueke, G. Jurgella, R. Koppang, T. Lesmeister, K. Mallon, G. Mell, P. Misica, M. Pace, M. Pfister-Genskow, N. Strelchenko, G. Voelker, S. Watt, S. Thompson, M. Bishop, Nat. Biotechnol. 2000, 18, 1055-1059. Onishi, A., M. Iwamoto, T. Akita, S. Mikawa, K. Takeda, T. Awata, H. Hanada, A.C. Perry, Science 2000, 289, 1188-1190. Polejaeva, I.A., S.H. Chen, T.D. Vaught, R.L. Page, J. Mullins, S. Ball, Y. Dai, J. Boone, S. Walker, D.L. Ayares, A. Colman, K.H. Campbell, Nature 2000, 407, 86-90. Chesné, P., P.G. Adenot, C. Viglietta, M. Baratte, L. Boulanger, J.-P. Renard, Nat. Biotechnol. 2002, 20, 366-369. Woods, G.L., K.L. White, D.K. Vanderwall, G.P. Li, K.I. Aston, T.D. Bunch, L.N. Meerdo, B.J. Pate, Science 2003, 301, 1063. Galli, C., I. Lagutina, G. Crotti, S. Colleoni, P. Turini, N. Ponderato, R. Duchi, G. Lazzari, Nature 2003, 424, 635. Shin, T., D. Kraemer, J. Pryor, L. Liu, J. Rugila, L. Howe, S. Buck, K. Murphy, L. Lyons, M. Westhusin, Nature 2002, 415, 859. Lee, B.C., M.K. Kim, G. Jang, H.J. Oh, F. Yuda, H.J. Kim, M.H. Shamim, J.J. Kim, S.K. Kang, G. Schatten, W.S. Hwang, Nature 2005, 436, 641. Campbell, K.H., R. Alberio, I. Choi, P. Fisher, R.D. Kelly, J.H. Lee, W. Maalouf, Reprod. Domest. Anim. 2005, 40, 256-268. Cibelli, J.B., S.L. Stice, P.J. Golueke, J.J. Kane, J. Jerry, C. Blackwell, F.A. Ponce de Leon, J.M. Robl, Science 1998, 280, 1256-1258. Schnieke, A.E., A.J. Kind, W.A. Ritchie, K. Mycock, A.R. Scott, M. Ritchie, I. Wilmut, A. Colman, K.H.S. Campbell, Science 1997, 278, 2130-2133. Wells, K., Nat. Biotechnol. 2001, 19, 529-530. Piedrahita, J.A., Theriogenology 2000, 53, 105-116.
23
24
References 66 Dai, Y., T.D. Vaught, J. Boone, S.H. Chen, C.J. Phelps, S. Ball, J.A. Monahan, P.M. Jobst, K.J. McCreath, A.E. Lamborn, J.L. Cowell-Lucero, K.D. Wells, A. Colman, I.A. Polejaeva, D.L. Ayares, Nat. Biotechnol. 2002, 20, 251-255. 67 Denning, C., S. Burl, A. Ainslie, J. Bracken, A. Dinnyes, J. Fletcher, T. King, M. Ritchie, W.A. Ritchie, M. Rollo, P. de Sousa, A. Travers, I. Wilmut, A.J. Clark, Nat. Biotechnol. 2001, 19, 559-562. 68 Lai, L., D. Kolber-Simonds, K.W. Park, H.T. Cheong, J.L. Greenstein, G.S. Im, M. Samuel, A. Bonk, A. Rieke, B.N. Day, C.N. Murphy, D.B. Carter, R.J. Hawley, R.S. Prather, Science 2002, 295, 10891092. 69 McCreath, K.J., J. Howcroft, K.H.S. Campbell, A. Colman, A.E. Schnieke, A.J. Kind, Nature 2000, 405, 1066-1069. 70 Kuroiwa, Y., P. Kasinathan, H. Matsushita, J. Sathiyaselan, E.J. Sullivan, M. Kakitani, K. Tomizuka, I. Ishida, J.M. Robl, Nat. Genet. 2004, 36, 775-780. 71 Cibelli, J.B., K.H. Campbell, G.E. Seidel, M.D. West, R.P. Lanza, Nat. Biotechnol. 2002, 20, 13-14. 72 Renard, J.P., Q. Zhou, D. LeBourhis, P. Chavatte-Palmer, I. Hue, Y. Heyman, X. Vignon, Theriogenology 2002, 57, 203-222. 73 Lanza, R.P., J.B. Cibelli, D. Faber, R.W. Sweeney, B. Henderson, W. Nevala, M.D. West, P.J. Wettstein, Science 2001, 294, 1893-1894. 74 Wilmut, I., Nat. Med. 2002, 8, 215-216. 75 Perry, M.M., H.M. Sang, Transgenic Res. 1993, 2, 125-133. 76 Love, J., C. Gribbin, C. Mather, H. Sang, Biotechnology 1994, 12, 60-63. 77 Salter, D.W., E.J. Smith, S.H. Hughes, S.E. Wright, A.M. Fadly, R.L. Witter, L.B. Crittenden, Poult. Sci. 1986, 65, 14451458. 78 Iba, H., Dev. Growth Differ. 2000, 42, 213-218. 79 Harvey, A.J., G. Speksnijder, L.R. Baugh, J.A. Morris, R. Ivarie, Nat. Biotechnol. 2002, 19, 396-399. 80 Ivarie, R., Trends Biotechnol. 2003, 21, 14-19. 81 Lillico, S.G., M.J. McGrew, A. Sherman, H.M. Sang, Drug Discovery Today 2005, 10, 191-196. 82 Stern, C.D., Dev. Cell 2005, 8, 9-17.
83 Zbikowska, H.M., Transgenic Res. 2003, 12, 379-389. 84 Rocha, A., S. Ruiz, A. Estepa, J.M. Coll, Mar. Biotechnol. (NY) 2004, 6, 118-127. 85 Dorer, D.R., Transgenic Res. 1997, 6, 3-10. 86 Garrick, D., S. Fiering, D.I.K. Martin, E. Whitelaw, Nat. Genet. 1998, 18, 56-59. 87 Saffery, R., K.H. Choo, J. Gene Med. 2002, 4, 5-13. 88 Vos, J.M., Curr. Opin. Mol. Ther. 1999, 1, 204-215. 89 Robl, J.M., P. Kasinathan, E.J. Sullivan, Y. Kuroiwa, K. Tomizuka, I. Ishida, Theriogenology 2003, 59, 107-113. 90 Kuroiwa, Y., P. Kasinathan, Y.J. Choi, R. Naeem, K. Tomizuka, E.J. Sullivan, J.G. Knott, A. Duteau, R.A. Goldsby, B.A. Osborne, I. Ishida, J.M. Robl, Nature Biotechnol. 2002, 20, 889-894. 91 Hohn, B., A.A. Levy, H. Puchta, Curr. Opin. Biotechnol. 2001, 12, 139-143. 92 Baer, A., J. Bode, Curr. Opin. Biotechnol. 2001, 12, 473-480. 93 Gorman, C., C. Bullock, Curr. Opin. Biotechnol. 2000, 11, 455-460. 94 Coates, C.J., J.M. Kaminski, J.B. Summers, D.J. Segal, A.D. Miller, A.F. Kolb, Trends Biotechnol. 2005, 23, 407-419. 95 Kolb, A.F., C.J. Coates, J.M. Kaminski, J.B. Summers, A.D. Miller, D.J. Segal, Trends Biotechnol. 2005, 23, 399-406. 96 Mittal, V., Nat. Rev. Genet. 2004, 5, 355-365. 97 Novina, C.D., P.A. Sharp, Nature 2004, 430, 161-164. 98 Shinagawa, T., S. Ishii, Genes Dev. 2003, 17, 1340-1345. 99 Maga, E.A., Trends Biotechnol. 2005, 23, 533-535. 100 Verrinder Gibbins, A.M., Anim. Biotechnol. 1998, 9, 173-179. 101 Verrinder Gibbins, A.M., Nat. Biotechnol. 1998, 16, 1013-1014. 102 Palmiter, R.D., R.L. Brinster, R.E. Hammer, M.E. Trumbauer, M.G. Rosenfeld, N.C. Birnberg, R.M. Evans, Nature 1982, 360, 611-615. 103 Solomon, M.B., V.G. Pursel, E.W. Paroczay, D.J. Bolt, J. Anim. Sci. 1994, 72, 1242-1246. 104 Pinkert, C.A., E.J. Galbreath, C.W. Yang, L.J. Striker, Transgenic Res. 1994, 3, 401-405.
1 Transgenic Modification of Production Traits in Farm Animals 105 Ebert, K.M., T.E. Smith, F.C. Buonomo, E.W. Overstrom, M.J. Low, Anim. Biotechnol. 1990, 1, 145-159. 106 Niemann, H., Proc. Natl. Acad. Sci. U S A 2004, 101, 7211-7212. 107 Nottle, M.B., H. Nagashima, P.J. Verma, Z.T. Du, C.G. Grupen, S.M. McIlfatrick, R.J. Ashman, M.P. Harding, C. Giannakis, P.L. Wigley, I.G. Lyons, D.T. Harrison, B.G. Luxford, R.G. Campbell, R.J. Crawford, A.J. Robins, Production and analysis of transgenic pigs containing a metallothionein procine growth hormone gene construct, in Transgenic animals in agriculture, J.D. Murray, et al., Editors. 1999, CAB International: Wallingford UK. p. 145-156. 108 Pursel, V.G., A.D. Mitchell, G. Bee, T.H. Elsasser, J.P. McMurtry, R.J. Wall, M.E. Coleman, R.J. Schwartz, Anim. Biotechnol. 2004, 15, 33-45. 109 Bowen, R.A., M.L. Reed, A. Schnieke, G.E. Seidel, J.A. Stacey, W.K. Thomas, O. Kajikawa, Biol. Reprod. 1994, 50, 664-668. 110 Bellinge, R.H., D.A. Liberles, S.P. Iaschi, A. O’Brien P, G.K. Tay, Anim. Genet. 2005, 36, 1-6. 111 McPherron, A.C., A.M. Lawler, S.J. Lee, Nature 1997, 387, 83-90. 112 Yang, J., T. Ratovitski, J.P. Brady, M.B. Solomon, K.D. Wells, R.J. Wall, Mol. Reprod. Dev. 2001, 60, 351-361. 113 Pirottin, D., L. Grobet, A. Adamantidis, F. Farnir, C. Herens, H. Daa Schroder, M. Georges, Proc. Natl. Acad. Sci. U S A 2005, 102, 6413-6418. 114 Du, S.J., Z. Gong, G.L. Fletcher, M.A. Shears, M.J. King, D.R. Idler, C.L. Hew, Biotechnology 1992, 10, 176-181. 115 Devlin, R.H., T.Y. Yesaki, C.A. Biagi, E.M. Donaldson, P. Swanson, W.-K. Chan, Nature 1994, 371, 209-210. 116 Devlin, R.H., C.A. Biagi, T.Y. Yesaki, D.E. Smailus, J.C. Byatt, Nature 2001, 409, 781-782. 117 Devlin, R.H., L.F. Sundstrom, W.M. Muir, Trends Biotechnol. 2005. 118 Karatzas, C.N., Nat. Biotechnol. 2003, 21, 138-139. 119 Brophy, B., G. Smolenski, T. Wheeler, D. Wells, P. L’Huillier, G. Laible, Nat. Biotechnol. 2003, 21, 157-162. 120 Krimpenfort, P., A. Rademakers, W. Eyestone, A. van der Schans, S. van
den Broek, P. Kooiman, E. Kootwijk, G. Platenburg, F. Pieper, R. Strijker, H. DeBoer, Bio/Technology 1991, 9, 844-847. 121 Maga, E.A., G.B. Anderson, M.C. Huang, J.D. Murray, Transgenic Res. 1994, 3, 36-42. 122 van Berkel, P.H.C., M.M. Welling, M. Geerts, H.A. van Veen, B. Ravensbergen, M. Salaheddine, E.K.J. Pauwels, F. Pieper, J.H. Nuijens, P.H. Nibbering, Nat. Biotechnol. 2002, 20, 484-487. 123 Thomassen, E.A., H.A. van Veen, P.H. van Berkel, J.H. Nuijens, J.P. Abrahams, Transgenic Res. 2005, 14, 397-405. 124 Kumar, S., A.R. Clarke, M.L. Hooper, D.S. Horne, A.J.R. Law, J. Leaver, A. Springbett, E. Stevenson, J.P. Simons, Proc. Natl. Acad. Sci. USA 1994, 91, 61386142. 125 Stinnakre, M.G., J.L. Vilotte, S. Soulier, J.C. Mercier, Proc. Natl. Acad. Sci. USA 1994, 91, 6544-6548. 126 Stacey, A., A. Schnieke, M. Kerr, A. Scott, C. McKee, I. Cottingham, B. Binas, C. Wilde, A. Colman, Proc. Natl. Acad. Sci. USA 1995, 92, 2835-2839. 127 L’Huillier, P.J., S. Soulier, M.G. Stinnakre, L. Lepourry, S.R. Davis, J.C. Mercier, J.L. Vilotte, Proc. Natl. Acad. Sci. USA 1996, 93, 6698-6703. 128 Jost, B., J.L. Vilotte, I. Duluc, J.L. Rodeau, J.N. Freund, Nat. Biotechnol. 1999, 17, 160-164. 129 Brower, V., Nat. Biotechnol. 1998, 16, 728-731. 130 Reh, W.A., E.A. Maga, N.M. Collette, A. Moyer, J.S. Conrad-Brink, S.J. Taylor, E.J. DePeters, S. Oppenheim, J.D. Rowe, R.H. BonDurant, G.B. Anderson, J.D. Murray, J. Dairy Sci. 2004, 87, 3510-3514. 131 Wheeler, M.B., J. Anim. Sci. 2003, 81 Suppl 3, 32-37. 132 Muller, M., G. Brem, Rev. Sci. Tech. 1998, 17, 365-378. 133 Muller, M., G. Brem, J. Biotechnol. 1996, 44, 233-242. 134 Wall, R.J., A.M. Powell, M.J. Paape, D.E. Kerr, D.D. Bannerman, V.G. Pursel, K.D. Wells, N. Talbot, H.W. Hawk, Nat. Biotechnol. 2005, 23, 445-451. 135 Donovan, D.M., D.E. Kerr, R.J. Wall, Transgenic Res. 2005, 14, 563-567.
25
26
References 136 Clements, J.E., L.B. Hu, L. Lindstrom, A. Powell, C. Rexroad, M.C. Zink, AIDS Res. Hum. Retroviruses 1996, 12, 421-423. 137 Ernst, L.K., V.I. Zakcharchenko, N.M. Suraeva, T.I. Ponomareva, O.I. Miroshnichenko, M.I. Prokof’ev, T.I. Tikchonenko, Theriogenology 1990, 35, 1257-1271. 138 Muller, M., B. Brenig, E.L. Winnacker, G. Brem, Gene 1992, 121, 263-270. 139 Arnheiter, H., S. Skuntz, M. Noteborn, S. Chang, E. Meier, Cell 1990, 62, 51-61. 140 Weidle, U.H., H. Lenz, G. Brem, Gene 1991, 98, 185-191. 141 Lo, D., V. Pursel, P.J. Linto, E. Sandgren, R. Behringer, C. Rexroad, R.D. Palmiter, R.L. Brinster, Eur. J. Immunol. 1991, 21, 25-30. 142 Saif, L.J., M.B. Wheeler, Nat. Biotechnol. 1998, 16, 334-335. 143 Grosse-Hovest, L., S. Muller, R. Minoia, E. Wolf, V. Zakhartchenko, H. Wenigerkind, C. Lassnig, U. Besenfelder, M. Muller, S.D. Lytton, G. Jung, G. Brem, Proc. Natl. Acad. Sci. U S A 2004, 101, 6858-6863. 144 Zasloff, M., Nature 2002, 415, 389-395. 145 Yarus, S., J.M. Rosen, A.M. Cole, G. Diamond, Proc. Natl. Acad. Sci. USA 1996, 93, 14118-14121. 146 Reed, W.A., P.H. Elzer, F.M. Enright, J.M. Jaynes, J.D. Morrey, K.L. White, Transgenic Res. 1997, 6, 337-347. 147 Jia, X., A. Patrzykat, R.H. Devlin, P.A. Ackerman, G.K. Iwama, R.E. Hancock, Appl. Environ. Microbiol. 2000, 66, 19281932. 148 Kerr, D.E., K. Plaut, A.J. Bramley, C.M. Williamson, A.J. Lax, K. Moore, K.D. Wells, R.J. Wall, Nat. Biotechnol. 2001, 19, 66-70. 149 Ono, E., K. Amagai, S. Taharaguchi, Y. Tomioka, S. Yoshino, Y. Watanabe, P. Cherel, L.M. Houdebine, M. Adam, M. Eloit, M. Inobe, T. Uede, Proc. Natl. Acad. Sci. U S A 2004, 101, 16150-16155. 150 Bueler, H., A. Aguzzi, A. Sailer, R.A. Greiner, P. Autenried, M. Aguet, C. Weissmann, Cell 1993, 73, 1339-1347. 151 Weissmann, C., Cell 2005, 122, 165-168. 152 Weissmann, C., A. Aguzzi, Annu. Rev. Med. 2005, 56, 321-344. 153 Hunter, C.V., L.S. Tiley, H.M. Sang, Trends Mol. Med. 2005, 11, 293-298.
154 Golovan, S.P., R.G. Meidinger, A. Ajakaiye, M. Cottrill, M.Z. Wiederkehr, D.J. Barney, C. Plante, J.W. Pollard, M.Z. Fan, M.A. Hayes, J. Laursen, J.P. Hjorth, R.R. Hacker, J.P. Phillips, C.W. Forsberg, Nat. Biotechnol. 2001, 19, 741-745. 155 Ward, K.A., Nat. Biotechnol. 2001, 19, 415-416. 156 Ward, K.A., Trends Biotechnol. 2000, 18, 99-102. 157 Saeki, K., K. Matsumoto, M. Kinoshita, I. Suzuki, Y. Tasaka, K. Kano, Y. Taguchi, K. Mikami, M. Hirabayashi, N. Kashiwazaki, Y. Hosoi, N. Murata, A. Iritani, Proc. Natl. Acad. Sci. U S A 2004, 101, 6361-6366. 158 Bawden, C.S., A.V. Sivaprasad, P.J. Verma, S.K. Walker, G.E. Rogers, Transgenic Res. 1995, 4, 87-104. 159 Bawden, C.S., B.C. Powell, S.K. Walker, G.E. Rogers, Transgenic Res. 1998, 7, 273-287. 160 Bawden, C.S., B.C. Powell, S.K. Walker, G.E. Rogers, Exp. Dermatol. 1999, 8, 342-343. 161 Damak, S., H.Y. Su, N.P. Jay, D.W. Bullock, Bio/Technology 1996, 14, 185-188. 162 Powell, B.C., S.K. Walker, C.S. Bawden, A.V. Sivaprasad, G.E. Rogers, Reprod. Fertil. Dev. 1994, 6, 615-623. 163 Palka-Santini, M., B. Schwarz-Herzke, M. Hosel, D. Renz, S. Auerochs, H. Brondke, W. Doerfler, Mol. Genet. Genomics 2003, 270, 201-215. 164 Heritage, J., Nat. Biotechnol. 2004, 22, 170-171. 165 Reichhardt, T., Nature 2000, 406, 10-12. 166 Muir, W.M., R.D. Howard, Proc. Natl. Acad. Sci. USA 1999, 96, 13853-13856. 167 Van Reenen, C.G., T.H.E. Meuwissen, H. Hopster, K. Oldenbroek, T.A.M. Kruip, H.J. Blokhuis, J. Anim. Sci. 2001, 79, 1763-1779. 168 Kaiser, M., Rev. Sci. Tech. 2005, 24, 75-87. 169 Davies, K.G., Trends Biotechnol. 2001, 19, 424-427. 170 Niemann, H., W. Kues, J.W. Carnwath, Rev. Sci. Tech. 2005, 24, 285-298. 171 Bulfield, G., Trends Biotechnol. 2000, 18, 10-13. 172 Fadiel, A., I. Anidi, K.D. Eichenbaum, Nucleic Acids Res. 2005, 33, 6308-6318. 173 Basrur, P.K., W.A. King, Rev. Sci. Tech. 2005, 24, 31-49.
2 Genetically Modified Plants Susanne Stirn and Horst Lörz
2.1 Methods for Establishing Genetically Modified Plants
As an introduction to genetically modified plants, we would first like to describe the methods of transformation currently used and the molecular requirements for stable introduction and expression of the genes of interest.
2.1.1 Transformation Methods
In general, two different means of transfer of foreign DNA into plant cells can be distinguished: 1. vector-mediated transformation (via Agrobacterium); and 2. direct gene-transfer methods.
2.1.1.1 Agrobacterium Transformation In the first method the natural ability of the bacterial phytopathogen Agrobacterium to transfer DNA into plant cells is exploited. Agrobacterium tumefaciens and Agrobacterium rhizogenes are soil microorganisms that induce crown gall tumors and hairy root disease, respectively, on a wide range of dicotyledonous plants and some monocotyledonous plants. For plant transformation, mainly A. tumefaciens is used; this bacterium contains a large tumor-inducing plasmid (Ti). During infection, a specific segment of the plasmid DNA, referred to as T-DNA (transferred DNA), is inserted into the plant genome. The T-DNA contains genes for phytohormones which are responsible for cell proliferation and for formation of the crown gall, and genes for the formation of special nutrients (opines) in the plant cell [1]. When Agrobacterium is used as a tool in genetic engineering these genes are deleted and replaced by the genes of interest. This is possible because only the 25 bp T-DNA border sequences on the right and left border are needed for DNA transfer. A wide
28
2.1 Methods for establishing genetically Modified Plants
variety of such “disarmed” (nontumor-inducing) vectors have been developed. Agrobacterium-mediated transformation is the most commonly used method for most dicotyledonous plants [2]. Advantages include the typical insertion of only one or a few copies of the transgene [3] and the transfer of relatively large segments of DNA with only minimal rearrangements [4].
2.1.1.2 Direct Gene Transfer For many years, Agrobacterium could not be used to transform monocotyledonous and other recalcitrant species, so direct gene-transfer methods were developed as an alternative. These include DNA uptake into protoplasts (protoplast transformation) and the shooting of DNA-coated particles into tissues (particle bombardment). Transformation of protoplasts In contrast with animal cells, plant cells have a solid cell wall which is the first barrier to overcome when foreign genes are to be transferred into them. One way of circumventing this barrier is to use plant cells of which the wall has been digested enzymatically, resulting in so-called protoplasts. DNA uptake into protoplasts can then be stimulated by the use of either poly(ethylene glycol) (PEG-transformation) or electric pulses (electroporation). When an appropriate protoplast-to-plant regeneration system is available, large numbers of transformed clones can be regenerated to afford fertile transgenic plants [5]. When a barrier to gene transfer has not been detected, virtually every protoplast system has proven transformable, although with substantial differences in efficiency [5]. Problems can, however, arise in the regeneration of fertile plants from protoplasts, because the regeneration is strongly species and genotype-dependant, and undesired somaclonal variation can occur, because of the relatively long tissue culture phase [6]. One advantage of protoplast transformation method is its great independence from other patented techniques. Particle bombardment The new method of using high-velocity microprojectiles to deliver DNA into plant tissue was developed by Sanford and colleagues in 1987 [7]. A particle gun is used to accelerate DNA-coated microprojectiles into cells, past the cell wall and the cell membrane. The microprojectile is small enough (0.5–5 μm) to enter the plant cell without causing too much damage yet is large enough to penetrate the cell wall and carry an appropriate amount of DNA on its surface [8]. The main advantage of particle bombardment is the absence of the biological incompatibilities observed when using biological vectors. Organelles such as chloroplasts have also been transformed by use of particle bombardment. Unfortunately, particle bombardment and other direct DNA uptake methods often result in complex insertion loci, which can cause gene silencing [2, 3].
2 Genetically Modified Plants
2.1.2 Tissue Requirements
The ability to cultivate plant tissue in vitro is a prerequisite in almost all current transformation procedures. Transformation requires competent (i.e. transformable) cultured cells that are embryogenic or organogenic. Plant cells suitable for regeneration are either cocultivated with Agrobacterium or bombarded. For Agrobacterium transformation, leaf disks or immature embryos are usually used for particle bombardment of monocotyledonous plant scutellar tissues.
2.1.3 Molecular Requirements
A typical plant gene consists of a promoter, a coding sequence, a transcription terminator, and a polyadenylation signal. The expression level of the gene is mainly determined by these components, but can also be affected by the surrounding sequences.
2.1.3.1 Promoter The promoter is the main determinant of the expression pattern in the transgenic plant. Constitutive promoters direct expression in all or almost all tissues, irrespective of developmental or environmental signals. The promoter directing the synthesis of the cauliflower mosaic virus 35S RNA is the most frequently used constitutive promoter; other constitutive promoters, for example the nopaline synthase (nos) promoter or the octopine synthase (ocs) promoter, are derived from agrobacterial T-DNA. Both are mainly used in dicotyledonous plants [9]. For monocotyledonous plants, promoters from the rice actin 1 gene (act1) [10] or the maize ubiquitin 1 gene (ubi1) [11] are usually used. To enhance expression levels, the first intron of the respective genes has been added to the expression cassettes [12]. In dicotyledonous plants, addition of introns seems to have fewer pronounced effects on the expression level. Nevertheless, insertion of an intron is always necessary when expression of the gene product in bacteria must be completely avoided (e.g. for genes conferring bacterial resistance – Section 2.3.1.3). When transgene expression should be directed at certain tissues or developmental stages, regulated promoters are required. Promoter elements responsible for expression in seeds, tubers, vegetative organs, and leaves have been isolated. Environmental effects can induce gene expression after wounding, heat or cold stress, or anaerobiosis. The use of natural inducible promoters has the disadvantage of causing pleiotropic effects, because endogenous genes will also be turned on [9]. Chemically induced promoters are favored for production of pharmaceuticals in transgenic plants, because production of the desired compound can be restricted to a certain time.
29
30
2.1 Methods for establishing genetically Modified Plants
2.1.3.2 Codon Usage Expression of the gene of interest can also be affected at the level of translation. Because codon usage differs between plants and bacteria, removal of rare codons, e.g., codons not frequently used in plant cells, from genes of bacterial origin can enhance expression substantially. This was first described for a modified Bacillus thuringiensis toxin gene, for which expression was enhanced up to one-hundredfold [13].
2.1.3.3 Selectable Marker and Reporter Genes In plant transformation systems, the efficacy of stable gene transfer is low; hence systems are required which enable the selection of the transformed cells. A selection system consists of a selective agent (which interferes with plant metabolism) and a selectable marker gene (which codes for a protein, enabling inactivation or evasion of the selective agent) [14]. The most commonly used selectable marker genes in transgenic plants code for antibiotic or herbicide resistance including the following. Antibiotic resistance genes • nptII gene: The neo or nptII gene, isolated from transposon Tn5 from Escherichia coli K12 codes for neomycin phosphotransferase (NPTII). This enzyme detoxifies a range of aminoglycoside antibiotics, for example neomycin, kanamycin, and geneticin [15]. These antibiotics are added to the culture medium after the transformation procedure. Only transformed cells or tissues will survive and will be regenerated to plants. • hpt gene: The hpt gene has been isolated from E. coli and codes for hygromycin phosphotransferase, which detoxifies the antibiotic hygromycin B. Most plant tissues are more sensitive to hygromycin B than to kanamycin or geneticin. In particular, cereals which are resistant to kanamycin and geneticin can be selected with hygromycin [14]. • bla gene: The blaTEM-1 gene codes for the TEM-1 β-lactamase, the most encountered ampicillin resistance marker in molecular biology. TEM-1 β-lactamase attacks narrow-spectrum cephalosporins and all the anti-Gram-negative-bacterium penicillins, except temocillin. Ampicillin resistance in transgenic plants is not usually used as selectable marker for plant transformation but is a remnant of the transformation method. With direct gene transfer methods it is used as a selectable marker during the cloning procedure before plant transformation. When present on the plasmid used for transformation, the ampicillin resistance gene is transferred and integrated together with the genes of interest, and remains under the control of its prokaryotic promoters [16]. • aadA gene: The aadA gene confers resistance to streptomycin and spectinomycin. The gene has been found in association with several transposons (Tn7, Tn21, …) and is ubiquitous among Gram-negative bacteria [15].
2 Genetically Modified Plants
Herbicide resistance genes • bar/pat gene: The bar gene from Streptomyces hygroscopicus and the pat gene from S. viridichromogenes code for phosphinotricin acetyltransferase (PAT) which confers resistance to the herbicide compound phosphinotricin [17]. It is an inhibitor of glutamine synthetase, a plant enzyme involved in ammonia assimilation. Besides phosphinotricin, the commercially available nonselective herbicides Basta and Bialaphos can be used as selective agent. Selection can be applied in the culture medium or by spraying of regenerated plantlets [14]. • EPSPS gene: The EPSPS gene codes for the enzyme 5-enolpyruvylshikimate5-phosphate synthase (EPSPS), which is involved in the skimatic acid pathway of aromatic amino acid biosynthesis. EPSPS is present in all plants, bacteria, and fungi, but not in animals. The nonselective herbicide glyphosate binds to and inactivates EPSPS. By transferring a glyphosate-resistant EPSPS gene from the soil bacterium Agrobacterium strain CP4 to plants, glyphosate-resistant crop plants have been obtained. Glyphosate is the active ingredient of the commercially available herbicide Roundup [18]. Reporter genes In contrast with selectable marker genes, reporter genes do not confer resistance to selective agents inhibitory to plant development. Reporter genes code for products which can be detected directly or catalyze reactions whose products are detectable [14]. • gusA gene: The gusA (uidA) gene encodes β-glucuronidase (GUS), which hydrolyzes a wide range of β-glucuronides [19]. Substrates for GUS are available for spectrometric, fluorimetric, and histochemical assays. The GUS reporter gene system enables easy quantification with high sensitivity [14]. One disadvantage of this system is its nonviability: examined cells and tissues cannot be regenerated into transgenic plants. This system is, therefore, mainly used to optimize a specific transformation procedure. • luc gene: The luciferase reporter gene assay use bioluminescence reactions with substrate–enzyme combinations which lead to detectable light emission. The luc gene originates from the firefly Photinus pyralis, and codes for a luciferase which decarboxylates beetle luciferin. In contrast with the GUS reporter system, the luciferase reporter gene is nonlethal to plant cells [20, 21]. Alternative marker and excision systems Because of discussion of the possible risk of transfer of antibiotic resistance genes from transgenic plants to clinically important microorganisms, alternative marker systems have been developed. Also, by use of excision systems the presence of antibiotic or herbicide resistance genes in the final product can be avoided [22]. • Alternative markers: Several alternative marker systems have recently been developed. For example, Chua and coworkers [23] successfully selected transgenic plants using an inducible Agrobacterium gene encoding for isopentenyltransferase (IPT). This enzyme catalyzes the first step in biosynthesis of cytokinins, a class of phytohormones. Only cells containing this gene are able to form shoots and differentiate into mature plants [23].
31
32
2.2 GM Plants Already on the Market (EU, USA, Canada, Japan)
As another alternative selection system, phosphomannose isomerase (PMI) was successfully used in transgenic sugar beet and maize. PMI catalyzes the interconversion of mannose-6-phosphate and fructose-6-phosphate. PMI is absent from most plants except leguminous plants and therefore only transgenic plants expressing the E. coli manA gene can survive on media containing mannose as a carbon source [24]. • Excision systems: Another approach is the use of recombination systems which enable the excision of marker genes in the successfully transformed plant. Four different site-specific recombination systems have been shown to function in plant cells. The best-characterized system in plants is the CRE/lox system of bacteriophage P1: the CRE recombinase enzyme specifically recognizes and catalyzes recombination between two lox sequences. Marker genes flanked by these lox sites can be precisely excised in the presence of the CRE recombinase. One disadvantage of the system was that the CRE protein had to be introduced in the transgenic plant via secondary transformation or sexual crossing with a CRE transformant [25]. When inducible developmental stage promoter or tissue-specific promoter are used, both components of the CRE/lox system can be transferred to one transformant. After selection of the transformants the promoter will be intentionally induced, resulting in excision of the marker gene [26, 27]. This system is also applicable to vegetatively propagated plants. A recent publication describes the efficient excision of selectable marker genes which are framed by attP-sites without the induction of a recombinase. The molecular basis of the reaction is still unknown, but presumably it is because of illegitimate recombination. Further experiments are necessary to reveal the underlying mechanism and to verify its general applicability [28, 29].
2.2 GM Plants Already on the Market (EU, USA, Canada, Japan)
In Europe, 23 genetically modified (crop) plants (GMPs) or products thereof have been approved for commercial use. These approvals covered different uses as applied for by the applicant. Approval usually covers the import and processing of genetically modified plants. Three genetically modified maize lines (Bt 176, Mon 810, T25) have also been approved for cultivation (Table 2.1). Nevertheless, few commercial plantings have been conducted in Europe (mainly Spain), and in Germany GMPs are grown only on an experimental scale. Worldwide, GMPs were grown on 81 million hectares in 2004, according to ISAAA, an increase of 20% in comparison with 2003. The rise in area is mainly because of increased planting of insect-resistant maize and cotton (+25%). Since 1996 the global area of transgenic crops has increased more than forty-sevenfold, with an increasing proportion grown by developing countries. The main producers of GMPs are the USA (47.6 million hectares), Argentina (16.2 million hectares), Canada (5.4 million hectares), Brazil (5 million hectares), China (3.7 million
2 Genetically Modified Plants Tab. 2.1 Genetically modified crop plants and products approved in the EU [30]. Plant (line)
Trait (gene)
Applicant
Approved use
Year
Soybean (GTS-40-3-2)
HR (CP4 EPSPS)
Monsanto
Import and processing
1996
Maize (Bt 176)
IR (cryIAb), HR (bar), ABR (bla)
Ciba–Geigy
Cultivation; import and processing
1997
Maize (Bt 11)
IR (cryIAb), HR (pat)
Northrup King
Import and processing; food use
1998; 2004
Maize (MON 810)
IR (cryIAb)
Monsanto
Cultivation; flour, semolina, starch and starch products, oil
1998; 1997
Maize (MON 809)
IR (cryIAb), HR (CP4 EPSPS, gox)
Pioneer
Food additives
1998
Maize (T 25)
HR (pat), ABR (partial bla)
AgrEvo
Cultivation; refined oil, starch 1998 and starch products, fermented or heat-treated products from maize flour
Maize (NK 603) HR (CP4 EPSPS)
Monsanto
Import and processing
2004
Maize (MON 863)
IR (cryIIIBb2), ABR (nptII)
Monsanto
Import and processing
2005
Maize (GA 21)
HR (maize EPSPS)
Monsanto
Processed food
2005
Maize (TC 1507)
IR (cryIFa2), HR (pat)
Mycogen/Pio- Food and feed use neer
Oil-seed rape (MS1 × RF1; MS1 × RF2)
MS/RF PGS (barnase/barstar), HR (bar), ABR (nptII)
Oil-seed rape (MS8 × RF3)
MS/RF (barnase/barstar), HR (bar)
PGS
Refined oil
1999
Oil-seed rape (HCN 92 = Topas 19/2)
HR (pat), ABR (nptII)
AgrEvo
Import and processing (feed); refined oil
1997
Oil-seed rape HR (pat) (HCN 28 = T45)
AgrEvo
Import and processing
2005
Oil-seed rape (GT 73)
HR (CP4 EPSPS, gox)
Monsanto
Refined oil
1997
Cotton (MON 1445/1698)
HR (CP4 EPSPS), ABR (nptII, aad)
Monsanto
Refined oil
2002
2005
Cultivation (breeding purposes); 1997 refined oil
33
34
2.2 GM Plants Already on the Market (EU, USA, Canada, Japan) Tab. 2.1 (continued) Plant (line)
Trait (gene)
Applicant
Approved use
Year
Cotton (MON 531/757/1076)
IR (cryIAc), ABR (nptII, aad)
Monsanto
Refined oil
2002
Cotton (MON 15985)
IR (cryIAc, cryIAb), ABR (nptII, aad), RP (uidA)
Monsanto
Refined oil
2002
HR = herbicide resistance (glyphosate resistance CP4 EPSPS gene, glyphosate resistance oxidoreductase gene (gox), glufosinate resistance pat or bar gene); ABR = antibiotic resistance (ampicillin resistance (bla), kanamycin resistance (nptII)), streptomycin resistance gene (aad); IR = insect resistance (Bacillus thuringiensis cryIA(b)); MS = male sterility (barnase); RF = restorer of fertility (barstar)
hectares), Paraguay (1.2 million hectares), India (0.5 million hectares), and South Africa (0.5 million hectares) [32, 33]. Genetically modified soybeans occupied 48.4 million hectares; GM maize was planted on 19.3 million hectares, transgenic cotton on 9.0 million hectares, and GM oil-seed rape on 4.3 million hectares. Fifty-six percent of global soybean production is now genetically modified and the percentage of GMPs in cotton, oil-seed rape, and maize is 28, 19, and 14%, respectively. Approximately 72% of GMPs contain a herbicide resistance gene, followed by 19% carrying insect resistance genes, and 9% carrying both herbicide and insectresistance genes (stacked genes). The two dominant crop–trait combinations in 2004 were herbicide-resistant soybean occupying 48.4 million hectares (or 60% of the global biotech area and grown in nine countries) and Bt maize (occupying 11.2 million hectares, equivalent to 14% of global biotech area and also grown in nine countries) [32]. 2.2.1 Herbicide Resistance in Soybean, Maize, Oil-seed rape, Sugar Beet, Wheat, Rice, and Cotton
As mentioned above, herbicide resistance is the leading trait in commercialized GMP, with 23 lines having been approved for cultivation and/or food and feed use worldwide (Table 2.2). 2.2.2 Insect Resistance in Maize, Potatoes, Tomatoes, and Cotton
Insect resistance is the trait found second most often in approved GMPs. Insectresistant lines, and lines which acquire an insect-resistance gene in combination with a herbicide resistance or virus resistance gene, are listed in Table 2.3.
2 Genetically Modified Plants Tab. 2.2 Herbicide-resistant crop plants and products worldwide [30, 31]. Plant (line)
Trait (gene)
Applicant
Country
Soybean (GTS-40-3-2)
HR (CP4 EPSPS)
Monsanto
Argentina, Australia, Brazil, Canada, China, Czech Republic, EU, Japan, Korea, Mexico, Philippines, Russia, Switzerland, South Africa, Taiwan, UK, Uruguay, USA
Soybean (A 2704-12, A 2704-21, A 5547-35)
HR (pat)
AgrEvo
Canada, Japan, USA
Soybean (A 5547-127)
HR (pat), ABR (partial bla)
AgrEvo
USA
Soybean (GU 262)
HR (pat), ABR (partial bla)
AgrEvo
USA
Soybean (W 62, W 98)
HR (bar), RP (gus)
AgrEvo
USA
Maize (GA 21)
HR (maize EPSPS)
Monsanto
Argentina, Australia, Canada, China, EU, Japan, Korea, Philippines, Taiwan, USA
Maize (NK 603)
HR (CP4 EPSPS)
Monsanto
Argentina, Australia, Canada, EU, Japan, Philippines, Taiwan, South Africa, USA
Maize (MON 832)
HR (CP4 EPSPS, gox), ABR (nptII)
Monsanto
Canada
Maize (B 16 = DLL 25)
HR (bar), ABR (bla)
DeKalb
Canada, Japan, Philippines, Taiwan, USA
Maize (T 14, T 25)
HR (pat), ABR (partial bla)
AgrEvo
Argentina, Australia, Canada, EU, Japan, Philippines, Taiwan, USA
Oil-seed rape (GT 73)
HR (CP4 EPSPS, gox)
Monsanto
Australia, Canada, China, EU, Japan, Philippines, USA
Oil-seed rape (GT 200)
HR (CP4 EPSPS, gox)
Monsanto
Canada, USA
Oil-seed rape (HCN 92 = Topas 19/2)
HR (pat), ABR (nptII)
AgrEvo
Canada, EU, Japan, USA
Oil-seed rape (HCN 10)
HR (pat)
AgrEvo
Canada, Japan, USA
Oil-seed rape (HCN 28 = T 45)
HR (pat)
AgrEvo
Australia, Canada, EU, Japan, USA
35
36
2.2 GM Plants Already on the Market (EU, USA, Canada, Japan) Tab. 2.2 (continued) Plant (line)
Trait (gene)
Applicant
Country
Oil-seed rape (Oxy 235)
HR (bxn)
Rhone Poulenc
Australia, Canada, Japan, USA
Brassica rapa (ZSR 500, 501, 502)
HR (CP4 EPSPS, gox)
Monsanto
Canada
Cotton (MON 1445/1698)
HR (CP4 EPSPS), ABR (nptII, aad)
Monsanto
Argentina, Australia, Canada, China, EU, Japan, Philippines, South Africa, USA
Cotton (BXN)
HR (bxn), ABR (nptII)
Calgene
Australia, Canada, Japan, USA
Cotton (LL Cotton 25)
HR (bar)
Bayer Crop Science
Canada, USA
Cotton (19-51A)
HR (als)
DuPont
USA
Cotton (MON 88913)
HR (CP4 EPSPS)
Monsanto
USA
Sugar beet (T120-7)
HR (pat), ABR (nptII)
AgrEvo
Canada, Japan, USA
Sugar beet (GTSB 77)
HR (CP4 EPSPS, gox)
Novartis
Australia, Philippines, USA
Sugar beet (H7-1)
HR (CP4 EPSPS)
Monsanto
Philippines, USA
Wheat (MON 71800)
HR (CP4 EPSPS)
Monsanto
USA
Rice (LLRICE 06, 62)
HR (bar)
AgrEvo
USA
Flax (FP967)
HR (als) ABR (nptII)
University of Canada, USA Saskatoon
HR = herbicide resistance (glyphosate resistance CP4/maize EPSPS gene, glyphosate resistance oxidoreductase gene (gox), glufosinate resistance pat or bar gene, romoxynil herbicide resistance nitrilase gene (bxn), sulfonylurea resistance als gene); ABR = antibiotic resistance (ampicillin resistance gene bla, kanamycin resistance gene nptII, streptomycin resistance gene (aad)); RP = reporter gene (gus)
2.2.3 Virus-resistance, Male Sterility, Delayed Fruit Ripening, and Fatty Acid Content of GMPs
GMPs with virus resistance (potato, squash, and papaya; Table 2.4), male sterility (oil-seed rape, maize, and chicory; Table 2.5), delayed fruit ripening (tomato; Table 2.6) and modified fatty acid content (soybean, oil-seed rape; Table 2.7) have also been approved in some countries.
2 Genetically Modified Plants Tab. 2.3 Insect-resistant crop plants and products worldwide [30, 31]. Plant (line)
Trait (gene)
Applicant
Country
Maize (MON 810)
IR (cryIAb)
Monsanto
Argentina, Australia, Canada, China, EU, Korea, Japan, Philippines, South Africa, Switzerland, Taiwan, USA
Maize (MON 802)
IR (cryIAb), HR (CP4 EPSPS, gox), ABR (nptII)
Monsanto
Canada, Japan, USA
Maize (MON 80100)
IR (cryIAb), HR (CP4 EPSPS, gox), ABR (nptII)
Monsanto
USA
Maize (MON 863)
IR (cryIIIBb2), ABR (nptII)
Monsanto
Australia, Canada, EU, Japan, Philippines, Taiwan, USA
Maize (MON 88017)
IR (cryIIIBb1), HR (CP4 EPSPS)
Monsanto
USA
Maize (MON 809)
IR (cryIA(b)), HR (CP4 EPSPS, gox)
Pioneer
Canada, Japan, USA
Maize (Bt 176)
IR (cryIAb), HR (bar), ABR (bla)
Ciba–Geigy
Argentina, Australia, Canada, EU, Japan, Philippines, Switzerland, Taiwan, USA
Maize (Bt 11)
IR (cryIAb), HR (pat)
Northrup King (Syngenta)
Argentina, Australia, Canada, China, EU, Korea, Japan, Philippines, Russia, Taiwan, South Africa, Switzerland, UK, Uruguay, USA
Maize (DBT 418)
IR (cryIAc, protease inhibitor II (pinII)); HR (bar), ABR (bla)
DeKalb
Argentina, Australia, Canada, Japan, Philippines, Taiwan, USA
Maize (TC1507)
IR (cryIFa2), HR (pat)
Mycogen/ Pioneer
Argentina, Canada, EU, Japan, Philippines, South Africa, Taiwan, USA
Maize (DAS-06275-8)
IR (cryIF), HR (bar)
Dow Agro Sciences
USA
Maize (DAS-59122-7)
IR (cry34Ab1, cry35AB1), Dow Agro HR (pat) Sciences
USA
Potato (Bt 6, Russet Burbank New Leaf)
IR (cryIIIA), ABR (nptII)
Canada, Japan, Philippines, USA
Monsanto
37
38
2.2 GM Plants Already on the Market (EU, USA, Canada, Japan) Tab. 2.3 (continued) Plant (line)
Trait (gene)
Applicant
Country
Potato (ATBT04-6 etc., 4 lines Atlantic and Superior New Leaf)
IR (cryIIIA), ABR (nptII)
Monsanto
Australia, Canada, Japan, Philippines, USA
Potato (SEMT 15-15, New Leaf Y)
IR (cryIIIA), VR (coat protein PVY) ABR (nptII, aad)
Monsanto
Australia, Canada, Philippines, USA
Potato (RBTM 21-350, Russet Burbank New Leaf Plus)
IR (cryIIIA), VR (replicase PLRV, helicase PLRV) ABR (nptII)
Monsanto
Australia, Canada, Japan, Philippines, USA
Cotton (MON 531, 757, 1076, Bollgard)
IR (cryIAc), ABR (nptII, aad)
Monsanto
Argentina, Australia, Brazil, Canada, China, India, Japan, Mexico, Philippines, South Africa, USA
Cotton (MON 15985, Bollgard II)
IR (cryIAc, cryIAb), ABR (nptII, aad), RP (uidA)
Monsanto
Australia, Canada, EU, Japan, Philippines, USA
Cotton (31807/31808)
IR (cryIAc), HR (bxn) ABR (nptII)
Calgene
Japan, USA
Cotton (3006-210-23)
IR (cryIAc), HR (pat)
Dow AgroSciences
Mexico, USA
Cotton (281-24-236)
IR (cryIFa2), HR (pat)
Dow AgroSciences
Mexico, USA
Tomato (5345)
IR (cryIAc), ABR (nptII, aad)
Monsanto
Canada, USA
IR = insect resistance (delta endotoxin genes of Bacillus thuringiensis (cryIAb, cryIAc, cryIIIA, cryIFa2; protease inhibitor II (pinII)); HR = herbicide resistance (glyphosate resistance CP4 EPSPS gene, glyphosate resistance oxidoreductase gene (gox), glufosinate resistance pat or bar gene, bromoxynil herbicide resistance nitrilase gene (bxn)); VR = virus resistance (potato virus Y (PVY) coat protein gene, replicase and helicase gene of potato leafroll virus (PLRV), respectively); ABR = antibiotic resistance (ampicillin resistance (bla), kanamycin resistance (nptII), streptomycin resistance (aad)); RP = reporter gene (beta-D-glucuronidase (gus))
2 Genetically Modified Plants Tab. 2.4 Virus-resistant crop plants and products worldwide [31]. Plant (line)
Trait (gene)
Applicant
Country
Potato (SEMT 15-15, New Leaf Y)
VR (coat protein PVY), IR (cryIIIA), ABR (nptII, aad)
Monsanto
Australia, Canada, Philippines, USA
Potato (RBTM 21-350, Russet Burbank New Leaf Plus)
VR (replicase PLRV, helicase PLRV), IR (cryIIIA), ABR (nptII)
Monsanto
Australia, Canada, Japan, Philippines, USA
Squash (CZW-3)
VR (coat protein CMV, coat protein ZYMV, coat protein WMV 2), ABR (nptII)
Asgrow
Canada, USA
Squash (ZW20)
VR (coat protein ZYMV, Upjohn coat protein WMV 2)
Canada, USA
Papaya (55-1/63-1)
VR (coat protein PRSV), Cornell University RP (gus), ABR (nptII)
Canada, USA
VR = virus resistance (coat protein genes of potato virus Y (PVY), cucumber mosaic virus (CMV), zucchini yellows mosaic virus (ZYMV) and watermelon mosaic virus (WMV) 2, respectively; replicase and helicase genes of potato leafroll virus (PLRV)); IR = insect resistance (delta endotoxin gene of Bacillus thuringiensis (cryIIIA)); ABR = antibiotic resistance (kanamycin resistance (nptII), streptomycin resistance (aad)); RP = reporter gene (gus)
Tab. 2.5 Male sterility in crop plants worldwide [30, 31]. Plant (line)
Trait (gene)
Applicant
Country
Oil-seed rape (MS1, RF1 (PGS1))
MS (barnase), FR (barstar), HR (bar), ABR (nptII)
PGS
Australia, Canada, EU, Japan, USA
Oil-seed rape (MS1, RF2 (PGS2))
MS (barnase), FR (barstar), HR (bar), ABR (nptII)
PGS
Australia, Canada, EU, Japan, USA
Oil-seed rape (MS8 × RF3)
MS (barnase), FR (barstar), HR (bar)
PGS
Australia, Canada, Japan, USA
Oil-seed rape (PHY14, PHY35)
MS (barnase), FR (barstar), HR (bar)
PGS
Japan
39
40
2.2 GM Plants Already on the Market (EU, USA, Canada, Japan) Tab. 2.5 (continued) Plant (line)
Trait (gene)
Applicant
Country
Oil-seed rape (PHY36)
MS (barnase), HR (bar), ABR (bla)
PGS
Canada, USA
Maize (MS3)
MS (barnase), HR (bar), ABR (bla)
PGS
Japan
Maize (MS6)
MS (barnase), HR (bar), ABR (bla)
PG
USA
Maize (676, 678, 680)
MS (dam), HR (pat)
Pioneer
USA
Chicory (RM3-3, RM3-4, RM3-6)
MS (barnase), HR (bar), ABR (nptII)
Bejo Zaden
EU, USA
MS = male sterility (barnase from Bacillus amyloliquefaciens, dam (DNA adenine methylase from E. coli); FR = fertility restoration (barstar from Bacillus amyloliquefaciens); HR = herbicide resistance (glufosinate resistance bar gene); ABR = antibiotic resistance (ampicillin resistance (bla), kanamycin resistance (nptII))
Tab. 2.6 Delayed fruit ripening in tomatoes and tomato products worldwide [31]. Plant (line)
Trait (gene)
Applicant
Country
Tomato (FLAVR SAVR)
DR (PG, anti-sense) ABR (nptII)
Calgene
Canada, Japan, Mexico, USA
Tomato (B, Da, F)
DR (PG, sense or antisense) ABR (nptII)
Zeneca
Canada, USA
Tomato (8338)
DR (ACCd) ABR (nptII)
Monsanto
USA
Tomato (35 1 N)
DR (sam-K) ABR (nptII)
Agritope
USA
Tomato (1345-4)
DR (ACC, sense) ABR (nptII)
DNA Plant Canada, USA Technology Corporation
DR = delayed ripening (polygalacturonase gene in sense or anti-sense direction (PG); 1-aminocyclopropane-1-carboxylic acid deaminase gene (ACCd); S-adenosylmethionine hydrolase gene with Kozak consensus sequence (sam-K); aminocyclopropane cyclase synthase gene in sense orientation (ACC)); ABR = antibiotic resistance (kanamycin resistance (nptII))
2 Genetically Modified Plants Tab. 2.7 Modified fatty acid content in crop plants and products worldwide [31]. Plant (line)
Trait (gene)
Applicant
Country
Soybean (G94-1, G94-19, G168, high-oleic soybean)
MFA (GmFad2-1), ABR (bla), RG (gus)
DuPont
Australia, Canada, Japan, USA
Oil-seed rape (23-18-17, 23-198, high-laurate canola)
MFA (BayTE), ABR (nptII)
Calgene
Canada, USA
MFA = modified fatty acid content (delta 12 desaturase gene (GmFad2-1); thioesterase gene from Umbellaria californica (Bay TE); ABR = antibiotic resistance (ampicillin resistance (bla), kanamycin resistance (nptII)); RP = reporter gene (gus)
2.3 GM Plants “In the Pipeline” 2.3.1 Input Traits
The following sections contain selected examples of studies being conducted in the genetic engineering of crop plants. First, attempts to reduce the production costs of crop plants are summarized. These are studies of crop plants with genetically engineered resistance against insects, diseases, and abiotic stresses, and with improved agronomic properties.
2.3.1.1 Insect Resistance The best-characterized insecticidal proteins are the delta-endotoxins of Bacillus thurigiensis (B. t.-toxins), which have been used as biopesticides in agriculture (and organic farming), forestry, and as a mosquito vector control for many years. B. t. insecticidal activity is highly specific in that the endotoxins are nontoxic to nontarget insects, birds, and mammals. Besides the commercially available B. t.-maize, potato, cotton, and tomato lines (Table 2.3), insect-resistant rice (cryIAb and cryIAc) [34, 35], soybeans (cryIAc) [36], oil-seed rape (cryIAc) [37] and eggplants (cryIIIB) [38] have been developed. Field trials have also been performed in the USA with insect-resistant sunflower, lettuce, grapefruit, sugarcane, apple, walnut, grape, and peanut [39]. To control corn rootworm infections, Mycogen c/o Dow AgroSciences and Pioneer Hi-Bred have developed transgenic maize which contains two novel proteins from Bacillus thuringiensis strain PS149B1. These proteins belong to another class of insecticidal proteins with no homology to the delta-endotoxins (Bt PS149B1 toxins) [40, 41].
41
42
2.3 GM Plants “In the Pipeline”
Another approach used to obtain insect-resistant plants is to use plant defense proteins such as proteinase inhibitors [42, 43], lectins [44] or alpha-amylase inhibitor [45]. Lectins are thought to confer resistance toward sap-sucking insects (e.g. the rice brown planthopper) which act as vector for virus transmission [44]. Since the publication of Ewen and Pusztai, the possible toxic effects of the snowdrop lectin on mammals have been widely discussed [45, 46]. Morton and colleagues transferred the alpha-amylase inhibitor 1 gene from beans to peas and conducted field trials with the insect-resistant pea plants; they reported high insect mortality in transgenic plants [47]. One advantage of using alpha-amylase inhibitor genes is the long history of human consumption of beans and the fact that bean alpha-amylase has no effect on starch digestion in humans [47]. In an attempt to confer broad-spectrum resistance to storage pests, maize was transformed with the chicken avidin gene [48]. Because the mode of action of avidin is to cause a deficiency of the vitamin biotin in insects, thorough safety testing for human consumption must be conducted before commercial use of biotin maize.
2.3.1.2 Virus, Fungal, Bacterial, and Nematode Resistance Virus resistance One strategy used to obtain virus-resistant plants is to transfer genes from the pathogen itself into the plant (pathogen-derived resistance). The most widely used approach is to express the virus coat protein in transgenic plants. In theory, the expression of viral genes disrupts viral infection or symptom development. All but one of the commercially available virus-resistant plants contain viral coat proteins (Table 2.4), and this technique has been extended to other plants, for example rice [49], plum tree [50], tomato [51], pea [52], and peanut [53]. Field trials have also been performed, in the USA, with coat protein-mediated virusresistant wheat, soybean, sugarcane, sugar beet, cucumber, sweet potato, grapefruit, pineapple, and papaya [39]. Another form of pathogen-derived resistance is the use of viral replicase genes (or RNA-dependent RNA polymerase genes), which presumably act by post-transcriptional gene silencing. This technique has been used to confer resistance to potato leafroll virus in potato (Table 2.4), to barley yellow dwarf virus in oats, cucumber mosaic virus in tomato, rice tungro spherical virus in rice, and wheat streak mosaic virus in wheat [54–57]. Because different degrees of virus resistance have been obtained with coat protein-mediated resistance, attempts have been made to ameliorate resistance against cucumber mosaic virus via satellite RNA, especially in tomato [58, 59]. This approach has caused controversy, however, because a single-point mutation in the satellite RNA can transform it into a harmful necrogenic form [60]. To protect plants against more than one virus, ribosome-inactivating proteins (RIPs) have been expressed in transgenic plants. RIPs are strong inhibitors of protein synthesis and, depending on the plant species from which they originate, they have different levels of toxicity against different hosts. Poke weed antiviral protein
2 Genetically Modified Plants
(PAP) confers resistance to PVX and PVY in transgenic potatoes and PAPII confers resistance to TMV, PVX, and fungal infections in tobacco [61, 62]. On a more experimental scale are approaches to achieve virus resistance by using antibodies against the virus coat protein. Such antibodies can neutralize virus infection, presumably by interacting with newly synthesized coat protein and disrupting viral particle formation [63, 64]. Similar to RIPs, broad-spectrum antibodies might be used to protect plants against a wider range of viruses, as has been demonstrated for poty viruses [64]. Fungal resistance Fungal resistance can be conferred by activation of specific self-defense mechanisms in the plant. One of the mechanisms is the so-called hypersensitive response (HR), which enables plants to enclose the pathogen in the infected area by formation of necrotic lesions. HR induces many defense-related signal molecules such as salicylic acid, ethylene, and phytoalexin. HR is also characterized by an accumulation of pathogenesis-related (PR) proteins that include fungal cell wall-degrading enzymes, antimicrobial peptides, thionins, lipid-transfer proteins, and proteinase inhibitors [65]. In rice, the introduction of chitinase and thaumatin-like protein led to increased resistance to sheath blight (Rhizoctonia solani) [66–68]. Enhanced resistance to the rice blast fungus Magnaporthe grisea was observed on constitutive expression of chitinase and defense-related protein genes in transgenic rice [69, 70]. Pathogenesis-related proteins from plants have been used to confer fungal resistance in alfalfa [71], cucumber [72], oil-seed rape [73], tomatoes [74], wheat [75–77], grape vine [78], and oranges [79]. Other antifungal genes of plant origin are genes for RIPs [80], genes for phytoalexins [81–84], and anthocyanin genes [85]. An example of an antifungal gene from nonplant sources which has been transferred to plants is the human lysozyme gene [86]. In the USA field trials have been performed with fungus-resistant wheat, barley, maize, soybean, potato. rice, bananas, and cotton using different antifungal proteins [39]. Individual PR-proteins, however, have a narrow spectrum of antifungal activity, and must function collectively to provide modest but long-term resistance. Research is, therefore, currently focusing on genes from mycoparasitic fungi as a means of improving resistance to fungal pathogens. An endochitinase of the mycoparasitic fungus Trichoderma harzianum has been transferred to tobacco and potato, and has been reported to confer a high level and broad spectrum of resistance [87]. When transferred to apple, however, the endochitinase of Trichoderma harzianum increased resistance to apple scab but also reduced plant growth [88]. A similar approach has been taken by transferring to wheat an antifungal protein from a virus that persistently infects Ustilago maydis. Transgenic wheat plants had increased resistance against stinking mut (Tilletia tritici) [89]. For a comprehensive survey of the different approaches used to achieve fungal resistance in transgenic plants see Tables 1 and 2 in Ref. [90].
43
44
2.3 GM Plants “In the Pipeline”
Bacterial resistance Resistance to bacterial infections is not yet as well developed as virus and fungal resistance, partly because bacterial diseases are a major problem only in crop plants such as potato, tomato, rice, and some fruit trees. The most efficient form of protection is genetic resistance, which is based on single dominant or semidominant genes. These R genes usually confer race-specific resistance, and their effectiveness is based on their interaction with complementary pathogen avirulence (AV) genes in the pathogen, the so called gene-forgene interaction [91]. Resistance to bacterial blight caused by Xanthomonas oryzae pv. oryzae was achieved by transferring the resistance gene Xa21 from a wild rice species to the elite indica rice variety “IR72” [92]. In the same way, the resistance gene Bs2 from pepper was transferred to tomato, which then had resistance to bacterial spot disease [93]. The tomato disease resistance gene Pto gives race-specific resistance to Pseudomonas syringae pv. tomato carrying the avrPto gene. By overexpressing Pto race-nonspecific resistance was observed in transgenic tomatoes [94]. Resistance based on single dominant gene expression always bears the danger of early evolution of counter-resistance in the pathogen as a result of the emergence of strains that no longer express the specific avirulence gene product [93]. Therefore, new resistance genes are being investigated for use in pyramiding strategies (combination of resistance genes against the same pathogen, but with different targets). One example is the AP1 gene from sweet pepper which delays the hypersensitive response when expressed in transgenic rice plants and which can be used in combination with Xa21 or other resistance genes [95]. Similarly to fungal resistance, overexpression of PR proteins or transfer of PR protein genes from other sources has led to enhanced resistance against bacterial infections – expression of barley lipid transfer protein LTP2 resulted in enhanced tolerance to bacterial pathogens in transgenic tobacco plants [96]. In several plant species, bifunctional enzymes with lysozyme activity have been detected which are thought to be involved in defense against bacteria. After transfer of the bacteriophage T4 lysozyme gene, transgenic potatoes had reduced susceptibility toward Erwinia carotovora atroseptica infections [97]. Transfer of the human lysozyme gene to tobacco led to enhanced resistance against both fungal and bacterial diseases [98]. Plant defense responses also involve production of active oxygen species, for example hydrogen peroxide (H2O2). This mechanism was exploited by transferring a fungal gene encoding H2O2-generating glucose oxidase to potato plants. The transgenic potato tubers had strong resistance to Erwinia carotovora subsp. carotovora infections, which cause bacterial soft rot disease, and enhanced resistance to potato late blight, caused by Phytophthora infestans [99]. Insects produce antimicrobial peptides as a major defense response to pathogen attack. These include sarcotoxins, cecropins, and attacins. The last of these have been transferred to apples and pears which then had improved resistance to Erwinia amylovora, which causes fire blight [100, 101]. Sarcotoxins seem to confer greater anti-bacterial activity and a broader spectrum of resistance, as indicated by experiments with transgenic tobacco [65]. Similarly, the expression of synthetic
2 Genetically Modified Plants
antimicrobial peptide chimeras in transgenic tobacco led to broad-spectrum resistance against both bacterial and fungal pathogens [102]. Bacteria-resistant grapes, transformed with the antibiotic protein mangainin from toads, are being field tested in the USA [39]. Nematode resistance In the USA, field tests are being conducted with nematoderesistant soybeans, carrots, tomatoes, potatoes, and pineapples [39]. In carrot, tomato, potato, and pineapple cysteine proteinase inhibitors from cowpea and rice have been expressed in the transgenic plants. Proteinase inhibitors are an important aspect of natural plant defense strategies. The cowpea trypsin inhibitor (CpTI), a serine proteinase inhibitor, and oryzacystatin (Oc-I), an inhibitor of cysteine proteinase, have been shown to be effective against proteinases of a cyst nematode. After site-directed mutagenesis of the latter, the modified cystatin had enhanced efficacy as a transgene against potato cyst nematode. In field trials no detrimental effect on plant growth was observed in transgenic potatoes [103]. When two partial nematode-resistant potato varieties were transformed with the cystatin, full resistance to potato cyst nematode Globodera was achieved [104]. Cysteine proteinase inhibitors are of particular interest because they are the only class of proteinase that is not expressed in the digestive system of mammals [105].
2.3.1.3 Tolerance Against Abiotic Stress The effects of weather, erosion, and depleted soils expose plants to a variety of stresses. Genetic engineering has been used to provide plants with additional stress response genes to counteract these environmental stresses. These genes can be grouped into two categories: 1. genes that respond directly against a particular stress; and 2. genes that regulate stress gene expression and signal transduction. Transfer or overexpression of both types of gene has been used in transgenic approaches to enhance tolerance against abiotic stresses. In the following section, salt, drought, and cold stress are considered together, because on a cellular basis all act as dehydration stress. Genes conferring dehydration-stress tolerance to transgenic plants Plants react to these stresses by displaying complex, quantitative traits that involve the function of many genes. Expression of these genes leads to the accumulation of low-molecular-weight components, for example osmolytes, synthesis of late-embryogenesisabundant (LEA) proteins, and activation of detoxifying enzymes. In transgenic approaches, genes for the enzymes responsible for production of these compounds have been transferred to nontolerant plants. Most of these studies have been performed in model plants such as Arabidopsis or tobacco, but some investigations have been extended to food crops such as rice. Bajaj and coworkers summarized results from these studies in a recent review [106]. After transfer of genes encoding enzymes for osmoprotectants such as glycinebetaine [107], proline [108] or putrescine [109], transgenic rice plants had
45
46
2.3 GM Plants “In the Pipeline”
increased tolerance to salt and drought stress. Constitutive overexpression of the oat arginine decarboxylase gene in rice led to severely affected developmental patterns [109]. When the arginine decarboxylase gene was under control of an ABAinducible promoter, an increase in biomass was observed for transgenic rice plants under salinity-stress conditions [110]. Transgenic rice plants expressing the arginine decarboxylase gene (adc) from Datura produced high levels of the polyamine putrescine under stress; this protected the plants from drought [111]. The expression of an LEA protein in transgenic rice plants led to increased tolerance to water deficit and salt stress in the plants [112]. As it is believed that abiotic stress primarily affects plants by causing oxidative damage; genes for detoxifying enzymes have been transferred to sensitive plants. McKersie et al. [113] showed that transgenic alfalfa overexpressing Mn superoxide dismutase, which reduces free radicals, was more tolerant of water deficit and freezing and had better winter survival rates. It is envisaged that use of stress-inducible promoters and the introduction of multiple genes will improve dehydration-stress tolerance [106]. Regulatory genes encoding transcription factors Another promising approach for conferring tolerance to dehydration stress is to transfer regulatory genes. Because the products of these genes regulate gene expression and signal transduction under stress conditions, their overexpression can activate the expression of many stress-tolerance genes simultaneously. Overexpression of the transcription factor DREB1A in transgenic Arabidopsis led to increased tolerance to drought, salt, and freezing stresses. The constitutive overexpression of DREB1A also resulted in severe growth retardation under normal growth conditions, however. In contrast, the stress-inducible expression of this gene had minimal effects on plant growth, and provided greater tolerance to stress conditions than genes driven by the 35S promoter [106, 114]. Drought-tolerant wheat lines transformed with DREB1A are currently being field tested in Mexico [115]. Lee and colleagues [116] cloned the functional homolog of the yeast Dbf2 kinase that enhances salt, drought, cold, and heat tolerance on overexpression in yeast and in transgenic plant cells. Use of this gene to engineer transgenic crops with enhanced stress tolerance has still to be demonstrated, however [116]. Additional genes that confer tolerance to salt stress The detrimental effects of salt on plants are a consequence both of a water deficit, resulting in osmotic stress, and of the effects of excess sodium ions on key biochemical processes. To tolerate high levels of salts, plants should be able to use ions for osmotic adjustment and should be able to distribute these ions internally to keep sodium away from the cytosol. The first transgenic approaches introduced genes that modulated cation-transport systems. Hence, transgenic tomato plants overexpressing a vacuolar Na+/H+ antiport were able to grow, flower, and produce fruits in the presence of 200 mM sodium chloride [117].
2 Genetically Modified Plants
Overexpression of the HAL1 gene from yeast in transgenic tomato plants had a positive effect on salt tolerance by reducing K+ loss and reducing intracellular Na+ from the cells under salt stress [118]. Genes conferring tolerance to low iron In the arid and semi-arid regions of the world, soils are alkaline in nature and, therefore, crop yields are limited by lack of available iron. Under iron stress, some plants release specific Fe(III)-binding compounds, known as siderophores, which bind the otherwise insoluble Fe(III) and transport it to the root surface. To increase the quantity of siderophores released under conditions of low iron availability, Takahashi et al. [119] transferred two barley genes (naat-A and naat-B) coding for the enzyme nicotianamine aminotransferase and the endogenous promoters into rice plants. When under iron stress transgenic rice plants excreted approximately 1.8 times more siderophore than wild-type rice plants. This relatively small increase enabled transgenic rice plants to withstand iron deprivation remarkably better, resulting in a fourfold increase in grain yield compared with the wild-type plants [119]. Alternatively, increasing the rate-limiting step of Fe(III) chelate reduction, which reduces iron to the more soluble Fe(II) form, might enhance iron uptake in alkaline soils [120]. Aluminum tolerance Aluminum toxicity is a major factor limiting crop productivity in acidic soils, which comprise about 40% of the world’s arable land. One of the most visible symptoms of aluminum toxicity is inhibition of root elongation. One possible mechanism of aluminum tolerance is the chelation of aluminum by organic ions, for example citrate or malate in the rhizosphere or within root cells. Overproduction of citrate has been shown to result in aluminum tolerance in transgenic tobacco, papaya, and oil-seed rape [121, 122]. Expression of the ALMT1 gene (aluminum-activated malate transporter) from wheat in transgenic barley plants resulted in high aluminum tolerance [123].
2.3.1.4 Improved Agronomic Properties Acceleration of sprouting time in the potato The ability to control sprouting time in potato tubers is of substantial economic importance to the potato industry. The potato industry currently uses a range of chemical treatments to achieve the desired control. To use a biotechnological approach, the pyrophosphatase gene from E. coli under the control of the tuber-specific patatin promoter was transferred into potatoes. The pyrophosphatase gene was chosen because of the central role of inorganic phosphate in starch degradation and sucrose biosynthesis. It is believed that starch breakdown and subsequent formation of a variety of metabolites is needed for growth of the sprout. Significantly accelerated sprouting was observed for transgenic potatoes – transgenic tubers sprouted on average six to seven weeks earlier than control tubers. After cold storage most transgenic tubers sprouted within one week whereas wildtype tubers needed eight weeks or more [124].
47
48
2.3 GM Plants “In the Pipeline”
Reduction of generation time in citrus trees Citrus trees have a long juvenile phase that delays their reproductive development by between six and twenty years. With the objective of accelerating flowering time, juvenile citrus seedlings were transformed with the Arabidopsis LEAFY (LFY) and APETALA (AP1) genes, which promote flower initiation in Arabidopsis. Both types of transgenic citrus produced fertile flowers as early as the first year. These traits are submitted to the offspring as dominant traits, generating trees with a generation time of one year from seed to seed [125]. Constitutive expression of LFY also promoted flower initiation in transgenic rice [126]. 2.3.2 Traits Affecting Food Quality for Human Nutrition
The sections below give examples of how the nutritional value of food crops can be improved by genetic engineering, although none of these genetically engineered food plants has yet reached the marketplace. In addition to the safety of the GMPs for health and environment, the effectiveness of this approach in comparison with alternative methods must be shown for these traits.
2.3.2.1 Increased Vitamin Content One of the most advanced projects to fortify food crops with vitamins is the socalled “golden rice”. To enable provitamin A biosynthesis in the rice endosperm, four additional enzymes are required. Immature rice embryos were co-transformed with two Agrobacterium constructs containing the psy and the lcy gene from daffodil, coding for phytoene synthase and lycopene β-cyclase, respectively, and the crtI gene from Erwinia uredovora, coding for a bacterial phytoen desaturase. Ten plants harboring all the transferred genes were recovered, and all showed a normal vegetative phenotype and were fertile. The transformed endosperms were usually yellow, indicating carotenoid formation [127]. After transfer of the new trait into locally best adapted varieties, either by traditional breeding or de-novo transformation, it is hoped that vitamin A deficiency in developing countries can be prevented [128]. In contrast with rice, tomato plants already produce carotenoids, and tomato products are viewed as the principal dietary source of lycopene and a major source of β-carotene. Because lycopene and β-carotene are regarded as beneficial to health (reducing chronic conditions such as coronary heart disease and some cancers), an attempt has been made to enhance the carotenoid content and profile of tomato fruits by genetic engineering. The bacterial carotenoid gene (crtI), which encodes for phytoene desaturase, has therefore been introduced into tomato plants. Transgenic plants had an increased β-carotene content (up to 45% of the total carotenoid content), although total carotenoid content was not elevated [129]. Regular uptake of vitamin C (ascorbic acid) is essential for humans, because they lack the ability to synthesize it. In plants, ascorbic acid can be regenerated from its oxidized form in a reaction catalyzed by dehydroascorbate reductase (DHAR).
2 Genetically Modified Plants
Overexpression of a DHAR cDNA from wheat in maize and tobacco led to a two to fourfold increase in ascorbic acid levels in foliage and kernels [130].
2.3.2.2 Production of Very-long-chain Polyunsaturated Fatty Acids Very-long-chain polyunsaturated fatty acids (VLCPUFAs), for example arachidonic, icasopentaenoic, or docosahexaenoic acid, have important roles in human health and nutrition. They are components of membrane phospholipids, precursors of prostaglandins, required for the development of the fetal neuronal system, and are reported to reduce the incidence of cardiovascular diseases. The diet of most modern societies is relatively low in ω3-PUFAs, with a concomitant increased level of ω6-PUFA intake. Oily fish are an important source of VLCPUFAs whereas not all plant oils contain VLCPUFAs. First results have been obtained from attempts to genetically engineer the capacity to synthesize these fatty acids in oilseed species. The seed-specific expression of cDNAs encoding fatty acid acyl-desaturases and elongases resulted in the accumulation of up to 5% of VLCPUFAs in linseed [131].
2.3.2.3 Increased Iron Level Because cereal grain is deficient in some essential mineral nutrients, including iron, several approaches have been used to increase iron accumulation and alter iron metabolism. Because ferritin is a general iron-storage protein in all living organisms, ferritin genes have been introduced into rice and wheat plants. Goto et al. [132] generated transgenic rice plants expressing soybean ferritin under the control of the seed-specific rice Glu-B1 promoter. Transgenic rice seeds accumulated up to three times more iron than wild-type seeds [132]. Likewise, increased iron levels were found in transgenic rice seeds expressing bean ferritin under the control of the related Gt-1 promoter [133]. Two approaches have been used not only to increase iron accumulation but also improve its absorption in the human intestine. First, the level of the main inhibitor of iron absorption, phytic acid, has been reduced by introduction of a heat-tolerant phytase from Aspergillus fumigatus. Transgenic rice plants had at least twice the phytase activity whereas in one individual transgenic line phytase activity in the grain increased approximately one-hundred and thirtyfold. Second, because cysteine peptides are regarded as a major enhancer of iron absorption, the endogenous cysteine-rich metallothionein-like protein gene (rgMT) was overexpressed and the cysteic acid content increased significantly in transgenic seeds. The authors suggested that high-phytase rice, with a increased iron content and rich in cysteine-peptide, has the potential to greatly improve iron supply for rice-eating populations [133, 134].
2.3.2.4 Improved Amino Acid Composition Potatoes contain limited amounts of the essential amino acids lysine, tryptophan, methionine, and cysteine. To improve the nutritional value of potatoes a nonal-
49
50
2.3 GM Plants “In the Pipeline”
lergenic seed albumin gene (AmA1) from Amaranthus hypochondriacus has been transferred to potato plants. The seed-specific albumin was under the control of a tuber-specific or a constitutive promoter. In both transgenic lines a 35–45% increase in total protein content was reported in transgenic tubers; this corresponded to an increase in the most essential amino acids. A twofold increase in tuber number and a 3.0 to 3.5-fold increase in tuber yield were also observed [135].
2.3.2.5 Reduction in the Amount of Antinutritive Factors Cassava is one of the few plants in nature that contains toxic cyanogenic glycosides in the leaves and roots. Sufficient processing of the harvested roots normally renders the cassava safe, although the processing which renders toxic cassava varieties safe also removes some nutritional value. Moller et al. isolated the genes responsible for cyanogenic glycoside production and are now transforming cassava with anti-sense constructs of the respective genes CYP79D1 and CYP79D2 [136]. Another strategy for reducing the cyanide toxicity of cassava roots is to introduce a gene that codes for the enzyme hydroxynitrile lyase (HNL). This enzyme breaks down the major cyanogen acetone cyanohydrin, and is expressed only in the leaves. After transformation of the cDNA encoding HNL, HNL activity in cassava roots was comparable with that in leaves. Field trials will determine whether expression of HNL in roots reduces the cyanide toxicity of cassava food products [137, 138].
2.3.2.6 Production of “Low-calorie Sugar” Koops and coworkers have developed a new sugar beet that produces fructan, a low-calorie sweetener, by inserting a single gene from Jerusalem artichoke that encodes an enzyme for converting sucrose to fructan (1-sucrose:sucrose fructosyl transferase [1-sst]). Short-chain fructans have the same sweetness as sucrose, but provide no calories because humans lack the fructan-degrading enzymes necessary to digest them. Longer-chain fructans form emulsions with a fat-like texture, and fructans also promote the growth of beneficial bacteria present in the gut. Transgenic sugar beet roots produce the same amount of total sugar, but expression of the 1-sst gene resulted in conversion of more than 90% of the stored sucrose into fructans. Under greenhouse conditions, the “fructan beets” developed normally and their root dry weight was almost the same as that of normal sugar beet. The yield of 110 μmol g−1 freshweight of fructan makes extraction of these compounds of economic interest [139].
2.3.2.7 Seedless Fruits and Vegetables In plants able to develop fruits without fertilization (parthenocarpic fruits), the seeds are absent – a feature that can increase fruit acceptance by consumers. To achieve parthenocarpic development, it is common practice to treat flower buds with synthetic auxinic hormones. To mimic the hormonal effects by genetic engineering, the expression of a gene able to increase auxin content and activity should
2 Genetically Modified Plants
be induced in the ovule. Rotino and coworkers [140] used the iaaM gene from Pseudomonas syringae pv. savastanoi under control of an ovule-specific promoter (DefH9) from Antirrhinum majus to induce parthenocarpic development in transgenic tobacco and eggplants. In transgenic eggplants, fruit setting took place even under environmental conditions prohibitive for the untransformed line. Fruit size and weight were similar to those obtained by pollination in transgenic and control plants [140]. It was envisaged that this approach might also be valuable in other horticultural species, for example pepper and tomatoes, in which fruit quality is susceptible to uneven pollination and seed set during lower temperature fluctuations associated with “winter season” production. A similar approach might also be used to produce seedless watermelons rather than the cumbersome triploid seed production system now employed [141].
2.3.3 Traits that Affect Processing 2.3.3.1 Altered Gluten Level in Wheat to Change Baking Quality The bread-making quality of wheat flour depends primarily on the presence of high-molecular-weight (HMW) glutenins. Wheat is unique among cereals in having this property. The glutenin proteins are encoded by six genes, and the total glutenin content of the grain is proportional to the expression of these genes. It has been shown that the quality of dough can be affected by both the quantity and quality of the expressed genes. When specific glutenin genes were added back to wheat lines missing some of the glutenin genes, the dough-mixing characteristics were improved significantly [142]. This same technique could be applied to wheat lines that have already been optimized for baking, and could result in flour with glutenin levels higher than the current maximum of 10% of total protein [143]. The quality of durum wheat (Triticum turgidum L. var. durum) for bread and pasta making has also been modified by insertion of HMW glutenin subunit genes [144].
2.3.3.2 Altered Grain Composition in Barley to Improve Malting Quality β-Glucan is the major constituent of the cell wall of the starchy endosperm of barley. These cell wall molecules are very large, water-soluble, and produce viscous worts if not sufficiently reduced in size by hydrolysis. This leads to slow filtration of wort and beer, and glucan precipitate in the finished product. β-Glucan hydrolysis is likely to be a function of the level of (1-3,1-4)-β-glucanase produced by the aleurone, and how much of the enzyme survives high-temperature kilning and mashing. Doubling the amount of β-glucanase activity is likely to ensure sufficient β-glucan hydrolysis, and this could be achieved either by increasing the amount of enzyme synthesized or by changing the heat stability of β-glucanase [145]. The latter has been achieved by transferring a fungal thermotolerant endo-1,4-β-glucanase to two barley cultivars. The amount of heterologous enzyme has been shown to be sufficient to reduce wort viscosity by reducing the soluble β-glucan content [146].
51
52
2.3 GM Plants “In the Pipeline”
In another approach, biochemically active wheat thioredoxin h has been overexpressed in the endosperm of transgenic barley grain. Such overexpression in germinated grain effected an up to fourfold increase in the activity of the debranching enzyme pullulanase, a rate-limiting enzyme in the breakdown of starch. The breakdown of starch is a key step in the malting process, and tests with transgenic varieties showed that the time required could be reduced by up to a day [147, 148].
2.3.4 Traits of Pharmaceutical Interest
2.3.4.1 Production of Vaccines Vaccines are designed to elicit an immune response without causing disease. Typical vaccines comprise killed or attenuated disease-causing organisms; recombinant vaccines are desirable as an alternative because they usually cause fewer sideeffects than occur when the whole organism is delivered. Many candidate proteins have been identified that may function as effective subunit vaccines. Currently, the most common large-scale production of recombinant proteins are genetically engineered bacteria and yeast, because of the ease of manipulation and their rapid growth. Recombinant proteins overexpressed in microorganisms must be extensively purified, however, to remove host proteins and compounds. Transgenic plants are an alternative system, with the great practical advantage of producing directly an edible plant tissue for oral immunization. In addition, edible plantbased recombinant vaccines are safe, provide nutrition, and are easy to administer [149, 150]. Much research is currently focused on understanding transgene expression, stability, and processing in plants. Typical experiments investigating in-plant protein expression employ plant model systems such as potato, tomato, and maize. The ideal plant for human vaccination would be bananas, because they are readily eaten by babies, are consumed uncooked, and are indigenous to many developing countries. Because regeneration and growth to maturity can take up to three years in bananas, it is necessary to optimize high-level expression of a vaccine antigen in model plants [150]. For viral infections, virus-like particles (VLPs), which form by self-assembly of viral surface proteins, are effective as vaccines. The hepatitis B surface antigen (HbsAg) has successfully been used as a vaccine against hepatitis B virus. The vaccine was first produced in yeast by Merck and SmithKline Beecham, and was the first recombinant subunit vaccine. It thus served as a model for the first attempt to produce a plant-based vaccine. HbsAg was expressed in tobacco and potato plants and shown to assemble into VLPs similar to the yeast-derived commercial vaccine [151, 152]. In the United States, preliminary clinical trials have been performed, and a good systemic response was observed for two out of three volunteers who ate transgenic
2 Genetically Modified Plants
lettuce carrying a hepatitis B antigen. Likewise, an immune response was observed for 19 of 20 people who ate a potato vaccine aimed at the Norwalk virus [153]. Mice fed with potato plants transgenic for a cholera toxin B subunit gene (CTB) developed immunity against the bacterial endotoxin [149]. Currently, clinical trials with a plant-based vaccine against a bacterial pathogen are under way in the United States. Arntzen and colleagues inserted a gene for part of an Escherichia coli enterotoxin (LT-B subunit gene) that caused diarrhea in humans into potato plants, and all but one of the 11 volunteers who ate the transgenic raw potatoes produced antibodies to the toxin [154]. A common problem of vaccine antigens expressed in plants has been the low level of expression. In LT-B-expressing plants this has been overcome by using a “plant codon usage optimized” synthetic gene encoding LT-B and the use of the tuber-specific patatin promoter (Mason et al., 1998, cited in Ref. [150]). Future considerations must include containment of the transgenes and quality control for antigen content. These considerations are particularly important, because inappropriate dosing of vaccines can impair their effectiveness and constant dosing can lead (potentially) to immunological tolerance [150]. In more recent discussion the feasibility of direct oral immunization by eating transgenic plants was doubted because of poor lot-to-lot consistency; processing to pills prescribed by doctors was favored.
2.3.4.2 Production of Pharmaceuticals Some recombinant proteins are already available commercially, including human erythropoietin or glucocerebrosidase. Until now, commercial production has used E. coli, yeast, or mammalian cells for fermentation. These expression systems have limitations, however: bacteria cannot perform the complex post-translational modifications required for bioactivity of many human proteins, and production of proteins such as growth regulators or cell-cycle inhibitors would negatively affect the transgenic animal cell culture [155]. Plants have several advantages compared with traditional systems for molecular farming of pharmaceutical proteins. These include: 1. low production costs; 2. reduced time to market; 3. unlimited supply; 4. eukaryotic protein processing; and 5. safety from blood or animal tissue-borne human pathogens [156]. Production of a range of therapeutic proteins in transgenic plants has proven their capability for production of bioactive human proteins of pharmaceutical value–the proteins seem to be fully functional and structurally comparable with the analogous proteins produced in animal cell culture [155]. Examples of human therapeutic proteins include serum proteins, for example hemoglobin, as blood substitute, interferons as viral protection agents, lysosomal enzymes lacking in patients with Gaucher or Fabry disease, and other proteins, for
53
54
2.3 GM Plants “In the Pipeline”
example hirudin, which is effective as an anticoagulant (a summary of this work has been published elsewhere [157]). Most of these pharmaceuticals are produced in model plants that are easy to transform, for example tobacco and potato, by using the constitutive 35S promoter from the cauliflower mosaic virus. Because high levels of protein accumulation may negatively affect yield and/or growth of the transgenic plants, however, inducible or tissue-specific promoters are preferable [157]. Tobacco is an excellent biomass producer, but does produce toxic compounds. Crop-based production systems (e.g. wheat, rice, corn) lack these toxic substances and provide an existing infrastructure for their cultivation, harvest, distribution, and processing [158]. This makes food crops highly attractive but leads to the potential for the unintended presence of therapeutic proteins in human food. Recently publicized incidents in which genetically modified crops have been inadvertently mixed with those destined for human consumption have highlighted the need for mechanisms to ensure the segregation of plants that express pharmaceutical products. Cereal crops (rice and wheat) were first used as production and storage system for a single-chain antibody against carcinoembryogenic antigen (CEA), a wellcharacterized tumor-associated marker antigen. The antibodies could be stored in dried seeds for at least five months without significant loss of activity of the antibody [159]. An alternative technique employs targeting of the recombinant protein to the oil bodies of Brassica napus seeds. A synthetic gene coding for a hirudin variant was fused to an Arabidopsis oleosin gene and transferred to oil-seed rape. The recombinant hirudin was correctly targeted and accumulated on the oil bodies of transgenic seeds which, because of their lower density could easily be separated by flotation centrifugation. The functional biopharmaceutical was then released by protease treatment [160]. Recent work has revealed the potential for producing recombinant proteins in the guttation fluid of tobacco. Guttation, which is the loss of water and dissolved materials from uninjured plant organs, leads to the production of guttation fluid. This can be collected throughout the plant’s life, thereby providing a continuous and nondestructive system for recombinant protein production [161].
2.4 Outlook
It is likely that rapid development of molecular and technological methods will occur in the future, and that this will include the initial development of new transgenic approaches in model plants such as Arabidopsis, then transfer of ready-established methods to most crop plants. The combination of genetic engineering and molecular marker technology with conventional crossings and subsequent selection will enable a rapid progress in plant breeding. Despite these possibilities, limitations of widespread application can be foreseen in the patent situation, and this will lead to a partial unpredictability in production
2 Genetically Modified Plants
costs. One hindrance to worldwide trade – and therefore also to the marketability of genetically modified foods – is different legal regulations, e.g. in the USA and Europe. Lack of acceptance by the public of genetically modified food, especially in central Europe, might also delay the commercial exploitation of transgenic plants, even when there might be advantages for the consumer.
References 1 Hansen, G., Chilton, M. D. 1999. Lessons in Gene Transfer to Plants by a Gifted Microbe. In: Hammond, J., McGarvey, P., Yushibov, V. (eds.), Plant Biotechnology: New Products and Applications, Springer, Berlin, New York, 21–58. 2 Hammond, J. 1999. Overview: The Many Uses and Applications of Transgenic Plants. In: Hammond, J., McGarvey, P., Yushibov, V. (eds.), Plant Biotechnology: New Products and Applications, Springer, Berlin, New York, 1–20. 3 Dai, S., Zheng, P., Marmey, P., Zhang, S., Tian, W., Chen, S., Beachy, R. N., Fauquet, C. 2001. Comparative analysis of transgenic rice plants obtained by Agrobacterium-mediated transformation and particle bombardment. Mol. Breeding 7 (1):25–33. 4 Arencibia, A. D., Carmona, E. R., Tellez, P., Chan, M.-T., Yu, S.-M., Trujillo, L. E., Oramas, P. 1998. An efficient protocol for sugarcane (Saccharum spp. L.) transformation mediated by Agrobacterium tumefaciens. Transgenic Res. 7:213–222. 5 Potrykus, I. 1995. Direct Gene Transfer to Protoplasts. In: Potrykus, I. and Spangenberg, G. (eds.), Gene Transfer to Plants. Springer Lab Manual, Berlin, 55–57. 6 Arencibia, A. D., Carmona, E. R., Cornide, M. T., Castiglione, S., O’Reilly, J., Chinea, P., Oramas, P., Sala, F. 1999. Somaclonal variation in insect-resistant sugarcane (Saccharum hybrid) plants produced by electroporation. Transgenic Res. 8:349–360. 7 Sanford, J. C., Klein, T. M., Wolf, E. D., Allen, N. 1987. Delivery of substances into cells and tissues using a particle bombardment process. J. Part. Sci. Tech. 5:27–37. 8 Finer, J. J., Finer, K. R., Ponappa, T. 1999. Particle Bombardment Mediated Transformation. In: Hammond, J., McGarvey,
9
10
11
12
13
14
15
16
P., Yushibov, V. (eds.), Plant Biotechnology: New Products and Applications, Springer, Berlin, New York, 59–80. Fütterer, J. 1995. Genetic Markers and Expression Signals. In: Potrykus, I. and Spangenberg, G. (eds.), Gene Transfer to Plants. Springer Lab Manual, Berlin, 311–324. Wang, Y., Zhang, W., Cao, J., McElroy, D., Wu, R. 1992. Characterization of cis-acting elements regulating transcription from the promoter of a constitutively active rice actin gene. Mol. Cell. Biol. 12:3399–3406. Christensen, A. H., Sharrock, R. A., Quail, R. H. 1992. Maize polyubiquitin genes: structure, thermal perturbation of expression and transcript splicing, and promoter activity following transfer to protoplasts by electroporation. Plant Mol. Biol. 18:675–689. McElroy, D., Brettell, R. I. S. 1994. Foreign gene expression in transgenic cereals. Trends Biotechnol. 12:62–68. Fujimoto, H., Yamamoto, M., Kyozuka, J, Shimamoto, K. 1993. Insect-resistant rice generated by introduction of a modified δ-endotoxin gene from Bacillus thuringiensis. Bio/Technology 11:1151–1155. Schrott, M. 1995. Selectable Marker and Reporter Genes. In: Potrykus, I. and Spangenberg, G. (eds.), Gene Transfer to Plants. Springer Lab Manual, Berlin, 325–336. Collard, J.-M. 1999. Aminoglycoside resistance. http://www.antibioresistance. be/aminoglycosides.html (accessible August 2005). Moens, W., Collard, J.-M. 2002. GM Plants containing antibiotic resistance genes. http://www.biosafety.be/ARGMO/ GMO_Plants.html (accessible August 2005).
55
56
References 17 De Block, M., Botterman, J., Vandewiele, M., Dockx, J., Thoen, C., Gossele, V., Movva, N. R., Thompson, C., Van Montague, M., Leemans, J. 1987. Engineering herbicide resistance in plants by expression of a detoxifying enzyme. EMBO J. 6:2513–2518. 18 Anonymus (2000) University of Toronto, Eucaryotic Molecular Biology, Genetically Modified Foods Project, Herbicide resistance. http://dragon.zoo.utoronto. ca/~jlm-gmf/T0201A/herb1.htm (accessible August 2005) 19 Jefferson, R. A., Kavanagh, T. A., Bevan, M. W. 1987. GUS fusions: β-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO J. 6:39001–3908. 20 Ow, D. W., Wood, K. V., DeLuca, M., de Wet, J. R., Helinski, D. R., Howell, S. H. 1986. Transient and stable expression of the firefly luciferase gene in plant cells and transgenic plants. Science 234:856– 859. 21 Millar, A. J., Short, S. R., Hiratsuka, K., Chua, N. H., Kay, S. A. 1992. Firefly luciferase as a reporter of regulated gene expression in higher plants. Plant Mol. Biol. Rep. 10:324–337. 22 Stirn, S. 2000. Antibiotic resistance and horizontal gene transfer. In: GTZ (Gesellschaft für Technische Zusammenarbeit) (ed.), Development of Frame Conditions for the Utilisation of Biotechnology and Genetic Engineering. http://www2.gtz. de/biotech/dokumente/biotech5.pdf (accessible August 2005). 23 Kunkel, T., Niu, Q.-W., Chan, Y.-S., Chua, N.-H. 1999. Inducible isopentenyl transferase as a high-efficiency marker for plant transformation. Nature Biotechnol. 17: 916–919. 24 Joersbo, M., Donaldson, I., Petersen, S. G., Brunstedt, J., Okkels, F. T. 1998. Analysis of mannose selection used for transformation of sugar beet. Mol. Breeding 4:111–117. 25 Odell, J. T., Russell, S. H. 1994. Use of Site-Specific Recombination Systems in Plants. In: Paszkowski J. (ed.), Homologous Recombination and Gene Silencing in Plants. Kluwer Academic Publ., Netherlands, 219–270.
26 Schiemann, J., Weber, A., Hassa, A. 1998. Überprüfung von Konzepten zur nachträglichen Fremdgen-Eliminierung aus transgenen Pflanzen. In: Jahresbericht der Biologischen Bundesanstalt für Land- und Forstwirtschaft 1998, Berlin und Braunschweig, Abstract Nr. 189. 27 Zuo, J., Niu, Q.-W., Møller, S. G., Chua, N.-H. 2001. Chemical-regulated, site-specific DNA excision in transgenic plants. Nature Biotechnol. 19:157–161. 28 Zubko, E., Scutt, C., Meyer, P. 2000. Intrachromosomal recombination between attP regions as a tool to remove selectable marker genes from tobacco transgenes. Nature Biotechnol. 18:442–445. 29 Puchta, H. 2000. Removing selectable marker genes: taking the short cut. Trends Plant Sci. 5 (7):273–274. 30 Transgen (Transparenz für Gentechnik bei Lebensmitteln) 2005. Gentechnisch veränderte Pflanzen: Zulassungspraxis EU. http://www.transgen.de/zulassung (data from Mai 2005). 31 AGBIOS (Agriculture and Biotechnology Strategies (Canada) Inc.) 2005. Biotech Crop Database. http://www.agbios.com/ dbase.php?action=ShowForm (data from August 2005). 32 ISAAA (International Service for the Acquisition of Agri-biotech Applications) 2005. Preview: Global Status of Commercialized Biotech/GM Crops: 2004. http://www.isaaa.org/kc/CBTNews/pressrelease/breifs32/ESummary/Executive Summary (English).pdf (August 2005) 33 Transgen 2002. Anbauflächen gentechnisch veränderter Pflanzen 2001. http:// www.transgen.de/Aktuell/ISAAA_2001_ preview.html (data from January 2005). 34 Cheng, X., Sardana, R., Kaplan, H., Altosaar, I. 1998. Agrobacterium-transformed rice plants expressing synthetic cryIA(b) and cryIA(c) genes are highly toxic to striped stem borer and yellow stem borer. Proc. Natl. Acad. Sci. USA 95:2767–2772. 35 Tu, J., Zhang, G., Datta, K., Xu, C., He, Y., Zhang, Q., Khush, G. S., Datta, S. K. 2000. Field performance of transgenic elite commercial hybrid rice expressing Bacillus thurigiensis δ-endotoxin. Nature Biotechnol. 18:1101–1104.
2 Genetically Modified Plants 36 Stewart, C. N., Adang, M. J., All, J. N., Boerma, H. R., Cardineau, G., Tucker, D., Parrott, W. A. 1996. Genetic transformation, recovery, and characterization of fertile soybean transgenic for a synthetic Bacillus thuringiensis cryIAc gene. Plant Physiol. 112 (1):121–129. 37 Stewart, C. N., Adang, M. J., All, J. N., Raymer, P. L., Ramachandran, S., Parrott, W. A. 1996b. Insect control and dosage effects in transgenic canola containing a synthetic Bacillus thuringiensis cryIAc gene. Plant Physiol. 112 (1):115–120. 38 Arpaia, S., Mennella, G., Onofaro, V., Perri, E., Sunseri, F., Rotino, G. L. 1997. Production of transgenic eggplant (Solanum melongena L.) resistant to Colorado Potato Beetle (Leptinotarsa decemlineata Say). Theoret. Appl. Genet. 95:329–334. 39 USDA (United States Department of Agriculture) 2002. Field tests release database for the U.S.. http://www.isb. vt.edu/cfdocs/fieldtests1.cfm (data from August 2005). 40 EPA (Environmental Protection Agency, USA) 2001. Biopesticides Federal Register Notices – 2005. http://www.epa.gov/ pesticides/biopesticides/regtools/frnotices2005.htm (data from June 2005). 41 Moellenbeck, D. J., Peters, M. L., Bing, J. W. et al. 2001. Insecticidal proteins from Bacillus thuringiensis protect corn from corn root worms. Nature Biotechnol. 19:668–672. 42 Gatehouse, A. M. R., Hilder, V. A., Powell, K. S., Wang, M., Davison, G. M., Gatehouse, L. N., Down, R. E., Edmonds, H. S., Boulter, D., Newell, C. A., Merryweather, A., Hamilton, W. D. O., Gatehouse, J. A. 1994. Insect-resistant transgenic plants: choosing the gene to do the ‘job’. Biochem. Soc. Trans. 22:944–949. 43 Marchetti, S., Delledonne, M., Fogher, C., Chiabà, C., Chiesa, F., Savazzini, F., Giordano, A. 2000. Soybean Kunitz, C-II and PI-IV inhibitor genes confer different levels of insect resistance to tobacco and potato transgenic plants. Theoret. Appl. Genet. 101: 519–526. 44 Rao, K. V., Rathore, K. S., Hodges, T. K., Fu, X., Stoger, E., Sudhakar, D., Williams, S., Christou, P., Bharathi, M., Bown, D. P., Powell K. S., Spence, J., Gatehouse, A. M. R., Gatehouse, J. A. 1998. Expression
45
46
47
48
49
50
51
52
53
of snowdrop lectin (GNA) in transgenic rice plants confers resistance to rice brown planthopper. Plant J. 15(4): 469–477. Ewen, S. W. B., Pusztai, A. 1999. Effects of diets containing genetically modified potatoes expressing Galanthus nivalis lectin on rat small intestine. Lancet 354:1353–1354. Kuiper, H. A., Noteborn, H. P. J. N., Peijenburg, A. A. C. M. 1999. Adequacy of methods for testing the safety of genetically modified food. Lancet 354:1315– 1316. Morton, R. L., Schroeder, H. E., Bateman, K. S., Chrispeels, M. J., Armstrong, E,. Higgins, T. J. 2000. Bean alpha-amylase inhibitor 1 in transgenic peas (Pisum sativum) provides complete protection from pea weevil (Bruchus pisorum) under field conditions. Proc. Natl. Acad. Sci. USA 97(8):3820–3835. Kramer, K. J., Morgan, T. D., Throne, J. E., Dowell, F. E., Bailey, M., Howard, J. A. 2000. Transgenic avidin maize is resistant to storage insect pests. Nature Biotechnol. 18: 670–674. Hayakawa, T., Zhu, Y., Itoh, K., Izawa, T., Shimamaoto, K., Toriyama, S. 1992. Genetically engineered rice resistant to rice stripe virus, an insect-transmitted virus. Proc. Natl. Acad. Sci. USA 89 (20):9865–9869. Ravelonandro, M., Scorza, R., Bachelier, J. C., Labonne, G., Levy, L., Damsteegt, V., Callahan, A. M., Dunez, J. 1997. Resistance of transgenic Prunus domestica to plum pox virus infection. Plant Dis. 81: 1231–1235. Kaniewski, W., Ilardi, V., Tomassoli, L., Mitsky, T., Layton, J., Barba, M. 1999. Extreme resistance to cucumber mosaic virus (CMV) in transgenic tomato expressing one or two viral coat proteins. Mol. Breeding 5:111–119. Chowrira, G. M., Cavileer, T. D., Gupta, S. K., Lurquin, P. F., Berger, P. H. 1998. Coat-protein-mediated resistance to pea enation mosaic virus in transgenic Pisum sativum L. Transgenic Res. 7:265–271. Magbanua, Z. V., Wilde, H. D., Roberts, J. K., Chowdhury, K., Abad, J., Moyer, J. W., Wetzstein, H. Y., Parrott, W. A. 2000. Field resistance to tomato spotted wilt virus in transgenic peanut (Arachis
57
58
References
54
55
56
57
58
59
60
61
62
hypogaea L.) expressing an antisense nucleocapsid gene sequence. Mol. Breeding 6:227–236. Koev, G., Mohan, B. R., Dinesh-Kumar, S. P., Torbert, K. A., Somers, D. A., Miller, W. A. 1998. Extreme reduction of disease in oats transformed with the 5’ half of the barley yellow dwarf virus-PAV genome. Phytopathology 88:1013–1019. Gal-On, A., Wang, Y., Faure, J. E., Pilowsky, M., Zelcer, A. 1998. Transgenic resistance to cucumber mosaic virus in tomato: blocking of long-distance movement of the virus in lines harbouring a defective viral replicase. Phytopathology 88 (10):1101–1107. Huet, H., Mahendra, S., Wang, J., Sivamani, E., Ong, C. A., Chen, L., de Kochko, A., Beachy, R. N., Fauquet, C. 1999. Near immunity to rice tungro spherical virus achieved in rice by replicase-mediated resistance strategy. Phytopathology 89: 1022–1027. Sivamani, E., Brey, C. W., Dyer, W. E., Talbert, L. E., Qu, R. 2000. Resistance to wheat streak mosaic virus in transgenic wheat expressing the viral replicase (Nib) gene. Mol. Breeding 6:469–477. Valanzuolo, S., Catello, S., Colombo, M., Dani, M., Monti, M. M., Uncini, L., Petrone, P., Spingo, P. 1994. Cucumber Mosaic Virus resistance in transgenic San Marzano tomatoes. Acta Horticulturae 376:377–386. Stommel, J. R., Tousignant, M. E., Wai, T., Pasini, R., Kaper, J. M. 1998. Viral satellite RNA expression in transgenic tomato confers field tolerance to cucumber mosaic virus. Plant Dis. 82 (4):391–396. Tepfer, M. 1993. Viral genes and transgenic plants. Bio/Technology 11:1125– 1132. Lodge, J. K., Kaniewski, W. K., Tumer, N. E. 1993. Broad-spectrum resistance in transgenic plants expressing pokeweed antiviral protein. Proc. Natl. Acad. Sci. USA 90:7089–7093. Wang, P., Zoubenko, O., Tumer, N. E. 1998. Reduced toxicity and broad spectrum resistance to viral and fungal infection in transgenic plants expressing pokeweed antiviral protein II. Plant Mol. Biol. 38:957–964.
63 Tavladoraki, P., Benvenuto, E., Trinca, S., De Martinis, D., Cattaneo, A., Galeffi, P. 1993. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 366:469–472. 64 Xiao, X. W., Chu, P. W. G., Frenkel, M. J., Tabe, L. M., Shukla, D. D., Hanna, P. J., Higgins, T. J. V., Müller, W. J., Ward, C. W. 2000. Antibody-mediated improved resistance to CIYVV and PVY infections in transgenic tobacco plants expressing a single-chain variable region antibody. Mol. Breeding 6: 421–431. 65 Mitsuhara, I., Matsufuru, H., Ohshima, M., Kaku, H., Nakajima, Y., Murai, N., Natori, S., Ohashi, Y. 2000. Induced expression of sarcotoxin IA enhanced host resistance against both bacterial and fungal pathogens in transgenic tobacco. Mol. Plant–Microbe Interact. 13 (8):860–868. 66 Lin, W., Anuratha, C. S., Datta, K., Potrykus, K., Muthukrishnan, S., Datta, S. K. 1995. Genetic engineering of rice for resistance to sheath blight. Bio/Technology 13:686–691. 67 Datta, K., Velazhahan, R., Oliva, N., Ona, I., Mew, T., Khusgh, G. S., Muthukrishnan, S., Datta, S. K. 1999. Over-expression of the cloned rice thaumatin-like protein (PR-5) gene in transgenic rice plants enhances environmental friendly resistance to Rhizoctonia solani causing sheath blight. Theoret. Appl. Genet. 98: 1138–1145. 68 Datta, K., Tu, J. M., Oliva, N., Ona, I., Velazhahan, R., Mew, T. W., Muthukrishnan, S., Datta, S. K. 2001. Enhanced resistance to sheath blight by constitutive expression of infection-related rice chitinase in transgenic elite indica rice cultivars. Plant Sci. 160 (3):405–414. 69 Nishizawa, Y., Nishio, Z., Nakazono, K., Soma, M., Nakajima, E., Ugaki, M., Hibi, T. 1999. Enhanced resistance to blast (Magnaporthe grisea) in transgenic Japonica rice by constitutive expression of rice chitinase. Theoret. Appl. Genet. 99 (3/4):383–390. 70 Schaffrath, U., Mauch, F., Freydell, E., Schweizer, P., Dudler, R. 2000. Constitutive expression of the defense-related Rir1b gene in transgenic rice plants confers enhanced resistance to the rice
2 Genetically Modified Plants
71
72
73
74
75
76
77
78
79
blast fungus Magnaporthe grisea. Plant Mol. Biol. 43:59–66. Dixon, R. A., Lamb, C. J., Masoud, S., Sewalt, V. J. H., Paiva, N. L. 1996. Metabolic engineering: prospects for crop improvement through the genetic manipulation of the phenylpropanoid biosynthesis and defense responses – a review. Gene 179 (1):61–71. Tabei, Y., Kitade, S., Nishizawa, Y., Kikuchi, N., Kayano, T., Hibi, T., Akutsu, K. 1998. Transgenic cucumber plants harbouring a rice chitinase gene exhibit enhanced resistance to gray mold (Botrytis cinerea). Plant Cell Rep. 17 (3):159–164. Wang Y., Nowak, G., Culley, D., Hadwiger, L. A., Fristensky, B. 1999. Constitutive expression of pea defense gene DRR206 confers resistance to blackleg (Leptoshaeria maculans) disease in transgenic canola (Brassica napus). Mol. Plant–Microbe Interact. 12 (5):410–418. Tabaeizadeh, Z., Agharbaoui, Z., Harrak, H., Poysa, V. 1999. Transgenic tomato plants expressing a Lycopersicon chilense chitinase gene demonstrate improved resistance to Verticillium dahliae race 2. Plant Cell Rep. 19 (2): 197–202. Bliffeld, M., Mundy, J., Potrykus, I., Fütterer, J. 1999. Genetic engineering of wheat for increased resistance to powdery mildew disease. Theoret. Appl. Genet. 98 (6/7): 1079–1086. Chen, W. P., Chen, P. D., Liu, D. J., Kynast, R., Friebe, B., Velazhahan, R., Muthukrishnan, S., Gill, B. S. 1999. Development of wheat scab symptoms is delayed in transgenic wheat plants that constitutively express a rice thaumatinlike protein gene. Theoret. Appl. Genet. 99 (5):755–760. Oldach, K., Becker, D., Lörz, H. 2001. Heterologous expression of genes mediating enhanced fungal resistance in transgenic wheat. Mol. Plant–Microbe Interact. 14 (7):832–838. Yamamoto, T., Iketani, H., Ieki, H., Nishizawa, Y., Notsuka, K., Hibi, T., Hayashi, T., Matsuta, N. 2000. Transgenic grapevine plants expressing a rice chitinase with enhanced resistance to fungal pathogens. Plant Cell Rep. 19 (7):639–646. Fagoaga, C., Rodrigo, I., Conejero, V., Hinarejos, C., Tuset, J. J., Arnau, J., Pina,
80
81
82
83
84
85
86
87
J. A., Navarro, L., Pena, L. 2001. Increased tolerance to Phytophthora citrophthora in transgenic orange plants constitutively expressing a tomato pathogenesis related protein PR-5. Mol. Breeding 7 (2):175–185. Maddaloni, M., Forlani, F., Balmas, V., Donini, G., Stasse, L., Corazza, L., Motto, M. 1997. Tolerance to the fungal pathogen Rhizoctonia solani AG4 of transgenic tobacco expressing the maize ribosome inactivating protein b-32. Transgenic Res. 6 (6):393–402. Hain, R., Reif, H. J., Krause, E., Langbartels, R., Kindl, H., Vornam, B., Wiese, W., Schmelzer, E., Schreier, P. H., Stocker, R. H., Stenzel, K. 1993. Disease resistance results from foreign phytoalexin expression in a novel plant. Nature 361:153–156. Stark-Lorenzen, P., Nelke, B., Hanssler, G., Mühlbach, H.-P., Thomzik, J. E. 1997. Transfer of a grapevine stilbene synthase gene to rice (Oryza sativa L.). Plant Cell Rep. 16 (10):668–673. Leckband, G., Lörz, H. 1998. Transformation and expression of a stilbene synthase gene of Vitis vinifera L. in barley and wheat for increased fungal resistance. Theoret. Appl. Genet. 96 (8):1004–1012. He, X. Z., Dixon, R. A. 2000. Genetic manipulation of isoflavone 7-O-methyltransferase enhances biosynthesis of 4’-O-methylated isoflavonoid phytoalexins and disease resistance in alfalfa. Plant Cell 12 (9):1689–1702. Gandikota, M., de Kocho, A., Chen, L., Ithal, N., Fauquet, C., Reddy, A. R. 2001. Development of transgenic rice plants expressing maize anthocyanin genes and increased blast resistance. Mol. Breeding 7 (1):73–83. Takaichi, M., Oeda, K. 2000. Transgenic carrots with enhanced resistance against two major pathogens, Erysiphe heraclei and Alternaria dauci. Plant Sci. 153:135– 144. Lorito, M., Woo, S. L., Fernandez, I. G., Colucci, G., Harman, G. E., Pintor-Toro, J. A., Filippone, E., Muccifora, S., Lawrence, C. B., Zoina, A., Tuzun, S., Scala, F. 1998. Genes from mycoparasitic fungi as source for improving plant resistance to fungal pathogens. Proc. Natl. Acad. Sci. USA 95:7860–7865.
59
60
References 88 Bolar, J. P., Norelli, J. L., Wong, K. W., Hayes, C. K., Harman, G. E., Aldwinckle, H. S. 2000. Expression of endochitinase from Trichoderma harzianum in transgenic apple increases resistance to apple scab and reduces vigor. Phytopathology 90:72–77. 89 Clausen, M., Kräuter, R., Schachermayr, G., Potrykus, I., Sautter, C. 2000. Antifungal activity of a virally encoded gene in transgenic wheat. Nature Biotechnol. 18:446–449. 90 Husemann, M., Oldendorf, S., Schütte, G. 2001. Krankheitsresistenz gegen Pilze und Bakterien. In: Schütte, G., Stirn, S., Beusmann, V. (eds.). Transgene Nutzpflanzen: Sicherheitsforschung, Risikoabschätzung und Nachgenehmigungs-Monitoring, Birkhäuser, Basel, 154–174. 91 Prakash, C. S. 1998. Regulatory Gene Confers Resistance to Multiple Diseases. ISB News Report, June 1998. http://www. isb.vt.edu/news/1998/news98.jun. html#jun9803 (accessible August 2005). 92 Tu, J., Ona, I., Zhang, Q., Mew, T. W., Khush, G. S., Datta, S. K. 1998. Transgenic rice variety ‘IR72’ with Xa21 is resistant to bacterial blight. Theoret. Appl. Genet. 97 (1/2): 31–36. 93 Tai, T. H., Dahlbeck, D., Clark, E. T., Gajiwala, P., Pasion, R., Whalen, M. C., Stall, R. E., Staskawicz, B. J. 1999. Expression of the Bs2 pepper gene confers resistance to bacterial spot disease in tomato. Proc. Natl. Acad. Sci. USA 96 (24):14153–14158. 94 Tang, X., Xie, M., Kim, Y. J., Zhou, J., Klessig, D. F., Martin, G. B. 1999. Overexpression of Pto activates responses and confers broad resistance. Plant Cell 11 (1):15–29. 95 Tang, K., Sun, X., Hu, Q., Wu, A., Lin, C.H., Lin, H.-J., Twyman, R. M., Christou, P., Feng, T. 2001. Transgenic rice plants expressing the ferredoxin-like protein (AP1) from sweet pepper show enhanced resistance to Xanthomonas oryzae pv. oryzae. Plant Sci. 160:1035–1042. 96 Molina, A., Garcia-Olmedo, F. 1997. Enhanced tolerance to bacterial pathogens caused by the transgenic expression of barley lipid transfer protein LPT2. Plant J. 12 (3):669–675. 97 Düring, K., Porsch, P., Fladung, M., Lörz, H. 1993. Transgenic potato plants resis-
tant to the phytopathogenic bacterium Erwinia carotovora. Plant J. 3(4):587–598. 98 Nakajima, H., Muranaka, T., Ishige, F., Akutsu, K., Oeda, K. 1997. Fungal and bacterial disease resistance in transgenic plants expressing human lysozyme. Plant Cell Rep. 16:674–679. 99 Wu, G., Shortt, B. J., Lawrence, E. B., Fitzsimmons, K. C., Shah, D. M. 1995. Disease resistance conferred by expression of a gene encoding H2O2-generating glucose oxidase in transgenic potato plants. Plant Cell 7:1357–1368. 100 Norelli, J. L., Aldwinckle, H. S., Destéfano-Beltrán, A., Jaynes, J. M. 1994. Transgenic ‘Malling 26’ apple expressing the attacin E gene has increased resistance to Erwinia amylovora. Euphytica 77:123–128. 101 Reynoird, J. P., Mourges, F., Norelli, J., Aldwinckle, H. S., Brisset, M. N., Chevreau, E. 1999. First evidence for improved resistance to fire blight in transgenic pear expressing the attacin E gene from Hyalophora crecropia. Plant Sci. 149:23–31. 102 Osusky, M., Zhou, G., Osuska, L., Hancock, R. E., Kay, W. W., Misra, S. 2000. Transgenic plants expressing cationic peptide chimeras exhibit broad-spectrum resistance to phytopathogens. Nature Biotechnol. 18:1162–1166. 103 Urwin, P.E., Troth, K.M., Zubko, E.I., Atkinson, H.J. 2001. Effective transgenic resistance to Globodera pallida in potato field trials. Mol Breed. 8:95–101. 104 Urwin, P.E., Green, J., Atkinson, H.J. 2003. Expression of a plant cystatin confers partial resistance to Globodera, full resistance is achieved by pyramiding a cystatin with natural resistance. Mol Breed. 12:263–269. 105 Atkinson, H. J., Urwin, P. E., Hansen, E., McPherson, M. J. 1995. Designs for engineered resistance to root-parasitic nematodes. Trends Biotechnol. 13:369–374. 106 Bajaj, S., Targolli, J., Liu, L.-F., Ho, T.-H., Wu, R. 1999. Transgenic approaches to increase dehydration-stress tolerance in plants. Mol Breeding 5:493–503. 107 Sakamoto, A., Alia, Murata, N. 1998. Metabolic engineering of rice leading to biosynthesis of glycinebetaine and tolerance to salt and cold. Plant Mol. Biol. 38:1011–1019.
2 Genetically Modified Plants 108 Zhu, B., Su, J., Chang, M. C., Verma, D. P. S., Fan, Y. L., Wu, R. 1998. Overexpression of a Δ1-pyrroline-5-carboxylate synthetase gene and analysis of tolerance to water- and salt-stress in transgenic rice. Plant Sci. 139:41–48. 109 Capell, T., Escobar, C., Liu, H., Burtin, D., Lepri, O., Christou, P. 1998. Overexpression of the oat arginine decarboxylase cDNA in transgenic rice (Oryza sativa) affects normal development patterns in vitro and results in putrescine accumulation in transgenic plants. Theoret. Appl. Genet. 97:246–254. 110 Roy, M., Wu, R. 2001. Arginine decarboxylase transgene expression and analysis of environmental stress tolerance in transgenic rice. Plant Sci. 160:869–875. 111 Capell, T., Bassie, L., Christou,P. 2004. Modulation of the polyamine biosynthetic pathway in transgenic rice confers tolerance to drought stress. PNAS 101:9909– 9914. 112 Xu, D., Duan, X., Wang, B., Hong, B., Ho, T. H. D., Wu, R. 1996. Expression of a late embryogenesis abundant protein gene, HVA1, from barley confers tolerance to water deficit and salt stress in transgenic rice. Plant Physiol. 110:249–257. 113 McKersie, B. D., Bowley, S. R., Jones, K. S. 1999. Winter survival of transgenic alfalfa overexpressing superoxide dismutase. Plant Physiol. 119:839–847. 114 Kasuga, M., Liu, Q., Yamaguchi-Shinozaki, K., Shinozaki, K. 1999. Improving plant drought, salt, and freezing tolerance by gene transfer of a single stress-inducible transcription factor. Nature Biotechnol. 17:287–291. 115 CIMMYT 2004. Results of transgenic wheat trial look promising. CIMMYT´s Electronic News, September 2004. http://www.cimmyt.org/english/wps/enews/index?mo=9&year=2004 (accessible August 2005) 116 Lee, J. H., van Montague, M., Verbruggen, N. 1999. A highly conserved kinase is an essential component for stress tolerance in yeast and plant cells. Proc. Natl. Acad. Sci. USA 96:5873–5877. 117 Zhang, H.-X., Blumwald, E. 2001. Transgenic salt-tolerant tomato plants accumulate salt in the foliage but not in fruit. Nature Biotechnol. 19:765–768.
118 Gisbert, C., Rus, A. M., Bolarin, C., Lopez-Coronado, J. M., Arrilaga, I., Montesinos, C., Caro, M., Serrano, R., Moreno, V. 2000. The yeast HAL1 gene improves salt tolerance of transgenic tomato. Plant Physiol. 123:393–402. 119 Takahashi, M., Nakanishi, H., Kawasaki, S., Nishizawa, N. K., Mori, S. 2001. Enhanced tolerance of rice to low iron availability in alkaline soils using barley nicotianamine aminotransferase genes. Nature Biotechnol. 19:466–469. 120 Guerinot, M. L. 2001. Improving rice yields – ironing out the details. Nature Biotechnol. 19:417–418. 121 de la Fuente, J.M., Ramirez-Rodriguez,V., Cabrera-Ponce, J.L., Herrera-Estrella, L. 1997. Aluminum tolerance intransgenic plants by alteration of citrate synthesis. Science 276:1566–1568. 122 Anoop, V.M., Basu, U., McCammon, M.T., McAlister-Henn, L., Taylor, G.J. 2003. Modulation of citrate metabolism alters aluminium tolerance in yeast and transgenic canola overexpressing a mitochondrial citrate synthase. Plant Physiology 132:2205–2217. 123 Delhaize,E., Ryan, P.R., Hebb, D.M., Yamamoto, Y., Sasaki, T., Matsumoto, H. 2004. Engineering high-level aluminium tolerance in barley with the ALMT1 gene. PNAS 101:15249–15254. 124 Farré, E. M., Bachmann, A., Willmitzer, L., Trethewey, R. N. 2001. Acceleration of potato tuber sprouting by the expression of a bacterial pyrophosphatase. Nature Biotechnol. 19:268–272. 125 Pena, L., Martin-Trillo, M., Juarez, J., Pina, J. A., Navarro, L., Martinez-Zapater, J. M. 2001. Constitutive expression of Arabidopsis LEAFY or APETALA1 genes in citrus reduces their generation time. Nature Biotechnol. 19:263–267. 126 He, Z., Zhu, Q., Dabi, T., Li, D., Weigel, D., Lamb, C. 2000. Transformation of rice with the Arabidopsis floral regulator LEAFY causes early heading. Transgenic Res. 9:223–227. 127 Ye, X., Al-Babili, S., Klöti, A., Zhang, J., Lucca, P., Beyer, P., Potrykus, I. 2000. Engineering the provitamin A (β-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 287:303–305.
61
62
References 128 Potrykus, I. 2001. Golden Rice and Beyond. Plant Physiol. 125:1157–1161. 129 Römer, S., Fraser, P. D., Kiano, J. W., Shipton, C. A., Misawa, N., Schuch, W., Bramley, P. M. 2000. Elevation of the provitamin A content of transgenic tomato plants. Nature Biotechnol. 18:666–669. 130 Chen, Z., Young, T.E., Ling, J., Chang, S.-C., Gallie, D.R. 2003. Increasing vitamin C content of plants through enhanced ascorbate recycling. PNAS 100:3525–3530. 131 Abbadi, A., Domergue, F., Bauer, J., Napier, J.A., Welti, R., Zähringer, U., Cirpus, P., Heinz, E. 2004. Biosynthesis of Very-Long-Chain Polyunsaturated Fatty Acids in Transgenic Oilseeds: Constraints on their Accumulation. The Plant Cell 16:2734–2748. 132 Goto, F., Yoshihara, T., Shigemoto, N., Toki, S., Takaiwa, F. 1999. Iron fortification of rice seeds by the soybean ferritin gene. Nature Biotechnol. 17:282–286. 133 Lucca, P., Wünn, J., Hurrell, R. F., Potrykus, I. 2000. Development of iron-rich rice and improvement of its absorption in humans by genetic engineering. J. Plant Nutr. 23 (11/12):1983–1988. 134 Lucca, P., Hurrell, R., Potrykus, I. 2001. Genetic engineering approaches to improve the bioavailability and the level of iron in rice grains. Theoret. Appl. Genet. 102:392–397. 135 Chakraborty, S., Chakraborty, N., Datta, A. 2000. Increased nutritive value of transgenic potato by expressing a nonallergenic seed albumin gene from Amaranthus hypochondriacus. Proc. Natl. Acad. Sci. USA 97 (7):3724–3729. 136 Pratt, T. 1999. The quest for nontoxic cassava. ISB News Report, January 1999. http://www.isb.vt.edu/articles/jan9902. htm (accessible August 2005). 137 Sayre, R. T. 2000. Cyanogen reduction in transgenic cassava. Generation of safer food product for subsistence farmers. ISB News Report, August 2000. http://www. isb.vt.edu/articles/aug0003.htm (accessible August 2005). 138 Siritunga, D., Sayre, R.T. 2003. Generation of cyanogen-free transgenic casssava. Planta 217:367–373. 139 Sevenier, R., Hall, R. D., van der Meer, I., Hakkert, H. J. C., van Tunen, A. J.,
Koops, A. J. 1998. High level fructan accumulation in a transgenic sugar beet. Nature Biotechnol. 16: 843–846. 140 Rotino, G. L., Perri, E., Zottini, M., Sommer, H., Spena, A. 1997. Genetic engineering of parthenocarpic plants. Nature Biotechnol. 15:1398–1401. 141 Tomes, D. T. 1997. Seedless hopes bode well for winter vegetables. Nature Biotechnol. 15:1344–1345. 142 Barro, F., Rooke, L., Békés, F., Gras, P., Tatham, A. S., Fido, R., Lazzeri, P., Shewry, P. R., Barcelo, P. 1997. Transformation of wheat with high molecular weight subunit genes results in improved functional properties. Nature Biotechnol. 15:1295–1299. 143 Westwood, J. 1997. Transgenic bread is on the rise. ISB News Report, December 1997. http//:www.isb.vt.edu/articles/ dec9704.htm (accessible August 2005). 144 He, G. Y., Rooke, L., Steele, S., Békés, F., Gras, P., Tatham, A. S., Fido, R., Barcelo, P., Shewry, P. R., Lazzeri, P. A. 1999. Transformation of pasta wheat (Triticum turgidum L. var. durum) with high molecular weight glutenin subunit genes and modification of dough functionality. Mol. Breeding 5(4): 377–386. 145 McElroy, D., Jacobsen, J. 1995. What’s brewing in barley biotechnology? Bio/ Technology 13:245–249. 146 Nuutila, A. M., Ritala, A., Skadsen, R. W., Mannonen, L., Kaupinnen, V. 1999. Expression of fungal thermotolerant endo1,4-beta-glucanase in transgenic barley seeds during germination. Plant Mol. Biol. 41 (6):777–783. 147 Cho, M.-J., Wong, J. H., Marx, C., Jiang, W., Lemaux, P. G., Buchanan, B. B. 1999. Overexpression of thioredoxin h leads to enhanced activity of starch debranching enzyme (pullulanase) in barley grain. Proc. Natl. Acad. Sci. USA 96 (25):14641– 14646. 148 Pew Initiative on Food and Biotechnology 2001. Harvest on the horizon: future uses of agricultural biotechnology. http:// pewagbiotech.org/research/harvest/harvest.pdf. (accessible August 2005). 149 Arakawa, T., Chong, D. K. X., Langridge, W. H. R. 1998. Efficacy of a food plantbased oral cholera toxin B subunit vaccine. Nature Biotechnol. 16:292–297.
2 Genetically Modified Plants 150 Richter, L., Kipp, P. B. 2000. Transgenic plants as edible vaccines. In: Hammond, J., McGarvey, P., Yusibov, V. (eds.), Plant Biotechnology: New Products and Applications, Springer, Berlin, New York, 159–176. 151 Mason, H. S., Lam, D. M. K., Arntzen, C. J. 1992. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89:11745–11749. 152 Thanavala, Y., Yang, Y.-V., Lyons, P., Mason, H. S., Arntzen, C. J. 1995. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 92:3358–3361. 153 Langridge, W. H. R. 2000. Edible vaccines. Sci. Am. 283 (3):66–71. 154 Tacket, C. O., Mason, H. S., Losonsk, G., Clements, J. D., Levine, M. M., Arntzen, C. J. 1998. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Med. 4:607–609. 155 Goldstein, D.A., Thomas, J.A. 2004. Biopharmaceuticals derived from genetically modified plants. Q J Med 97:705–716. 156 Ma, J.K.-C., Drake, P.M.W., Christou, P. 2003. The production of recombinant pharmaceutical proteins in plants. Nature Reviews Genetics 4:794–805.
157 Cramer, C. L., Boothe, J. G., Oishi, K. K. 2000. Transgenic plants for therapeutic proteins: Linking upstream and downstream strategies. In: Hammond, J., McGarvey, P., Yusibov, V. (eds.), Plant Biotechnology: New Products and applications, Springer, Berlin, New York, pp. 95–118. 158 Fischer, R., Drossard, J., Commandeur, U., Schillberg, S., Emans, N. 1999. Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants. Biotechnol. Appl. Biochem. 30:101–108. 159 Stöger, E., Vaquero, C., Torres, E., Sack, M., Nicholson, L., Drossard, J., Williams, S., Keen, D., Perrin, Y., Christou, P., Fischer, R. 2000. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol. Biol. 42:583–590. 160 Parmenter, D. L., Boothe, J. G., Van Rooijen, G. J. H., Yeung, E. C., Moloney, M. M. 1995. Production of biological active hirudin in plant seeds using oleosin partitioning. Plant Mol. Biol. 29:1167–1180. 161 Komarnytsky, S., Borisjuk, N. V., Borisjuk, L. G., Alam, M. Z., Raskin, I. 2000. Production of recombinant proteins in tobacco guttation fluid. Plant Physiol. 124:927–933.
63
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi Rena Leisegang, Elke Nevoigt, Anja Spielvogel, Georg Kristan, Anke Niederhaus, and Ulf Stahl
3.1 Introduction 3.1.1 Why do we Ferment Foodstuffs?
Mankind has been fermenting foodstuffs such as bread, cheese, and wine for thousands of years. For example the brewing of beer or the making of bread evolved in ancient Babylon approximately 8,000 years ago [1]. Fermentation is the process of bioconversion of organic substances by microorganisms and/or enzymes. It is one of the oldest and most globally applied forms of preservation of a range of raw agricultural materials (cereals, roots, tubers, fruit and vegetables, milk, meat, fish etc.). The fermentation process can, first and foremost, be seen as a means of conserving food and protecting it against spoilage. The use of ethanol or acids obtained by fermentation hinders unwanted microorganisms and results in a product, for example beer, wine, and vinegar, which is more-or-less preserved. Beyond preservation, fermentation has been used to develop novel foodstuffs. There has always been a need to render raw materials more nutritious, to create something more palatable out of raw foodstuffs, making them more easy to digest, and, of course, to improve taste [2]. Our demands of food have not changed much with time. The ability of microorganisms to break down undigestable polymers by means of amylolytic or proteolytic enzymes contributes to the palatability of the product. Other metabolic activity can reduce levels of toxins in raw foodstuffs or produce vitamins and essential amino and fatty acids, thus increasing nutritional value. These actions also contribute to: 1. the flavor and texture of the food, by excreting metabolites such as aldehydes, acids, esters, ketones and sulfur compounds; and 2. the content of reductones, antioxidants, and antimicrobial compounds.
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
3.1.2 Fermented Foods of Plant and Animal Origin
This section provides a short overview on fermented foods which are produced using yeast or filamentous fungi. These are also categorized according to the type of raw material (plant or animal origin) involved. These listings (Table 3.1) are, naturally, far from complete.
Tab. 3.1 Fermented food of plant origin. Raw material
Product and/or process
Predominant yeast or fungus (bacteria)
Refs.
Barley
Beer
Saccharomyces cerevisiae
3
Barley, wheat
Lambic beer
Brettanomyces lambicus/ B. bruexellensis
4
Sorghum
Pito
Saccharomyces cerevisiae
5
Cereals
Bread
Saccharomyces cerevisiae
6
Rice
Sake
Saccharomyces cerevisiae Aspergillus oryzae
7, 8
Maize
Sour maize gruel
Saccharomyces cerevisiae (Lactobacillus confusus) Candida krusei
9, 10
Sugar cane
Cachaca (Aguardente)
Saccharomyces cerevisiae
11, 12
Grape
Wine
Saccharomyces cerevisiae
13
Grape
Champagne
Saccharomyces bayanus
14
Millet
Pombe (beer)
Schizosaccharomyces pombe
14
Palm juice
Ogogoro (gin)
Schizosaccharomyces pombe
14
Tea extract
Kombucha
Brettanomyces bruxellensis Candida stellata Schizosaccharomyces pombe Torulaspora delbrueckii Zygosaccharomyces bailii
15, 16
Olives
Olive fermentation
Pichia anomala Saccharomyces spp. Candida spp. Debaromyces spp. Geotrichum candidum
17, 18
65
66
3.1 Introduction Tab. 3.1 (continued) Raw material
Product and/or process
Predominant yeast or fungus (bacteria)
Refs.
Soy bean, wheat
Shoyu (Soy sauce)
Aspergillus spp. (Koji) Zygosaccharomyces rouxii (Moromi)
2, 8, 19
Soy bean, rice
Miso
Aspergillus oryzae Zygosaccharomyces rouxii
2, 20
Soy bean, peanuts, coconut
Tempe
Rhizopus spp.
8
Soy bean (milk)
Sufu (Tofu)
Rhizopus spp. Mucor spp. Aspergillus spp.
2
Peanut
Oncom
Rhizopus oligosporus Neurospora sitophila
2
In general, the microorganisms used to produce foodstuffs must fulfill certain criteria [2]: 1. the absence of toxinogenic and pathogenic potential; 2. competitiveness; 3. mycelia (for fungi) of white, yellowish, and ivory color; and 4. proteolytic and lipolytic activity for aroma formation. Fermentation of plants by yeasts results, for instance, in different, widespread, alcoholic beverages for example beer, wine, and sake and in a variety of traditional beverages, for example Cachaca and Ogogoro. Fermentation of raw foodstuffs of animal origin results in products such as cheese and meat. Examples of mold-ripened cheese are blue-veined cheeses such as Roquefort (France), Gorgonzola (Italy), and Stilton (UK). Roquefort is only made from sheep’s milk, whereas Gorgonzola and Stilton are produced from cows’ milk. All blue cheese are made with Penicillium roqueforti which grows inside the product. Examples of mold-ripened soft cheeses with Penicillium camemberti growing on the surface are Camembert and Brie [2]. Other cheeses, for example Limburger, Tilsiter, Port Salut, Trappist, Brick, and Danish Danbo are also surface-ripened cheese. The use of yeast is predominant during the initial period of ripening, in which it is used to increase the pH on the cheese surface, thereby enabling growth of bacteria present in the smear. Strains of Debaryomyces hansenii (among Kloeckera and Trichosporon species) in particular are supposed to be responsible for the increase of pH by degrading lactic acid [21]. The yeast Klyveromyces lactis is also used for cheese ripening [22]. Naturally fermented sausages produced in Italy are examples of fermentation of meat by a combination of different microorganisms. Several Lactobacillus and
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
Staphylococcus bacteria species and the yeast genera Candida, Debaromyces, and Willopsis are involved in the preservation of meat products [23]. Nontoxic Penicillium species, for example Penicillium nalgiovense, are used as a starter culture for cured and fermented meat to prevent the surface growth of mycotoxic molds such as Aspergillus. Other meat products include mold-ripened hams, for example “Bündnerfleisch” from Switzerland, “Südtiroler Bauernspeck” from Tirol, and Italian “coppa” [2]. A mixed culture consisting of a variety of species of the genera Kluyveromyces, Candida, Pichia, and Saccharomyces and some lactic acid bacteria can be used to produce Kefir by fermenting milk whey or fruit juice [24].
3.2 Yeast
This section deals with the use of molecular genetics for optimizing yeast strains relevant in the production of fermented foods. The emphasis here is on enhancement of metabolism in respect to faster fermentation, changes to optimize particular fermentation features relevant to the production process (e.g. flocculation), extension of yeast’s substrate spectrum, and alteration of byproduct formation. Genes referred to in the text are summarized in Table 3.2. 3.2.1 Methods of Recombinant DNA Technology in Yeast
Saccharomyces cerevisiae is by far the most analyzed yeast strain as regards genetics, physiology, and biochemistry. In fact, bakers’ yeast was the first eukaryotic organism to be genetically transformed [25], and its genome has been fully sequenced [26]. Many databases are now available on the Web, for example the Saccharomyces Genome Database (SGD, http://www.yeastgenome.org/), the Munich Information Center for Protein Sequences (MIPS, http://mips.gsf.de/genre/proj/ yeast/), the Yeast Proteome Database (YPD, http://www.proteome.com/), and the European Saccharomyces cerevisiae Archive for Functional Analysis (EUROSCARF, http://web.uni-frankfurt.de/fb15/mikro/euroscarf/) etc., which contain an enormous amount of information about each open reading frame of this organism. As Saccharomyces species are the yeasts most used for fermentation of foodstuffs (Table 3.1), we first focus on recombinant techniques in S. cerevisiae (other reviews are available elsewhere [14, 25, 27–32]. We also provide more information later in the section on non-Saccharomyces yeasts (again, reviews are available elsewhere [33, 34]). The first procedure on molecular transformation in S. cerevisiae, which involves the production of protoplasts by means of enzymes such as glucuronidase or zymolyase, was described in 1978 [25]. Protoplasts were incubated in the presence of transforming DNA and polyethylene glycol (PEG) and then spread on selective media. One of the main disadvantages of this “spheroplast method” is that PEG stimulates cell fusion, because of incomplete removal of the cell wall [35], which
67
68
3.2 Yeast Tab. 3.2 Genes relevant to genetic modification of yeasts. Gene
Organism
Function
ADE1
S. cerevisiae
ALD6 ALD7 ATF1 FAS2 FLO1 FLO5 FLO8 FLO11 GOX1 GPD1 HAP4 HIS3 his5+ HSP30 HXT ILV5 LEU2 MAL MEL1 MET2 MET3 MET10 MET14 MET25 MIG1 MIG2 PGK1 PGU1 rhaA STA2 SSU1 TRP1 URA3
S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae Aspergillus niger S. cerevisiae S. cerevisiae S. cerevisiae S. pombe S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae S. cerevisiae A. aculeatus S. diastaticus s. cerevisiae S. cerevisiae S. cerevisiae
Phosphoribosyl amino imidazolesuccinocarbozamide synthetase Aldehyde dehydrogenase Aldehyde dehydrogenase Alcohol acetyltransferase Fatty acid synthase Cell wall protein, mannose binding Cell wall protein, mannose binding RNA polymerase II transcription factor Cekk surface protein Glucose oxidase Glycerol 3-phosphate dehydrogenase Transcription factor Dehydratase in histidine biosynthesis complements S. cerevisiae his3 mutation Heat-shock-protein 30 Permease gene family Acetohydroxyacid reductoisomerase Dehydrogenase in leucine biosynthesis Maltose permease gene family Melibiase Homoserine acetyltransferase Sulfate adenyltransferase Sulfite-reductase Adenyl-sulfatekinase Acetyl homoserine-(thiol)-lyase Transcription co-repressor Transcription co-repressor Phosphoglyceratkinase Endopolygalacturonase α-I-rhamnosidase Glucoamylase Plasma membrane sulfite pump Phosphoribosylanthranilate isomerase Dexarboxylase
may result in diploids and polyploids [36]. An alternative procedure used to transform yeast is referred to as the lithium acetate method. Whole cells are treated with lithium salts then PEG is added [37]. The successful uptake of DNA by whole cells using PEG alone was demonstrated in the same year [38], but transformation was only one third as efficient as treatment with additional lithium acetate [39]. It has also been demonstrated that the efficiency of transformation varied for different strains and methods [28], thus emphasizing that strain and method of transformation have to be carefully selected. Yeasts can also be transformed by electro-
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
poration. Electric pulses are applied both to yeast spheroplasts [40] and to intact yeast cells, including PEG in the electroporation buffer [41]. Other variations of the procedure used for pretreatment of the yeast cells in the early phase of exponential growth are treatment with dithiothreitol [42], sorbitol [43] or HEPES buffer [44]. A hybrid technique using elements of both the LiAc/PEG and electroporation procedures has also been reported [45]. Other methods used for transformation of yeast cells are agitation with glass beads in the presence of DNA [46] or the biolistic approach, first developed for plant cells [47] and then successfully transferred to yeast cells [48]. Lithium acetate and electroporation are currently the methods of choice [49–52]. All genetic engineering approaches require at least one selectable genetic marker to successfully identify transformed cells. There are two general types of selection marker for yeasts: 1. genes complementing an auxotrophy of the yeast strain used; and 2. genes conferring resistance against antibiotics or other toxic agents. The latter are referred as to dominant markers. The first type of genetic marker can only be used in yeast strains carrying mutations conferring auxotrophy, i.e. use is virtually limited to haploid laboratory yeasts. For example, mutants defective in one of the genes encoding enzymes involved in biosynthesis of amino acids (leu2, trp1, his1) or nucleic bases (ade1, ura3) are often used [53]. These mutations, i.e. the phenotypic defects enabling growth on minimal medium without respective nutrients, can be complemented after transforming the mutants with the corresponding wild-type genes (LEU2, TRP1, HIS1, ADE1 and URA3). It is important to know that yeast strains which only contain a simple point mutation in the auxotrophic marker gene can change to the wild-type phenotype without transformation, but only by reverse mutation and with very low efficiency. Hence, it is much better to work with auxotrophic strains which have either a gene deletion or more than two point mutations in the gene of interest. Ideally, the genetic marker enables efficient selection without affecting cellular functions. In this context, the reader is referred to the review by Pronk [54], which covers several important aspects relevant to the application of yeast strains bearing auxotrophies and the complementing marker genes. For integrative approaches (see below), it is important that the genetic marker used has no sequence homology with the wild-type genome, to reduce the frequency of integration at nontargeted loci. For this reason heterologous marker genes which complement auxotrophies in S. cerevisiae, for example URA3 and LEU2 from Kluyveromyces lactis and his5+ from Schizosaccharmomyces pombe, are often used [55]. Markers complementing auxotrophies are less suitable for these purposes, because industrial strains are often diploid or even polyploid and, hence, auxotrophic mutant strains are rarely available. In such circumstances dominant markers are an excellent alternative (see above). The most widely used dominant marker is resistant to Geneticin 418 (geneticin is a derivative of kanamycin). The bacterial kanamycin-resistance gene of Tn309 can confer resistance to geneticin in yeast [56].
69
70
3.2 Yeast
When fused to a yeast promoter it can even be used as a selectable marker in single-copy transformants of yeast. Many alternative dominant markers are available. In addition to those listed by Akada [32] genes conferring resistance to hygromycin B [57], neomycin [58], nourseothricin, and bialaphos [59] have also been tested for their utility in yeast. There are two methods by which transformed DNA can be established in yeast cells: 1. as an autonomously replicated molecule; or 2. integrated into one of the yeast chromosomes enabling stable inheritance without selection pressure. Vectors used for yeast transformation therefore fall into two classes – those which are maintained as an episomal plasmid which replicates autonomously i.e. yeast episomal plasmids (YEp) and yeast centromeric plasmids (YCp), and those which are integrated into the host’s genome while being passively inherited, i.e. yeast integrative plasmids (YIp) [29]. Yeast integrative plasmids are becoming increasingly obsolete because of the ease of one-step gene integration methods using integration cassettes simply created by PCR (see below). Yeast vectors are E. coli-yeast shuttle vectors and contain a backbone of an E. coli vector mainly derived from pBR322 or pUC, including an origin and a selection marker for E. coli (mainly genes encoding enzymes which confer resistance to antibiotics). This is usually necessary to clone and propagate the plasmids in E. coli. There is, however, an elegant strategy which can partly circumvent time-consuming cloning steps in E. coli. This method which relies on homologous recombination in yeast has been referred to as recombinational cloning [60]. Two types of yeast sequence are mainly used as origins in yeast self-replicating vectors: 1. a fragment of the 2-μm plasmid in yeast; and 2. autonomous replicating sequences (ARS). The 2-μm plasmids are naturally occurring plasmids (circular and doublestranded DNA) in S. cerevisiae. There are approximately 50–100 copies per cell. The biological function of these plasmids are unknown. They confer no obvious advantage on the cells. They can, however, replicate themselves, and contain an origin and so-called “partitioning elements” which are responsible for equal partitioning during cell division. The first 2-μm plasmid-derived yeast vectors contained the whole 2 μm plasmid combined with pBR322 for replication in E. coli, plus the LEU2 gene for selection [61]. Later, smaller vectors were designed containing, for example, only the ORI-STB region as the minimum portion [29] circumventing the recombination with the endogenous 2-μm plasmid of yeast observed earlier. Vectors derived from 2-μm plasmids have high transformation efficiency and a high copy number (10–40 per cell). They are, however, less stable than integrative vectors and get lost during growth without selective pressure. The second type of self-replicating vector contains an ARS sequence. These plasmids are usually very unstable. Cloning centromeric sequences (CEN) in ARSbased plasmids yields centromeric plasmids (YCp). These vectors behave like chro-
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
mosomes, i.e. there are one or two copies per cell and they are very stable even under nonselective conditions. Yeast integrative vectors do not contain an origin of replication for yeast. Those vectors can only be stably inherited by yeast if integrated into one of the yeast chromosomes after transformation. Integration relies on the mechanism of homologous recombination, which is very effective in yeast. This process requires a sequence in the vector which is homologous with yeast chromosomal DNA. The efficiency of this type of transformation is very low (usually about 100 to 1000-fold lower than for use of self-replicating vectors) and is highly dependent on the length of homologous sequence used. The frequency of transformation events can be improved by linearizing the vector DNA using a restriction enzyme within the region which is homologous with the target site at the chromosome [62]. After transformation and homologous recombination, an integrative vector is mainly present in one copy and mitotically stable. Target sites for integration should be carefully chosen to prevent or minimize negative effects on yeast physiology. If desired, the copy number of integrated DNA can be increased by choosing repeating target sequences within the genome, for example ribosomal DNA [63, 64] or the delta sequences of the yeast retrotransposon Ty1 [65, 66]. Nowadays, integration of DNA sequences or disruption of genes by gene replacement is mainly performed using linear PCR fragments instead of YIp-based vectors. The PCR-generated integration cassettes contain a genetic marker and, if desired, an additional sequence, e.g. a gene of interest. The cassette must be flanked by sequences homologous with the desired integration site, because integration is mediated by homologous recombination (double crossover). As 30–45 bp of homology are sufficient to promote homologous recombination in yeast [67], the flanking sequences can simply be added by designing the PCR primers in the appropriate way. For commercial applications in food production and processing, yeast strains should be free from nonessential foreign DNA, especially genetic markers conferring resistance to antibiotics. For complete marker rescue, the marker genes can be surrounded by direct repeats. Homologous recombination between the two repeats results in marker removal, leaving behind a single repeat at the integration locus [68–70]. The frequency of mitotic recombination is very low, however, which makes the selection process very laborious. This selection process can be facilitated by counter-selection, e.g. use of growth conditions in which only those cells which have lost the marker can grow. A wide variety of counter-selection systems has been listed by Akada [32]. Alternatively, the Cre-loxP recombination system of bacteriophage P1 has been shown to mediate efficient recombination between loxP sites flanking a marker gene in yeast, resulting in excision of the marker [71] and leaving one loxP sequence in the yeast genome. A collection of variable genetic markers flanked by loxP-sequences has been provided [55, 72]. Storici et al. [73] developed a marker recycling system based on FLP-FRT recombinase from 2-μm plasmid. Amounts of genetic, biochemical, and physiological information and technology for non-Saccharomyces yeasts, for example Klyveromyces spp., Pichia spp., Hansenu-
71
72
3.2 Yeast
la spp., and Zygosaccharomyces spp., are, in general, much less than for S. cerevisiae, but growing constantly (reviews are available elsewhere [33, 34, 74]). Transformation systems for these so called nonconventional yeasts depend heavily on those developed for S. cerevisiae [75]. The most commonly used markers are derived from the biosynthetic pathway of the homologous system, but those from S. cerevisiae are also found to be effective [76–78]. Endogenous plasmids have been isolated and characterized for Yarrowia lipolytica, K. lactis, Z. rouxxii, and Z. baili [34]. Autonomous replication may also be based on ARS-like sequences, e.g. the PARS sequences for Pichia pastoris [79], or HARS sequences for Hansenula polymorpha [80]. Alternatively, integrative approaches have been used. Targeted integration or gene disruption can be performed for many types of yeast, as described for S. cerevisiae [81–84]. For example, two integrating vectors developed for use in S. cerevisiae were successfully used for cloned gene integration in K. lactis [85].
3.2.2 Genetically Modified Saccharomyces Strains
Until the 1970s, strain development resulted mainly from work on selection, mutation, and classical breeding. During the last few years methods of strain improvement have changed radically from these classical attempts to more rational approaches, for example genetic engineering. This involves introduction of directed genetic changes into the cell by recombinant DNA technology. In 1991 Bailey defined this approach as “metabolic engineering”; this is simply the “technological manifestation of applied molecular biology”. Since this initial definition of metabolic engineering this term has broadened its meaning and now covers a variety of different aspects of molecular biology, for example heterologous protein production, extension of substrate range, introducing pathways leading to novel products or to degradation of xenobiotics, elimination or reduction of byproduct formation, engineering of cellular physiology for process improvement, and improvement of yield or productivity [86]. In the following text we describe different approaches for improving industrial strains by means of metabolic engineering. Species of the genus Saccharomyces are used for biologically processed food products, for example bread, spirits, wine, and beer. The exploitation of non-Saccharomyces yeast and filamentous fungi for production of food will be discussed later. To modify biochemical pathways in industrial yeasts, one needs extensive knowledge of their genetic structure. The most detailed studies were performed for a lager brewers’ yeast strain called Saccharomyces carlsbergensis, which was isolated by E. C. Hansen in 1883 [87]. The lager brewing yeast (“bottom-fermenting”) is currently classified as S. pastorianus [88] and is thought to be a natural hybrid between S. cerevisiae and another unknown Saccharomyces species [89] which is closely related to S. monacensis [90, 91] or to S. bayanus [92, 93]. Ale yeasts (“top-fermenting”) are a diverse group of polyploid yeasts. These are not, in contrast with lager-brewing yeasts, genetic hybrids and are, therefore, more genetically related to laboratory strains of S. cerevisiae.
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
Most wine yeasts are isolates of S. cerevisiae or S. bayanus [94, 95]. S. bayanus seems to contain a genome which originates from both S. cerevisiae and S. monacensis [90, 96].
3.2.2.1 Beer Beer is produced from malted barley or other cereals, hops, and water, according to the German “Reinheitsgebot” of 1516 (purity regulations for beer brewing). It was not until 1680, however, that the microscope was developed and brewers’ yeast was identified. In addition to improving the brewing process by technological means, in the last 20 years much effort has been devoted to genetic modification of brewers’ yeast. The genetically modified strains which have been developed can ferment a wider range of carbohydrates, have altered flocculation properties, and can produce beers with modified flavors (other reviews are available elsewhere [97–100]). Carbohydrate utilization Brewers’ yeast utilizes mono, di, and trihexoses only. To metabolize other oligomers (e.g. maltotriose dextrins or β-glucans) several attempts have been made to express glucoamylase and β-glucanase genes of different origin. Biodegradation of usually unfermented wort compounds leads to a low-carbohydrate beer. Elimination of β-glucans resulted in improved filterability and haze stability, thus providing an example of both extension of the substrate range and the improvement in the production process and the quality of the beer. Examples of, and references to, extension of the substrate range in industrial yeast strains are listed in Table 3.3.
Tab. 3.3 Extension of the range of substrates for industrial yeast strains (modified from Ref. [100]). Substrate extension
Achievements
Refs.
Starch and dextrins
Expression of α-amylase (AMY1) and glucoamylase (GAM1) genes of Schwanniomyces occidentalis[*,**]
101
β-Glucans
Integration of a β-glucanase gene of barley[*]
102
Malate
Expression of malate permease (MAE1) of Schizosaccharomyces pombe and malic enzyme of S. pombe (MAE2) or Lactococcus lactis (mleS)[***]
103
Melibiose
Introduction of melibiase gene (MEL1)[**]
104
* ** ***
Brewers’ yeast Bakers’ yeast Wine yeast
73
74
3.2 Yeast
Reduction of ethanol content To produce beer with a reduced alcohol content, the GPD1 gene encoding glycerol-3-phosphate dehydrogenase was overexpressed in a lager brewing yeast to increase glycerol production at the expense of ethanol formation. The amount of glycerol produced by the GPD1-overexpressing yeast was increased 5.6 times and ethanol was reduced by 18% compared with the wild-type. Concentrations of several byproducts, particularly acetoin, diacetyl, and acetaldehyde, also increased substantially, however [105]. Flocculation A suitable brewers’ yeast strain should be able to flocculate, leading to natural clearing of beer at the end of fermentation. Flocculation is a very complex process that depends on expression of a variety of specific genes, for example FLO1, FLO5, FLO8, and FLO11 [106]. Because flocculation throughout the fermentation process results in lower cell counts and increased fermentation time, regulated expression of the flocculation genes is crucial. For example, phase-specific expression of FLO1 was achieved by using the HSP30 promoter, inducing high gene expression during the late stationary phase [107]. Flavor Applications of genetic engineering to brewing yeast with the objective of optimization of beer flavor are, for example, elimination of unwanted byproducts, for example diacetyl and hydrogen sulfide, or the increased production of antioxidants such as sulfur dioxide. Diacetyl is a major off-flavor in beer resulting from overflow of the valine biosynthetic pathway. It is formed during fermentation by spontaneous oxidation of α-acetolactate, which diffuses from yeast cells into the fermenting wort. The expensive and time-consuming maturation of green beer is, to some extent, because of the slow conversion of diacetyl to acetoin and then to 2,3-butanediol; a metabolite with a much higher taste threshold than diacetyl. There are many ways of avoiding the extensive maturation time by reducing diacetyl formation (Ref. [97] and references cited therein). These methods imply introduction of the heterologous gene for α-acetolactate decarboxylase (ALDC), thus enabling the cell to produce acetoin directly from α-acetolactate and reducing the time of lagering from weeks to hours. Other attempts to minimize diacetyl formation involve the overexpression or deletion of genes encoding enzymes of the valine biosynthetic pathway to reduce the formation of α-acetolactate (a review is available elsewhere [87]). The construction of a strain of recombinant brewers’ yeast with reduced capacity to produce hydrogen sulfide has also been successful. This approach will also result in a shorter maturation time and reduced costs of lagering. A promising attempt by Omura et al. [108] was placing the MET25 gene of the sulfate metabolic pathway downstream of a constitutive glycolytic promoter. The expression cassette was integrated into the rDNA array of a brewers’ yeast strain. Flavor stability in the finished beer is maintained by sufficient levels of sulfur dioxide which acts both as an antioxidant and a complexing agent of carbonyl compounds responsible for stale flavors. Many strategies have been employed on a variety of genes of the sulfate metabolic pathway to alter sulfur dioxide levels. Increased sulfite production and excretion have been achieved by overexpression of
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
genes such as SSU1 and MET14 [109, 110]. The objectives of other strategies include disruption of the MET2 and MET10 genes, the latter being more successful than the former (Ref. [97] and references cited therein).
3.2.2.2 Wine Wine has been produced for thousands of years from grapes and their inhabitant microflora, provided either by the vineyard or the winery. The predominant yeast species responsible for the wine-making process are S. cerevisiae and subspecies such as S. bayanus (in the following text referred to as wine yeast) which convert grape sugars. The objectives of recombinant technology with wine yeast are improvement of fermentation performance, processing efficiency, and flavor characteristics. Several attempts have been carefully reviewed [95]. Fermentation performance To extend the range of carbon and nitrogen assimilation beyond catabolite repression, experiments have been conducted on the basis of the extensive knowledge of the genes involved in the glycolytic and nitrogen pathways [95, 100]. Efficient sugar utilization was the objective of overproducing all glycolytic enzymes, but ethanol formation could not be increased [111]. A different approach could be overexpression of genes of the HXT permease gene family which enable high-affinity glucose uptake [95]. Processing efficiency Refining and clarification at the end of wine processing comprises removal of excess amounts of some compounds. Because polysaccharides have a detrimental effect on clarification and stabilization of must and wine, both heterologous and endogenous genes have been overexpressed to enable enzymatic degradation of pectins, glucans, and hemicellulose (mainly xylans) [95]. Overexpression of an endogenous PGU1 gene coding for an endopolygalacturonase in an oenological S. cerevisiae strain recently led to significant reduction of filtration time in wine production [112]. Flavor Improvement of wine flavor and other sensory qualities entails enhancement of terpenoids of grape origin, volatile esters, and glycerol produced, and, last but not least, the adjustment of wine acidity. Terpenoids are secondary metabolites of grapes and desirable volatile compounds in wine. By heterologous expression of the β-1,4-glucanase gene of Trichoderma longibrachiatum in wine yeast, aroma intensity was presumably increased because of hydrolysis of glycosylated terpenoid precursors [113]. The expression of the rhaA gene, encoding an α-1-rhamnosidase from Aspergillus aculeatus, in combination with overexpression of β-D-glucosidase from Candida molischiana resulted in increased content of the aromatic compound linalool [114]. Esters have characteristically fruity odors and require acetyltransferase activity for their synthesis. Levels of esters formed during primary fermentation vary substantially. The ATF1-encoded alcohol acetyltransferase (AAT) is one of the beststudied in S. cerevisiae [106]. Integration of the ATF1 gene under the control of
75
76
3.2 Yeast
the constitutive PGK1-promoter in commercial wine yeast strains resulted in an improved flavor profile of the wine produced because of increased formation of desirable esters [115]. Glycerol, a nonvolatile compound, contributes to sensory characteristics such as the sweetness, smoothness, consistency, and overall body of the wine. Attempts have been made to overproduce glycerol to improve the wine’s organoleptic quality. This is especially useful for white wine, which contains smaller amounts of glycerol than red wine. It has been shown that both overexpression of GPD1 and disruption of ALD6 and ALD7 led to two to threefold greater glycerol production (at the expense of ethanol) and a significant decrease of acetate formation [116, 117]. The predominant organic acids in wine are tartaric and malic acid, which account for 90% of the titratable acidity of grapes. When these are not suitably adjusted, imbalance or even spoilage of the product can result. The ability of S. cerevisiae strains to assimilate malic acid varies widely, mainly because of the absence of an active malate transport system. In addition to S. cerevisiae’s inefficient metabolism of malate, substrate specificity of malic enzyme is low. It has been shown that integration of Schizosaccharomyces pombe genes encoding for malate permease (mae1) and malic enzyme (mae2) into the genome of S. cerevisiae resulted in efficient degradation of malic acid in Chardonnay grape must [118]. The sulfate reductase MET10 gene has been used to develop wine yeasts producing less hydrogen sulfide, to improve wine flavor [119]. Becker et al. recently developed a wine-yeast which produces resveratrol, a natural compound of red wine with antioxidant and antimutagenic properties [120].
3.2.2.3. Sake Sake is a typical Asian alcoholic beverage produced from rice by use of sake yeast (mainly S. cerevisiae) and Aspergillus oryzae. A few attempts have been made to genetically modify sake yeast strains to enhance flavor. Flavor To improve the flavor profile of sake, a self-cloning yeast that overexpressed ATF1 gene was constructed [121]; this led to an increase in the isoamyl acetate production. A greater amount of ethyl caproate, which is the apple-like flavor component, was achieved by point mutation of the yeast’s fatty acid synthase gene FAS2 [122].
3.2.2.4. Bread Bread is made by fermenting dough, mainly from wheat and other cereals, with bakers’ yeast and, for sourdough, Lactobacillus also. The requirements of a well performing bakers’ yeast are [6, 86, 98, 100]: 1. efficient respiratory metabolism during biomass production to enable an economic yield from raw substrates; and 2. formation of substantial quantities of carbon dioxide during dough production. Improvements to bakers’ yeast encompassed both requirements.
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
Fermentation in dough substrates The ability of bakers’ yeast to ferment depends on a high potential to utilize maltose, which results from hydrolysis of starch by endogenous amylases present in the dough. The presence of glucose prevents maltose from being absorbed by the cell and metabolized – a general regulatory mechanism widely known as catabolite repression. Glucose represses synthesis of maltase (MalS) and maltose-permease (MalT) and inactivates maltase enzyme (MalR), leading to a substantial lag in adaptation to the maltose. Strategies for metabolic engineering to diminish the extent of glucose control imply the constitutive expression of the MAL genes together with disruption of regulatory genes such as MIG1 and MIG2. This attempt could partly alleviate glucose control, and the specific growth rate was increased with both glucose and maltose, leading to shorter processing time for bread production [123, 124]. Biomass yield To increase biomass yield, bakers’ yeast strains able to utilize melibiose by expressing the MEL1 gene have been constructed by use of metabolic engineering [104]. Another promising strategy for expanding productivity is overexpression of the transcription factor Hap4p [125], which results in an improved growth rate with a 40% gain of biomass yield and a significant reduction of ethanol production. 3.2.3 Genetically Modified Non-Saccharomyces Strains
Nonconventional yeasts have particular advantages compared with S. cerevisiae, for example ability to grow on unusual carbon sources, better ability to cope with several types of stress, absence of the Crabtree-effect which results in high cell densities, lack of hyperglycosylation, or the availability of stringently regulated promoters for the expression of toxic proteins. Nonconventional yeasts are therefore becoming increasingly important for economic production of heterologous proteins [34]. Numerous non-Saccharomyces yeasts are involved in food production, however, e.g. Schizosaccharomyces (alcoholic beverages, Kombucha), Zygosaccharomyces (fermentation of soy bean), Candida (meat fermentation, wine production, Kefir production), Pichia (olive fermentation, meat fermentation, wine production), Klyveromyces (meat fermentation, cheese ripening) (Table 3.1). Few examples of genetic engineering of food-relevant non-Saccharomyces yeasts are known. The importance of S. pombe for production of traditionally fermented beverages, for example pombe and ogogoro, has already been discussed, but little is known about strain improvement either by the classical breeding approach or by genetic modification [28]. To remove gluconic acid from musts of rotten grapes glucose-transport-deficient Schizosaccharomyces pombe mutants were used and could remove 93% of gluconic acid and 80% of initial malic acid [126]. Zygosaccharomyces rouxii is an osmotolerant and halophilic yeast used to provide characteristic aromas to Japanese soy sauce and miso. Methionol (3-methylthio-1propanol) is a characteristic flavor compound of soy sauce. Strain improvement for production of soy sauce has been achieved by simple selection for mutants [127].
77
78
3.3 Filamentous Fungi
An L-methionine-resistant mutant strain was found to be partly deficient in conversion of methionine into S-adenosyl-methionine (SAM); this led to a sixtyfold increase in methionol production.
3.3 Filamentous Fungi
This section describes progress in biotechnology of filamentous fungi, the focus being on methods which can be used to improve products based on filamentous fungi and on applications of the amended fungi. Filamentous fungi are used not only for direct fermentation of foodstuffs (Section 3.1.1) but also to produce proteins used as additives in the food industry. As with yeast, the development of improved strains of filamentous fungi requires genetic engineering techniques to impart favorable and remove adverse properties.
3.3.1 Recombinant DNA Technology in Filamentous Fungi
Several filamentous fungi have been investigated at the genetic level. In particular, fundamental and applied aspects of the model filamentous fungi Aspergillus nidulans and Neurospora crassa have been studied in great detail. This has led to the development of fungal vectors and genetic engineering techniques. Subsequently, other Ascomycetes and Deuteromycetes of biotechnological interest have been successfully transformed. The first fungal transformation of N. crassa was performed more than 25 years ago [128]. Methods must, however, be adapted for every fungal class or even strain.
3.3.1.1 Strategies used to Transform Filamentous Fungi Protoplast transformation (Calcium/PEG) Transformation of protoplasts is the general method used to transform filamentous fungi. By use of this method protoplasts from mycelia, germinating conidia, or basidiospores are commonly prepared by use of lytic enzymes, for example Novozym 234, Glusulase, and Zymolyase [129–131]. All these enzyme preparations contain a mixture of cell-walldegrading enzymes, mainly glucanases and chitinases. Enzyme preparations differ between batches, however, and isolation of protoplast is very time-consuming. Traditionally, uptake of DNA is achieved via protoplasts exposed to calcium ions and polyethylene glycol (PEG).
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
Electroporation Electroporation has been widely used to transform animal cells, plant protoplasts, yeast, and bacteria [85, 132, 133]. Filamentous fungi can be transformed via electroporation either after cell-wall weaking [134], with protoplasts [135] or germinating conidia [136]. Systems for electroporation have been established for many filamentous fungi (e.g. N. crassa, A. oryzae [134], A. nidulans [136], and A. niger [137]). Biolistic transformation Whole mycelium can be transformed by use of a particle gun (shotgun or biolistic approach) where DNA-coated tungsten balls are shot into the mycelium [138]). The transformation methods mentioned above are described in detail in a recent review by Ruiz-Diez [139]. Agrobacterium tumefaciens-mediated transformation (ATM) The most recent approach used to obtain integrative transformants is the Agrobacterium tumefaciensbased method. Several fungi (Aspergillus spp. [140, 141], Basidiomycetes [141], Zygomycetes [142], and Oomycetes [143]) have been successfully transformed and the number of fungi is still increasing. Transformation can be achieved without the need for protoplast. Integration occurs at random [144], although efficient homologous integration has also been reported [145]. A recent publication by Michielse et al. [146] summarizes the current state-of-the-art of using ATM in fungi.
3.3.1.2 Selection Systems A wide range of selection systems based on auxotrophic markers and drug-resistance markers is available for filamentous fungi. Here the complementing or resistance gene can be homologous or heterologous, even when from a bacterial source [147]. One of the disadvantages of using auxotrophic markers is that appropriate mutant strains are required; these are difficult to obtain for species for which genetic engineering methods have not been established. For example, to utilize the pyrG [148] (orotidine-5-decarboxylase) and niaD [149] genes (nitrate reductase) as selectable markers, uracil auxotrophs and strains lacking nitrate reductase are necessary. The most common methods used to screen for these mutants use 5-fluoroorotic acid (5-FOA) and chlorate, respectively. The use of pyrG as a selectable marker has several advantages over other selection systems. It has been reported by Fierro et al. [150] that: 1. transformation rates using pyrG are much higher than with any other system; 2. homologs have been isolated from a variety of fungi (P. nalgiovense, A. nidulans, N. crassa), thus homologous selection markers can be used; this overcomes concerns about genetically engineered strains of microorganisms used in the food industry, because no heterologous genes are actually introduced into the production strain; in addition 3. pyrG enables counter-selection using 5-FOA, thus the selection marker can be eliminated and used for successive transformations of the same strain.
79
80
3.3 Filamentous Fungi
Another commonly used system is characterized by incorporation of the amdS gene of A. nidulans, coding for acetamidase [149]. Drug-resistance markers have the advantage that no detailed genetic information and mutants are necessary to perform a successful transformation. Resistance genes, e.g. to oligomycin or benomyl, encoded either by fungal genes or by bacterial genes (cloned together with a fungal promoter), for example phleomycin or hygromycin B are frequently used. Ruiz-Dìez [139] summarized the following disadvantages of using drug-resistance genes: 1. the allele for resistance must be isolated to transform wild-type strains; 2. the resistance gene may not show significant dominance, resulting in selection difficulties; 3. some species are relatively resistant to, e.g., hygromycin; and 4. compounds used for selection are often very expensive and result in selective media being expensive. Drug-resistance markers are, nevertheless, usually used.
3.3.1.3 The Fate of the Transforming DNA DNA that has been introduced into filamentous fungi will either be maintained autonomously (rarely) or integrated into the genome via homologous or heterologous integration events. Homologous integration can target special loci in the genome, in which the integration cassette can integrate once or in tandem repeats, whereas heterologous recombination events can occur at undefined sites, resulting in single or multicopy integrations. Homologous integration can be achieved via a single cross-over event (leading, e.g., to a disruption of an undesired gene) or via a double cross-over event (leading to gene deletion). In general, this approach requires long homologous flanking regions (1000 bp) and has to be optimized for every fungal strain. In a recent study, Yu et al. [151] used integration constructs with flanking regions ranging from 480 bp to 4.3 kb and observed an homologous recombination (HR) frequency of 0–40%. Homologous integration is necessary to target a gene of interest to a locus which houses strongly expressed genes coding for secreted proteins (e.g. genes such as cellobiohydrolase I in Trichoderma reesei and glucoamylase in A. niger). The advantage of replacing the strongly expressed gene with the gene of interest is that the capacity of the secretory pathway that is naturally used for secretion of the endogenous protein can be used for secretion of the protein of interest [152]. Use of this gene-replacement approach can also eliminate unfavorable genes essential for the biosynthesis of mycotoxin, antibiotic, or other secondary metabolites (e.g. isocoumarins – Ref. [153] and references cited therein) in food-fermenting fungi. Because the frequency of homologous integration in filamentous fungi is often very low, several methods have been developed to improve the efficiency of homologous recombination. Michielse et al. [146] suggested combination of ATM with the TAGKO method (transposon-arryed gene knock-outs) [154], which has been reported to yield high homologous integration frequency in Mycosphaerella graminicola and Magnaporthe grisea [155, 156]. The molecular mechanism of non-
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
homologous recombination has been elucidated at the molecular level and termed “nonhomologous end-joining” (NHEJ) [157]. This process depends on protein kinase catalytic subunits Ku70 and Ku80. Homologs of Ku70 and Ku80 have been located in yeasts [157] and N. crassa [158]. In mutant strains of N. crassa in which Ku70 and Ku80 homologs have been knocked out, exogenous DNA integrated homologously at a frequency of 100% [158]. Detection of KU70 and KU80 homologs in A. nidulans has recently been reported [159]; the genes were designated nkuA and nkuB, respectively. The single deletion of nkuA dramatically increased the frequency of homologous integrations (from approximately 13% to 90%). They also could reduce homologous flanking region to 500 bp to enable efficient gene targeting in an ΔnkuA strain. Ku70 and Ku80 homologs will certainly be found in other fungi, with permit a higher rate of homologous recombination. Heterologous integration does not require homology between transforming DNA and target sites. In contrast with yeast, heterologous integration is favored in filamentous fungi. This results in transformants with high copy numbers and considerable mitotic stability [160]. A strict correlation between copy number and gene dosage is often not observed in such strains, however, because of the effects of position and titration. The position of integration seems to play a major role in the level of expression achieved, whereas limitation of transcription factors available could somewhat downsize the approach [161]. The use of autonomously replicating vectors is restricted, because of an almost complete lack of natural plasmids in hyphal fungi which could act as a basis for such vectors. The AMA (autonomous maintenance in Aspergillus) sequence of A. nidulans [162] confers autonomous replication of vectors on Aspergillus and other fungi, similar to the ARS sequence of S. cerevisiae. Penicillium nalgiovense, used as a starter for cured and fermented meat products, has been transformed with reasonably high mitotic stability and high transformation frequency using an AMA1-based plasmid [150]. Nevertheless, plasmids are easily lost when transformants are grown under nonselective conditions.
3.3.2 Application of RNA-based Methods for Strain Improvement
RNA interference (RNAi) is a new field that has been successfully applied to filamentous fungi [161]. This method enables interference in gene expression at the post-transcriptional level without altering the genetic background of the production strain. Takeno et al. [164] used the RNAi approach to improve the production of arachidonic acid (ARA) with Mortierella alpina. Another successful application of the RNAi approach is the increased expression of (wanted) glucose repressible genes by RNAi downregulation of creA in A. nidulans [165] without complete disruption of gene function. By use of this strategy, the unwanted impaired growth phenotype of a creA null mutant deletion strain [166], which renders such a strain not applicable for industrial exploitation, could be circumvented.
81
82
3.3 Filamentous Fungi
In addition to RNAi, hammerhead ribozymes can target virtually any mRNA sequence of choice and prevent gene expression at the post-transcriptional level. This method can also be applied to metabolic engineering of filamentous fungi [167]. RNAi and ribozyme techniques are the only methods available that modulate gene expression at the post-transcriptional level and enable fine tuning in comparison with deletion methods and thus can be useful for reducing gene products of multicopy genes or mRNAs of essential genes, where disruption would either be lethal or result in an undesirable phenotype.
3.3.3 Industrial Filamentous Fungi
Traditional food of plant origin, for example soy sauce in East Asia, cheese in Europe, and, nowadays, nutritional supplements (for example enzymes, vitamins, lipids, and a meat substitute) are produced using filamentous fungi (Section 3.1.1). This section focuses on exemplarily selected applications of filamentous fungi in food technology. Several properties of hyphal fungi make them an ideal host for homologous and heterologous protein production. They have a naturally high-volume secretion system and the capacity for post-translational modifications. Fermentation processes have, furthermore, already been developed (antibiotics production) and molecular genetic methods are available for directed strain improvement. The filamentous fungi most widely used for protein production are A. niger, A. oryzae, and T. reesei [152]. Recently, a new fungus, Chrysosporium lucknowense, has been discovered and used for protein production, with some advantages, for example high transformation frequency, production at neutral pH, low viscosity (nonfilamentous strain), and short fermentation time [152].
3.3.3.1 Fungi Used for Fermentation of Plant Material Aspergillus, Rhizopus, and Mucor strains are used for fermentation of soybeans, rice, and peanut products (Table 3.1). In Japan these starter cultures are known as koji. Strains are selected for their specific enzymes. For soy sauce production, strains should have high proteolytic and amylolytic activity whereas strains for rice wine production should have high amylolytic activity to convert starch into sugar [2]. Strain improvement for koji molds should result in new strains with regard to production of desirable enzymes, aroma compounds, organic acids, and pigments, enhancement of characteristics for growth, and temperature and salt tolerance, for example. The method of choice is genetic breeding, i.e. the protoplast fusion technique. A variety of filamentous fungi, for example Aspergillus, Mucor, Penicillium and Trichoderma, have been subjected to intra and interspecific protoplast fusion. Principles and applications of genetic recombination of industrial koji molds have been carefully reviewed [168].
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
3.3.3.2 Fungal Oils and Other Metabolites Oils are produced by several molds (A. sydowii, Fusarium oxysporum, F. equiseti) [169], but single-cell oil production by filamentous fungi cannot compete commercially with lipids of plant origin. There is, however, a large market, e.g. in neonatal nutrition, for oils containing very long polyunsaturated fatty acids (PUFA), which are not available from plant sources [170]. Arachidonic acid (ARA) and docosahexaenoic acid (DHA), both absent from cow’s milk and infant formulas, have been found to be important for neural and retinal development. ARA and DHA are produced by several companies and have been reviewed by Ratledge [170]. There is an increasing demand of these two PUFA, with a market of up 1000 tons per year [170]. Other lipids produced by fungi (e.g. Mucor circinelloides) are gammalinoleic acid and cocoa butter substitutes [171]. Riboflavin (vitamin B2), produced by Ashbya gossypii, is an essential factor for humans and animals, because it is the precursor of flavoenzymes. It is used in the food industry as a supplement in multivitamin juices, and as a colorant (E101) in soft drinks and yoghurts. A naturally overproducing strain of A. gossypii is currently used to produce riboflavin. Purines are essential precursors for the biosynthesis of riboflavin. The de novo purine biosynthetic pathway is a highly regulated system with a direct affect on the yield of riboflavin. Manipulations to enhance the metabolic flow through the purine pathway could increase the production of riboflavin tenfold, to 228 mg mL−1 [172].
3.3.3.3 Fungal Proteins and Enzymes Thaumatin is a sweet protein (approx. 3000 times sweeter than sucrose) derived from the tropical plant Thaumatococcus danielii [173] and has been approved as food-grade ingredient [174]. Availability from the plant is very limited [175], and several attempts to heterologously express thaumatin in bacteria, yeast, and A. oryzae have failed. Successful expression has been achieved in P. roquefortii and A. niger var. awamori [176] at titers of 2–7 mg L−1. An increase of thaumatin production (14 mg L−1) was initially achieved by using strong fungal promoters to express thaumatin and higher gene dosage (14 copies). There was good correlation between gene copy number and secreted protein [177]. Similar results were obtained when aspergillopepsin, a fungal protease, was deleted [177]. The yield of thaumatin could also be increased 2 to 2.5-fold in A. awamori in comparison with the parental strain because of the overexpression of the chaperone BipA [178]. Overexpression of chaperones is a strategy commonly used to improve the expression of heterologous proteins in filamentous fungi. Xylanases are used as a supplement in animal feed, for the manufacture of bread, food and drink, textiles, bleaching of cellulose pulp, and ethanol and xylitol production. Among microbial sources, filamentous fungi (mainly A. niger, Trichoderma spp., and Humicola insolens.) secrete xylanases into the medium and levels are higher than those found in yeasts and bacteria [179]. Xylanases can be used to improve bakery products such as wheat–rye and whole meal bread. Application of xylanases results in easier kneading, increased loaf
83
84
3.3 Filamentous Fungi
volume, better crumb porosity, higher moisture, and an extended shelf life (Refs [179], and references cited therein, and Ref. [180]). Xylanases are also used in the juice and wine industry to aid the liquefaction of fruit and vegetables and the stabilization of the fruit pulp, to increase the recovery of aromas, essential oils, vitamins, mineral salts, edible dyes, pigments etc., to reduce viscosity, and for hydrolysis of substances that hinder clearing of the juice. The main advantage of using xylanases derived from filamentous fungi is high stability and optimum activity at acid pH [179]. Lipases can be used to alter the fatty acid composition of oils derived from plants or fish [171]. This is achieved by selective hydrolysis, which leads to accumulation of lipids where the lipases used are not specific for. Examples are eicosapentaenoic acid (EPA) and DHA in fish oils, which have been increased by use of lipases from Rhizopus niveus [181]. Lipases also play a role in flavor development and also affect the consistency of cheese. Blue cheese flavoring could be enhanced and accelerated using P. roquefortii lipases [182, 183]; in addition, rancidity of butter fat can be avoided by the removal of butyric acid by interesterification with A. niger lipase [171]. Ratledge [170] and Sancholle and Lösel [171] provide detailed information about lipid production and application of lipases. DSM Food Specialties is a leading producer of value-added ingredient solutions for the international food, feed, and beverage industries. DSM have screened 14,000 genes of the Aspergillus niger genome, for which they determined the DNA sequence in 2001. DSM have discovered that A. niger contains approximately 200 genes encoding proteases with a variety of functions; of these 60 are secreted, A. niger proteases are used to produce the PeptoPro energy-recovering drink. In addition DSM have found an A. niger asparaginase which can be used to prevent acrylamide formation [184] during food preparation.
3.3.3.4 Fungi as Single-cell Protein (SCP) During the early 1960s a variety of microorganisms were screened for production of SCP. A potential microbial protein should be cheap and easy to produce, palatable, and have a suitable taste and texture. Fusarium venenatum was chosen for development of a mycoprotein, and in 1984 this was approved for sale as a food product by the Ministry of Agriculture, Fisheries, and Food in the UK [185]. According to Wiebe [185], Quorn (brand name) has found a important market role in Europe as an alternative to meat for vegetarians and people seeking a healthier diet, because F. venenatum mycoprotein contains approximately 44% (w/w) protein (dry weight), all the essential amino acids are present, and it contains no cholesterol, is low in saturated fats [186], and comprises 25% fiber. Major advantages of fungal single-cell proteins is the low nucleic acid content compared with bacterial and yeast single-cell proteins, because high concentrations of purines causes articular gout, and in comparison with tofu the texture of Quorn is more meat-like. There are, however, concerns about the allergic potential of fungal proteins present in Quorn, and adverse gastrointestinal reactions have been reported [187].
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
3.4 Prospects
The biotechnology of yeast and filamentous fungi has been a very important issue in the last few decades and a large number of industries are highly dependent on improving the productivity of yeast and fungal production strains. Substantial progress has been made in developing novel food strains of yeasts and filamentous fungi by means of genetic engineering. Enormous effort has been devoted to research development of Saccharomyces cerevisiae strains (brewing yeast, wine yeast, bakers’ yeast) resulting in improved fermentation capacities which can enhance, for example, the sensory quality of bread or beer. In general, the public have a low opinion of genetically modified (GM) food. Mainly because industry fears negative consumer reaction, none of these GM strains has actually been used commercially. Only one GM yeast, produced at The Brewing Research Foundation International (BRFi), has received approval for use in beer production. “Nutfield Lyte”, a lowcalorie and low-alcohol beer, has been brewed for research purposes only. Beyond genetic engineering of food-relevant yeasts, many GM yeast strains have been developed and applied in the production of: 1. recombinant proteins (e.g. enzymes, inhibitors, interferons, hormones, antibodies); and 2. industrially useful chemicals (antibiotics, organic, amino, and fatty acids, vitamins, sterols and other biologically active substances). GM filamentous fungi are also used for the industrial production of, for example, enzymes, vitamins, pigments, and lipids. Filamentous fungi are also extremely effective at performing biotransformation processes, for example the production of steroids. The potential of GM yeast and filamentous fungi to produce numerous biological active substances may also affect modern food production. Conceivable applications for yeasts and filamentous fungi are in the production of functional food – the production of “positive” food additives, for example vitamins, organic acids, and prebiotic and bioactive substances. The resulting products would have a clear advantage over conventionally produced foods and could even prevent diseases or compensate for malfunctions. In fact, improvement of the nutrition value of food products is one of the most important challenges for the future.
Acknowledgments
We thank V. Meyer for useful discussions and R. Bensmann for correcting the English in the manuscript.
85
86
References
References 1 Bamforth, C. W. (1998) Tap into the art and science of brewing. Plenum Press, New York and London. 2 Wolf, G. (1997) Traditional fermented food, in: Fungal Biotechnology (Anke, T., Ed.), Chapman and Hall, Weinheim, pp. 3–13. 3 Tornai-Lehoczki, J., Dlauchy, D. (2000) Delimination of brewing yeast strains using different molecular techniques. Int. J. Food Microbiol. 62, 37–45. 4 Verachtert, H., Debourg, A. (1995) Properties of Belgian acid beers and their microflora. Cerev. and Biotech. 20 (1), 39–41. 5 Van der Aa Kuhle, A., Jesperen, L., Glover, R. L., Diawara, B., Jakobsen, M. (2001) Identification and characterization of Saccharomyces cerevisiae strains isolated from West African sorghum beer. Yeast 18, 1069–1079. 6 Attfield, P. V. (1997) Stress tolerance: The key to effective strains of industrial bakers’ yeast. Nat. Biotech. 15, 1351–1357. 7 Nakazato, A., Kadokura, T., Amano, M., Harayama, T., Murakami, Y., Takeda, M., Ohkuma, M., Kudo, T., Kaneko, T. (1998) Comparison of the structural characteristics of chromosome VI in Saccharomyces sensu stricto: the divergence, species-dependent features and uniqueness of sake yeasts. Yeast 14, 723–731. 8 Krämer, J. (1992) Lebensmittel-Mikrobiologie 2. Auflage, Eugen Ulmer, Stuttgart. 9 Zulu, R. M., Dillon, V. M., Owens, J. D. (1997) Munkoyo beverage, a traditional Zambian fermented maize gruel using Rhynchosia root as amylase source. Int. J. Food Microbiol. 34, 249–258. 10 Hayford, A.E., Jakobsen, M. (1999) Characterization of Candida krusei strains from spontaneously fermented maize dough by profiles of assimilation, chromosome profile, polymerase chain reaction and restriction endonuclease analysis. J. Appl. Microbiol. 87(1), 29–40. 11 Guerra, J. B., Araujo, R. A., Pataro, C., Franco, G. R., Moreira, E. S., MendoncaHagler, L. C., Rosa, C. A. (2001) Genetic diversity of Saccharomyces cerevisisae strains during the 24 h fermentative
12
13
14
15
16
17
18
19
20
cycle for the production of the artisanal Brazilian cachaca. Lett. Appl. Microbiol. 33, 106–111. Schwan R. F., Mendonca, A. T., da Silva Jr., J. J., Rodrigues, V., Wheals, A. E. (2001) Microbiology and physiology of Cachaca (Aguardente) fermentations, Antonie Van Leeuwenhoek 79, 89–96. Mortimer, R., Polsinelli, M. (1999) On the origins of wine yeast. Res. Microbiol. 150, 199–204. Walker, G. M. (1998) Yeast. Physiology and Biotechnology. John Wiley and Sons, Chichester. Teoh, A. L., Heard, G., Cox, J. (2004) Yeast ecology of Kombucha fermentation. Int. J. Food Microbiol. 95 (2), 119–126. Steels, H., James, S.A., Bond, C.J., Roberts, I.N., Stratford, M. (2002) Zygosaccharomyces kombuchaensis: the physiology of a new species related to the spoilage yeast Zygosaccharomyces lentus and Zygosaccharomyse bailii. Yeast 2, 113–21. Coton, E., Coton, M., Levert, D., Casaregola, S., Sohier, D.(2005) Yeast ecology in French cider and black olive natural fermentations. Int. J. Food Microbiol. (in press). Giannoutsou, E.P., Meintanis, C., Karagouni, A.D.(2004) Identification of yeast strains isolated from a two-phase decanter system olive oil waste and investigation of their ability for its fermentation. Bioresour Technol. 93(3), 301–6. Jansen, M., Veurink, J. H., Euverink, G. J., Dijkhuizen, L. (2003) Groth of a salttolerant yeast Zygosaccharomyces rouxii in microtiter plates: effects of NaCl, pH and temperature on growth and fusel alcohol production from branched-chain amino acids. FEMS Yeast Res. 3 (3), 313–318. Sujaya, I.N., Tamura, Y., Tanaka, T., Yamaki, T., Ikeda, T., Kikushima, N., Yata, H., Yokota, A., Asano, K., Tomita, F. (2003) Development of internal transcribed spacer regions amplification restriction fragment length polymorphism method and its application in monitoring the population of Zygosaccharomyces rouxii M2 in miso fermentation. J. Biosci. Bioeng. 96(5), 438–47.
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi 21 Eliskases-Lechner, F., Ginzinger, W. (1995) The yeast flora of surface ripened cheeses. Milchwissenschaft 50, 458–462. 22 Arif, K., Spinnler, H. E., Tache, R., Bonnarme, P. (2002) Production of volatile compounds by cheese-ripening yeasts: requirement for a methanethiol donor for S-methylthioacetate synthesis by Kluyveromyces lactis. Appl. Microbiol. Biotechnol. 58(4), 503–510. 23 Rantsiou, K., Urso, R., Iacumin, L., Cantoni, C., Cattaneo, P., Comi, G., Cocolin, L. (2005) Culture-dependent and -independent methods to investigate the microbial ecology of Italian fermented sausages. Appl. Environ. Microbiol. 71(4), 1977–86. 24 Kourkoutas, Y., Psarianos, C., Koutinas, A.A., Kanellaki, M., Banat, I.M, Marchant, R. (2002) Continuous whey fermentation using kefir yeast immobilized on delignified cellulosic material. J. Agric. Food Chem. 50(9), 2543–7. 25 Hinnen, A., Hicks, J. B. and Fink, G. R. (1978) Transformation of yeast. Proc. Natl. Acad. Sci. 75, 1929–33. 26 Goffeau, A., Barrell, B.G., Bussey, H., Davis, R.W., Dujon, B., Feldmann, H., Galibert, F., Hoheisel, J.D., Jacq, C., Johnston, M., Louis, E.J., Mewes, H.W., Murakami, Y., Philippsen, P., Tettelin, H., Oliver, S.G. (1996) Life with 6000 genes. Sci. 274(5287), 546, 563–7. 27 Romanos, M. A., Scorer, C. A., Clare, J. J. (1992) Foreign gene expression in yeast: a review. Yeast 8, 423–488. 28 Sudbery, P. E. (1993) Genetic engineering of yeast, in: Biotechnology. Second Edition, Vol. 2 (Rehm, H.-J., Reed, G., Pühler, A., Stadler, P., Eds.), VCH Weinheim, pp. 507–528. 29 Hadfield, C. (1994) Construction of cloning and expression vectors, Molecular Genetics of Yeast. A practical approach (Johnston, J. R., Ed.), Oxford University Press, pp. 17–48. 30 Archer, D. B., MacKenzie D. A., Jeenes D. J. (2001) Genetic engineering: yeasts and filamentous fungi, in: Basic Biotechnology. Second Edition (Ratledge, C., Kristiansen B., Eds.), Cambridge University Press, pp. 95–126. 31 Gietz, R. D. and Woods, R. A. (2006) Yeast transformation by the LiAc/SS
32
33
34
35
36
37
38
39
40
41
42
43
44
Carrier DNA/PEG method. Methods Mol. Biol. 313, 107–20. Akada, R. (2002) Genetically modified industrial yeast ready for application. J. Biosci. Bioeng. 94, 536–44. Wolf, K., Breuning, K., Barth, G. (eds.): Non-conventional yeasts in genetics, biochemistry and biotechnology. Practical Protocols, Springer, Berlin, 2003. Porro, D., Sauer, M., Branduardi, P. and Mattanovich, D. (2005) Recombinant protein production in yeasts. Mol. Biotechnol. 31, 245–59. Hutchison, H. T., Hartwell, L. H. (1967) Macromolecule synthesis in yeast spheroplasts. J. Bacteriol. 94, 1697–1705. Kao, K. N., Michayluk, M. R. (1974) A method for high-frequency intergeneric fusion of plant protoplasts. Planta 115, 355–367. Ito, H., Fukuda, Y., Murata, K., Kimura, A. (1983) Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153, 163–168. Klebe, R. J., Harriss, J. V., Sharp, Z. D., Douglas, M. G. (1983) A general method for polyethylene-glycol-induced genetic transformation of bacteria and yeast. Gene 25, 333–341. Yamakawa, M., Hishinuma, F., Gunge, N. (1985) Intact cell transformation of Saccharomyces cerevisiae by poly(ethylene glycol). Agric. Biol. Chem. 49, 869–871. Karube, I., Tamiya, E., Matsuoka, J. (1985) Transformation of Saccharomyces cerevisiae spheroplasts by high electric pulse. FEBS Lett. 182, 90–94. Hashimoto, H., Morikawa, H., Yamada, K., Kimura, A. (1985) A novel method for transformation of intact yeast cells by electroinjection of plasmid DNA. Appl. Microbiol. Biotechnol. 21, 336–339. Meilhoc, E., Masson, J. M. and Teissie, J. (1990) High efficiency transformation of intact yeast cells by electric field pulses. Biotechnology (NY) 8, 223–7. Becker, D. M., Guarente, L. (1991) Highefficiency transformation of yeast by electroporation. Methods Enzymol. 194, 182–187. Grey, M., Brendel, M. (1992) A ten-minute protocol for transforming Saccharomyces cerevisiae by electroporation. Curr. Genet. 22, 335–336.
87
88
References 45 Manivasakam, P., Schiestl, R. H. (1993) High efficiency transformation of Saccharomyces cerevisiae by electroporation. Nucl. Acids Res. 21, 4414–4415. 46 Costanzo, M. C., Fox, T. D. (1988) Transformation of yeast by agitation with glass beads. Genetics 120, 667–670. 47 Klein, T. M., Wolf, E. D., Wu, R., Sanford, J. C. (1987) High-velocity microprojection for delivering nucleic acids into living cells. Nature 327, 70–73. 48 Johnston, S. A., Anziano, P. Q., Shark, K., Sanford, J. C., Butow, R. A. (1988) Mitochondrial transformation in yeast by bombardment with microprojectiles. Science 240, 1538–1541. 49 Gietz, R. D, Woods, R. A. (2001) Genetic transformation of yeast. BioTechniques 30, 816–831. 50 Pribylova, L., Sychrova, H. (2003) Efficient transformation of the osmotolerant yeast Zygosaccharomyces rouxii by electroporation. J. Microbiol. Meth. 55, 481–4. 51 Suga, M., Kusanagi, I. and Hatakeyama, T. (2003) High osmotic stress improves electro-transformation efficiency of fission yeast. FEMS Microbiol. Lett. 225, 235–9. 52 Wu, S. and Letchworth, G. J. (2004) High efficiency transformation by electroporation of Pichia pastoris pretreated with lithium acetate and dithiothreitol. Biotechniques 36, 152–4. 53 Hinnen, A., Buxton, F., Chandury, B. Heim, J., Hottiger, T., Meyhack, B., Pohlig, G. (1995) Gene expression in recombinant yeast, in Gene Expression in Recombinant Miroorganisms (ed. A. Smith) Marcel Dekker Inc. New York, pp. 121–193. 54 Pronk, J. T. (2002) Auxotrophic yeast strains in fundamental and applied research. Appl. Environ. Microbiol. 68, 2095–100. 55 Gueldener, U., Heinisch, J., Koehler, G. J., Voss, D., Hegemann, J. H. (2002) A second set of loxP marker cassettes for Cre-mediated multiple gene knockouts in budding yeast. Nucl. Acids Res 30, e23. 56 Webster, T. D. and Dickson, R. C. (1983) Direct selection of Saccharomyces cerevisiae resistant to the antibiotic G418 following transformation with a DNA vector
57
58
59
60
61
62
63
64
65
66
67
carrying the kanamycin-resistance gene of Tn903. Gene 26, 243–52. Gritz, L. and Davies, J. (1983) Plasmidencoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25, 179–88. Riley, J. H., Morten, J. E. and Anand, R. (1992) Targeted integration of neomycin into yeast artificial chromosomes (YACs) for transfection into mammalian cells. Nucl. Acids Res. 20, 2971–6. Goldstein, A. L. and McCusker, J. H. (1999) Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 15, 1541–53. Raymond, C. K., Pownder, T. A. and Sexson, S. L. (1999) General method for plasmid construction using homologous recombination. Biotechniques 26, 134–8, 140–1. Beggs, J. D. (1978) Transformation of yeast by a replicating hybrid plasmid. Nat. 275, 104–109. Rothstein, R. (1991) Targeting, disruption, replacement, and allele rescue: integrative DNA transformation in yeast. Methods Enzymol. 194, 281–301. Lopes, T. S., Klootwijk, J., Veenstra, A. E., van der Aar, P. C., van Heerikhuizen, H., Raue, H. A. and Planta, R. J. (1989) High-copy-number integration into the ribosomal DNA of Saccharomyces cerevisiae: a new vector for high-level expression. Gene 79, 199–206. Rosel, H. and Kunze, G. (1998) Integrative transformation of the dimorphic yeast arxula adeninivorans LS3 based on hygromycin B resistance. Curr. Genet. 33, 157–63. Lee, W. and Dasilva, N. A. (2006) Application of sequential integration for metabolic engineering of 1,2-propanediol production in yeast. Metab Eng. 8(1), 58–65. Parekh, R. N., Shaw, M. R. and Wittrup, K. D. (1996). An integrating vector for tunable, high copy, stable integration into the dispersed Ty delta sites of Saccharomyces cerevisiae. Biotechnol. Prog. 12, 16–21. Baudin, A., Ozier-Kalogeropoulos, O., Denouel, A., Lacroute, F. and Cullin, C.
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi
68
69
70
71
72
73
74
75
76
77
(1993) A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae. Nucl. Acids Res. 21, 3329–30. Alani, E., Cao, L. and Kleckner, N. (1987) A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116, 541–5. Langle-Rouault, F., Jacobs, E. (1995) A method for performing precise alterations in the yeast genome using a recycable selectable marker. Nucl. Acids Res. 23, 3079–81. Wach, A., Brachat, A., Pohlmann, R. and Philippsen, P. (1994) New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10, 1793–808. Sauer, B. (1987) Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol. Cell Biol. 7, 2087–96. Güldener, U., Heck, S., Fiedler, T., Beinhauer, J., Hegemann, H. (1996) A new efficient gene disruption cassette for repeated use in budding yeast. Nucl. Acids Res. 24, 2519–2524. Storici, F., Coglievina, M., Bruschi, C. V. (1999) A 2-micron DNA-based marker recycling system for multiple gene disruption in the yeast Saccharomyces cerevisiae. Yeast 15, 271–83. Cereghino, J.L., Cregg, J.M. (2000) Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev. 24(1), 45–66. Wang, T. T., Choi, Y. J., Lee, B. H. (2001) Transformation systems of non-Saccharomyces yeasts. Crit. Rev. Biotechnol. 21, 177–218 Thor, D., Xiong, S., Orazem, C.C., Kwan, A.C., Cregg, J.M., Lin-Cereghino, J., Lin-Cereghino, G.P. (2005) Cloning and characterization of the Pichia pastoris MET2 gene as a selectable marker. FEMS Yeast Res. 5(10), 935–42. Lin-Cereghino, G.P., Lin-Cereghino, J., Sunga, A.J, Johnson, M.A., Lim, M., Gleeson, M.A., Cregg, J.M. (2001) New selectable marker/auxotrophic host strain combinations for molecular genetic manipulation of Pichia pastoris. Gene 263(1/2), 159–69.
78 Nett, J.H., Hodel, N., Rausch, S., Wildt, S. (2005) Cloning and disruption of the Pichia pastoris ARG1, ARG2, ARG3, HIS1, HIS2, HIS5, HIS6 genes and their use as auxotrophic markers. Yeast 22(4),295–304. 79 Lueking, A., Holz, C., Gotthold, C., Lehrach, H., Cahill, D. (2000) A system for dual protein expression in Pichia pastoris and Escherichia coli. Protein Expr. Purif. 20, 372–8. 80 Sohn, J. H., Choi, E. S., Kim, C. H., Agaphonov, M. O., Ter-Avanesyan, M. D., Rhee, J. S. and Rhee, S. K. (1996) A novel autonomously replicating sequence (ARS) for multiple integration in the yeast Hansenula polymorpha DL-1. J. Bacteriol. 178, 4420–8. 81 Bahler, J., Wu, J. Q., Longtine, M. S., Shah, N. G., McKenzie, A., 3rd, Steever, A. B., Wach, A., Philippsen, P., Pringle, J. R. (1998). Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Yeast 14, 943–51. 82 Cregg, J. M., Cereghino, J. L., Shi, J., Higgins, D. R. (2000) Recombinant protein expression in Pichia pastoris. Mol. Biotechnol. 16, 23–52. 83 Gellissen, G. (2000) Heterologous protein production in methylotrophic yeasts. Appl. Microbiol. Biotechnol. 54, 741–750. 84 Madzak, C., Gaillardin, C. and Beckerich, J. M. (2004). Heterologous protein expression and secretion in the non-conventional yeast Yarrowia lipolytica: a review. J. Biotechnol. 109, 63–81. 85 Wang, Y.C., Chuang, L.L., Lee, F.W., da Silva, N.A. (2003) Sequential cloned gene integration in the yeast Kluyveromyces lactis. Appl. Microbiol. Biotechnol. 62(5/6), 523–7. 86 Nielsen, J. (2001) Metabolic engineering. Appl. Microbiol. Biotechnol. 55, 263–283. 87 Dequin, S. (2001) The potential of genetic engineering for improving brewing, wine-making and baking yeasts. Appl. Microbiol. Biotechnol. 56, 577–88. 88 Barnett, J. A. (1992) The taxonomy of the genus Saccharomyces Meyen ex Rees: a short review for non-taxonomists. Yeast 8, 1–23. 89 Kodama, Y., Nakao, Y., Nakamura, N., Fujimura, T., Shirahige, K., Ashikari, T. (2003) Diversity of the chromosomal
89
90
References structure in lager brewing yeasts. XXIth YGM Conference Göteborg, Sweden, http://www.yeast2003.se 90 Hansen, J., Kielland-Brandt, M. C. (1994) Saccharomyces carlsbergensis contains two functional MET2 alleles similar to homologues from S. cerevisiae and S. monacensis. Gene 140, 33–40. 91 Pedersen, M. D. (1994) Molecular analysis of yeast DNA – tools for pure yeast maintenance in the brewery. J. Am. Soc. Brew. Chem. 52, 23–7. 92 Vaughan-Martini, A., Kurtzmann, C. P. (1985) Desoxyribonucleic acid relatedness amongst species of the genus Saccharomyces stricto sensu. Int. J. Syst. Bacteriol. 35, 5008–5011. 93 Turakainen, H., Kristo, P., Korhola, M. (1994) Consideration of the evolution of the Saccharomyces cerevisiae MEL gene family on the basis of the nucleotide sequences of the genes and their flanking regions. Yeast 10, 1559–1568. 94 Masneuf, I., Hansen, J., Groth, C., Piskur, J., Dubourdieu, D. (1998) New Hybrids between Saccharomyces Sensu Stricto Yeast Species Found among Wine and Cider Production Strains. Appl. Environ. Microbiol. 64(10), 3887–3892. 95 Pretorius, I. S. (2000) Tailoring wine yeast for the new millennium: novel approaches to the ancient art of winemaking, Yeast 16, 675–729. 96 Pedersen, M. B. (1986) DNA sequence polymorphism in the genus Saccharomyces IV. Homologous chromosomes III in Saccharomyces bayanus, S. carlsbergensis and S. uvarum. Carlsberg Res. Commun., 51, 185–202. 97 Hammond, J. R. M. (1995) Genetically-modified brewing yeasts for the 21st century. Progress to date. Yeast 11, 1613–1627. 98 Benitez, T. Gasent-Ramirez, J. M., Castrejon, F., Codon, A. C. (1996) Development of new strains for the food industry. Biotechnol. Prog. 12, 149–163. 99 Hansen J., Kielland-Brandt, M. C. (1996) Modification of biochemical pathways in industrial yeasts. J. Biotechnol. 49, 1–12. 100 Ostergaard, S., Olsson, L., Nielsen, J. (2000a) Metabolic engineering of Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 64, 34–50.
101 Hollenberg, C. P., Strasser, A. W. M. (1990) Improvement of bakers’ and brewers’ yeast by gene technology. Food Biotechnol. 4, 527–534. 102 Berghof, K., Stahl, U. (1991) Improving the filterability of beer by the use of β-glucanase active brewers’ yeast. BioEngineering 7, 27–32. 103 Volschenk, H., Viljoen, M., Grobler, J., Petzold, B., Bauer, F., Subden, R. E., Young, R. A., Lonvaud, A., Denayrolles, M., van Vuuren, H. J. J. (1997) Engineering pathways for malate degradation in Saccharomyces cerevisiae. Nat. Biotechnol. 15, 253–257. 104 Ostergaard, S., Roca, C., Ronnow, B., Nielsen, J., Olsson, L. (2000b) Physiological studies in aerobic batch cultivations of Saccharomyces cerevisiae strains harbouring the MEL1 gene. Biotechnol. Bioeng. 68, 252–259. 105 Nevoigt, E., Pilger, R., Mast-Gerlach, E., Schmidt, U., Freihammer, S., Eschenbrenner, M., Garbe, L., Stahl, U. (2002) Engineered Brewing Yeasts Overproducing Glycerol at the Expense of Ethanol. FEMS Yeast Res. 2, 225–232. 106 Verstrepen, K. J., Derdelinckx, G., Verachtert, H., Delvaux, F.R. (2003) Yeast flocculation: what brewers should know. Appl. Microbiol. Biotechnol. 61(3), 197–205. 107 Verstrepen, K., Bauer, F., Michiels, C., Derdelinckx, G., Delvaux, F., Pretorius, I. S. (2000) Controlled expression of FLO1 in Saccharomyces cerevisiae, EBC Monogr. 28, Symposium Yeast Physiology, Fachverlag Hans Carl, Nürnberg, pp. 30–42, 108 Omura, F., Shibano, Y., Fukui, N., Nakatani, K. (1995) Reduction of hydrogen sulfide production in brewing yeast by constitutive expression of MET25 gene. J. Am. Soc. Brew. Chem. 53, 58–62. 109 Donalies, U. (2002) Genetische Optimierung der Sulfitbildung in Saccharomyces cerevisiae. Dissertation TU Berlin, Mensch und Buch 110 Donalies, U. E., Stahl, U. (2002) Increasing sulphite formation in Saccharomyces cerevisiae by overexpression of MET14 and SSU1.Yeast 19(6), 475–84. 111 Schaaff, I., Heinisch, J., Zimmermann, F. K. (1989) Overproduction of glycolytic enzymes in yeast. Yeast 5, 285–290.
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi 112 Vilanova, M., Blanco, P., Cortes, S., Castro, M., Villa, T. G., Sieiro, C. (2000) Use of a PGU1 recombinant Saccharomyces cerevisiae strain in oenological fermentations. J. Appl. Microbiol. 89, 876–883. 113 Perez-Gonzalez, J. A., Gonzalez, R., Querol, A., Sendra, J., Ramon, D. (1993) Construction of a recombinant wine yeast strain expressing β-(1,4)-endoglucanase and its use in microvinification processes. Appl. Environ. Microbiol. 59, 2801–2806. 114 Manzanares, P., Orejas, M., Gil, J. V., de Graaff, L. H., Visser, J. Ramon, D. (2003) Construction of a Genetically Modified Wine Yeast Strain Expressing the Aspergillus aculeatus rhaA Gene, Encoding an α-L-Rhamnosidase of Enological Interest. Appl. Environ. Microbiol. 69(12), 7558– 7562. 115 Lilly, M., Lambrechts, M. G., Pretorius, I. S. (2000) Effect of increased yeast alcohol acetyltransferase activity on flavor profiles of wine and distillates. Appl. Environ. Microbiol. 66, 744–753. 116 Remize, F., Roustan, J. L., Sablayrolles, J. M., Barre, P., Dequin, S. (1999) Glycerol overproduction by engineered Saccharomyces cerevisiae wine yeast strains leads to substantial changes in by-product formation and to a stimulation of fermentation rate in stationary phase. Appl. Environ. Microbiol. 65, 143–149. 117 Remize, F., Barnavon, L., Dequin, S. (2001) Glycerol export and glycerol3-phosphate dehydrogenase, but not glycerol phosphatase, are rate limiting for glycerol production in Saccharomyces cerevisiae. Metab. Eng. 3(4), 301–12. 118 Volschenk, H., Viljoen-Blom, M., Subden, R. E., van Vuuren, H. J. (2001), Maloethanolic fermentation in grape must by recombinant strains of Saccharomyces cerevisiae. Yeast 18, 963–970. 119 Sutherland, C. M., Henschke, P. A., Langridge, P., Lopes, M. D. (2003) Subunit and cofactor binding of S. cerevisiae sulfite reductase towards developing wine yeasts ability to produce hydrogen sulphide. Aust. J. Grape Wine Res. 9, 186–193. 120 Becker, J.V,, Armstrong, G.O., van der Merwe, M.J., Lambrechts, M.G., Vivier, M.A., Pretorius, I.S. (2003) Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related anti-
oxidant resveratrol. FEMS Yeast Res. 4(1), 79–85. 121 Hirosawa, I., Aritomi, K., Hoshida, H., Kashigawi, S., Nishizawa, Y., Akada, R. (2004) Construction of a self-cloning sake yeast that overexpresses alcohol acetyltransferase gene by a two-step gene replacement protocol. Appl. Microbiol. Biotechnol. 65 (1), 68–73. 122 Aritomi, K., Hirosawa, I., Hoshida, H., Shigi, M., Nishizawa, Y., Kashigawi, S., Akada, R. (2004) Self-cloning yeast strains containing novel FAS2 mutations produce a higher amount of ethyl caproate in Japanese sake. Biosci. Biotech. Biochem. 68 (1), 206–214. 123 Klein, C. J. L., Olsson, L., Ronnow, B., Mikkelsen, J. D., Nielsen, J. (1997) Glucose and maltose metabolism in MIG1disrupted and MAL-constitutive strains of Saccharomyces cerevisiae, Food Technol. Biotechnol. 35, 287–292. 124 Klein, C. J. L., Rasmussen, J., Ronnow, B., Olsson, L., Nielsen, J. (1999), Investigation of the impact of MIG1 and MIG2 on the physiology of Saccharomyces cerevisiae, J. Biotechnol. 68, 197–212. 125 Blom, J., De Mattos, M. J. T., Grivell, L. A. (2000) Redirection of the respiro-fermentative flux distribution in Saccharomyces cerevisiae by overexpression of the transcription factor Hap4p. Appl. Environ. Microbiol. 66, 1970–1973. 126 Peinado, R. A., Moreno, J. J., Medina, M., Mauricio, J. C. (2005) Potential application of a glucose-transport-deficient mutant of Schizosaccharomyces pombe for removing gluconic acid from grape must. J. Agri. Food Chem. 53 (4), 1017–1021. 127 Aoki, T., Uchida, K. (1991) Enhanced formation of 3-(methylthio)-1-propanol in a salt-tolerant yeast, Zygosaccharomyces rouxii, due to deficiency of S-adenosylmethionine synthase. Agric. Biol. Chem. 55, 2113–2116. 128 Case, M.E., Schweizer, M., Kushner, S.R., Giles, N.H. (1979) Efficient transformation of Neurospora crassa by utilizing hybrid plasmid DNA. Proc. Natl. Acad. Sci. 76 (10), 5259–63. 129 Ballance, D.J., Buxton, F.P., Turner, G. (1983) Transformation of Aspergillus nidulans by the orotidine-5-phosphate decarboxylase gene of Neurospora crassa.
91
92
References Biochem. Biophys. Res. Commun. 112 (1), 284–9. 130 Tilburn, J., Scazzocchio, C., Taylor, G.G., Zabicky-Zissman, J.H., Lockington, R.A., Davies, R.W. (1983) Transformation by integration in Aspergillus nidulans. Gene 6 (2/3), 05–21. 131 Yelton, M.M., Hamer, J.E., Timberlake, W.E. (1984) Transformation of Aspergillus nidulans by using a trpC plasmid. Proc. Natl. Acad. Sci. 81 (5), 1470–4. 132 Miller, J.F. (1994) Bacterial transformation by electroporation. Meth. Enzymol. 235, 375–85. 133 Rakoczy-Trojanowska, M. (2002) Alternative methods of plant transformation – a short review. Cell. Mol. Biol. Lett. 7 (3), 849–58. 134 Chakraborty, B.N., Patterson, N.A., Kapoor, M. (1991) An electroporation-based system for high-efficiency transformation of germinated conidia of filamentous fungi. Can. J. Microbiol. 37 (11), 858–63. 135 Kothe, G.O., Free, S.J. (1996) Protocol for the Electroporation of Neurospora Spheroplasts. Fung. Gen. Newslett. 43, 31–33. 136 Sánchez, O., Aguirre, J. (1996) Efficient transformation of Aspergillus nidulans by electroporation of germinating conidia. Fun. Gen. Newslett. 43, 31–33. 137 Ozeki, K., Kyoya, F., Hizume, K., Kanda, A., Hamachi, M., Nunokawa, Y. (1994) Transformation of intact Aspergillus niger by electroporation. Biosci. Biotechnol. Biochem. 58(12), 2224–7. 138 Armaleo, D., Ye, G.N., Klein, T.M., Shark, K.B., Sanford, J.C., Johnston, S.A. (1990) Biolistic nuclear transformation of Saccharomyces cerevisiae and other fungi. Curr Genet. 17(2), 97–103. 139 Ruiz-Diez, B. (2002) Strategies for the transformation of filamentous fungi. J. Appl . Microbiol. 92 (2), 189–95. 140 Meyer, V., Mueller, D., Strowig, T., Stahl, U. (2003) Comparison of different transformationmethods for Aspergillus giganteus.Curr Genet. 43 (5), 371–7. 141 de Groot, M.J., Bundock, P. Hooykaas, P.J., Beijersbergen, A.G. (1998) Agrobacterium tumefaciens-mediated transformation of filamentous fungi. Nat Biotechnol. 16(9), 839–42. Erratum in: Nat Biotechnol (1998) 16(11), 1074.
142 Michielse, C.B., Salim, K., Ragas, P., Ram, A.F., Kudla, B., Jarry, B., Punt, P.J., van den Hondel, C.A. (2004) Development of a system for integrative and stable transformation of the zygomycete Rhizopus oryzae by Agrobacterium-mediated DNA transfer. Mol Genet Genomics. 271(4), 499–510. 143 Vijn, I., Govers, F. (2003) Agrobacterium tumefaciens mediated transformation of the oomycete plant pathogen Phytophthora infestans. Mol. Plant Pathol. 4 (6), 459–467. 144 Degefu, Y., Hanif, M. (2003) Agrobacterium tumefaciens-mediated transformation of Helminthosporium turcicum, the maize leaf-blight fungus. Arch Microbiol. 180 (4), 279–84. 145 Bundock, P., Hooykaas, P.J. (1996) Integration of Agrobacterium tumefaciens T-DNA in the Saccharomyces cerevisiae genome by illegitimate recombination. Proc. Natl. Acad. Sci. 93 (26), 15272–5. 146 Michielse, C.B., Hooykaas, P.J., van den Honde, C.A., Ram, A.F. (2005) Agrobacterium-mediated transformation as a tool for functional genomics in fungi. Curr Genet. 48 (1), 1–17. 147 Punt, P.J., van den Hondel, C.A. (1992) Transformation of filamentous fungi based on hygromycin B and phleomycin resistance markers. Meth. Enzymol. 216, 447–57. 148 d’Enfert, C. (1996) Selection of multiple disruption events in Aspergillus fumigatus using the orotidine-5-decarboxylase gene, pyrG, as a unique transformation marker. Curr. Genet. 30(1), 76–82. 149 Daboussi, M.J., Djeballi, A., Gerlinger, C., Blaiseau, P.L., Bouvier, I., Cassan, M., Lebrun, M.H., Parisot, D., Brygoo, Y. (1989) Transformation of seven species of filamentous fungi using the nitrate reductase gene of Aspergillus nidulans. Curr Genet. 15 (6), 453–6. 150 Fierro, F., Laich, F., Garcia-Rico, R.O., Martin, J.F. (2004) High efficiency transformation of Penicillium nalgiovense with integrative and autonomously replicating plasmids. Int. J. Food Microbiol. 90 (2), 237–48. 151 Yu, J.H., Hamari, Z., Han, K.H., Seo, J.A., Reyes-Dominguez, Y., Scazzocchio, C. (2004) Double-joint PCR: a PCR-based
3 Fermentation of Food by Means of Genetically Modified Yeast and Filamentous Fungi molecular tool for gene manipulations in filamentous fungi. Fung. Gen. Biol. 41 (11), 973–81. 152 Nevalainen, K.M., Te’o, V.S., Bergquist, P.L. (2005) Heterologous protein expression in filamentous fungi.Trends Biotechnol. 23 (9), 468–74. 153 Larsen, T.O., Breinholt, J. (1999) Dichlorodiaportin, diaportinol, and diaportinic acid: three novel isocoumarins from penicillium nalgiovense. J. Nat. Prod. 62 (8), 1182–4. 154 Lo, C., Adachi, K., Shuster, J.R., Hamer, J.E., Hame, L. (2003) The bacterial transposon Tn7 causes premature polyadenylation of mRNA in eukaryotic organisms: TAGKO mutagenesis in filamentous fungi. Nucleic Acids Res. 31 (16), 4822–7. 155 Adachi, K., Nelson, G.H., Peoples, K.A., Frank, S.A., Montenegro-Chamorro, M.V., DeZwaan, T.M., Ramamurthy, L., Shuster, J.R., Hamer, L., Tanzer, M.M. (2002) Efficient gene identification and targeted gene disruption in the wheat blotch fungus Mycosphaerella graminicola using TAGKO. Curr Genet. 42 (2), 123–7. 156 Hamer, L., Adachi, K., MontenegroChamorro, M.V., Tanze, M.M., Mahanty, S.K., Lo, C., Tarpey, R.W., Skalchunes, A.R., Heiniger, R.W., Frank, S.A., Darveaux, B.A., Lampe, D.J., Slater, T.M., Ramamurthy, L., DeZwaan, T.M., Nelson, G.H., Shuster, J.R., Woessner, J., Hamer, J.E. (2001) Gene discovery and gene function assignment in filamentous fungi. Proc. Natl. Acad. Sci. 98 (9), 5110–5. 157 Dudasova, Z., Dudas, A., Chovanec, M. (2004) Non-homologous end-joining factors of Saccharomyces cerevisiae. FEMS Microbiol. Rev. 28 (5), 581–601. 158 Ninomiya, Y., Suzuki, K., Ishii, C., Inoue, H. (2004) Highly efficient gene replacements in Neurospora strains deficient for nonhomologous end-joining. Proc. Natl. Acad. Sci. 101 (33), 12248–53. 159 Nayak, T., Szewczyk, E., Oakley, C.E., Osmani, A., Ukil, L., Murray, S.L., Hynes, M.J., Osmani, S.A., Oakley, B.R. (2005) A versatile and efficient gene targeting system for Aspergillus nidulans. Genetics. Dec 30 (n press) 160 Tudzynski, P., Tudzynski, B. (1997) Fungal genetics: novel techniques and regulation circuits, in: Fungal Biotechnol-
ogy (Anke T., Ed.), Chapman and Hall, Weinheim, pp. 229–249. 161 Turner, G. (1997) Genetic engineering of filamentous fungi, in Biotechnology (Rehm HJ, Reed G, Pühler H, Stadler P, Eds.), VCH Weinheim, Second Edition, Vol. 2 pp. 529–543. 162 Gems, D., Johnstone, I.L., Clutterbuck, A.J. (1991) An autonomously replicating plasmid transforms Aspergillus nidulans at high frequency. Gene. 98 (1), 61–7. 163 Kitamoto, N., Yoshino, S., Ohmiya, K., Tsukagoshi, N. (1999) Sequence analysis, overexpression, and antisense inhibition of a beta-xylosidase gene, xylA, from Aspergillus oryzae KBN616. Appl. Environ. Microbiol. 65 (1), 20–4. 164 Takeno, S., Sakuradani, E., Tomi, A., Inohara-Ochiai, M., Kawashima, H., Ashikari, T., Shimizu, S. (2005) Improvement of the fatty acid composition of an oilproducing filamentous fungus, Mortierella alpina 1S-4, through RNA interference with delta12-desaturase gene expression. Appl. Environ. Microbiol. 71 (9), 5124–8. 165 Bautista, L.F, Aleksenko, A., Hentzer, M., Santerre-Henriksen, A., Nielsen, J. (2000) Antisense silencing of the creA gene in Aspergillus nidulans. Appl. Environ. Microbiol. 66 (10), 579–81. 166 Shroff, R.A., O’Connor, S.M., Hynes, M.J., Lockington, R.A., Kelly, J.M. (1997) Null alleles of creA, the regulator of carbon catabolite repression in Aspergillus nidulans. Fung. Gen. Biol. 22 (1), 28–38. 167 Mueller, D., Stahl, U., Meyer, V. (2005) Application of hammerhead ribozymes in filamentous fungi. J. Microbiol. Methods. Nov 17 (in press) 168 Ogawa, K. (1994) Approaches to hybridisation and appliedgenetics by protoplast fusion: koji-moulds and mushrooms, in: Recombinant microbes for industrial and agriculture applications (Murooka, Y and Imanaka T, Eds.), Marcel Dekker Inc., New York , pp. 581–603. 169 Azeem, A., Neelagund, Y.F., Rathod, V. (1999) Biotechnological production of oil: fatty acid composition of microbial oil. Plant Foods Hum Nutr. 53 (4), 381–6. 170 Ratledge, C. (2004) Fatty acid biosynthesis in microorganisms being used for Single Cell Oil production. Biochimie. 86 (11), 807–15.
93
94
References 171 Sancholle, M., Lösel, D. (1996) Lipids in fungal biotechnology, in: The mycota. II. Genetics and biotechnology (Kück, U., Ed.), Springer, Berlin, pp. 339–367. 172 Jimenez, A., Santos, M.A., Pompejus, M., Revuelta, J.L. (2005) Metabolic engineering of the purine pathway for riboflavin production in Ashbya gossypii. Appl. Environ. Microbiol. 71 (10), 5743–51. 173 Witty, M., Higginbotham, J.D. (Editors) (1994) in: Thaumatin. CRC Press, 174 Adrio, J.L., Demain, A.L. (2003) Fungal biotechnology. Int Microbiol. 6 (3), 191–9. 175 Zemanek, E.C., Wasserman, B.P. (1995) Issues and advances in the use of transgenic organisms for the production of thaumatin, the intensely sweet protein from Thaumatococcus danielli. Crit. Rev. Food Sci. Nutr. 35 (5), 455–66. 176 Faus, I. (2000) Recent developments in the characterization and biotechnological production of sweet-tasting proteins. Appl. Microbiol. Biotechnol. 53 (2), 145–51. 177 Moralejo, F.J., Cardoza, R.E., Gutierrez, S., Martin, J.F. (1999) Thaumatin production in Aspergillus awamori by use of expression cassettes with strong fungal promoters and high gene dosage. Appl. Environ. Microbiol. 65 (3), 1168–74. 178 Lombrana, M., Moralejo, F.J., Pinto, R., Martin, J.F. (2004) Modulation of Aspergillus awamori thaumatin secretion by modification of bipA gene expression. Appl Environ Microbiol. 70 (9), 5145–52. 179 Polizeli, M.L., Rizzatti, A.C., Monti, R., Terenzi, H.F., Jorge, J.A., Amorim, D.S.
(2005) Xylanases from fungi: properties and industrial applications. Appl. Microbiol. Biotechnol. 67 (5), 577–91. 180 Romanowska, I., Polak, J., Janowska, K., Bielecki, S. (2003) The application of fungal endoxylanase in bread-making. Commun. Agric. Appl. Biol. Sci. 68 (2), 317–20. 181 Yadwad, V. B., Ward, O. P., Noronha, L. C. (1991) Application of lipase to concentrate the docosahexaenoic acid (DHA) fraction of fish oil. Biotech. Bioeng. 38 (8), 956–959. 182 Revah, S., Lebeault, J. (1989) Accelerated Production of Blue Cheese Flavors by Fermentation on Granular Curds with Lipase Addition. Le Lait 69, 281– 289. 183 Huang, H. T., Dooley, J. G. (1976) Enhancement of cheese flavors with microbial esterases. Biotech. Bioeng. 18 (7), 909–919. 184 Blank, I. (2005) Current status of acrylamide research in food: measurement, safety assessment, and formation. Ann N Y Acad Sci. 1043, 30–40. 185 Wiebe, M.G. (2002) Myco-protein from Fusarium venenatum: a well-established product forhuman consumption. Appl. Microbiol. Biotechnol. 58(4), 421–7. 186 Turnbull, W.H., Leeds, A.R., Edwards, G.D. (1990) Effect of mycoprotein on blood lipids. Am. J. Clin. Nutr. 52 (4), 646–50. 187 Katona, S.J., Kaminski, E.R. (2002) Sensitivity to Quorn mycoprotein (Fusarium venenatum) in a mould allergic patient. J. Clin. Pathol. 55 (11), 876–7.
4 Production of Food Additives Using Filamentous Fungi Carsten M. Hjort
4.1 Filamentous Fungi in Food Production
Fungi are eukaryotic microorganisms that have been used as foods or to manufacture food for more than a thousand years. The fungal kingdom consists of yeasts that are unicellular organisms and of filamentous fungi that are multicellular organisms with the cells organized in chains known as hyphae. The hyphae can be branched to different extents. Some fungi are dimorphic, meaning they have both unicellular and filamentous growth stages. Yeasts have been used extensively for food production. The yeast Saccharomyces cerevisiae (bakers’ yeast) is used in baking, brewing, and winemaking. In all of these applications the ability to ferment glucose to ethanol and carbon dioxide is the key property of the yeast. Since the advent of recombinant production technology, a variety of yeasts have been used for production of enzymes and metabolites. Recombinant expression systems suitable for large-scale production have been developed for Saccharomyces cerevisiae, Schizosaccharomyces pompe, Pichia pastoris, Pichia methanolica, Hansenula polymorpha, Klyveromyces lactis, Yarrowia lipolytica, and other species [1, 2]. For production of food enzymes, filamentous fungi are, however, much more widely used than yeast systems. Filamentous fungi have been used in food production for a very long time. Sometimes the fungus is the food itself. Mushroom (Agaricus bisporus) is one example; more recently the ascomycete Fusarium venenatum was developed as a single-cell protein food source marketed under the name “Quorn” by the company Marlow foods [3]. Occasionally the fungus is an ingredient in the food, for example in cheese, in which a variety of species of Penicillium (e.g. P. roqueforti and P. camemberti) is part of the cheese product. The oldest examples of the use of filamentous fungi in food production are their use for fermentation of the food. In Japan the filamentous fungi Aspergillus oryzae (Fig. 4.1), Aspergillus sake, and related species have been used for fermenting sake, shoyu, and miso. In these processes the fungus ferments sugar to alcohol, but equally important is that the
96
4.1 Filamentous Fungi in Food Production
Fig. 4.1 Aspergillus oryzae agar culture. A strain of Aspergillus oryzae was grown on an agar plate. The picture shows different stages of sporulating phialides.
fungus secretes enzymes-like proteases and amylases that modify the raw material into the desired product. The potential of the enzyme complex produced by Aspergillus oryzae for the food industry was acknowledged late in the nineteenth century. In 1894 the Japanese–American enzyme pioneer Jockichi Takamine started manufacture, in a small plant in Chicago, of an enzyme complex from Aspergillus oryzae that was marketed under the trade name Takadiastase [4]. Later, in the 1950s, the submerged fermentation industry was developed in the United states. Aspergillus oryzae was developed to produce an array of different enzyme products by submerged fermentation, still with emphasis on proteases and amylases. Other Aspergillus species, for example the black Aspergilli, Aspergillus niger, Aspergillus awamori, Aspergillus fetidus, Aspergillus aculeatus, and Aspergillus japonicus were also used, mainly for production of the enzyme glucoamylase [5]. This enzyme was the basis for the enzyme revolution in the starch industry. Traditionally, starch was hydrolyzed to glucose in a process using hydrochloric acid, followed by neutralization. In this process several byproducts were formed, and large quantities of salt were produced in the neutralization step. By introducing enzymatic hydrolysis byproduct formation was avoided so a product of a better quality could be manufactured at a lower price. Aspergillus niger has also been used for production of bulk quantities of primary metabolites, for example citric acid [5]. So fermentation process development was conducted for production of enzymes and metabolites. The production strains were also dramatically improved by mutagenesis of the strains using chemicals or radiation then yield screening. Although major improvements were achieved by classical strain improvement and fermentation optimization, recombinant DNA technology revolutionized microbial enzyme production. The reasons for this are many. First, it is possible to produce enzymes isolated from virtually any organism in good yields in a highly developed safe expression system. Accumulated toxicity and safety studies for the
4 Production of Food Additives Using Filamentous Fungi
products produced in these systems has resulted in very good documentation of the safety of these products. In this way several different enzyme products can be produced in the same production equipment using essentially the same production process. Second, the host organism (the organism into which the foreign DNA is transferred) can be modified to suit the quality specifications of the enzyme product. These modifications include removal of unwanted side-activity, resulting in product purity that cannot be achieved by use of non recombinant methods. The fermentation yields of the enzymes can also be increased, often severalfold, compared with the yields that can be obtained from the donor organism. Finally, by use of recombinant DNA technology genetically engineered enzymes can be produced. Genetically engineered enzymes range from enzymes in which one or more amino acids are substituted for other amino acids to enzymes that are hybrids of those produced by two or more enzyme genes. By genetic engineering, enzymes with substantially improved properties can be obtained. At the dawn of the recombinant production age, one of the first, and one of the most critical, choices that had to be made was the choice of expression systems. Extensive experience with the Aspergilli made them obvious candidates as host organisms. First, they were known to be capable of producing huge amounts of extracellular protein. They were well suited for production in submerged cultures in stainless-steel tanks and mutants that were even better adapted to this production environment had been selected. Because of the long use of Aspergillus oryzae [6] and Aspergillus niger [7] as production organisms for food enzymes, products from these organisms had been recognized as GRAS (generally regarded as safe) for several years by the FDA. Although Aspergillus species such as Aspergillus oryzae [8], Aspergillus niger, and Aspergillus awamori [9] are dominant in enzyme production, other fungal systems have also been successfully developed. Trichoderma reesei a.k.a. Trichoderma longibrachiatum is a wood-degrading fungus that first attracted attention because of its ability to produce huge amounts of cellulases and hemicellulases. T. reesei proved to be suitable for submerged fermentation and was developed as an expression system [10]. A new fungal expression system, the Fusarium venenatum expression system, has recently been developed [11]. Fusarium venenatum is used for single-cell protein production, as mentioned above. One of the key characteristics of this fungus is that it is well suited for submerged fermentation. It is easy to aerate, as a consequence of the rheological properties of a Fusarium venenatum broth. Use of the fungus as a food formed as the basis for establishing the history of safe use. Recombinant DNA technology has not only been used as a tool for improved enzyme production systems. By manipulating the metabolism of the fungus it has been suggested to increase the yields of desired metabolites, for example citric acid [12], to eliminate unwanted metabolites, e.g. oxalic acid [13], or to enable production of metabolites foreign to the fungus, for example astaxanthin [14]. Such manipulation of the metabolism is referred to as metabolic engineering.
97
98
4.3 Design of Genetically Modified Microorganisms for Production
4.2 Additives for the Food Industry
The food industry uses additives of microbial origin for many different purposes. Today, enzymes are the best established example of substances produced using genetically modified microorganisms (GMMs) that are used for food production. Enzymes have been used in the food industry for thousands of years. Chymosin isolated from calves has been used in cheese making, amylases produced by barley have been used in brewing, and amylases and pectinases produced by grapes have been used in wine making, to mention just three examples. The deliberate use of microbial enzymes is a more recent development and enzymes produced by GMMs were not introduced for use in the food industry until the late eighties. Depending on in which country the enzymes are used, such enzymes are classified as food additives or as food-processing aids. The starch industry uses the largest amounts of enzymes by volume. Alfa amylases and amyloglycosidase are used to degrade starch into glucose. Part of the glucose syrup formed is processed further – glucose isomerase is used to convert the glucose into fructose for production of high-fructose corn syrups. In the baking industry amylases and xylanases are used to improve the quality of bread by giving it more volume, a better crumb structure, and a longer shelf life. More recently lipases have been introduced to baking to enable in situ formation of emulsifiers. In the diary industry chymosin extracted from calves for cheese production has been supplemented with proteases of microbial origin. Chymosin produced by recombinant Aspergillus niger has also become a quite important product. Enzymes other than the rennet proteases are used in the diary industry. For example, lactase is used to hydrolyze lactose. Such microbial lactase is of benefit to people suffering from lactose intolerance. Microbial amylases are used in the brewing industry to achieve a more robust and efficient mashing process. Enzymes have also been developed to remove the bad tasting metabolite diacetyl from beer. Because beer is seen by many as a very traditional product, however, many countries strictly regulate the types of additive which may be used in brewing. The wine industry is another example of a conservative industry in which the penetration of microbial enzymes is slow. This is especially true for enzymes produced by recombinant microorganisms. Pectinases are used to increase juice yield during mashing. Betaglucanases are used to remove haze resulting from Botrytis growth on the grapes. A more curious use of enzymes in this industry is the use of laccases to preserve cork stoppers, to prevent cork off-flavor in the wine.
4.3 Design of Genetically Modified Microorganisms for Production of Food Additives and Processing Aids
Enzymes are the most important examples of food additives and food-processing aids produced by use of GMMs, so in this section a thorough description of the
4 Production of Food Additives Using Filamentous Fungi
development of host strains and expression vectors for enzyme production will be provided. A brief description of tools for production of metabolites will also be given. As already mentioned, Aspergillus oryzae is one of the most important filamentous fungi used for recombinant production of enzymes. Aspergillus oryzae was selected as host strain because of a history of safe use for products with GRAS status, because of experience already gained using this organism for production, and because of the huge protein production potential of this microorganism. The production of, especially, amylases and proteases by this fungus was, however, also a major drawback. Two primary requirements when producing enzymes are product purity and product stability. When producing a given enzyme, the presence of amylases is unwanted, because this is contaminating protein and the amylase activity may even give some unwanted side-reactions. The presence of host strain proteases is also unwanted, because these proteases are not merely contaminating proteins, they may have a dramatic negative effect on the stability of the enzyme product. These unwanted enzymes activities have, therefore, to a very large extent, been removed; the most important tool for this is gene disruption [15]. Gene disruption has also been widely used for improvement of the Aspergillus niger, Trichoderme reesei, and Fusarium venenatum expression systems. The basic steps for disrupting a gene are: 1. the gene to be disrupted is cloned as a genomic clone with 1–2 kb (kilobase pairs) of the upstream and downstream sequence (i.e. 1000–2000 base pairs preceding the coding sequence of the gene and 1000–2000 after the coding sequence); 2. part or all of the coding sequence is replaced with a selectable marker to form the gene-disruption plasmid; 3. the gene disruption plasmid is linearized (typically by digesting it with a restriction enzyme) and subsequently transferred into the fungus; and 4. transformants are recovered using the selection system of the disruption plasmid and the transformants are then screened for the desired genotype. The gene-disruption event is outlined in Fig. 4.2. The pyrG (orotidine-5-phosphate decarboxylase) marker shown in the example is an auxotrophic marker that is widely used in Aspergillus oryzae and in other Aspergilli for gene disruption [16]. It is a biosynthetic gene in the pyrimidine pathway. It requires that the strain to be transformed is pyrG negative. The advantage of this marker is that it is bidirectional, that is, selection for both the presence and absence of the marker is possible. Selection for the presence of pyrG is achieved simply by transforming a pyrG negative strain and selection on a minimal medium for pyrimidine prototrophy (only cells having an intact pyrG gene can grow on such plates). Selection for the absence of the pyrG gene is achieved by plating out on a minimal medium containing uridine and the compound 5-fluoroorotic acid. Addition of the uridine will enable cells to grow without a functional pyrG gene and 5-fluoroorotic acid enables counter selection for the pyrG gene. This compound is converted into a toxic product by cells harboring a functional pyrG gene.
99
100
4.3 Design of Genetically Modified Microorganisms for Production pyrG 5’ upstream
pyrG 5’ repeat NP I 3’ downstream sequence
NP I 5’ upstream sequence
pyrG
Disruption plasmid
pyrG 5’ repeat pyrG 3’
Genome of mother strain. NP I 5’ upstream sequence
NP 1
pyrG 5’ upstream
NP I 3’ downstream sequence
pyrG 5’ repeat NP I 3’ downstream sequence
NP I 5’ upstream sequence
pyrG Genome of transformant.
pyrG 5’ repeat pyrG 3’
Fig. 4.2 Gene disruption in filamentous fungi. The principle is illustrated by disruption of the gene NP I. A disruption plasmid was made by replacing the coding part of the NP I gene with the selectable marker pyrG (orotidine-5-phosphate decarboxylase). The details of the components involved are described in the main text.
In this example a repeating sequence flanking the pyrG selection cassette has been included (pyrG 5 repeat). Recombination between the repeats results in the loss of the pyrG gene, and so these repeats greatly facilitate selection of a pyrG negative strain with a predictable genotype for subsequent gene disruption.
The bidirectional pyrG selection system is a very convenient tool for sequential disruption of several genes. A disruption plasmid is constructed for each of the genes that should be disrupted and a pyrG negative mutant of the selected host strain is isolated using 5-fluoroorotic acid. The pyrG mutant is then transformed with the first selection plasmid using selection for pyrimidine prototrophy. Transformants with the correct genotype, typically confirmed by Southern blot analysis [17], are then counter-selected for pyrG. The resulting strain is then ready for a new round of gene disruption using the next gene-disruption plasmid. Other bidirectional markers are known, for example the niaD (nitrate reductase) system [18], but the pyrG system is most applied. It is evident from Fig. 4.2 that the gene-disruption event leads to major changes in the DNA sequence of the effected locus. These changes are irreversible, meaning they will be present in all strains later in the pedigree of that particular host strain. They will thus also be present in transformants transformed with a particular product gene which is in the final GMM used for production. The gene disruption locus is thus an obvious target for analysis for the presence of DNA from the final GMM. In this way recombinant host-strain DNA may be detected, but if this host strain has been used for more products, it cannot reveal the specific product of the GMM.
4 Production of Food Additives Using Filamentous Fungi
By use of gene disruption several amylase, glycoamylase, and protease genes have been disrupted in Aspergillus oryzae, Aspergillus niger, and Aspergillus awamori. Very similar technology has been used to disrupt cellulose genes in Trichoderma reesei and metabolic pathways in Fusarium venenatum [19] and in Aspergillus niger [13]. Rather than disrupting all of the individual genes it is also possible to disrupt global activators that regulate the expression of entire classes of enzymes. For example, in Aspergillus niger a general protease regulator activates the expression of a range of extra cellular proteases. By just disrupting this single gene all of these proteases are silenced [20]. Development of the host strain is very important to the efficiency of the expression system and the quality of the final product, and host-strain improvement generates sequence tags in the final GMM suitable for analysis. The expression vector is the other leg in the final GMM, and the expression vector is usually specific for the product that should be expressed and, therefore, a natural target for analysis when analyzing for a specific product. Expression vectors in general consist of the following elements: 1. the gene encoding the product to be produced; 2. a promoter to drive expression of the product gene; this promoter can be a promoter developed for the expression system, that is a generic promoter, or it can be a promoter specific to the product gene, typically the product gene’s own promoter; 3. a translational terminator; just like the promoter, this can be a terminator generic for the expression system or it can be a specific terminator, typically the terminator of the product gene; 4. a selection marker for selection in the expression host; and 5. additional vector elements used to build the vector, for example an Escherichia coli selection marker and an E. coli origin of replication. The expression vector is transformed into the fungal host cell and the expression vector is integrated into the chromosome of the host cell, typically in more copies by tandem integration into one locus [21, 22]. An ideal integration of two copies is illustrated in Fig. 4.3. Typically the expression vectors are constructed in Escherichia coli, and so elements necessary for this are often present in the final expression vector. The most widely used selection marker in E. coli is the beta lactamase gene giving resistance to penicillins such as ampicillin. Public concern about the spreading of antibiotic resistance markers has drawn attention to this part of the expression construct even though antibiotic resistance markers from GMMs used in contained production cannot be found in nature, even when the biomass is spread to surrounding fields [23]. So antibiotic markers have been replaced by other markers such as auxotrophic markers by most enzyme producers, and often the E. coli parts of the expression vector are completely removed before transforming the construct into the host strain. The selection marker for selection of the expression vector in the fungus is very important, because different selection markers results in a different range of copy numbers of integrated expression vector copies. The pyrG gene is sometimes used
101
102
4.3 Design of Genetically Modified Microorganisms for Production Terminator
Product gene Selection marker Expression plasmid Promoter
Host Genome
GMM genome
Fig. 4.3 Integration of an expression plasmid into the genome. Tandem integration of an expression plasmid featuring a promoter, a product gene, a terminator, and a selection
marker into the genome of a filamentous fungus is illustrated. The integration shown is a head-to-tail integration in one locus with no further recombination.
for selection expression vector, typically when the strategy is to insert the heterologous gene into a particular locus. This locus could be the amyloglycosidase locus of Aspergillus awamori. The pyrG marker can also be used when the strategy is to remove the marker by recombination in a step after the transformation step, in very much the same way as described for the gene disruption [24]. The drawback of these strategies is that typically only one copy of the expression vector is integrated into the genome, giving low production yields. The amdS (acetamidase) gene of Aspergillus nidulans [25] is often used as selection marker in Aspergilli and even in other fungi. The selection principle is that the acetamide gene enables transformed cells to hydrolyze acetamide, and on hydrolysis to use the ammonium formed as the sole source of nitrogen or the acetate formed as the sole source of carbon. The advantage of this marker is that both in Aspergillus oryzae and in Aspergillus niger high copy numbers are obtained, and thus high fermentation yields in production. The choice of promoter is crucial for the yields and it is one of the elements that has been most extensively studied and developed. For expression in Aspergillus the amylase promoters were the natural choice as starting points for promoter development. These are very strong promoters and their regulation is convenient in a production set-up, because they are induced by starch, maltodextrins and maltose. One of their drawbacks is that they are carbon-catabolite-repressed, which puts a restraint on production. To avoid low productivity, the feed rate in batch-fed or in continuous fermentation must be carefully controlled. The Aspergillus amylase promoters are regulated very much in the same way, and they have been shown to be activated by the same activator [26].
4 Production of Food Additives Using Filamentous Fungi
The TAKA amylase is a very well expressed amylase in Aspergillus oryzae, so the TAKA amylase promoter is one of the broadly used Aspergillus amylase promoters [8]. The neutral amylase promoter from Aspergillus niger is highly homologous with the TAKA promoter from Aspergillus oryzae and is, likewise, widely used [27]. These two promoters share sufficient sequence similarity to enable establishment of analytical methods that will detect both. The amyloglycosidase promoter from Aspergillus niger or Aspergillus awamori is in the same range of promoter strength. The sequence is quite distant from the sequence of the TAKA and the neutral amylase promoters but is regulated by the same activator. The amyloglycosidase promoter is also widely used [9]. The choice of terminator is not as critical as the choice of promoter. In Aspergillus the amyloglycosidase terminator from Aspegillus niger is widely used [8]. The expression vectors for Trichoderma reesei are somewhat different from the Aspergillus expression vectors. The most frequently used promoter is the cellobiohydrolase I promoter or variants of this [28]. This promoter is, like sophorose, induced by cellulose but also by more readily available carbon sources. This promoter is also carbon-catabolite-repressed, but promoter variants in which the creA sites mediating this repression have been removed have been described [29]. Several different selection markers are used in Trichorderma. These are often dominant selection markers against drugs, for example the hygromycin or bleomycin resistance markers. A variety of yeast systems have also been developed for production of enzymes, for example Klyveromyces lactis, Hansenula polymorpha, and Pichia pastoris [30]. One notable difference between yeast systems and filamentous fungal systems is that most of the yeasts have self replicating plasmids, i.e. the transforming DNA is not necessarily integrated into the genome of the host strain. Genetic stability using self replicating plasmids is significantly lower that the stability of strains in which the DNA has been chromosomally integrated, so integrating expression vectors are preferred in yeasts also. Host strain development is achieved in very much the same way as for the filamentous fungi. Proteases, especially, are removed by gene disruption. The methylotrophic yeasts Hansenula polymorpha and Pichia pastoris produce large amounts of alcohol-utilization genes when induced by methanol. All or some of these genes have been disrupted in some host strains, or the expression plasmid is integrated into one of these genes when making the final GMM, thereby disrupting the gene. The promoters used to drive expression in the methylotrophic yeasts are typically promoters from the alcohol utilization genes, for example the alcohol oxidase 1 or formate dehydrogenase promoter in Pichia pastoris, or the methanol oxidase 1 or formate dehydrogenase promoter in Hansenula polymorpha. In Klyveromyces lactis the beta galactosidase promoter (LAC4) has been identified as a strong promoter. For all of the yeast systems several different selection markers, including both dominant and auxotrophic markers, have been developed. The URA3 marker, the yeast homolog of pyrG is very often used. The choice of design for the GMM is not only determined by strictly technical criteria, for example high yield and high product purity. Legal requirements and
103
104
4.3 Design of Genetically Modified Microorganisms for Production
product-approval procedures also play a major role when deciding on the design. As already mentioned, antibiotic resistance markers are usually avoided because of public concern and probably because of the expectation that constructs containing antibiotic resistance markers may be banned eventually. Another design that has gained increasing importance in some regions, for example Europe and Japan, is the so called “self cloning” concept. The definition of “self cloning” varies between regions. In the EU the definition is given in EU Directive 98/81/EC, and reads: “Self-cloning consisting in the removal of nucleic acid sequences from a cell of an organism which may or may not be followed by reinsertion of all or part of that nucleic acid (or synthetic equivalent) with or without prior enzymatic or mechanical steps, into cells of the same species or into cells of phylogenetically closely related species, which can exchange genetic material by natural physiological processes, where the resulting microorganism is unlikely to cause disease to humans, animals or plants. Selfcloning may include the use of recombinant vectors with an extended history of safe use in the particular microorganism.” There are advantages to the producer if a GMM can be assessed as being “selfcloned”. Product and production approval process may be faster and less demanding of resources and the legal status of GMM varies from country to country. In some countries, e.g. Germany, Finland, and Austria, a “self-cloned” GMM is not regarded as a recombinant organism. This may have a major effect on labeling requirements, depending on future EU regulations. Genetic manipulations for metabolites are very much of the same type as the manipulations described for enzyme production. The main tools in metabolic engineering are gene disruption, gene replacement, and overexpression of genes, for example by increasing the copy number or introduction of new genes. Gene replacement is a variant of gene disruption. The result of gene replacement is that a target gene is replaced with another gene, typically in a two-step strategy very similar to the gene disruption strategy previously described. The real challenge in metabolic engineering is to qualify suggestions for genetic changes and to develop models that can predict the outcome of these genetic changes. The number of genes is huge and the metabolic network is simply too complex to rely on “simple” predictions or a “trial and error” approach. Development of mathematical modeling tools combined with post-genomic experimental methods, for example transcriptomics, proteomics, and metabolomics, have evolved into a new scientific discipline known as “systems biology” [31]. A prerequisite for a “systems biology” approach to improving either enzyme or metabolite production of an organism is that the genome of the organism has been sequenced and sufficiently annotated. The genome sequences of the fungal systems used for enzyme or metabolism production have either just been made available or will be made available in a short time. Annotation of these genome sequences is still not complete and will remain scarce for years to come. So although systems biology is well implemented for the yeast Saccharomyces cerevisiae [32] it is
4 Production of Food Additives Using Filamentous Fungi
in its infancy for filamentous fungi. Despite the lack of well annotated sequence data, experimental work to improve Aspergillus systems using DNA array technology has been initiated [33] and systems biology approaches to improve protein production have been reported [34]. Systems biology is likely to enable production of new metabolites in fungi or to significantly improve the production strains for existing metabolites and improve the capacity for enzyme production.
4.4 Industrial Enzyme Production Processes
Nearly all industrial enzyme products are formulations of enzymes secreted from the fungus during fermentation. After the fermentation the fungal biomass is removed and the enzyme is recovered from the broth. Because the GMM DNA is present in the biomass, the DNA is removed with the biomass. So only GMM DNA released to the broth as a result of cell lysis, and which is not removed or degraded during the subsequent recovery and formulation processes, is present in the final product. This means that the utility of analysis of the final product for GMM based on the recombinant DNA will be totally dependent on the production process. A brief introduction to industrial fermentation processes is therefore given here. Traditionally, enzyme production using filamentous fungi has been based both on surface fermentation and on submerged fermentation processes. Today enzymes are produced almost exclusively by submerged fermentation processes. Fermentation processes to produce industrial enzymes using recombinant fungi start with inoculation of a small flask containing an agar medium with a vial of the GMM. The flask is placed in an incubator which provides the optimum temperature for the culture to sporulate. The spores are transferred to a seed fermenter – a small fermenter in which the biomass for the main fermentation is generated. The seed fermentation enables the cells to adapt to the environment and nutrients they will encounter later. After seed fermentation the cells are transferred to the main fermenter, where temperature, pH, and dissolved oxygen are carefully controlled to optimize enzyme production. The fermentation process can either be run as a batch process, a fed-batch process, or a continuous fermentation. In the batch process all media components are added at the start of the fermentation. In fed-batch fermentation the fungus is fed with additional medium during the fermentation. In continuous fermentation a steady state is reached by simultaneously supplying fresh medium and harvesting from the tank. The extent of cell lysis during fermentation is mainly dependent on the GMM that is fermented, the duration of the fermentation process, and the design of the fermenter (i.e. the shear stress the biomass will encounter). A typical fermentation process is outlined in Fig. 4.4. When the main fermentation is complete the mixture of cells, nutrients, and enzymes, referred to as the broth, is ready for filtration, recovery, and purification – collectively referred to as downstream processing.
105
106
4.4 Industrial Enzyme Production Processes Water
Raw materials
Mixing of nutrient medium
Carbohydrates:
Exhaust
Ground grain/corn Starch Glucose Sugar
Sterilization
Cooling water Proteins: Soy bean meal Gluten Corn steep liquor Casein Salts: Phosphates Sulfates Ammonium salts
Inoculation flask
Seed fermenter Air Compressor
Fig. 4.4 Outline of a fermentation process. A typical process flow is demonstrated. Spores from an inoculation flask are used to inoculate a seed fermenter, and this in turn is used to inoculate the main fermenter.
Fermenter
Pretreatment Filter aid is added
Culture broth
Sterile filter
Fermented broth for recovery of enzyme
The fermenter can be aerated, and large propellers in the fermenter stir the fermentation broth. Additional medium components can be prepared and added during fermentation.
Preservatives are added
Bacterial filtration
Ultrafiltration Stabilization
Salt is added
Cooling
Liquid product
Liquid concentrate for granulation
A B
Drum filtration
Bacterial filtration
Fig. 4.5 Outline of a recovery process. Typical process flows are shown. The biomass is separated from the broth by filtration.
Enzyme crystals for granulation Filtration of enzyme crystals
The broth is then concentrated and sterile filtered. Alternatively the enzyme is recovered by crystallization.
4 Production of Food Additives Using Filamentous Fungi
First, the broth containing the enzyme is separated from the biomass. This is achieved by various chemical treatments of the fermentation broth to ensure efficient separation, followed by removal of the biomass using either centrifugation or filtration. After the separation the enzyme is concentrated by means of semipermeable membranes or evaporation. For products with high purity demands, the downstream process often requires special steps to remove unwanted impurities. This is often done by selective precipitation or adsorption of the impurities or by crystallization, by which very pure enzyme products can be obtained. In rare cases costly column chromatography may be used. The recovery process is outlined in Fig. 4.5. The final step in the process is formulation of the enzyme product. The enzymes can be formulated either as liquid products or as granulates, depending on the application of the enzyme. The critical issues of the formulation are to secure stability of the enzyme product, release of the enzyme in the application, and prevention of enzyme dust formation that can cause allergy.
References 1 G. Gellissen, K. Melber, Z. A. Janowicz, U. M. Dahlems, U. Weydemann, M. Piontek, A. W. Strasser, C. P. Hollenberg, Antonie Van Leeuwenhoek. 1992, 62, 79–93. 2 C. K. Raymond, T. Bukowski, S. D. Holderman, A. F. Ching, E. Vanaja, M. R. Stamm, Yeast. 1998, 14, 11–23. 3 A. P. J. Trinci, Mycol. Res. 1992, 96, 1–13. 4 J. W. Bennet, SIM news, 2001, 51, 65–71. 5 J. W. Bennet, M. A. Klich. Aspergillus, Biology and industrial applications. Butterworth–Heinemann, Stoneham, USA, 1992. 6 P. Barbesgaard, H. P. Heldt-Hansen, B. Diderichsen, Appl Microbiol Biotechnol 1992 36, 569–72. 7 S. D. Martinelli, J. R. Kinghorn, Aspergillus: 50 years on, Progress in industrial microbiology vol 29, Elsevier, Amsterdam. 8 T. Christensen, H. Woeldike, E. Boel, S. B. Mortensen, K. Hjortshoej, L. Thim, M. T. Hansen, Biotechnology. 1988, 6, 1419–1422. 9 R. M. Berka, K.H. Kodama, M. W. Rey, L. J. Wilson, M. Ward, Biochem Soc Trans. 1991, 19,681–685. 10 S. Keränen, M. Pentillä, Curr. Opinion in Biotech. 1995, 6, 534–537.
11 J. C. Royer, D. L. Moyer, S. G. Reiwitch, M. S. Madden, E. B. Jensen, S. H. Brown, C. C. Yonker, J. A. Johnston, E. J. Golightly, W. T. Yoder, Biotechnology. 1995, 13,1479–1483. 12 B. Christensen, J. Nielsen, Adv Biochem Eng Biotechnol, 2000, 66, 209–231. 13 H. Pedersen, B. Christensen, C. Hjort, J. Nielsen, Metab Eng. 2000, 2, 34–41. 14 T. Hoshino, K. Ojima, Y Setoguchi, Hoffmann la Roche and Co AG, Roche vitamins inc. European patent EP-0108210, 1998. 15 J. Lehmbeck, Novo Nordisk A/S, European patent EP-0956338-A1, 1996. 16 D. J. Ballance, G. Turner, Gene, 1985, 321–331 17 J. Sambrook, E. F. Fritsch, T. Maniatis, Molecular cloning, a laboratory manual, second edition, Cold Spring Harbor Laboratory Press 1989. 18 S. E. Unkles, E. I. Campbell, D. Carrez, C. Grieve, R. Contreras, W. Fierss, C. A. M. J. J. van den Hondel, J. R. Kinghorn, Mol. Gen. Genet., 1989, 218, 99–104 19 J. C. Royer, L. M. Christianson, W. T. Yoder, G. A. Gambetta, A. V. Klotz, C. L. Morris, H. Brody, S. Otani, Fungal Genet Biol, 1999, 28, 68–78.
107
108
References 20 C. Hjort, A. M. J. J. van den Hondel, P. Punt, F. H. J. Schuren, Novo Nordisk A/S Patent WO 0020596, 1998. 21 J. R. Fincham, Microbiol Rev, 1989, 53, 148–170. 22 B. Ruiz-Díez, J Appl Microbiol, 2002, 92, 189–195. 23 J. T. Andersen, T. Schäefer, P. L. Joergensen, S. Moeller, Res Microbiol, 2001, 152, 823–833. 24 G. C. M. Selten, R. F. M. van Gorcom, B. W. Swinkels, Gist Brocades NV, European patent EP 0635574A1. 25 C. M. Corrick, A. P. Twomey, M. J. Hynes, Gene, 1987, 63–71. 26 K. L. Petersen, J. Lehmbeck, T. Christensen, Mol Gen Genet, 1999, 262, 668–676. 27 E. Boel, T. Christensen, H. F. Woeldike, Novo Nordisk A/S, European patent EP0238023, 1987.
28 J. M. Uusitalo, K. M. Nevalainen, A. M. Harkki, J. K. Knowles, M. E. Penttilä, J. Biotech.,1991, 17, 35–49. 29 M. Ilmén, M. L. Onnela, S. Klemsdal, S. Keränen, M. Penttilä, Mol Gen Genet, 1996, 253, 303–314. 30 G. Gellissen, C. P. Hollenberg, Gene, 1997, 190, 87–97. 31 D.B. Kell, M. Brown, H. M. Davey, W. B. Dunn, I Spasic, S. G. Oliver, Nature Reviews Microbiology, 2005, 3, 557–565. 32 J. Nielsen. FEMS Yeast Res.,2004, 4, 757–758. 33 A. H. Sims, M. E. Gent, K. Lanthaler, N. S. Dunn-Coleman, S. G. Oliver, G. D. Robson, 2005, Appl. Environ. Microbiol., 71, 2737–2747 34 K. R. Patil, J. Nielsen, PNAS, 2005, 102, 2685–2689
5 Genetic Engineering of Bacteria Used in Food Fermentation Arnold Geis
5.1 Introduction
Fermentation is very old technology used for food production in many parts of the world. Indigenous fermented foods, for example fermented milk products (e.g. cheeses), bread, fish, meat, and numerous vegetables and fruits have been prepared for thousands of years and are often strongly linked to tradition and culture. Production of fermented foods involves the use of microorganisms (and/or enzymes) which alters such properties of the raw material as taste, texture, digestibility, nutritional value, and shelf-life. Fermentation is a relatively efficient, low-energy preservation process and is, therefore, an appropriate technique for safe food production in developing countries with little or no access to sophisticated techniques for food preservation. In these countries a great variety of raw materials, mainly of plant origin, have been fermented. Fermentation is usually performed in spontaneous processes under non-aseptic conditions. The specific environment then gradually selects for those microorganisms required for the desired product. The underlying microbial and/or enzymatic processes are usually poorly understood, which makes the process difficult to control. Any refinement and up-scaling of the fermentation processes needs better understanding of the microorganisms involved and their metabolic capabilities. Such knowledge would enable the selection or development of more productive bacterial cultures and a better control and manipulation of the culture conditions. This, with improved fermentation technology, would have a large impact on nutrition and food safety in developing countries while reducing post-harvest losses. In developed countries, mainly located in the northern hemisphere with modest climate, milk – and to a lesser extent meat, fish, and vegetables – form the raw material for the production of fermented foods. During the long history of fermentation – especially of milk – sophisticated technology has been developed, and well-characterized fermentation cultures now enable the controlled, large-scale production of many safe, tasty products with high nutritional value. For example,
110
5.2 Lactic Acid Bacteria
approximately 13 × 106 tons of cheese were consumed in the USA and the EU in 2001. In addition to efforts to improve the production of traditional fermented milk products, in recent years an increasing amount of scientific effort has been devoted to developing new products with additional beneficial effects on the health of the consumer (these are termed “functional foods”). Products fermented with or containing added probiotic bacteria are thought to relieve lactose intolerance, reduce the duration of rotavirus-induced diarrhea, and to alleviate allergic reactions. Other proposed beneficial health effects of probiotics await confirmation. Likewise, many of the mechanisms behind these health-promoting effects must be elucidated by in-vitro and in-vivo studies. In addition to yeasts and filamentous fungi (Chapter 3) lactic acid bacteria (LAB) play a dominant role in food fermentation, causing characteristic changes in, and prolonging the shelf-life of, fermented food. LAB that grow during fermentation either originate from the raw material (plant material, meat) or are added as starter cultures (milk, meat). LAB used in food fermentation are generally regarded as safe or even advantageous for human health (probiotics).
5.2 Lactic Acid Bacteria
The lactic acid bacteria form a heterogeneous group of Gram-positive bacteria, but are physiologically related by their ability to ferment carbohydrates to lactic acid as the predominant metabolic end-product. Homofermentative LAB convert fermentable carbohydrates almost quantitatively into lactic acid whereas heterofermentative LAB produce lactic acid and other compounds, for example acetic acid, CO2, and ethanol as primary metabolic end products. Some LAB also produce flavor compounds that are essential to the final taste of the fermented product. Species from six genera of lactic acid bacteria have been used in industrial production of food, feed, and alcoholic beverages (Table 5.1). 5.2.1 Lactococcus lactis subsp. lactis and subsp. cremoris
Lactococci are mesophilic, homofermentative LAB which are used extensively in milk fermentation to produce a large number of different products. Lactococcus lactis is the best characterized LAB with regard to its physiology and molecular genetics. Determination of the complete nucleotide sequence of L. lactis subsp. lactis IL1403 (Bolotin et al., 1999, 2001) and L. lactis subsp. cremoris strains MG1363 and SK11 (Table 5.2) makes these bacteria amenable to transcriptome and proteome analysis and enables comparative and functional genetic analysis among lactococci (Kok et al. 2005). During the past two decades, a plethora of methods and molecular devices has been developed to perform almost any kind of genetic engineering of these bacteria. (see below and Chapter 12).
5 Genetic Engineering of Bacteria Used in Food Fermentation Tab. 5.1 Lactic acid bacteria used for food fermentation. Dairy products (butter and buttermilk, yogurt and cheeses) Lactococcus lactis subsp. lactis L. lactis subsp. lactis var. diacetylactis L. lactis subsp. cremoris Lactobacillus delbrueckii subsp. bulgaricus Lb. casei Lb. helveticus Lb. acidophilus Leuconostoc mesenteroides subsp. cremoris Ln. lactis Streptococcus thermophilus Meat and fish products (fermented sausages, many indigenous products) Lactobacillus curvatus Lb. sake Lb. plantarum Pediococcus acidilactici P. pentosaceus various undefined LAB Plant products (sauerkraut, olives, cassava products, soy sauce, and many indigenous products) Lactobacillus plantarum Lactobacillus ssp. Leuconostoc mesenteroides Pediococcus pentosaceus various undefined LAB Bakery products (sourdough products, cracker) Lactobacillus sanfrancisco Lb. plantarum Lb. fermentum Lb. reuteri, Lb. amylolyticus Lb. ssp.
5.2.2 Lactobacillus spp.
The genus Lactobacillus comprises a large number of relatively diverse species. Lactobacilli are widespread in nature, and many have been used in food-fermentation processes, including fermentation of milk, meat, and plant material. In addition, a few species of Lactobacillus are used as probiotic microorganisms in functional foods (Table 5.1). Lactobacilli have been divided approximately into three groups that reflect mainly their abilities to ferment the different hexoses, pentoses, and di-
111
112
5.2 Lactic Acid Bacteria Tab. 5.2 Genome sequences of lactic acid and related bacteria used in food biotechnology. Organism name
Strain
Status
Genome size (Mb)
Reference and/or accession number
Lb. brevis
ATCC367
IP[*]
1,88
JGI[**]
Lb. casei
ATCC334
IP
2,76
JGI/AAGR00000000
Lb. delbrueckii subsp. bulgaricus
ATCC BAA-365
IP
1.63
JGI/AAGQ00000000
ATCC11842
F
ATCC33323
IP
Lb. gasseri
Genoscope/CR954253
[***]
1.95
JGI/AAAO00000000
2.0
Altermann et al. 2003 CP000033
Lactobacillus acidophilus
NCFM
F
Lb. johnsonii
NCC 533
F
1.99
Pridmore et al. 2004/ AE017198
Lb. plantarum
WCFS1
F
3.3
Kleerebezem et al. 2003 AL935263
Lb. reuteri
JMC1112 100-23
IP IP
JGI/AAOV00000000 JGI/AAPZ00000000
Lb. sakei
23K
F
Dudez et al. 2002/ CR936503
Lactococcus lactis subsp. lactis
IL1403
F
2.3
Bolotin et al. 2001/ AE005176
L. lactis subsp. cremoris
SK11
IP
2.3
JGI/AAGO00000000
L. lactis subsp. cremoris
MG1363
IP
2.6
unpublished
Leuconostoc mesenteroides ATCC8293 subsp. mesenteroides
IP
2.13
JGI/AABH00000000
Leuconostoc citreum
KM20
IP
Oenococcus oeni
MCW PSU-1
IP
O. oeni
IOB 8413
IP
Pediococcus pentosaceus
ATCC25745
P
2.0
JGI/AAEV00000000
Streptococcus thermophilus
CNRZ1066
F
1.8
Bolotin et al. 2004/ CP000024
S. thermophilus
LMG18311
F
1.8
CP000023
S. thermophilus
LMD9
IP
1.7
JGI/AAGS00000000
* ** ***
IP, in progress JGI, Joint Genome Institute (www.jgi.doe.gov) F, finished
Korean Res. Inst. Biosci. Biotech. 1.78
JGI/AABJ00000000 unpublished
5 Genetic Engineering of Bacteria Used in Food Fermentation
saccharides to lactic acid or lactic acid and other metabolites (Hammes and Vogel, 1995; Axelsson, 1998). Currently (july 2006) determination of the genome sequences of eleven lactobacilli species has been completed (Table 5.2). For those species for which complete genomes are annotated and published a diverse picture emerges of conserved and varying biosynthetic and metabolic capabilities (Klaenhammer et al. 2005) On the basis of genome sequence the biochemical and genetic analysis of these bacteria, which is still rudimentary for many of the species, will further accelerate and enable better and extended exploitation of this important bacterial group for both traditional and new purposes. Comparative genetics of probiotic and nonprobiotic species may help to identify the genetic and biochemical determinants responsible for the health-promoting effects of probiotic lactobacilli. 5.2.3 Streptococcus thermophilus
S. thermophilus is the only streptococcal species used with Lactobacillus spp. as starter culture in food technology for the manufacture of yogurt, mozarella, and Swiss-type cheeses. It is distinguished from the other streptococci by its ability to grow at elevated temperatures (up to 52°C), and its limited ability to ferment sugars. The increasing manufacture of the above-mentioned products demands deeper understanding of the performance and production requirements of such starter cultures. The number of industrial strains which comply with these demands is limited. Several traits such as phage resistance and exopolymer synthesis have been targets for strain improvement programs (Delcour et al., 2000). The availability of the complete genome sequences of three S. thermophilus strains (Table 5.2) has strongly improved knowledge of the metabolism and the molecular genetics of this species (Hols et al. 2005). This will facilitate selection of appropriate strains for the food industry and for genetic engineering to develop new strains with improved or novel properties which may, e.g., enable better control of the large-scale fermentation processes currently used. 5.2.4 Leuconastoc spp.
Bacteria of the genus Leuconostoc have been found in many natural and man-made habitats. Numerous strains have been isolated from grass, herbage, and silage (Garvie, 1960; Whittenbury, 1966). These heterofermentative bacteria play an essential role in the fermentation of vegetables such as cabbage and cucumbers, where they initiate spontaneous lactic acid fermentation (Peterson, 1960; Daeschel, 1987). The ability of some species (especially Ln. mesenteroides subsp. cremoris) to ferment the citric acid of the milk to the flavor compound diacetyl has led to their use in dairy starter cultures for this purpose (Sandine and Elliker, 1970, Cogan and Jordan, 1994; Vedamuthu, 1994). The ability of Ln. mesnenteroides subsp. mesenteroides to produce dextrans and levans has been exploited for industrial production of these
113
114
5.2 Lactic Acid Bacteria
substances for use in the biochemical and pharmaceutical industries (Sutherland, 1996). Determination of the genome sequences of Ln. mesenteroides subsp. mesenteroides and Ln. citreus are still in progress (Table 5.2). 5.2.5 Pediococcus spp.
Members of the genus Pediococcus are homofermentative, acidophilic bacteria that divide alternately in two perpendicular directions to form tetrads (Simpson and Taguchi, 1995). Several species, for example P. pentosaceus and P. acidilactici, are used as starter cultures for sausage making, fermentation of vegetables and soy milk, and for silage inoculation (Hammes, 1990, Simpson and Taguchi, 1995) and are also found on ripening cheeses as constituents of nonstarter lactic acid microflora (Fox et al., 1990). P. pentosaceus strains may contain up to five plasmids linked to the ability to ferment raffinose, melibiose, and sucrose and to produce bacteriocins (Daeschel and Klaenhammer, 1985, Gonzales and McKay, 1986). Determination of the genome sequence of P. pentosaceum ATCC25745 has recently been finished and is publicly available (Table 5.2). This will make this organism an interesting subject for genetic and functional studies and for metabolic and genetic improvements of industrial strains. 5.2.6 Oenococcus spp.
Oenococcus oeni (formerly Leuconostoc oenos) is a highly acid and alcohol-tolerant lactic acid bacterium found naturally in fruit mashes and related habitats (Dicks et al. 1995). The most studied aspect of O. oeni is its ability to convert malate into lactate. This malolactic conversion is employed in wineries to reduce the acidity of high-acid wines and to improve the stability and quality of wines (Kunkie, 1991; Versari et al. 1999; Alexandre et al. 2004). Determination of the genome sequence of two commercially used O. oeni strains – PSU-1 and IOEB8413 – has been achieved and the O. oeni PSU-1 sequence is publicly accessible in a draft version (Acc. No. AABJ00000000). Knowledge of the O. oeni genome will be valuable for the development of new tools to control malolactic fermentation in wine (Mills et al. 2005).
5 Genetic Engineering of Bacteria Used in Food Fermentation
5.3 Perspectives and Objectives 5.3.1 Bioconservation
Preservation of food by drying, salting, and fermentation are traditional methods of food preservation. The industrialization of food processing had increased the need for and use of chemical additives to prolong shelf-live and prevent or reduce the deleterious effects of contamination by spoiling microorganisms. The growing demand of the consumer for more natural food and an awareness of the health risks of some chemical food preservatives has led to a demand for alternatives. The preservation of food by antagonistic microorganisms has been well known for many decades (Hurst, 1973) but has not yet been applied to food preservation on a large scale. The term “bioconservation” was coined to distinguish this type of preservation from the chemical preservation of foods. Bioconservation may consist of adding bacterial strains that produce antagonistic compounds or by adding the purified antagonistic substances. Some LAB produce, in addition to their main metabolic products, a variety of inhibitory substances, for example diacetyl, CO2, hydrogen peroxide and bacteriocins. Bacteriocins – proteinaceous compounds that inhibit the growth of closely related bacteria – are produced by a variety of lactococcal strains. In a survey of 280 strains isolated from dairy environments, 5% were found to produce such substances. On the basis of biochemical and physical properties, host range, and cross-reactivity eight bacteriocin types were predicted (Geis et al., 1983, Klaenhammer, 1993). In recent years several of these bacteriocins have been characterized by genetic and biochemical methods and assigned to two main classes: lantibiotics – class I – and small, heat stable nonlantibiotics – class II (Nes et al., 1996). Although most of the bacteriocins of LAB have a narrow host range and are effective only against closely related bacteria, some are active against a broad spectrum of Gram-positive bacteria, including food pathogens (e.g. Listeria spp., Clostridia spp.). Bacteriocins of the latter group have the greatest potential for use as food preservatives. Nisin, a lantibiotic, is the best known bacteriocin and the only one approved for biopreservation of food. It is produced by some L. lactis strains and has a broad antibacterial spectrum. Nisin is used as a protective agent in a variety of food products worldwide (a review has been published by Vandenbergh, 1993). Nisin is most effective in acidic environments, however, and consequently its use is limited. Lacticin 3147 is a two-component bacteriocin produced by Lactococcus lactis DPC 3147 (Ryan et al. 1996) and inhibits the growth of a variety of Gram-positive bacteria, including food pathogens such as Listeria monocytogenes, Clostridia, Staphylococci, and Streptococci. It can be used for food protection when delivered either as a food ingredient or through the action of a bacteriocin-producing starter. Lacticin 3147 is encoded on a conjugative plasmid and can easily be transferred, by conjugation, into industrially used starter strains. The effectiveness of this bacteriocin has been proven in cheese manufacture and ripening and even in mastitis control.
115
116
5.3 Perspectives and Objectives
Because of its broad pH range, Lacticin 3147 has an advantage over nisin as a food preservative and may even be used for prevention of dental caries and for treatment of acne (Ross et al. 2002; O’Sullivan et al. 2003, Guanine et al. 2005). A steadily increasing number of bacteriocins produced by different genera of LAB are currently under investigation by a variety of genetic and biochemical means. Some of these compounds show promise for potential use as food preservatives. Many of the bacteriocins can be expressed in heterologous hosts, and this may extend their application in food preservation (Rodriguez et al. 2002). Better knowledge of the genetics and biochemistry of these substances may, in future, enable the design of tailor-made bacteriocins by site-directed mutagenesis with improved stability, pH range, and activity spectrum. Placing a bacteriocin gene or operon under the control of a growth-phase, pH, or salt-dependent promoter might enable secretion of the protective substance on completion of the fermentation process, without having any detrimental effects on the starter and/or the ripening culture. The construction of multi-bacteriocinic strains by recombinant gene technological methods may further extend the usefulness of these compounds in food preservation. 5.3.2 Bacteriophage Resistance
Bacteriophage infection during fermentation, especially in the dairy industry and in other submerged fermentations (e.g. acetic acid) is a ever-present danger that can lead to significant economic losses. Thus, bacteriophage resistance of fermentation cultures is a property of great importance which has attracted extensive scientific interest. Most of these investigations have been – and still are – concentrated mainly on lactococci and, very recently, on other LAB. In general, bacteria have a variety of phage-defense systems that interfere with all steps of phage development – from phage adsorption to DNA injection and replication, expression of the phage genes, and assembly and maturing of the phage particle. Research into phage-resistance mechanisms of dairy starter strains and, especially, of lactococci, has been summarized recently in several comprehensive reviews (Klaenhammer, 1987; Hill, 1993; Forde and Fitzgerald, 1999; Coffey and Ross, 2002; Josephsen and Neve, 2004). In lactococci, the phage-defense systems are predominately encoded on plasmids, many of which are self-transmissible, and this affords the opportunity to transfer phage-resistance genes to other, industrially important strains by conjugation, a natural (food-grade) gene-transfer mechanism. Conjugation has been successfully used to create starters that perform reliable dairy fermentations. Genetic linkage of phage-defense systems with bacteriocin production and resistance and/or immunity genes as selection marker on lactococcal plasmids has been used for strain construction. Three different, potent phage-resistance mechanisms encoded on different plasmids were introduced to a recipient strain by sequential transfer. The resulting strain was highly phage-resistant and successfully used for cheese manufacture (O’Sullivan et al., 1998). The use of this method for strain construction is limited by the lack of dominant selection markers and often by instability of the
5 Genetic Engineering of Bacteria Used in Food Fermentation
transferred plasmids, although this may be because of incompatibility of the transferred plasmid with the indigenous plasmids of the recipient. In addition, many phage-resistance systems reside on nonconjugative plasmids. More than 50 different phage-defense systems, including abortive infection (Abi), restriction-modification (R/M) systems, and some others, all of which act on other stages of phage propagation, have been identified in lactococci. The number of these systems identified in other LAB has also increased steadily (Josephsen and Neve, 2004; Chopin et al. 2005). The genome-sequencing program currently being performed on LAB will further extend our knowledge about phage resistance in all members of this bacterial group. New tools of recombinant DNA technology and the growing number of suitable gene cloning systems (see below) will enable improvements to be made in the phage resistance of industrially used starter strains. In principle any combination of phage-defense systems acting on different stages of phage development and/ or on different phages could be transferred in many industrial strains by use of electrotransformation or sophisticated conjugation methods (Hickey et al. 2001). So far, the use of recombinant DNA technology to improve starter bacteria is limited by legislative constraints, although the development of food-grade gene-delivery systems may overcome these limitations. Vectors with bacteriocin resistance and/or immunity genes as selection marker are available, as also are other systems based on complementation (Sørensen, 2000). A two component food-grade cloning system was developed recently; it consists of a vector entirely made up of L. lactis DNA without any selection marker and a replication-deficient plasmid encoding a selectable marker gene that depends on the presence of the vector plasmid for maintenance. After cloning of the desired gene into the vector both plasmids were transferred to the host strain by co-electroporation. Under selective conditions only cells which contain both plasmids can grow. Because of intrinsic incompatibility the plasmid carrying the selection marker is easily lost from the cells during growth under nonselective conditions. In this way, a phage-defense system (AbiQ) was stably introduced into two industrial strains, resulting in an effective resistance phenotype against phages (Emond et al. 2001). An efficient recombinant anti-phage system, denoted PER (phage-encoded resistance) was first described by Hill et al. (1990). It is based on the observation that the lytic cycle of a phage can be interrupted by presenting the origin of replication (ori) of the phage in multiple copies in the host cell. After infection, the phage replication factors are titrated by the multi-copy ori present on a plasmid vector. This results in induction of the plasmid rather than replication of phage DNA. By cloning multiple copies of the phage ori increased efficiency of the PER phenotype was achieved (McGrath et al. 1999, 2001). Antisense RNA technology also has been used to construct phage-resistant strains. Transcription of the noncoding strand of phage genes results in nontranslatable RNA hybrids, which are rapidly degraded. The reduction of transcripts for essential phage components severely disturbs propagation of the phage (Kim and Batt, 1991). Several antisense RNA cassettes have been developed and used in combination with inducible promoters, explosive expression vectors, and phage
117
118
5.3 Perspectives and Objectives
triggered suicide traps (O’Sullivan et al., 1996; Djordjevic et al. 1997; Sturino and Klaenhammer, 2002). The suicide system makes use of phage-inducible promoters and a gene lethal to the host cell. Introduction of these constructs to L. lactis and S. thermophilus strains resulted in significant protection against phage attack. These approaches, in combination with the food-grade, two-component genedelivery system and the availability of genome sequence data, will provide new opportunities to construct highly phage-resistant, food-grade starter strains. 5.3.3 Exopolysaccharides
Polysaccharides, which form a very diverse group of polymers, have been used for many purposes in industry. High-molecular-weight exopolysaccharides (EPS) are important ingredients in many food products as thickeners, stabilizers, emulsifiers, fat replacers, or gelling agents. Most of these polysaccharides have been derived from plant material, but alternative sources of these compounds include bacteria. For food manufacture, EPS produced by lactic acid bacteria are of major importance to the texture and organoleptic properties of many fermented milk products. Health benefits have also been attributed to some EPSs, for example immunomodulating and antitumor activity (Zubilla et al. 2001; Chabot et al. 2001; Ruas-Madiedo et al. 2002; Welman and Maddox, 2003). The EPSs of LAB form a very diverse group with regard to chemical composition, size, molecular structure, and physicochemical properties (De Vuyst and Degeest, 1999, 2001; Vaningelgem et al. 2004). The genetic determinants for EPS synthesis in Lactococcus lactis (van Kranenburg et al. 1997), Streptococcus thermophilus (Stingele et al. 1996; AlmironRoig et al. 2000; Germond et al. 2001), Lactobacillus delbrueckii subsp bulgaricus (Lamothe et al. 2002), and Lactobacillus rhamnosus (Van Calsteren et al. 2002; Peant et al. 2005) have been sequenced and analyzed and reveal a common operon structure, which suggests a common biosynthesis mechanism (for a review, see Jolly and Stingele, 2001). The gene sequence in all EPS-biosynthesis clusters is: regulation, chain-length determination, biosynthesis of the repeating unit, polymerization, and export (Jolly et al. 2002). Although structure–function relationships of EPS and interaction of specific EPS with different food components are poorly understood, clarification of these is an ongoing objective of much scientific effort. A better knowledge of these relationships combined with a steadily increasing supply of genetic and biochemical data will doubtless enable the construction of recombinant LAB that produce tailor-made EPS for specific food products (Jolly et al. 2002; Welman and Maddox, 2003). The genetic modification of eps genes could result in EPSs with different repeating units or with different chain length and, consequently, specific desired properties. Most LAB strains produce only small amounts of EPS (if any) and cannot be used for EPS-linked purposes. Investigations to improve EPS yield have shown, however, that production of EPS is affected by the bacterial growth phase, carbon and nitrogen sources, and pH and temperature. EPS overexpression has been demonstrated in L. lactis by placing part of the EPS-operon under the control
5 Genetic Engineering of Bacteria Used in Food Fermentation
of an inducible promoter (van Kraneburg et al., 1999). In S. thermophilus, ESP production was increased by altering expression of enzymes involved in central carbohydrate metabolism (Levander et al. 2002). The glycosyltransferases could be the target in engineering approaches. Replacing existing genes by heterologous glycosyltransferase genes which encode for transferases with different sugar specificities may enable the synthesis of EPS with different sugar composition (van Kranenburg et al.). Better knowledge of the polymerization and export processes might enable optimization of EPS production with altered repeating units or changing the rheological properties of native EPS by engineering of the molecular mass (Jolly and Stingele, 2001). 5.3.4 Proteolysis
Because of amino acid auxotrophy and lack of sufficient amounts of free amino acids in milk, lactic acid bacteria need an efficient proteolytic system for growth in milk. Proteolysis of these bacteria has been studied in great detail by genetic, biochemical, and ultrastructural methods. From these studies it has emerged that the proteolytic system of dairy lactococci and lactobacilli are remarkably similar both in their components and in their mode of action. The proteolytic system of lactococci consists of a cell-wall bound serin-protease (PrtP), three peptide transporters (Opp, DtpT, DtpP), and a variety of peptidases (Pep). The genes for most, but not all, of the enzymes necessary for casein degradation and transport of the degradation products have been cloned, sequenced, and analyzed in detail. From these data the following pictures emerge. Milk caseins were partially degraded by cell-wall bound protease into a large number of oligopeptides. Some of these oligopeptides (≤10 aa residues) were taken up by the oligopeptide and di and tripeptide transport systems and subsequently hydrolyzed to amino acids by a plethora of peptidases. Mutants missing transporter and/or peptidase genes were constructed by targeting deletion or disruption of the corresponding genes. Those missing the Opp system but still with di and tripeptide transport activity were unable to grow in milk. Mutants with increasing numbers of peptidase mutations had decreasing growth rates in milk – a fivefold peptidase mutant grew at one-tenth the rate of the wild type. In lactococci the genes for peptide transport systems and the peptidase were located on the chromosome, those for the proteases exclusively on plasmids (Kunji et al., 1996; Mierau et al., 1997; Law and Haandrikman, 1997; Christensen et al., 1999; Siezen, 1999; Doeven et al. 2005; Juille et al. 2005, Manso et al. 2005). The degradation of casein is a crucial process in formation of the texture and flavor in many fermented dairy products, especially cheeses. With the genetic and biochemical tools currently available it is possible to manipulate the pathways of protein and peptide degradation in LAB by quantitative and qualitative means. L. lactis strains that express heterologous proteases, for example neutral proteinase from Bacillus subtilis (van der Guchte et al. 1990) and peptidase from LAB and other genera (Leenhouts et al. 1998; Joutsjoki et al. 2002), have been constructed. Some were tested in cheese manufacture, ripening, and flavor development.
119
120
5.3 Perspectives and Objectives
The wealth of genetic information arising within the LAB genome sequencing project in combination with the development of sophisticated genomic and/or proteomic tools has resulted in better understanding of proteolytic pathways and their regulation in LAB (Kok et al. 2005; Hols et al. 2005); this will enable the construction of strains with controlled synthesis of amino acid catabolites and may include reduction of biogenic amines and controlled production of specific flavor compounds in fermented foods (Christensen et al. 1999; Smit et al. 2005). Proteins from milk and other foods are known to be precursors of many different biologically active peptides (Meisel and Bockelmann, 1999; Kitts and Weiler, 2003; Meisel and FitzGerald, 2003; Bouhallab and Bougle, 2004; Silva and Malcata, 2005). These peptides can be released in the active form during intestinal digestion or during fermentation. Fermented milks containing angiotensin-I-converting enzyme (ACE)-inhibitory peptides have been produced with selected LAB strains (Gobbetti et al. 2000; Muguerza et al. 2005). ACE inhibition results in an antihypertensive effect and may also affect other regulatory systems (Takano, 2002). Genetic engineering of the proteolytic system of LAB may provide the opportunity to overproduce these valuable peptides. 5.3.5 Metabolic Engineering of Lactic Acid Bacteria
Genetic engineering is direct improvement of the biochemical properties of cells by modification of specific reactions or introduction of new reactions using recombinant DNA technology. To develop strategies for metabolic engineering, a thorough understanding of the metabolic network and metabolic fluxes is necessary. LAB have a relatively simple and, in some species, well-known metabolism in which sugars are fermented mainly to lactic acid. Lactococcus lactis is the most extensively studied LAB and, therefore, the first employed in metabolic engineering efforts. An L. lactis strain has been constructed for efficient conversion of sugar into diacetyl by α-acetolactate decarboylase inactivation and simultaneous NADHoxidase overexpression. Approximately eighty percent of the carbon flux was found to be rerouted via α-acetolactate to the production of diacetyl (Hugenholtz et al. 2000). Diacetyl is essential as aroma compound in many fermented dairy products, for example butter and fresh cheeses. Overexpression of serine hydroxymethyltransferase in S. thermophilus resulted in an increase of acetaldehyde – a major flavor compound in yogurt- and folic acid formation (Chaves et al. 2002). Introduction and efficient expression of a heterologous alaD gene, encoding alanine dehydrogenase, in lactate dehydrogenase-deficient L. lactis cells resulted, in the presence of ammonium, in complete conversion of pyruvate to alanine. Inactivation of the endogenous alanine racemase (alr) gene led to stereospecific L-alanine production as the only end-product of fermentation (Hols et al. (1999). L-Alanine is used as a sweetener in the food industry and its in-situ production can lead to dairy products with intrinsic sweetness. Further metabolic engineering activity focuses on the removal of galactose and/or lactose from dairy products, and the production of nonfermentable (low calorie) sugars, oligosaccharides, and
5 Genetic Engineering of Bacteria Used in Food Fermentation
vitamins (e.g. folic acid) (Hugenholtz et al. 2002; Wisselink et al. 2002; Leroy and De Vuyst. 2004). On the basis of data derived from annotated genome sequences, complete metabolic networks of lactic acid bacteria can be established. These models, in connection with high-throughput genomic approaches, will enable efficient design and practical evaluation of novel metabolic engineering strategies for these bacteria (de Vos and Hugenholtz, 2004; Smid et al. 2005). 5.3.6 Stress Responses in Lactic Acid Bacteria
Lactic acid bacteria used in fermentation processes are, at different stages of their life cycle (starter culture handling, fermentation, and subsequent storage), subjected to a wide variety of harsh conditions. To survive the physical (high and low temperatures) and chemical (high acidity, nutritional starvation, oxidative and osmotic stress) changes in the environment, LAB have developed numerous stress-resistance mechanisms (for recent reviews see Duwat et al. 2000 and van der Guchte et al. 2002). Bacterial stress responses rely on complex regulatory circuits, which act together to improve stress tolerance. The bacterial heat shock response is characterized by elevated expression of several heat-shock proteins as chaperons, small heat-shock proteins, and specific proteases. Induction of the heat shock response by a short heat shock at sublethal temperatures increased the viability of LAB under subsequent stress conditions (Desmond et al. 2001; Gouesbet et al. 2002). A variety of different systems that may contribute to acid tolerance have been identified in LAB including different ATPases, the arginine deiminase pathway, ureases, decarboxylation reactions coupled with electrogenic transporters, and other less well characterized systems. (Rallu et al. 2000; van der Guchte et al. 2002, Grandvalet et al. 2005). Low-temperature adaptation and cryoprotection were found to be connected with the synthesis of cold-shock proteins induced at temperatures far below the optimum growth temperature in LAB. (Mayo et al. 1997; Wouters et al. 1999, 2001, Marceau et al. 2004). The presence of oxygen is a factor that greatly affects the outcome of a fermentation process. In the presence of oxygen, hydrogen peroxide is formed which, if not degraded by peroxidases and/or catalases, may accumulate and have deleterious effects, leading to cell death. After cloning and expression of the catalase gene of Lb. sake in a catalase-deficient Lb. curvatus strain which was frequently used for meat fermentation, no H2O2 accumulation was observed and the recombinant strain remained viable in the stationary phase (Hertel et al. 1998). Although LAB are regarded as fermentative anaerobes, in the presence of oxygen and heme Lactococcus lactis has a respiratory life cycle (Duvat et al. 2001, Gaudu et al. 2002). Whole-genome microarray analysis led to an optimized procedure for starter production under aerobic conditions; this resulted in increased biomass production by different industrially used L. lactis strains. Cells grown under aerobic conditions also had improved stress-tolerance. The amount of starter cul-
121
122
5.4 Methods
tures produced by this technology is measured in tons per year, and is tending to increase (Petersen et al. 2005) Stress response of LAB is currently a field of extensive research. A better understanding of the molecular basis of different stress response mechanisms and their interaction will in future enable the development of new strategies to screen and select for stress-tolerant or sensitive strains. Alternatively, strains used in many fermentation processes may be directly manipulated by use of recombinant gene technology.
5.4 Methods 5.4.1 Transformation
In the last 20 years or so sophisticated genetic tools – efficient transformation and special vector systems – have been developed which enable gene cloning, expression, and regulation of homologous and heterologous genes. The transformation of LAB is routinely performed using electroporation (Harlander, 1987; Holo and Nes, 1989; Powell et al., 1988. Serror et al. 2002). Several procedures enable efficient transformation, even of strains which were resistant to the formerly used method of poly(ethylene glycol) (PEG)-induced protoplast transformation, and are also useable for many industrial strains. In addition, conjugal gene-transfer systems enable efficient exchange of plasmids among lactic acid bacteria. 5.4.2 Gene Delivery and Expression Systems
Many vector systems now enable cloning and expression of genes from different sources, random and targeted inactivation of genes, selection for promoter, terminator, and signal sequences, and anchoring of proteins to the surface of lactococci (Kok et al., 1984; Law, J. et al. 1995; Leenhouts et al., 1998; Maguin et al., 1996; O’Sullivan et al., 1996; Poquet et al., 1998; Russel and Klaenhammer, 2001; Simon and Chopin, 1988; van der Guchte et al., 1989; van der Vossen et al., 1985). Only one of the most sophisticated expression vector systems, which enables very efficient control of gene expression in Lactococcus and other lactic acid bacteria (de Ruyter et al., 1996), will be described briefly. The system makes use of the autoregulatory properties of the nisin gene cluster. Nisin, at concentrations well below of the minimal inhibitory concentration, acts as an inducer from outside via a two-component signal-transduction system – a histidine protein kinase (NisK), and a response repressor (NisR). The two genes, nisK and nisR under the control of a constitutive promoter were delivered by recombinant plasmids or are integrated into the chromosome of the expression
5 Genetic Engineering of Bacteria Used in Food Fermentation
strain. The gene to be expressed is fused to the nisA promoter which is part of the expression vectors. Vectors for transcriptional and translational fusions have been constructed. Homologous and heterologous proteins can be produced in amounts up to 47% of total cell protein with increasing amounts of the inducer. This system has become one of the most successful and widely used tools for regulated gene expression in Gram-positive bacteria. The NICE system has been used for different purposes – over-expression of homologous and heterologous genes, metabolic engineering, expression of membrane proteins, protein secretion and anchoring in the cell envelope, expression of toxic products, analysis of essential genes, and large scale applications (an overview has been published by Mierau and Kleerebezem, 2005). In addition, a plethora of “food-grade” vectors is now available both for delivery and expression of exogenous genes via native or recombinant plasmids or by integration into the bacterial chromosome. These vectors consist solely of DNA derived from LAB and are devoid of antibiotic resistance genes as selectable markers (Axelsson et al. 2003, Bron et al. 2002, Cotter et al. 2003, El Demerdash et al. 2006, Emond et al. 2001, Henrich et al. 2002, Leenhouts et al. 1996, Liu et al. 2005, Maguin et al. 1996, Platteeuw et al.; Russell and Klaenhammer, 2001, Sasaki et al. 2004, Simoes-Barbosa et al. 2004, Sørensen et al., 2000; Takala and Saris, 2003, Takala et al. 2003; see also J. Kok in this book). With these tools many heterologous (eukaryotic or prokaryotic) peptides and proteins can be produced by use of Lactococcus lactis and, to a lesser extent, by other lactic acid bacteria. When required, these molecules can be secreted and/ or targeted to the cell envelope by fusion of genes to appropriate secretion and anchor signals. With this technique a variety of peptides and proteins could be anchored and at least partially presented at the cell surface of lactococci (Nouaille et al. 2003). This enabled alteration of the outside composition of the cells, which may aid understanding of the mechanisms of protein targeting. Changes in surface composition may also affect interactions between the bacteria and its environment and enable potentially important biotechnological applications, for example immobilization of enzymes on the bacterial surface (Buist et al., 1997, Poquet et al., 1998), fixing of cells to special surfaces, for example intestinal epithelial cells (Avall-Jääskeleinen and Palva, 2005), and display of epitopes. The latter includes epitopes of the human cytomegalovirus (Franke, 1998), of the human immunodeficiency virus, the Plasmodium falciparum merocoite stage surface antigene (Leenhouts et al., 1999), and the Clostridium tetani toxin C-fragment (Norton et al., 1995, 1996). Lactic acid bacteria producing the correct antigens and/or cytokines may, in future, be used as live bacterial vaccine-delivery systems (Martin et al. 2004, Norton et al., 1995; Robinson et al., 1997; Steidler et al., 1998; 2003). The development of such systems is a topic of extensive scientific effort. Some probiotic LABs are, in addition to their GRAS status, able to stimulate the immune system of the host. These properties and the availability of excellent genetic tools which enable the construction of food-grade recombinant (edible) LAB make the development of LAB as live vaccines a realistic prospect (Hanniffy et al. 2004, Nouaille et al. 2003, Seegers, 2002).
123
124
References
5.5 Conclusions
During the past few decades a good understanding has emerged of the microbial processes involved in the industrial scale production of fermented dairy products. Some of the microorganisms involved in milk fermentation, and especially Lactococcus lactis, have been so well characterized that sophisticated molecular and genetic tools are now available for the manipulation of these bacteria in many respects. Starter strains have been constructed, and will continue to be constructed, to enable better control of traditional fermentation processes, and to develop new products with higher nutritional values and health-promoting properties. Genetically engineered LAB may also be used for production of food-related products, for example neutraceuticals and other food additives such as flavor compounds and enzymes. Extensive research effort is now being devoted to the use of LAB as production and delivery systems for pharmaceutically active substances and vaccines. Despite the importance of fermented foods for nutritional purposes in less-developed regions of the world, little is known about the microbial and enzymatic processes in many fermentations, and this indicates there is a clear and urgent need for further research in this field. The selection and development of optimized starter cultures which can be easily propagated, stored at ambient temperatures, and which are resistant to different stress factors encountered during fermentation and storage is only one aspect of improvement among many fermentation processes. The genome sequences of approximately 30 strains from all biotechnologically important LAB have been or are being determined. Hence, with the vast amount of genetic data available, better understanding is emerging of their biochemical potential, technological properties, and health-promoting activity. Comparative and functional genetics will enable determination of similarities and differences for these bacteria. Undoubtedly, this will result in a wealth of new screening, selection, and genetic engineering strategies applicable to fermentation processes in the production of food.
References Alexandre, H., P.J. Costello, F. Remize, J. Altermann. E., W. M. Russel, M.A. AzcarateGuzzo, and M. Guilloux-Benatier. 2004. Peril, R. Barrangou, B. L. Buck, O. McAuSaccharomyces cerevisiae–Oenococcus oeni cliffe, N. Southern, A. Dobson, T. Doung, interaction in wine: current knowledge and M. Callanan; S. Lick, A. Hamrich, R. Cano, perspectives. Int. J. Food Microbiol.93: and T. Klaenhammer. 2005. Complete ge141–154. nome sequence of the probiotic lactic acid Almiron-Roig, E., E. Mulholland, M.J. Gasson, bacterium Lactobacillus acidophilus NCFM. and A.M.Griffin. 2000. The complete cps Proc. Natl. Acad. Sci. USA 102:3906–3912. gene cluster from Streptococcus thermophilus Avall-Jääskeläinen, S. and A. Palva. 2005. LacNCFB 2393 involved in the biosynthesis tobacillus surface layers and their applicaof a new exopolysaccharide. Microbiology, tion. FEMS Microbiol. Rev. 29:511–529. 146:2793–2802.
5 Genetic Engineering of Bacteria Used in Food Fermentation Axelsson, L. 1998. Lactic acid bacteria: classification and physiology, pp. 1–72. In, S. Salminen and A. Von Wright (eds). Lactic acid bacteria: Microbilogy and Functional Aspects, 2nd ed., Marcel Dekker, Inc, New York Axelsson, L., G. Lindstad, and K. Naterstad. 2003. Development of an inducible gene expression system for Lactobacillus sakei. Lett. Appl. Microbiol. 37:115–120. Bolotin, A., S.Mauger, K. Malarme, S.D. Ehrlich, and A. Sorokin. 1999. Low redundancy sequencing of the entire Lactococcus lactis IL 1403 genome. Antonie van Leeuwenhoek 76:27–76. Bolotin, A., P. Winker, S. Mauger, S. Jaillon, K. Malarme, J. Weissenbach, S.D. Ehrlich, and A. Sorokin. 2001.The complete genome sequence of the lactic acid bacteria Lactococcus lactis subsp. lactis IL 1403. Genome Res. 11:128–132 Bolotin, A., B. Quinquis, P. Renault, A. Sorokin, S. D. Ehrlich, S. Kulakauskas, A. Lapidus, E. Goltsman, M. Mazur, G. D. Pusch, M. Fonstein, R. Overbeek, N. Kyprides, B. Prunelle, d. Prozzi, K. Ngui, D. Masuy, F. Hancy, S. Burteau, M. Boutry, J. Delcour, A. Goffeau, and P. Hols. 2004. Complete sequence and comparative genome analysis of the dairy bacterium Streptococcus thermophilus. Nat. Biotechnol. 22:1554–1558. Bouhallab, S. and D. Bougle. 2004. Biopeptides of milk: caseinophosphopeptides and mineral bioavailability. Reprod. Nutr. Dev. 44:493–498. Bron, P.A., M.G. Bencimol, J. Lambert, E. Palumbo, M. Deghorain, J. Delcour, W.M. de Vos, M. Kleerebezem,and P. Hols. Use of the alr gen as a food-grade selection marker in lactic acid bacteria. Appl. Environ. Microbiol. 68:5663–5670. Buist, G. 1997. AcmA of Lactococcus lactis, a cell-binding major autolysin. Ph.D. thesis, University of Groningen, Haren, The Netherlands. Chabot, S., H.-L. Yu, L. De Leseleuc, D. Cloutier, M.-R. Van Calsteren, M. Lessard, D. Roy, M. Lacroix, and D. Oth. 2001. Exopolysaccharides from Lactobacillus rhamnosus RW-9595M stimulate TNF, IL-6 and IL-12 in human and mouse cultured immunocompetent cells, and IFN-gamma in mouse splenocytes. Lait 81:683–697.
Chaves, A. C. S. D., M. Fernandez, A.L.S. Lerayer, I. Mierau, M. Kleerebezem, and J. Hugenholtz. 2002. Metabolic engineering of acetaldehy production by Streptococcus thermophilus. Appl. Environ. Microbiol. 68:5656–5662. Chopin, M.C., Chopin, A., and E. Bidnenko. 2005. Phage abortive infection: variations on a theme. Curr. Opin. Microbiol. 8:473–479. Christensen, J.E., E.G. Dudley, J.A. Pederson, and J.L. Steele. 1999. Peptidases and amino acid catabolism in lactic acid bacteria. Antonie van Leeuwenhoek 76:217–246 Coffey, A. and R.P. Ross. 2002. Bacteriophageresistance systems in dairy starter strains: molecular analysis to application. Antonie van Leeuwenhoek 82:303–321. Cogan, T.M. and K.N. Jordan. 1994. Metabolism of Leuconostoc bacteria. J. Dairy Sci. 77:2704–2717. Cotter, P.D., C. Hill, and R.P. Ross.2003. A food-grade approach for functional analysis and modification of native plasmids in Lactococcus lactis. Appl. Environ. Microbiol. 69:702–706. Daeschel, M.A. and T.R. Klaenhammer. 1985. Association of a 13.6-megadalton plasmid in Pediococcus pentosaceus with bacteriocin activity. Appl. Environ. Microbiol. 50:1528–1541. Daeschel, M.A., R.E. Andersson, and H.P. Fleming. 1987. Microbial ecology of fermenting plant material. FEMS Microbiol. Rev. 46:357–367. Delcour, J., T. Ferain, and P. Hols. 2000. Advances in the genetic of thermophilic lactic acid bacteria. Curr. Opin. Biotechnol. 11:497–504. De Ruyter, P.G.G.A., O.P. Kuiper, and W.M. deVos. 1996. Controlled gene expression for Lactococcus lactis with the food-grade inducer Nisin. Appl. Environ. Microbiol. 62:3662–3667. De Vos, W.M. and J. Hugenholtz. 2004. Engineering metabolic highways in Lactococci and other lactic acid bacteria. Trends Biotechnol. 22:72–79. De Vuyst, L. and B. Degeest. 1999. Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol. Rev. 23:153–177. De Vuyst, L., F. De Fin, F. Vaningelgem, and B. Degeest. 2001. Recent developements in the biosynthesis and application of hetero-
125
126
References polysaccharides from lactic acid bacteria. Int. Dairy J. 11:687–707. Delcour, J., T. Ferain, and P. Hols. 2000. Adcances in the genetics of thermophilic lactic acid bacteria. Curr. Opin. Biotechnol. 11:497–504. Desmond, C., C. Stanton, G.F. Fitzgerald; K. Collins, and R.P. Ross.2001. Environmental adaption of probiotic lactobacilli towards improved performance during spray drying. Int. Dairy J. 11:801–811. Dicks, L. M., F. Dellaglio, and M.D. Collins. 1995. Proposal to reclassify Leuconostoc oenos as Oenococcus oeni [corrig.] gen. nov., comb. nov. International Journal of Systematic Bacteriology 45:395–397. Djordjevic, G.M., D.J. O’Sullivan, S.A. Walker, M.A. Conkling, and T.R. Klaenhammer. 1997. Bacteriophage-triggered defence systems: phage adaption and design improvements. Appl. Environ. Microbiol. 63:4370–4376. Doeven, M.K., J. Kok, and B. Poolman. 2005. Specificity and selectivity determinants of peptide transport in Lactococcus lactis and other microorganisms. Mol. Microbiol. 57:640–649. Dudez, A. M., S. Chaillou, L. Hissler, R. Stentz, M. Champomier-Vergès, C.A. Alpert and M. Zagorec. 2002. Physical and genetic map of the Lactobacillus sakei 23K chromosome. Microbiology. 148:421–431. Duwat, P., S.S. Cesselin, and A. Gruss. 2000. Lactococcus lactis, a bacterial modell for stress responses and survival. Int. J. Food Microbiol. 55:83–86. Duwat, P., S. Sourice, B. Cesselin, G. Lamberet, K. Vido, P. Gaudu, Y. LeLoir, F. Violet, P. Loubière, and A. Gruss. 2001. Respiration capacity of the fermenting bacterium Lactococcus lactis and its positive effects on growth and survival. J. Bacteriol. 183:4509–4516. El Demerdash, H.A. Budde-Niekiel, A. Heller, K.J. and Geis, A. 2006. Yoghurt fermentation at elevated temperatures by strains of Streptococcus thermophilus expressing a small heat-shock protein: Application of a two-plasmid system for constructing foodgrade strains of Streptococcus thermophilus. Émond, É., R. Lavallée, G. Drolet, S. Moineau, and G. LaPointe. 2001. Molecular characterization of a theta replication plasmid and its use for development of a two-component
food-grade cloning system for Lactococcus lactis.. Appl. Environ. Microbiol. 67:1700– 1709. Forde, A and G.F. Fitzgerald. 1999. Bacteriophage defence systems in lactic acid bacteria. Antonie van Leeuwenhoek 76:89–113. Fox, P.F., J.A. Lucey, and T.M. Cogan. 1990. Glycolysis and related reactions during cheese manufacture and ripening. Crit.Rev. Food Sci. Nutr. 29:237–253. Franke, C.M. 1998. Topology of a type I secetion system for bacteriocins of Lactococcus lactis. Ph.D. thesis, university of Groningen, Haren, The Netherlands. Garvie, E. 1960. The genus Leuconostoc and its nomenclature. J. Dairy Science 27:301–306. Gaudu, P., K. Vido, B. Ceselin, S. Kalukauskas, J. Tremblay, L. Rezaiki, G. Lamberet, S. Sourice, P. Duwat, and A. Gruss. 2002. Respiration capacity and consequences in Lactococcus lactis. Antonie van Leeuwenhoek. 82:263–269 Geis, A., J. Singh, and M. Teuber. 1983. Potential of lactic streptococi to produce bacteriocin. Appl. Environ. Microbiol. 45:205–211. Germond, J.E., M. Delley, N. Damico, and S.J. Vincent. 2001. Hetereologous expression and characterization of the exopolysaccharide from Streptococcus thermophilus Sfi39. Eur. J. Biochem. 268:5149–5156. Gobbetti, M., P. Ferranti, E. Smacchi, F. Goffredi, and F. Addeo. 2000. Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobaccilus delbrueckii subsp. bulgaricus and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microbiol. 66:3898–3904. Gonzales, C.F. and L.L. McKay. 1986. Evidence for plasmid linkage of raffiose utilization and associated α-galactosidase and sucrose hydrolase activity in Pediococcus pentosaceus. Appl. Environ. Microbiol. 51:105–109 Gouesbet, G., G. Jan, and P. Boyaval. 2002. Two-dimensional electrophoresis study of Lactobacillus delbrueckii subsp. bulgaricus thermotolerance. Appl. Environ. Microbiol. 68:1055–1063. Grandvalet, C., F. Coucheney; C. Beltramo, and J. Guzzo. 2005. CtsR is the master regulator of stress response gene expression in Oenococcus oeni. J. Bacteriol. 187: 5614–5623.
5 Genetic Engineering of Bacteria Used in Food Fermentation Guanine, C.M., P.D. Potter, C. Hill, and R.P. Ross. 2005. Microbial solutions to microbial problems: lactococcal bacteriocins for the control of undesirable biota in food. J. Appl. Microbiol. 98:1316–1325 Hammes, W.P. and R.F. Vogel. 1995. The genus Lactobacillus, pp.19–54. In, B.J.B. Wood and W.H. Holzapfel (eds). The Genera of Lactic Acid Bacteria. Chapman and Hall, London Hammes, W.P., A. Bantleon, and S. Min. 1990. Lactic acid bacteria in meat fermentation. FEMS Microbiol. Rev. 87:165–173 Harlander, S.K. 1987. Transformation of Streptococcus lactis by electroporation, pp. 229–233. In: J.J. Ferretti and R. Curtiss III (ed.), Streptococcal genetics. American Society for Microbiology, Washington, D.C. Hannify, S., U. Wiedermann, A. Repa, A. Mercenier, C. Daniel, J. Fioramonti, H. Tlaskolova, H. Kozakova, H. Israelson, S. Madsen, A. Vrang, P. Hols, J. Delcour, P. Bron, M. Kleerebezem, and J. Wells.2004. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv. Appl. Microbiol. 56:1–64. Henrich, B., J.R. Klein, B. Weber, C. Delorme; P. Renault, and U. Wegmann. 2002. Food-grade delivery system for controlled gene expression in Lactococcus lactis. Appl. Environ. Microbiol. 68:5429–5436. Hertel, C., G. Schmidt, M. Fischer, K. Oellers, and Hammes, W. 1998. Oxygen-dependent regulation of the expression of the catalase gene katA of Lactobacillus sakei LTH677. Appl. Environ. Microbiol. 64:1359–1365. Hickey, R.M., D.P. Twomey, P. Ross, and C. Hill. 2001. Exploitation of plasmid pMRC01 to direct transfer of mobilizable plasmids into commercial lactococcal starter strains. Appl. Environ. Microbiol. 67:2853–2858. Hill, C., L.A. Miller, and T.R. Klaenhammer. 1990. Cloning, expression, and sequence determination of a bacteriophage fragment encoding bacteriophage resistance in Lactococcus lactis. J. Bacteriol. 172:6419–6426. Hill, C. 1993. Bacteriophage and bacteriophage resistance in lactic acid bacteria. FEMS Microbiol. Lett. 12:132–142. Holo, H. and I.F. Nes. 1989. High-frequency transformation by electroporation of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl. Environ. Microbiol. 55:3119–3123
Hols, P., M. Kleerebezem, A.N. Schank, T. Ferain, M. Hugenholtz, J. Delcour, and W. de Vos. 1999. Conversion of Lactococcus lactis from homolactic to homoalanine fermentation through metabolic engineering. Nat. Biotechnol. 17:588–592. Hols, P., F. Hancy; L. Fontaine; B: Grossiord, D. Prozzi, N. Leblond-Bourget, B. Decaris, A. Bolotin, C. Delorme, S.D. Ehrlich, E. Guedon, V. Monnet, P. Renault, and M. Kleerebezem. 2005. New insights in the molecular biology and physiology of Streptococccus thermophilus revealed by comparative genomics. FEMS Microbiol. Rev. 29:435–463. Hugenholtz, J., M. Kleerebezem, M. Starrenburg, J. Delcour, J., W. de Vos, and P. Hols. 2000. Lactococcus lactis as acell factory for high-level diacetyl production. Apll. Environ. Microbiol. 66:4112–4114. Hugenholtz, J.; W. Sybesma, M.N. Groot, W. Wisselink, V. Ladero, K. Burgess, D. van Sinderen, J.-C. Piard, G. Eggink, E.J. Smid, G. Savoy, F. Sesma, T. Jansen, P. Hols, and M. Kleerebezem. 2002. Metabolic engineering of lactic acid bacteria for the production of nutraceuticals. Antonie van Leeuwenhoek 82:217–235. Hurst, A. 1973. Microbial antagonism in foods. Can. Inst. Food Sci. Technol. J. 6:80–90 Jolly, L. and F. Stingele. 2001. Molecular organization and funtionality of exopolysaccharide gene cluster in lactic acid bacteria. Int. Dairy J. 11:733–745. Jolly, L., S.J.F. Vincent, P. Duboc, and J.-R. Neeser. 2002. Exploiting exopolysaccharides from lactic acid bacteria. Antonie van Leeuwenhoek 82:367–374. Josephsen, J and H. Neve. 2004. Bacteriophages and antiphage mechanisms of Lactic Acid Bacteria. In: Salminen, S. and van Wright, A. (Eds) Lactic Acid Bacteria: Microbiology and functional aspects, 3rd edn (pp. 295–349). Marcel Dekker Inc., New York Joutsjoki, V., S. Luoma, M. Tamminen, E. Johansen, and A. Palva, A. 2002. Recombinant Lactococcus starters as a potential source of additional peptidolytic activity in cheese ripening. Appl. Microbiol. 92:1159–1166. Juille, O., D. Le Bars, and V. Juillard. The specificity of oligopeptide transport by
127
128
References Streptococcus thermophilus resembles that of Lactococcus lactis and not that of pathogenic streptococci. Microbiology 151:1987–1994. Kim, S.G., and C.A. Batt. 1991.Antisense mRNA-mediated bacteriophage resistance in Lactococcus lactis ssp. lactis. Appl. environ. Microbiol. 57:1109–1113. Kitts, D.D. and K. Weiler. 2003. Bioactive proteins and peptides from food sources. Application of bioprocesses used in isolation and recovery. Curr. Pharm. Des. 9:1309–1329. Klaenhammer, T. R. 1987. Plasmid-directed mechanisms for bacteriophage defense in lactic streptococci. FEMS Microbiology Reviews 46:313–325. Klaenhammer, T.R. 1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12:39–86. Klaenhammer, T.R., R. Barrangou, B.L. Buck, M.A. Azcarate-Peril, and E. Altermann. 2005. Genomic features of lactic acid bacteria effecting bioprocessing and health. FEMS Microbiol. Rev. 29:393–409 Kleerebezem, M., J. Boekhorst, R. van Kranenburg, D. Molenaar, O. P. Kuiper, R. Leer, R. Tarchini, S. A. Peters, H. M. Sandbrink, M. W. Fiers, W. Stieckema, R. M. Landhorst, P. A. Bron, S. M. Hoffer, M. N. Groot, R. Kerkhoven, M. deVries, B. Ursing, W. M. deVos, and R. J. Siezen. 2003. Complete genom sequenze of Lactobacillus plantarum WCFS1. Proc. Natl. Acad. Sci. USA 100:1990–1995 Kok, J., J.M.B.M. van der Vossen, and G. Venema. 1984. Construction of plasmid cloning vectors for lactic streptococci which also replicate in Bacillus subtilis and Escherichia coli. Appl. Environ. Microbiol. 48:726–731. Kunji, E.R.S., I. Mierau, A. Hagting, B. Poolman, and W.N. Konings. 1996. The proteolytic system of lactic acid bacteria. Ant. van Leeuwenhoek. 70:87–221. Kok, J., G. Buist, A. L. Zomer, S.A F.T. van Hijum, and O.P. Kuiper. 2005. Comparative and functional genomics of lactococci. FEMS Microbiol. Rev. 29:411–433. Kunkie, R.E. 1991. Some role of malolactic fermentation in wine making. FEMS Microbiol. Rev. 88:55–72. Lamothe, T., L. Jolly, B. Mollet, and F.Stingele. 2002.Genetic and biochemical characterization of exopolysaccharide bio-
synthesis by Lactobacillus delbrueckii subsp. bulgaricus. Arch. Microbiol. 178:218–228. Law, J., and A. Haandrikman. 1997. Proteolytic enzymes of lactic acid bacteria. Int. Dairy J. 7:1–11. Law, J., G. Buist, A. Haandrikman, J. Kok, G. Venema, and K. Leenhouts. 1995. A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. Appl. Environ. Microbiol. 177:7011–7018. Leenhouts, K., G. Buist, A. Bolhuis, A. ten Berge, J. Kiel, I. Mierau, M. Dabrowska, G. Venema, and J. Kok. 1996. A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol. Gen. Genet. 253:217–224. Leenhouts, K., A. Bolhuis, G. Venema, and J. Kok. 1998. Construction of a food-grade multiple-copy integration system for Lactococcus lactis. Appl. Microbiol. Biotechnol. 49:417–423. Leenhouts, K., G. Buist, and J. Kok. 1999. Anchoring of proteins to lactic acid bacteria. Antonie van Leeuwenhoek 76:367–376. Leroy, F. and L. De Vuyst. 2004. Lactic acid bacteria as functional starter cultures for the food fermentation. Trends Food Sci: Technol. 15:67–78. Levander, F., M. Svensson, and P. Rådström. 2002. Enhanced exopolysaccharide production by metabolic engineering of Streptococcus thermophilus. Appl.Environ. Microbiol. 68:784–790. Liu, C.Q., P. Su, N. Khunajakr, Y.M. Deng, S. Sumual, W.S. Kim, J.E. Tandianus, and N.W. Dunn. 2005. Development of food-grade cloning and expression vectors for Lactococcus lactis. J. Appl. Microbiol. 98:127–135. Maguin, E., H. Prevost, S.D. Ehrlich, and A. Gruss. 1996. Efficient insertional mutagenesis in lactococci and other Gram-positive bacteria. J. Bacteriol. 178:931–935. Manso, M.A., J. Leonil, M. Piot, V. Gagnaire. 2005. Isolation and characterization of a Lactobacillus helveticus ITG LH1 peptidaserich sub-proteome. Int. J. Food Microbiol. In press Marceau, A., M. Zagorec, S. Chaillou; T. Méra, and M.-C. Champomier-Vergès. 2004. Evidence for involvement of at least six proteins in adaptation of Lactobacillus sakei to cold temperatures and addition of
5 Genetic Engineering of Bacteria Used in Food Fermentation NaCl: Appl: Environ. Microbiol. 70: 7260–7268. Martín, M.C., M. Fernández, J.M. MartínAlonso, F. Parra, J.A. Boga, M.A. Alvarez. 2004. Nisin-controlled expression of Norwalk virus VP60 protein in Lactobacillus casei. FEMS Microbiol. Lett. 237:385–391. Mayo, B., S. Derzelle, M. Fernández, C. Léonard, T. Ferain, P. Hols, J.E. Suárez, and J. Delcour. 1997. Cloning and characterization of cspL and cspP, two cold-inducible genes from Lactobacillus plantarum. J. Bacteriol. 179:3039–3042. McGrath, S., G.F. Fitzgerald, and D. van Sinderen. 2001. Improvement and optimization of two engineered phage resistance mechanisms in Lactococcus lactis. Appl. Environ. Microbiol. 67:608–616. McGrath, S., J.F. Seegers, G.F. Fitzgerald, and D. van Sinderen. 1999. Molecular characterization of a phage-encoded resistance systemin Lactococcus lactis. Appl. Environ. Microbiol. 65:1891–1899. Meisel, H. and W. Bockelmann. 1999. Biofunctional peptides milk proteins: proteolytic activation and thropho-functional properties. Antonie van Leeuwenhoek 76:207–215. Meisel, H. and R.J. Fitzgerald. 2003. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr. Pharm. Des. 9:1289–1295. Mierau, I., E.R.S. Kunji, G. Venema, and J. Kok. 1997. Casein and peptide degradation in lactic acid bacteria. Biotechn. Gen. Engin. Rev. 14:279–301. Mierau, I. And M. Kleerebezem. 2005. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl. Microbiol. Biotechnol. On line Muguerza, B., M. Ramos, E. Sánches, M.A. Manso, M. Miguel, A. Aleixandre, M.A. Delgado, and I. Recio. 2005. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk. Int. Dairy J. On line Nes, I.F., D.P. Diep, L.S. Håvarstein, M.B. Brurberg, V. Eijsink, and H. Holo. 1996. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie van Leeuwenhoek 70:17–32. Norton, P.M., R.W.F. LePage, and J.M. Wells. 1995. Progress in the developement of Lactococcus lactis as a recombinant mucosal
vaccine delivery system. Folia Microbiol. 40:225–230. Norton, P.M., H.W.G. Brown, J.M. Wells, A.M. Macpherson, P.W. Wilson, and R.W.F. LePage. 1996. Factors affecting the immunogenicity of tetanusd toxin fragment C expressed in Lactococcus lactis. FEMS Immunol. Med. Microbiol. 14:167–177. Nouaille, S., L.A.Ribeiro, A. Miyoshi, D. Pontes, Y. Le Loir, S.Costa Oliveira, P. Langella, and V. Azevedo. 2003. Heterologous protein production and delivery systems for Lactococcus lactis. Genet. Mol. Res.2:102–111. O’Sullivan, D.J., S.A. Walker, S.G. West, and T.R. Klaenhammer. 1996. Development of an expression strategy using a lytic phage to trigger explosive plasmid amplification and gene expression. Bio/Technol. 14:82–87. O’Sullivan, D., A. Coffey, G.F. Fitzgerald, C. Hill, and R.P. Ross. 1998. Design of a phage-insensitive lactococcal dairy starter strain via sequential transfer of naturally occuring conjugative plasmids. Appl. Environ. Microbiol. 64:4618–4622. O’Sullivan, L., M.P. Ryan, R.P. Ross, and C. Hill. 2003. Generation of food-grade lactococcal starters which produce the lantibiotics lacticin 3147 and lacticin 481. Appl. Environ. Microbiol. 69:3681–3685 Péant, B., G. LaPoint, C. Gilbert, D. Atlan, P. Ward, and D. Roy. 2005. Comparative analysis of the exopolysaccharide biosynthesis gene cluster from four strains of Lactobacillus rhamnosus. Microbiol. 151:1839–1851. Petersen, M.B., S.L. Iversen, K.I. Sorensen, and E. Johansen. 2005. The long and winding road from the research laboratory to industrial applications of lactic acid bacteria. FEMS Microbiol. Rev. 29:611–624. Peterson, C.S. 1960 Sauerkraut, In C.O. Chichester, E.M. Mrak, E.M. Steward (eds.) advances in Food Research, Vol. 10. Academic Press, London. Platteeuw, C., I. Van Alen-Boerrigter, S. van Schwalkwijk, and W.M. de Vos. 1996. Foodgrade cloning and expression system for Lactococcus lactis. Appl. Environ. Microbiol.62:1008–1013. Poquet, I., S.D. Ehrlich, and A. Gruss. 1998. An export-specific reporter designed for Gram-positive bacteria: application to Lactococcus lactis. J. Bacteriol. 180:1904–1912. Powell, I.B., M.G. Achen, A.J. Hillier, and B.E. Davidson. 1988. A simple and rapid
129
130
References method for genetic transformation of lactic streptococci by electroporation. Appl. Environ. Microbiol. 54: 655–660. Pridmore, R. D., B. Berger, F. Desiere, D. Vilanova, C. Barretto, A-C. Pittet, M.-C. Zwahlen, M. Rouvet, E. Altermann, R. Barrangou, B. Mollet, A. Mercenier, T. Klaenhammer, F. Arigoni, and M. A. Schell. 2004. The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Proc. Natl. Acad. Sci. USA 101:2512–2517. Rallu, F., A. Gruss, S.D. Ehrlich, and E. Maguin. 2000. Acid- and multistress-resistant mutants of Lactococcus lactis: identification of intracellular stress signals. Mol. Microbiol. 35:517–528. Robinson, K., L.M. Chamberlain, K.M. Schofield, J.K. Wells, and R.W.F. LePage. 1997. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nature Biotechnol. 15:653–657. Rodriguez, J.M., M.I. Martinez, N. Horn, and H.M. Dodd. 2002. Heterologous production of bacteriocins by lactic acid bacteria. Int. J. Food Microbiol. 80:101–116. Ross, R.P., M. Galvin, O. McAuliffe, S.M. Morgan, M.P. Ryan, D.P. Twomey, W. Meaney, and C. Hill. 1999. Developing applications for lactococcal bacteriocins. Antonie van Leeuwenhoek 76:337–346. Ross, R.P., S. Morgan, and C. Hill. 2002. Preservation and fermentation: past, presence and future. Int. J. Food Microbiol. 79:3–16. Ruas-Mediedo, P., J. Hugenholtz, and P. Zoon. 2002. An overview of the functionality of exopolysaccharides produced by lactic acid bacteria. Int. Dairy J. 12:163–171. Russell, W.M. and T.R. Klaenhammer. 2001. Efficient system for directed integration into the Lactobacillus acidophilus and Lactobacillus gasseri chromosomes via homologous recombination. Appl. Environ. Microbiol. 67:4361–4364. Ryan, M.P., M.C. Rea, C. Hill, and R.P. Ross. 1996. An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl. Environ. Microbiol. 62:612–619. Sandine, W. E. and P.R. Elliker. 1970. Microbially induced flavors and fermented foods – Flavor in fermented dairy products. J. Agric. Food Chemistry 18:557–567.
Sasaki, Y., Y. Ito, and T. Sasaki.2004. ThyA as a selection marker in construction of foodgrade host–vector and integration systems for Streptococcus thermophilus. Appl. Environ. Microbiol. 70:1858–1864. Seegers, F.M.L. 2002. Lactobacilli as live vaccine delivery vectors: progress and properties. Trends Biotechnol. 20:508–515. Serror, P., T.Sasaki, S.D. Ehrlich, and E. Maguin. 2002. Electrotransformation of Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus delbrueckii subsp. lactis with various plasmids. Appl. Environ. Microbiol. 68:46–52. Shinoda, T.S., M. Kajiyama, K. Okhi, N. Yamamoto, E. Okada, K. Oshima, and M. Hattori. 2005. Complete genome sequence of Lactobacillus helveticus CM4. 8th Symposium on Lactic Acid Bacteria, the Netherlands, poster E011 Siezen, R.J. 1999. Multi-domain, cell-envelope proteinases of lactic acid bacteria. Antonie van Leeuwenhoek 76: 139–155. Silva, S.V. and F.X. Malcata. 2005. Caseins as a source of bioactive peptides. Int. Dairy J. 15:1–15. Simon, D., and A. Chopin. 1988. Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis. Biochimie 70:559–566. Simoes-Barbosa, A., H. Abreu, A.Silva Neto, A. Gruss, and P. Langella. A food-grade delivery system for Lactococcus lactis and evaluation of inducible gene expression. Appl. Microbiol. Biotechnol. 65:61–67. Simpson, W.J. and H. Taguchi. 1995. The genus Pediococcus, with notes on the genera Tetragenococcus and Aerococcus, pp. 125– 172. In, B.J.B. Wood and W.H. Holzapfel (eds). The Genera of Lactic Acid Bacteria. Chapman and Hall, London. Smit, E.J., F.J.H. van Enckevort, A. Wegkamp, J. Boekhorst, D. Molenaar, J. Hugenholtz, R.J. Siezen, and B. Teusink. 2005. Metabolic models for rational improvement of lactic acid bacteria as cell factories. J. Appl. Microbiol. 98:1326–1331. Smit, G., B.A. Smit, and W.J.M. Engels. 2005. Flavour formation by lactic acid bacteria and biochemical flavour profiling of cheese products. FEMS Microbiol. Rev. 29:591–610. Sørensen, K.J., R. Larsen, A. Kibenich, M.P. Junge, and E. Johansen. 2000. A food-grade cloning system for industrial strains of
5 Genetic Engineering of Bacteria Used in Food Fermentation Lactococcus lactis. Appl. Environ. Microbiol. 66:1253–1258. Steidler L., J. Viaene, W. Fiers, and E. Remaut. 1998. Functional display of a heterologous protein on the surface of Lactococcus lactis by means of the cell wall anchor of Staphylococcus aureus protein A. Appl. Environ. Microbiol. 65:342–345. Steidler, L., S. Neirynck, N. Huyghebaert, V. Snoeck, A. Vermeire, B. Goddeeris, E. Cox, J.P.Remon, and E. Remaut. 2003. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nature Biotechnol. 12:785–789. Stingele, F., J.R. Neeser, and B. Mollet. 1996. Identification and characterization of the eps (Exopolysaccharide gene cluster from Streptococcus thermophilus Sfi6. J. Bacteriol. 178:1680–1690. Sturino,J.M. and T.R. Klaenhammer. 2002. Expression of antisense RNA targeted against Streptococcus thermophilus bacteriophages. Appl. Environ. Microbiol. 68:588–596. Sutherland, I.W. 1996. Extracellular polysaccharides, pp. 613–657. In: H.-J. Rehm, G. Reed, A. Pühler and P. Stadler (eds.) Biotechnology, 2nd ed., Vol 6: Products of Primary Metabolism. VCH, New York. Takano, T. 2002. Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie van Leeuwenhoek 82:333–340. Takala, T.M. and P.E. Saris. 2002. A foodgrade vector for lactic acid bacteria based on the nisin immunity gene nisI. Appl. Microbiol. Biotechnol. 59:467–471. Takala, T.M. and P.E. Saris, and S.S. Tynkkynen. 2003. Food-grade host/vector expression system for Lactobacillus casei baased on complementation of plasmid. associated phosphor-beta-galactosidase gene lacG. Appl. Microbiol. Biotechnol. 60:564–570. Vademuthu, E.R. 1994. The dairy Leuconostoc: use in dairy products. J. Dairy Sci. 77:2725–2737. Van Calsteren, M.R., C. Pau-Roblot; A. Begin, and D. Roy. 2002. Structure determination of the exopolysaccharide produced by Lactobacillus rhamnosus RW-9595M and R. Biochem. J. 363:7–17.
van der Guchte, M., J.M.B.M. van der Vossen, J. Kok, and G. Venema. 1989. Construction of a lactococcal expression vector: expression of hen egg white lysozyme in Lactococcus lactis. Appl. Environ. Microbiol. 55:224–228. van der Guchte, M., J. Kodde, J.M.B.M. van der Vossen, J. Kok, J., and G. Venema. 1990. Heterologous gene exprerssion in Lactococcus lactis subsp. lactis: Synthesis, secrection, and processing of Bacillus subtilis neutral protease. Appl. Environ. Microbiol. 56:2606–2611. van der Guchte, M., P. Serror, C. Chervaux, T. Smokvina, S.D. Ehrlich, and E. Maguin. 2002. Stress response in lactic acid bacteria. Antonie van Leeuwenhoek. 82: 187–216. Vaningelgem, F., M. Zamfir, F. Mozzi, T. Adriany, M. Vancanneyt, J. Swings, and L. De Vuyst. 2004. Biodiversity of exopolysaccharides produced by Streptococcus thermophilus strains reflected in their production and their molecular and functional characteristics. Appl. Environ. Microbiol. 70:900–912. van der Vossen, J.M.B.M., J. Kok, and G. Venema. 1985. Construction of cloning-, promoter and terminator screeningshuttle vectors for Bacillus subtilis and Streptococcus lactis. Appl. Environ. Microbiol. 50:540–542. van Kranenburg, R., J.D. Marugg, I.I. van Swam, N.J. Willem, and W.M. de Vos. 1997. Molecular characterization of the plasmid encoded eps gene cluster essential for exopolysaccharide biosythesis in Lactocccus lactis. Mol. Microbiol. 24:387–397. van Kranenburg, R., H.R. Vos, I.I. van Swam, M. Kleerebezem, and W.M. de Vos. 1999. Functional analysis of glycosyltransferase genes from Lactococcus lactis and other Gram-positive cocci: Complementation, expression, and diversity. J. Bacteriol. 181:6347–6353. Vandenbergh, P. A. 1993. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol. Rev. 12:221–238. Versari, A., G.P. Parpinello, and M. Cattaneo. 1999. Leuconostoc oenos and malolactic fermentation in wine: A review. Journal of Industrial Microbiology and Biotechnology 23:447–455. Welman, A.D. and I.S. Maddox. 2003. Exopolysacharides from lactic acid bacteria:
131
132
References perspectives and challenges. Trends Biotechnol. 21:269–274. Wisselink, H.W., R.A. Weusthuis, G. Eggink, J. Hugenholtz, and G.J. Grobben. 2002. Mannitol production by lactic acid bacteria: a review. Int. Dairy J. 12:151–161 Whittenbury, R. 1966. A study of the genus Leuconostoc. Archiv für Mikrobiologie 53:317–327 Wouters, J.A., F.M. Rombouts, W.M. de Vos, O.P. Kuipers, and T. Abee. 1999. Cold schock proteins and low-temperature response of Streptococcus thermophilus CNRZ302. Apll. Environ. Microbiol. 65:4436–4442.
Wouters, J.A., H. Frenkiel, W.M. de Vos, O. Kuipers, and T. Abee. 2001. Cold schock proteins of Lactococcus lactis MG1363 are involved in cryoprotection and in the production of cold-induced proteins. Appl. Environ. Microbiol. 67:5171–5178. Zubilla, M., R. Weill, E. Postaire, C. Goldman, R. Caro, and J. Boccio. 2000. Effect of probiotics and functional foods and their use in different diseases. Nut. Res. 21:569–579.
Part II Legislation in Europe
6 The Legal Situation for Genetically Engineered Food in Europe Rudolf Streinz and Jan Kalbheim
6.1 Introduction 6.1.1 The Need for Regulation
In 1985, in the context of its so called “new strategy” the Commission mentioned both “certain biotechnological techniques” and “other techniques and treatments” as areas of law requiring harmonization. By doing so it intended to secure the functioning of the common market by standardizing the relevant national rules (which were possible with regard to art. 30 TEC if they protected public health, but nevertheless might create conditions of unfair competition; cf. recitals 1 and 2 Novel Food Regulation (NFR) [1]). The Netherlands and Denmark, e.g., had statutory provisions which included rules concerning “novel foods”, in particular genetically modified foodstuffs. In the UK, also, there was a voluntary agreement between the food industry and the relevant authorities, which could be declared binding in accordance with the Food Safety Act 1990 [2]. 6.1.2 The History of the Regulation of Genetically Modified Food
Genetically modified food was originally treated as “novel food” and therefore included in the scope of application of the Novel Food Regulation. This regulation was the final result of a rather cumbersome process. Although the draft proposal for a regulation (OJ (EC) 1992, C 190/3) which the EC Commission (henceforth: Commission) presented in 1992, after years of discussion, was only the eleventh version, it was widely criticized, especially by the European Parliament. The criticism focused in particular on the rules concerning the scope of application and the labeling. Unfortunately the Commission considered this only in part when it presented its amended proposal for a Regulation (EC) of the European Parliament (EP) and of the Council concerning novel foods and food ingredients (OJ (EC)
136
6.1 Introduction
1994, C 16/10). Therefore, the following legislative procedures proved awkward – only a compromise put forward by the French Presidency enabled the Council to eventually formulate a common position, which was adopted on 23 October 1995 by a qualified majority against the votes of Denmark, Germany, Austria, and Sweden (OJ (EC) 1995, C 320/1). These four Member States regarded the rules on labeling as insufficient. This criticism was reflected in the EP during the joint legislative procedure (art. 251 TEC): Despite general acceptance of large parts of the proposal, the EP requested a number of amendments, especially with regard to labeling. These were in turn rejected by the Commission. Finally a compromise proposal which originated in the Conciliation Committee on 27 November 1996 under the Irish presidency was accepted by both the Council and the EP. The Novel Food Regulation nevertheless did not cover all genetically modified food and food ingredients. It expressly excluded additives, flavorings and extraction solvents from its scope of application (Art. 2 para. 1 lit. a–c NFR); these were therefore dealt with by Commission Regulation (EC) No 50/2000 [3], which made these substances subject to specific labeling requirements. Also, food and food ingredients which are to be delivered as such to the final consumer produced, in whole or in part, from genetically modified soybeans or genetically modified maize were not covered by the Novel Food Regulation because of lack of novelty at the time when the Novel Food Regulation was enacted. Again, specific labeling requirements were provided for, initially in the so called Supplementary Regulation [4] and then in the so called Replacement Regulation [5] which repealed the Supplementary Regulation. In addition, the placing on the market of genetically modified food normally involved the deliberate release of genetically modified organisms into the environment which was generally regulated by the so called Deliberate Release Directive 1990 [6] which provided for specific environmental safety requirements. In the Annex to its White Paper on Food Safety of 12 January 2000 [7] the Commission demanded in its catalog of actions to: • enact legal rules for the assessment, authorization and labeling of novel foods (White Paper on Food Safety, Annex: Action Plan on Food Safety, no. 6), • make the procedures for authorization of novel foods more transparent (ibidem, no. 50), • review Regulation (EC) No. 258/97 on novel foods and novel food ingredients (ibidem, no. 51), • introduce a general requirement for a new safety evaluation (ibidem, no. 41) and • complete and harmonize the provisions governing labeling (ibidem, no. 52). To implement these projects the Commission submitted a number of proposals which led to the enactment of two regulations: • Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed (henceforth: the GMFFR) [8], which removed genetically modified food and feed from the scope of application of the Novel Food Regulation and repealed the Replacement Regulation;
6 The Legal Situation for Genetically Engineered Food in Europe
• Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the labeling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC [9] (henceforth: GMFFTraceLabelR) [10].
6.2 The Law Applicable to Genetically Modified Food 6.2.1 The Genetically Modified Food and Feed Regulation 6.2.1.1 Introduction According to its art. 1, the objective of the GMFFR is to provide the basis for ensuring a high level of protection of human life and health and animal, environmental, and consumer interests in relation to genetically modified food and feed by laying down provisions for Community procedures for authorization and supervision and for the labeling of such food and feed. Art. 2 of the GMFFR contains definitions of important terms used in the regulation. Unfortunately, twelve out of twenty-two terms are defined by referring to other Community acts. While it is true that references to the so called Basic Regulation [11] may serve to establish the coherence of food law rules, this makes it rather difficult for the lawyer – and even more so for the lay person – to grasp the law as it stands. Chapter II makes provisions for the authorization and supervision (art. 3–11) and for the labeling (art. 12–14) of genetically modified food. Chapter III provides for virtually identical rules concerning the same topics in relation to genetically modified feed (art. 15–23 and 24–26, respectively). This clearly shows the integral approach of the Commission to fashion a high level of protection for the whole food chain from the producer to the consumer. It is further ensured by the requirement to submit a single application under articles 5 and 17 where a product is likely to be used as both food and feed, which then leads to a single opinion from the European Food Safety Authority (henceforth: EFSA) and a single Community decision (art. 27 para. 1). The EFSA is under a duty to examine whether an application should be submitted both as food and feed (art. 27 para. 2). Chapter IV contains common provisions for genetically modified food and feed, relating inter alia to the Community register of genetically modified food and feed and the access to and the protection of the information contained therein (art. 28–31), to the Community reference laboratory (art. 32 and Annex: Duties and tasks of the Community reference laboratory), to emergency measures (art. 34), and to administrative review (art. 36).
137
138
6.2 The Law Applicable to Genetically Modified Food
6.2.1.2 Scope of Application According to its art. 3 para. 1 the Genetically Modified Food and Feed Regulation applies to • GMOs (cf. art. 2 no. 5 GMFFR) for food use (cf. art. 2 no. 8 GMFFR) – art. 3 para. 1 lit. a GMFFR – for example GM tomato; • food containing or consisting of GMOs (cf. art. 2 no. 6 GMFFR) – art. 3 para. 1 lit. b GMFFR – for example prepared pizza using GM tomato slices as a topping; • food produced from (cf. art. 2 no. 10 GMFFR) or containing ingredients produced from GMOs – art. 3 para. 1 lit. c GMFFR – for example tomato ketchup made from GM tomato, sugar made from GM sugar beet. Where this proves necessary, it is the task of the Standing Committee on the Food Chain and Animal Health (cf. art. 58 Basic Regulation) to determine whether a type of food falls within the scope of application of the GMFFR, using the regulatory procedure as defined in art. 5 Comitology Decision [12] (cf. infra 2.1.4.2)
6.2.1.3 Requirements for Genetically Modified Food and Feed Genetically modified food and feed covered by the GMFF Regulation must not – in accordance with the general principles of food law – have adverse effects on human health, animal health, or the environment or mislead the consumer. Likewise, they must not differ from foods or food ingredients which they are intended to replace to such an extent that their normal consumption would be nutritionally disadvantageous for the consumer or the animal (art. 4 para. 1, 16 para. 1 GMFFR).
6.2.1.4 Procedure Introduction Food law is based on the so called abuse principle (Mißbrauchsprinzip), according to which foodstuffs may be placed on the market autonomously, that is without prior authorization, if they meet the statutory requirements (under German law, especially, those of the protection of health, § 5, § 17 Lebensmittel- und Futtermittelgesetzbuch (LFGB – Food and Feed Act), and of the prohibition of deception, § 11, § 19 LFBG). In this respect, a general authorization to place foodstuffs on the market coupled with a corresponding power of prohibition reserved for the authorities has been put in place. This principle gives way to the so called prohibition principle (Verbotsprinzip) whenever specific needs of the preventive protection of health require this. The prohibition principle therefore provides for a general prohibition with reserved powers of authorization, forbidding everything which has not been explicitly permitted in the course of an authorization procedure. The regulatory concept of the GMFF Regulation employs the prohibition principle. Art. 4 para. 2 of the GMFFR provides that no person shall place on the market genetically modified food [13] unless it is covered by a prior authorization. The only exception to this rule, which remains applicable for three years from the date of application of the GMFF Regulation, i.e. until November 7th, 2006, is provided for by art. 47 of the GMFFR, which concerns the presence in food or feed of material
6 The Legal Situation for Genetically Engineered Food in Europe
which contains, consists of, or is produced from GMOs in a proportion no higher than 0.5%, provided that this presence is adventitious or technically unavoidable, the genetically modified material has benefited from a favorable opinion from the Community Scientific Committee(s) or the EFSA before the date of application of the GMFF Regulation, the application for its authorization has not been rejected in accordance with the relevant Community legislation, and detection methods are publicly available (art. 47 para. 1 GMFFR). Whereas genetically modified food covered by the Novel Food Regulation would have been subject to two different types of procedure, the GMFF Regulation provides for a single procedure (“one door – one key”) leading to the authorization to place a GMO or genetically modified food on the market, as required by art. 4 para. 2 of the GMFFR. This authorization, the legal fate of which exclusively depends on the provisions of the GMFF Regulation, may cover: • a GMO and foods containing or consisting of that GMO and foods produced from or containing ingredients produced from that GMO (art. 4 para. 4 lit. a GMFFR); or • food produced from a GMO and foods produced from or containing that food (art. 4 para. 4 lit. b GMFFR); or • an ingredient produced from a GMO and food containing that ingredient (art. 4 para. 4 lit. c GMFFR) The authorization may only be granted if the applicant has adequately and sufficiently demonstrated that the requirements of art. 4 para. 1 of the GMFFR are satisfied. The notification procedure which the Novel Food Regulation provided for and which allowed for the placing on the market of foods or food ingredients substantially equivalent to existing food or food ingredients without prior authorization has been abolished. The authorization procedure The application must come from an applicant established in the Community (art. 4 para. 6 GMFFR). According to art. 5 para. 2 of the GMFFR, the application for authorization shall be sent to the national competent authority of a Member State which acknowledges its receipt in writing to the applicant within 14 days, stating the date of the receipt of the application (art. 5 para. 2 lit. a (i) GMFFR), informs the European Food Safety Authority (EFSA), and makes available the application and any supplementary information supplied by the applicant to the EFSA (art. 5 para. 2 lit. a (ii) and (iii) GMFFR). The EFSA then informs, without delay, the other Member States and the Commission of the application and makes the application and any supplementary information supplied by the applicant available to them. The EFSA also makes the summary of the dossier, which is a necessary part of the application, available to the public (art. 5 para. 2 lit. b GMFFR). The mandatory content of the application is regulated by art. 5 paras 3–7 of the GMFFR and art. 1–7 Commission Regulation (EC) No 641/2004 [14]. The content of the application is designed to enable the EFSA to perform a scientific risk assessment covering both the environmental risk and risks to human and
139
140
6.2 The Law Applicable to Genetically Modified Food
animal health. The application must therefore be accompanied by information on the specification, including the transformation event(s) used (para. 3 lit. a), a copy of any available material demonstrating the food complies with the criteria referred to in art. 4 para. 1 (para. 3 lit. e), information on methods for detection, sampling, and identification of the transformation event (para. 3 lit. i), samples of food and their control samples, and information about the place where the reference material can be accessed (para. 3 lit. j), and, where appropriate, a detailed description of the methods of production and manufacture (para. 3 lit. d), information on the conditions for placing the food or foods produced from it on the market, including specific conditions for use and handling (para. 3 lit. h), and a proposal for postmarket monitoring with regard to use of the food for human consumption (para. 3 lit. k). In addition, a proposal for labeling the food in accordance with art. 13 paras. 2 and 3 of the GMFFR is required, or a reasoned statement why such labelling is unnecessary (para. 3 lit. f, g). Finally, the application must be accompanied by the information to be provided under the Cartagena Protocol [15], where applicable (para. 3 lit. c), and a summary of the dossier in a standardized form (para. 3 lit. l). In the case of an application concerning GMOs or food containing or consisting of GMOs the applicant must also provide a complete technical dossier supplying the information required by Annexes III and IV to the Deliberate Release Directive 2001 and information and conclusions about the environmental risk assessment conducted in accordance with the principles set out in Annex II to the Deliberate Release Directive 2001 or, where the placing on the market of the GMO has been authorized under part C of the Deliberate Release Directive 2001, a copy of the authorization decision, and a monitoring plan for environmental effects conforming with Annex VII to the Deliberate Release Directive 2001, including a proposal for the duration of the monitoring plan which may be different from the proposed period for the consent (art. 5 para. 5 GMFFR). In giving its opinion, the EFSA will normally respect a time limit of six months unless it has to request further information from the applicant, either of its own motion or prompted by a national competent authority (art. 6 paras 1 and 2 GMFFR). The opinion shall be based on: • verification that the particulars and documents submitted by the applicant are in accordance with Article 5 and an examination whether the food complies with the criteria referred to in Article 4 para. 1 (art. 6 para. 3 lit. a GMFFR); • any safety assessment of the food in accordance with the Basic Regulation or environmental risk assessment in accordance with art. 4 Deliberate Release Directive 2001, as performed by an appropriate national body on the request of the EFSA (art. 6 para. 3 lit. b, c GMFFR); • the Community reference laboratory’s test and validation of the method of detection and identification proposed by the applicant (art. 6 para. 3 lit. d GMFFR); • an examination of the applicant’s claim that the characteristics of the food are not different from those of its conventional counterpart (Art. 6 para. 3 lit. e GMFFR); and • in the event of requests to place products containing or consisting of GMO on the market, any opinion of a national competent authority which has replied within
6 The Legal Situation for Genetically Engineered Food in Europe
three months to the EFSA’s consultation on the application to the request of the environmental safety requirements referred to in the Deliberate Release Directive 2001 (Art. 6 para. 4 GMFFR). It is forwarded to the Commission, the Member States and the applicant, including a report describing the EFSA’s assessment of the food and stating the reasons for the opinion and the information on which the opinion is based, including the opinions of the competent authorities when consulted in accordance with paragraph 4 (art. 6 para. 6 GMFFR). A version of the opinion which is purged of any confidential information is also made public and may be commented on by the public within 30 days of publication (art. 6 para. 7 GMFFR). The opinion of the EFSA is taken into account by the Commission in producing a draft of the final decision refusing or granting authorization, which must be submitted for approval, within three months of receiving the EFSA’s opinion, to the Standing Committee on the Food Chain and Animal Health, which is a regulatory committee under art. 5 Comitology Decision and is composed of national experts. The Commission may diverge from the EFSA’s opinion, but it must then justify its position. If the Standing Committee approves of the draft decision, the Commission adopts it as the final decision. Otherwise, the Commission submits to the Council a proposal relating to the decision to be taken. Only if the Council rejects that proposal by qualified majority within three months, the Commission must re-examine its draft decision. Otherwise it is either adopted by the Council (if it approves of the draft) or by the Commission (if the Council fails to take a decision by qualified majority). This clearly shows that the Commission’s decision is a political decision, which the decision-making procedure is designed to carry through, even in the face of opposition from a (simple) majority of Member States [15*]. Although the Commission is free to propose the authorization of genetically modified food which the EFSA has assessed to be dangerous, the very fact that the EFSA publishes its report will make this very difficult. On the other hand, any proposal to refuse the authorization of food that has been assessed not to be dangerous would meet with criticism based on the right to freely choose and exercise a profession. The Commission without delay informs the applicant of the decision taken and publishes the details of the decision in the Official Journal of the EU (art. 7 para. 4 GMFFR). If the authorization is granted it is valid throughout the Community for ten years and renewable for further ten year periods (art. 11 GMFFR). It is without any bearing on the civil or criminal liability of any food operator in respect of the food concerned (art. 7 para. 7 GMFFR).
6.2.1.5 Labeling Conditions In addition to the standard requirements of Community law concerning the labeling of foodstuffs, art. 12 to art. 14 of the GMFFR and art. 4 para. 6 of the GMFFTraceLabelR provide for additional specific labeling requirements. These serve to enable the consumer to make an informed choice in relation to foodstuffs the production of which at some stage involved the use of techniques of genetic modification.
141
142
6.2 The Law Applicable to Genetically Modified Food
These specific labeling requirements apply to foods which are to be delivered as such to the final consumer or mass caterers (for example restaurants, canteens, hospitals) in the Community and which contain or consist of GMOs or are produced from or contain ingredients produced from GMOs (art. 12 para. 1 GMFFR). This means that genetically modified foods must be labeled, irrespective of whether or not DNA or proteins derived from genetic modification are contained in the final product. In contrast, products manufactured with the help of a genetically modified processing aid (for example genetically modified yeast, used in the production of wine) or obtained from animals fed with genetically modified feed or treated with genetically modified medicinal products (for example meat, milk or eggs) are not subject to the labeling requirements (cf. recital 16 GMFFR). The co-existence of transgenic crops and traditional or organic crops and the process of harvesting, storage, transport or processing make it practically impossible to achieve products that are 100% pure, that is absolutely not contaminated by GMOs. Art. 12 para. 2 of the GMFFR therefore excludes from the labeling requirements foods containing material which contains, consists of, or is produced from GMOs in a proportion no higher than 0.9 % of the food ingredients considered individually or food consisting of a single ingredient, if this presence is adventitious or technically unavoidable. To establish that the presence of this material is adventitious or technically unavoidable, operators must be in a position to supply evidence to satisfy the competent authorities that they have taken appropriate steps to avoid the presence of such material. Whether contamination occurring because of insufficient cleaning of transport facilities will be accepted as adventitious or technically unavoidable will probably require a decision by the European courts. This threshold only applies to GMOs which can be deemed to be safe because they have been authorized to be put on the market. If a GMO has not yet been authorized but has benefited from a favorable risk evaluation its adventitious or technically unavoidable presence up to a threshold of 0.5% is not illegal (art. 47 GMFFR); in that case it will not need to be mentioned on the label. Other GMOs are not tolerated in food or feed. Investigations by the competent authorities of the German Länder have shown that the labeling requirements are usually complied with; at the same time they found GMOs in a quantity below the threshold values in <10% to >90% of products analyzed [16]. The elements of the label Where an appropriate label is required, it must show the following elements: • for pre-packaged food, the words “This product contains genetically modified organisms” or “This product contains genetically modified [name of organism(s)]” (art. 4 para. 6 lit. a GMFFTraceLabelR); • in the list of ingredients as required by art. 6 Directive 2000/13/EC, the words “genetically modified” or “produced from genetically modified (name of the ingredient)” must appear in parentheses immediately after the ingredient con-
6 The Legal Situation for Genetically Engineered Food in Europe
•
•
•
•
•
•
cerned or in a footnote to the list in a font of at least the same size as the list (art. 13 para. 1 lit. a, d GMFFR); where the ingredient is designated by the name of a category, the words “contains genetically modified (name of organism)” or “contains (name of ingredient) produced from genetically modified (name of organism)” must appear in the list of ingredients or in a footnote to the list in a font of at least the same size as the list (art. 13 para. 1 lit. b, d GMFFR); where there is no list of ingredients, the words “genetically modified” or “produced from genetically modified (name of organism)” must appear clearly on the labeling (art. 13 para. 1 lit. c GMFFR); where the food is offered for sale to the final consumer as non-pre-packaged food, or as pre-packaged food in small containers of which the largest surface has an area of less than 10 cm2, the information required must be permanently and visibly displayed either on the food display or immediately next to it, or on the packaging material, in a font sufficiently large for it to be easily identified and read (art. 13 para. 1 lit. e GMFFR); a list of any characteristics or properties, as specified in the authorization, where a food is different from its conventional counterpart as regards composition, nutritional value or nutritional effects, intended use of the food, or implications for the health of certain sections of the population (art. 13 para. 2 lit. a GMFFR); a list of any characteristics or properties, as specified in the authorization, where a food may give rise to ethical or religious concerns (art. 13 para. 2 lit. b GMFFR); and as specified in the authorization, the labeling of foods which do not have a conventional counterpart shall also contain appropriate information about the nature and the characteristics of the foods concerned (art. 13 para. 3 GMFFR) [17].
Traceability and the unique identifier The shift in the basis of the labeling requirements away from the presence of DNA or modified protein in the product to the use of GMOs in the production of the product, to include foods produced from or containing ingredients produced from GMOs, makes it necessary to transmit and hold information that the food and feed consist of, contain or have been produced from GMOs. The rules to ensure this are contained in the GMFFTraceLabel Regulation. This regulation applies to products, including food and feed, consisting of, or containing, GMOs, placed on the market in accordance with Community legislation (art. 2 para. 1 lit. a GMFFTraceLabelR) and food and feed produced from GMOs, placed on the market in accordance with Community legislation (art. 2 para. 1 lit. b, c GMFFTraceLabelR). It requires operators who place a product consisting of or containing GMOs on the market for the first time to transmit in writing to the operator receiving the product the information that the product contains or consists of GMOs and the unique identifier of those GMOs (art. 4 para. 1 GMFFTraceLabelR). This information must be similarly transmitted to the operators receiving the product at all subsequent stages of placing the product on the market (art. 4
143
144
6.2 The Law Applicable to Genetically Modified Food
para. 2 GMFFTraceLabelR). An analogous requirement exists for food or feed produced from GMOs. When these are put on the market, the following information must be transmitted in writing to the operator receiving the product: • an indication of each of the food ingredients or of each of the feed materials or additives which is produced from GMOs (art. 5 para. 1 lit. a, b GMFFTraceLabelR) or, for products for which no list of ingredients exists, • an indication that the product is produced from GMOs (art. 5 para. 1 lit. c GMFFTraceLabelR). These requirements nevertheless do not apply to products falling under the de minimis rules contained in art. 12, 24 or 47 of the GMFFR (art. 4 para. 8, art. 5 para. 4 GMFFTraceLabelR). All operators involved must hold the information transmitted and information about by whom and to whom the product was sold for a period of five years from each transaction (art. 4 para. 4, art. 5 para. 2 GMFFTraceLabelR). The unique identifier referred to in art. 4 para. 1 of the GMFFTraceLabelR is made up of nine characters combined in a uniform way, using a format approved within the framework of the OECD. All unique identifiers are listed in the OECD’s Bio Track database. Commission Regulation (EC) No 65/2004 [18] contains detailed rules on the development and assignment of the unique identifier.
6.2.1.6 Other Questions New insights Whereas previously art. 12 of the NFR offered Member States the opportunity to restrict or suspend the trade in and use of genetically modified food when new insights justified considering that use of the product endangers human health or the environment, the new rules posit the Commission at the center of any such measure. Having obtained new insights, Member States must normally request the EFSA to give an opinion on whether a product still meets the conditions for its authorization (art. 10 para. 1 GMFFR). This opinion is the basis of the following administrative process which is essentially similar to the original authorization procedure. In the course of this process the Commission examines the opinion as soon as possible and takes appropriate measures in accordance with art. 34 of the GMFFR, which may include modification, suspension, or revocation of the (initial) authorization. If, however, it is evident that products authorized by or in accordance with this Regulation are likely to constitute a serious risk to human health, animal health, or the environment, art. 34 of the GMFFR refers to the procedures provided for in art. 53 and 54 of the Basic Regulation. According to art. 54 paras 1 and 3 of the Basic Regulation Member States may adopt interim measures until the Commission has put in place community-wide measures to deal with the problem. Sanctions Art. 45 of the GMFFR provides for a duty of the Member States to penalize breaches of its provisions by enacting rules which provide for effective, proportionate, and dissuasive penalties and to implement these rules effectively. Under German law this is achieved by § 6 and § 7 of the Act to implement regula-
6 The Legal Situation for Genetically Engineered Food in Europe
tions of the European Communities in the field of biotechnology (henceforth the ECBI Act) [19]. 6.2.2 Problems 6.2.2.1 Negative Labeling Recital 10 of the Novel Food Regulation expressly states that nothing shall prevent a supplier from informing the consumer on the labeling of a food or food ingredient that the product in question is not a novel food within the meaning of the Novel Food Regulation or that the techniques indicated in art. 1 para. 2 of the NFR were not used in the production of that food or food ingredient. This so called “negative labeling” (here the term “negative” does not imply any negative evaluation, but only refers to a lack of novelty of a foodstuff or of a novel food ingredient or the fact that the techniques indicated in art. 1 para. 2 of the NFR have not been used) is not mentioned again in the Novel Food Regulation. The GMFF Regulation does not mention the concept of negative labeling in relation to GM food or GM feed. Nevertheless the position on the legality of such negative labeling has not changed. With a view to European law it must be observed that the law of Member States regulating such labeling – in accordance with the general principles – must not breach primary community law, especially art. 28 TEC, that is the provisions of national law must not restrict the free movement of goods from other Member States in a discriminatory or disproportionate way. Although it was unclear for some time which precise requirements such labeling was subject to, these have been clarified in German law by the Novel Foods and Food Ingredients Instrument (NFI) [20] (cf. infra, Section 6.2.5.2).
6.2.2.2 Coexistence of Genetically Modified Food and Feed and Conventional or Organic Food and Feed Art. 43 of the GMFFR introduced into the Deliberate Release Directive 2001 a new art. 26a, which provides that Member States may take appropriate measures to avoid the unintended presence of GMOs in other products (para. 1) and requires the Commission to gather and coordinate information based on studies at Community and national level, observe developments regarding coexistence in the Member States, and, on the basis of the information and observations, develop guidelines on the coexistence of genetically modified, conventional, and organic crops (para. 2). It is therefore the task of the Member States to take measures to ensure co-existence. In Germany, art. 16a Biotechnology Act implements art. 26a Deliberate Release Directive 2001 (cf. infra Section 6.2.5.1 for details). Unintentional movements of GMOs between Member States and exports of GMOs to third countries are governed by Regulation (EC) No. 1946/2003 of the European Parliament and the Council of 15 July 2003 on transboundary movements of genetically modified organisms [21]. According to art. 14 of this Regulation (which is directly applicable in all Member States according to art. 249 para. 2
145
146
6.2 The Law Applicable to Genetically Modified Food
TEC) Member States shall take “appropriate measures” to prevent unintentional transboundary movements of GMOs. The scope of this Regulation is therefore limited to this case and does not deal with the problem of co-existence within the Member States. Some Member States have tried to ensure co-existence by declaring GM-free zones. An attempt by the Land Upper Austria to pass an Act declaring itself a GMfree zone was blocked by the Commission which prohibited it on the basis of art. 95 para. 5 TEC. This decision was upheld by the European Court of First Instance (ECFI) in its judgment of 5. October 2005 [22]. The ECFI found that both the Land and the Republic of Austria had not put forward evidence either to demonstrate that the structure of agricultural production was specific to Upper Austria and or to rebut the assessment of the EFSA that no proof had been presented establishing that that the territory of the Land Upper Austria contained unusual or unique ecosystems that required separate risk assessments [23]. The importance of the decision is not entirely clear, because it did not deal with the relevance of art. 26a Deliberate Release Directive 2001, which was only introduced after the facts of the case had occurred. But it has been suggested that it seems doubtful that art. 26a of the Deliberate Release Directive 2001 provides the final solution given its lack of substantive contours and that the (nonbinding) Commission Recommendation No. 2003/556/EC on Co-existence (Co-exRec) [24] will probably turn out to be the starting point for further European legislation [25]. The Commission’s Recommendation, nevertheless, is quite problematic. Although the Commission mentions the interests of European consumers in a real choice between GM food and non-GM food (1.1 para. 2 Co-exRec), its recommendation points out that only authorized GMOs can be cultivated in the EU and that the environmental and health aspects are already covered by the Deliberate Release Directive 2001, to claim that the pending issues still to be addressed in the context of co-existence concern solely economic aspects of the admixture of GM and nonGM crops (1.2 para. 4 Co-exRec). These economic aspects are, on the one hand, loss of income resulting from the duty to label crops as containing GMOs because of admixture of GMOs above the tolerance threshold and, on the other hand, the interest of the incoming producer – that is normally the producer interested in producing GM-crops – to avoid any unnecessary burden. The Commission’s solution of this problem is to entitle producers of conventional or organic foodstuff to claim these descriptions despite contamination with GMOs and defining as proportionate requirements relating to co-existence those which make sure that the traces of GMOs – still regarded as adventitious, notwithstanding the claimed inevitability of impurities! – stay below the tolerance threshold (2.1.4 para. 1 Co-exRec). As a result the Commission ensures the interests of those consumers who want to obtain GMfood, but disregards any interest to choose between truly conventional or, in particular, truly organic and GM products with the objective of obtaining the former.
6 The Legal Situation for Genetically Engineered Food in Europe
6.2.2.3 Compliance with World Trade Law The Agreement Establishing the World Trade Organization (WTO) of 15.4.1994 [26] has substantial influence on food law via the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement) and the Agreement on Technical Barriers to Trade (TBT Agreement) which were concluded within its framework and via their combination with the rules of the Codex Alim